
<html lang="en"     class="pb-page"  data-request-id="c209ab6e-72bf-4570-bded-15efce025b5d"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";issue:issue:10.1021/jmcmar.2020.63.issue-24;article:article:10.1021/acs.jmedchem.0c01573;requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Rational Design of 2-Chloroadenine Derivatives as Highly Selective Phosphodiesterase 8A Inhibitors" /></meta><meta name="dc.Creator" content="Yadan  Huang" /></meta><meta name="dc.Creator" content="Xu-Nian  Wu" /></meta><meta name="dc.Creator" content="Qian  Zhou" /></meta><meta name="dc.Creator" content="Yinuo  Wu" /></meta><meta name="dc.Creator" content="Dongxiao  Zheng" /></meta><meta name="dc.Creator" content="Zhe  Li" /></meta><meta name="dc.Creator" content="Lei  Guo" /></meta><meta name="dc.Creator" content="Hai-Bin  Luo" /></meta><meta name="dc.Description" content="To validate the hypothesis that Tyr748 is a crucial residue to aid the discovery of highly selective phosphodiesterase 8A (PDE8A) inhibitors, we identified a series of 2-chloroadenine derivatives b..." /></meta><meta name="Description" content="To validate the hypothesis that Tyr748 is a crucial residue to aid the discovery of highly selective phosphodiesterase 8A (PDE8A) inhibitors, we identified a series of 2-chloroadenine derivatives b..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="December 8, 2020" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.0c01573" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2020 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.0c01573" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.0c01573" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.0c01573" /></link>
        
    
    

<title>Rational Design of 2-Chloroadenine Derivatives as Highly Selective Phosphodiesterase 8A Inhibitors | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.0c01573" /></meta><meta property="og:title" content="Rational Design of 2-Chloroadenine Derivatives as Highly Selective Phosphodiesterase 8A Inhibitors" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01573/20201218/images/large/jm0c01573_0012.jpeg" /></meta><meta property="og:description" content="To validate the hypothesis that Tyr748 is a crucial residue to aid the discovery of highly selective phosphodiesterase 8A (PDE8A) inhibitors, we identified a series of 2-chloroadenine derivatives based on the hit clofarabine. Structure-based design targeting Tyr748 in PDE8 resulted in the lead compound 3a (IC50 = 0.010 μM) with high selectivity with a reasonable druglike profile. In the X-ray crystal structure, 3a bound to PDE8A with a different mode from 3-isobutyl-1-methylxanthine (a pan-PDE inhibitor) and gave a H-bond of 2.7 Å with Tyr748, which possibly interprets the 220-fold selectivity of 3a against PDE2A. Additionally, oral administration of compound 3a achieved remarkable therapeutic effects against vascular dementia (VaD), indicating that PDE8 inhibitors could serve as potential anti-VaD agents." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.0c01573"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c01573">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.0c01573&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.0c01573&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.0c01573&amp;href=/doi/10.1021/acs.jmedchem.0c01573" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2020</span><span class="cit-fg-volume">, 63</span><span class="cit-fg-issue">, 24</span><span class="cit-fg-pageRange">, 15852-15863</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/63/24" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.0c01561" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.0c01588" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Rational Design of 2-Chloroadenine Derivatives as Highly Selective Phosphodiesterase 8A Inhibitors</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Yadan Huang</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Yadan Huang</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">School of Pharmaceutical Sciences, Sun Yat-Sen University, Guangzhou 510006, P. R. China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Yadan++Huang">Yadan Huang</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Xu-Nian Wu</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Xu-Nian Wu</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">School of Pharmaceutical Sciences, Sun Yat-Sen University, Guangzhou 510006, P. R. China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Xu-Nian++Wu">Xu-Nian Wu</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Qian Zhou</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Qian Zhou</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">School of Pharmaceutical Sciences, Sun Yat-Sen University, Guangzhou 510006, P. R. China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Qian++Zhou">Qian Zhou</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Yinuo Wu</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Yinuo Wu</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">School of Pharmaceutical Sciences, Sun Yat-Sen University, Guangzhou 510006, P. R. China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Yinuo++Wu">Yinuo Wu</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Dongxiao Zheng</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Dongxiao Zheng</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Key Laboratory of Tropical Biological Resources of Ministry of Education, School of Life and Pharmaceutical Sciences, Hainan University, Haikou 570228, Hainan, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Dongxiao++Zheng">Dongxiao Zheng</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Zhe Li</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Zhe Li</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">School of Pharmaceutical Sciences, Sun Yat-Sen University, Guangzhou 510006, P. R. China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Zhe++Li">Zhe Li</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Lei Guo</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Lei Guo</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">School of Pharmaceutical Sciences, Sun Yat-Sen University, Guangzhou 510006, P. R. China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Lei++Guo">Lei Guo</a></span></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Hai-Bin Luo</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Hai-Bin Luo</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">School of Pharmaceutical Sciences, Sun Yat-Sen University, Guangzhou 510006, P. R. China</div><div class="loa-info-affiliations-info">Key Laboratory of Tropical Biological Resources of Ministry of Education, School of Life and Pharmaceutical Sciences, Hainan University, Haikou 570228, Hainan, China</div></div><span class="conrtib-corresp"><strong>*</strong>Email: <a href="/cdn-cgi/l/email-protection#b4d8c1dbdcd68383f4d9d5ddd89ac7cdc7c19ad1d0c19ad7da"><span class="__cf_email__" data-cfemail="e38f968c8b81d4d4a38e828a8fcd909a9096cd868796cd808d">[email protected]</span></a>. Fax: +86-20-39943000.</span><span class="conrtib-corresp"></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Hai-Bin++Luo">Hai-Bin Luo</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-2163-0509" title="Orcid link">http://orcid.org/0000-0002-2163-0509</a></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.0c01573&amp;href=/doi/10.1021%2Facs.jmedchem.0c01573" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2020</span></span><span class="cit-volume">, 63</span><span class="cit-issue">, 24</span><span class="cit-pageRange">, 15852–15863</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">December 8, 2020</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>8 September 2020</li><li><span class="item_label"><b>Published</b> online</span>8 December 2020</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 24 December 2020</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.0c01573" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01573</a></div><div class="article_header-article-copyright"><strong>Copyright © 2020 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D15852%26pageCount%3D12%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DYadan%2BHuang%252C%2BXu-Nian%2BWu%252C%2BQian%2BZhou%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D63%26issueNum%3D24%26contentID%3Dacs.jmedchem.0c01573%26title%3DRational%2BDesign%2Bof%2B2-Chloroadenine%2BDerivatives%2Bas%2BHighly%2BSelective%2BPhosphodiesterase%2B8A%2BInhibitors%26numPages%3D12%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D15863%26publicationDate%3DDecember%2B2020">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.0c01573"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">851</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">1</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.0c01573" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Rational Design of 2-Chloroadenine Derivatives as Highly Selective Phosphodiesterase 8A Inhibitors&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Yadan&quot;,&quot;last_name&quot;:&quot;Huang&quot;},{&quot;first_name&quot;:&quot;Xu-Nian&quot;,&quot;last_name&quot;:&quot;Wu&quot;},{&quot;first_name&quot;:&quot;Qian&quot;,&quot;last_name&quot;:&quot;Zhou&quot;},{&quot;first_name&quot;:&quot;Yinuo&quot;,&quot;last_name&quot;:&quot;Wu&quot;},{&quot;first_name&quot;:&quot;Dongxiao&quot;,&quot;last_name&quot;:&quot;Zheng&quot;},{&quot;first_name&quot;:&quot;Zhe&quot;,&quot;last_name&quot;:&quot;Li&quot;},{&quot;first_name&quot;:&quot;Lei&quot;,&quot;last_name&quot;:&quot;Guo&quot;},{&quot;first_name&quot;:&quot;Hai-Bin&quot;,&quot;last_name&quot;:&quot;Luo&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2020&quot;,&quot;month&quot;:&quot;12&quot;,&quot;day&quot;:&quot;08&quot;,&quot;issue&quot;:&quot;24&quot;,&quot;volume&quot;:&quot;63&quot;,&quot;pages&quot;:&quot;15852-15863&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.0c01573&quot;},&quot;abstract&quot;:&quot;To validate the hypothesis that Tyr748 is a crucial residue to aid the discovery of highly selective phosphodiesterase 8A (PDE8A) inhibitors, we identified a series of 2-chloroadenine derivatives based on the hit clofarabine. Structure-based design targeting Tyr748 in PDE8 resulted in the lead compound 3a (IC50 = 0.010 μM) with high selectivity with a reasonable druglike profile. In the X-ray crystal structure, 3a bound to PDE8A with a different mode from 3-isobutyl-1-methylxanthine (a pan-PDE inhibitor) and gave a H-bond of 2.7 Å with Tyr748, which possibly interprets the 220-fold selectivity of 3a against PDE2A. Additionally, oral administration of compound 3a achieved remarkable therapeutic effects against vascular dementia (VaD), indicating that PDE8 inhibitors could serve as potential anti-VaD agents.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c01573&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c01573" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c01573&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c01573" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c01573&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c01573" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.0c01573&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c01573&amp;href=/doi/10.1021/acs.jmedchem.0c01573" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.0c01573" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.0c01573" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (6 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01573&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.0c01573%26sid%3Dliteratum%253Aachs%26pmid%3D33291877%26genre%3Darticle%26aulast%3DHuang%26date%3D2020%26atitle%3DRational%2BDesign%2Bof%2B2-Chloroadenine%2BDerivatives%2Bas%2BHighly%2BSelective%2BPhosphodiesterase%2B8A%2BInhibitors%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D63%26issue%3D24%26spage%3D15852%26epage%3D15863%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291316" title="Mixtures">Mixtures</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a>,</li><li><a href="/action/doSearch?ConceptID=291711" title="Selectivity">Selectivity</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/63/24" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/jmcmar.2020.63.issue-24/20201224/jmcmar.2020.63.issue-24.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01573/20201218/images/medium/jm0c01573_0012.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01573/20201218/images/large/jm0c01573_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01573&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">To validate the hypothesis that Tyr748 is a crucial residue to aid the discovery of highly selective phosphodiesterase 8A (PDE8A) inhibitors, we identified a series of 2-chloroadenine derivatives based on the hit clofarabine. Structure-based design targeting Tyr748 in PDE8 resulted in the lead compound <b>3a</b> (IC<sub>50</sub> = 0.010 μM) with high selectivity with a reasonable druglike profile. In the X-ray crystal structure, <b>3a</b> bound to PDE8A with a different mode from 3-isobutyl-1-methylxanthine (a pan-PDE inhibitor) and gave a H-bond of 2.7 Å with Tyr748, which possibly interprets the 220-fold selectivity of <b>3a</b> against PDE2A. Additionally, oral administration of compound <b>3a</b> achieved remarkable therapeutic effects against vascular dementia (VaD), indicating that PDE8 inhibitors could serve as potential anti-VaD agents.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_32742" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_32742" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Both adenosine and guanosine 3′,5′-cyclic monophosphate (cAMP and cGMP) serve as the momentous second messengers in intracellular signal transduction, and their signaling systems are involved in the regulation of a series of physiological processes, including learning and memory, cell differentiation and proliferation, immune/inflammatory responses, airway smooth muscle relaxation, visual signal transduction, and metabolic functions.<a onclick="showRef(event, 'ref1 ref2 ref3'); return false;" href="javascript:void(0);" class="ref ref1 ref2 ref3">(1−3)</a> As the only enzymes to degrade cAMP and cGMP, phosphodiesterases (PDEs) are important drug targets for a variety of diseases,<a onclick="showRef(event, 'ref4 ref5 ref6 ref7'); return false;" href="javascript:void(0);" class="ref ref4 ref5 ref6 ref7">(4−7)</a> and over 20 marketed inhibitors<a onclick="showRef(event, 'ref1 ref2 ref3 ref4 ref5 ref6 ref7 ref8'); return false;" href="javascript:void(0);" class="ref ref1 ref2 ref3 ref4 ref5 ref6 ref7 ref8">(1−8)</a> have been approved including selective PDE4/5 inhibitors, such as apremilast, sildenafil, and tadalafil, and nonspecific PDE inhibitors, such as theophylline, pentoxifylline, and dipyridamole. These selective PDE4/5 inhibitors are used in clinics against psoriasis, erectile functions, and pulmonary hypertension.<a onclick="showRef(event, 'ref4 ref5 ref8'); return false;" href="javascript:void(0);" class="ref ref4 ref5 ref8">(4,5,8)</a></div><div class="NLM_p">Among the three cAMP-specific PDE isoforms (PDE4, 7, and 8),<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> PDE4 is arguably the most studied of all PDE families, and several studies suggested that PDE4 inhibition could be used to treat cognitive dysfunctions<a onclick="showRef(event, 'ref9 ref10 ref11 ref12'); return false;" href="javascript:void(0);" class="ref ref9 ref10 ref11 ref12">(9−12)</a> and memory impairment.<a onclick="showRef(event, 'ref13 ref14'); return false;" href="javascript:void(0);" class="ref ref13 ref14">(13,14)</a> Additionally, our recent studies demonstrated that PDE4 inhibitors could be used to prevent vascular dementia (VaD).<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> Many studies suggest that increasing cAMP signaling in a brain region-specific manner may prove a viable mechanism for treating age-related decline in brain functions.<a onclick="showRef(event, 'ref16 ref17 ref18 ref19'); return false;" href="javascript:void(0);" class="ref ref16 ref17 ref18 ref19">(16−19)</a> However, most PDE4 inhibitors show severe side effects, such as vomiting, diarrhea, and weight loss.<a onclick="showRef(event, 'ref9 ref10 ref11 ref12'); return false;" href="javascript:void(0);" class="ref ref9 ref10 ref11 ref12">(9−12)</a> Relative to PDE4 (<i>K</i><sub>m</sub> of 1–10 μM for cAMP),<a onclick="showRef(event, 'ref4 ref20'); return false;" href="javascript:void(0);" class="ref ref4 ref20">(4,20)</a> PDE8 has a stronger affinity for cAMP (<i>K</i><sub>m</sub> of 40–150 nM for cAMP).<a onclick="showRef(event, 'ref21 ref22 ref23'); return false;" href="javascript:void(0);" class="ref ref21 ref22 ref23">(21−23)</a> Therefore, we speculate that PDE8 is similar to PDE4 as a drug target for nervous system diseases and its inhibitors have potential therapeutic effects on cognitive dysfunctions such as VaD,<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> which is a very common subtype of dementias.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a></div><div class="NLM_p">However, few studies have attempted to identify selective phosphodiesterase 8A (PDE8A) inhibitors, which could be used as chemical probes to explore the biological functions of PDE8.<a onclick="showRef(event, 'ref25 ref26 ref27'); return false;" href="javascript:void(0);" class="ref ref25 ref26 ref27">(25−27)</a> PDE8 and PDE9 have the lowest <i>K</i><sub>m</sub> values among cAMP-specific and cGMP-specific PDE families, respectively,<a onclick="showRef(event, 'ref4 ref23 ref28'); return false;" href="javascript:void(0);" class="ref ref4 ref23 ref28">(4,23,28)</a> and share the same/unique residue (Tyr748 in PDE8, Tyr424 in PDE9, <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>A) in the PDE superfamily. Our previous studies resulted in two highly selective PDE9 inhibitors (<b>28</b> and <b>3r</b>, <a href="/doi/suppl/10.1021/acs.jmedchem.0c01573/suppl_file/jm0c01573_si_002.pdf" class="ext-link">Figure S1</a>) with a common scaffold of pyrazolo[3,4-<i>d</i>]pyrimidinone by targeting the unique tyrosine residue Tyr424.<a onclick="showRef(event, 'ref29 ref30'); return false;" href="javascript:void(0);" class="ref ref29 ref30">(29,30)</a> Thus, we speculate that the unique residue Tyr748 is an important residue in PDE8A that can promote the discovery of highly selective PDE8A inhibitors.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01573/20201218/images/medium/jm0c01573_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01573/20201218/images/large/jm0c01573_0002.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structure-based optimizations of 2-chloroadenine derivatives as novel PDE8A inhibitors with improved potency and selectivity by targeting Tyr748. (A) Sequence alignment of the residues in the active site across PDE families. (B) Two rounds of structural optimizations based on clofarabine resulted in the highly potent PDE8A inhibitor <b>3a</b>. The PDB IDs are <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=7CWA">7CWA</a> and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=7CWF">7CWF</a> for the crystal structures of the PDE8A–clofarabine and PDE8A–<b>2c</b> complexes (see their binding patterns in high resolution in <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>), respectively.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01573/20201218/images/large/jm0c01573_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01573&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In our previous study, clofarabine exhibited an IC<sub>50</sub> of 3.1 μM toward PDE2A.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> Herein, we identified clofarabine with an IC<sub>50</sub> of 0.12 μM against PDE8A, which gave a poor selectivity of 26-fold against PDE2A. To validate the hypothesis that Tyr748 is a crucial residue to aid the discovery of highly selective PDE8A inhibitors, medicinal chemistry optimizations targeting Tyr748 (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figures <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a> and <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>) were performed based on the hit clofarabine. As a result, lead <b>3a</b> (IC<sub>50</sub> = 0.010 μM) gave high selectivity and a reasonable druglike profile. Notably, the X-ray crystal structure of the PDE8A–<b>3a</b> complex first showed the binding pattern between a selective inhibitor and PDE8A, which could aid in the discovery of novel PDE8A inhibitors. In addition, oral administration of <b>3a</b> could achieve spatial learning and memory improvement in the VaD mice model, indicating that PDE8 inhibitors could serve as potential agents against VaD.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01573/20201218/images/medium/jm0c01573_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01573/20201218/images/large/jm0c01573_0003.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Structure-based optimization of selective PDE8A inhibitors. (A) Cartoon presentation of clofarabine binding to the active pocket of PDE8A (green sticks, PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=7CWA">7CWA</a>). (B) Design of a scaffold that may potentially form a H-bond with Tyr748 and fit tightly to the PDE8A pocket. (C) Cartoon presentation of <b>2c</b> binding to the pocket of PDE8A (purple sticks, PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=7CWF">7CWF</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01573/20201218/images/large/jm0c01573_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01573&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_35804" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_35804" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Our previous research revealed that clofarabine showed moderate inhibition against PDE2 (IC<sub>50</sub> = 3.1 μM).<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> Herein, a screening of the FDA drug database was performed to identify potent PDE8A inhibitors, and clofarabine was identified as a hit with an IC<sub>50</sub> of 0.12 μM against PDE8A (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01573/suppl_file/jm0c01573_si_002.pdf" class="ext-link">Figure S2</a>).</div><div class="NLM_p">To understand the binding pattern between clofarabine and PDE8A, we obtained the crystal structure of the PDE8A–clofarabine complex. In <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>A, the 2-chloroadenine core of clofarabine served as the scaffold that is sandwiched in the hydrophobic clamp between Phe781 and Ile744/Tyr748, and it provides four H-bonds with Gln778 and Asn729. The ribose moiety of clofarabine stretches toward the metal binding pocket, and it forms a H-bond with Asp726. These interactions together contributed to the inhibitory potency. Additionally, clofarabine forms a relatively weak H-bond with Tyr748 (3.2 Å) that is unique to PDE8A, which may account for its relatively poor selectivity.</div><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> Rational Design of Highly Selective PDE8A Inhibitors Targeting Tyr748</h3><div class="NLM_p">The hit-to-lead optimizations were performed based on clofarabine in order to improve potent inhibition against PDE8A as well as improve selectivity over PDE2 and other PDEs. According to sequence alignment of the residues in the active site (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>A), PDE8A as well as PDE9A contains a tyrosine residue at position 748, while the others contain phenylalanine. Therefore, introducing a H-bond with PDE8A Tyr748 may provide a new avenue for selectivity over other PDEs. To validate this strategy, we designed a pyridin-2-yl methyl group to replace the ribose moiety to improve the H-bond interaction between the N atom of pyridine and the hydroxyl group of Tyr748 (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>B). Based on the molecular docking studies, the ortho position of pyridine is suitable to introduce substituents with a large space volume (R<sub>1</sub> groups, <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a> and <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>) to fit the solvent-filled side pocket, while the para position is suitable to introduce relatively small substituents (R<sub>2</sub> groups, <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a> and <a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>) to occupy a hydrophobic subpocket (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>B).</div><figure id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01573/20201218/images/medium/jm0c01573_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01573/20201218/images/large/jm0c01573_0007.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthetic Route for Compounds <b>1a–i</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01573/20201218/images/large/jm0c01573_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01573&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) boric ester or boric acid derivatives (<b>M1</b>), Pd(dppf)Cl<sub>2</sub>·CH<sub>2</sub>Cl<sub>2</sub>, K<sub>2</sub>CO<sub>3</sub>, 1,4-dioxane/H<sub>2</sub>O, 100 °C, overnight; (b) sodium 2,2-difluoroethanolate, 2,2-difluoroethanol, reflux, 16 h; (c) PBr<sub>3</sub>, DCM, 0 °C to r.t., 4 h; (d) 2-chloro-9<i>H</i>-purin-6-amine, Cs<sub>2</sub>CO<sub>3</sub>, DMF, 70 °C, overnight; (e) Pd/C, H<sub>2</sub>, MeOH/THF, r.t., overnight.</p></p></figure><figure id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01573/20201218/images/medium/jm0c01573_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01573/20201218/images/large/jm0c01573_0008.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthetic Route for Compounds <b>2a–c</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01573/20201218/images/large/jm0c01573_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01573&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) sodium methoxide or sodium 2,2-difluoroethanolate, MeOH or 2,2-difluoroethanol, reflux, 16 h; (b) PBr<sub>3</sub>, DCM, 0 °C to r.t., 4 h; (c) 2-chloro-9<i>H</i>-purin-6-amine, Cs<sub>2</sub>CO<sub>3</sub>, DMF, 70 °C, overnight.</p></p></figure><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Inhibitory Affinities (IC<sub>50</sub>) of Targeted Compounds against PDE8A</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01573/20201218/images/medium/jm0c01573_0010.gif" alt="" id="GRAPHIC-d7e573-autogenerated" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01573/20201218/images/medium/jm0c01573_0011.gif" alt="" id="gr9" /></img><div></div></div><div class="NLM_p">Therefore, we first designed and synthesized compounds <b>1a–i</b> and <b>2a–c</b>. Compound <b>1g</b> (R<sub>1</sub> was the cyclopentyl group) showed a 1.6-fold higher inhibitory activity than clofarabine (0.046 vs 0.12 μM). However, <b>1c–f</b>, <b>1h–i</b>, and <b>2a–c</b> only showed moderate inhibitory activities against PDE8A (IC<sub>50</sub>, 0.13–0.92 μM), and <b>1a–b</b> showed week inhibitory activities (IC<sub>50</sub> > 1 μM). Interestingly, the cocrystal structure of PDE8A with bound <b>2c</b> (IC<sub>50</sub> = 0.36 μM) was achieved. As shown in <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>C, <b>2c</b> with a difluoroethoxyl substitution at the para position of pyridine occupies the same pocket as clofarabine. The interaction between <b>2c</b> and Tyr748 is reinforced from 3.2 to 2.9 Å compared with the PDE8A–clofarabine complex.</div><div class="NLM_p">To improve the inhibitory potency of <b>2c</b>, a methyl group (R<sub>3</sub>) was introduced to restrict the rotational freedom of the pyridin-2-yl methyl group, generating <b>3</b>, <b>3a</b>, and <b>3b</b>. As a result, inhibitor <b>3a</b> with an IC<sub>50</sub> value of 0.010 μM was discovered (<a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a> and <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>).</div><figure id="sch3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01573/20201218/images/medium/jm0c01573_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01573/20201218/images/large/jm0c01573_0009.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthetic Route for Compounds <b>3</b>, <b>3a</b>, and <b>3b</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01573/20201218/images/large/jm0c01573_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01573&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) sodium 2,2-difluoroethanolate, 2,2-difluoroethanol, reflux, 16 h; (b) pinacol vinylboronate, Pd(dppf)Cl<sub>2</sub>·CH<sub>2</sub>Cl<sub>2</sub>, K<sub>2</sub>CO<sub>3</sub>, 1,4-dioxane/H<sub>2</sub>O, 100 °C, overnight; (c) Pd/C, H<sub>2</sub>, MeOH/THF, r.t., overnight; (d) NBS, AIBN, CCl<sub>4</sub>, reflux, 4 h; (e) 2-chloro-9<i>H</i>-purin-6-amine, Cs<sub>2</sub>CO<sub>3</sub>, DMF, 70 °C, overnight; (f) chiral separation, CHIRALFLASH IA column, DCM/THF 99:1, 12 mL/min.</p></p></figure><div class="NLM_p last">To remove the pan-assay interference compounds (PAINS), we performed a virtual screening of the designed 15 compounds by the online program “PAINS-Remover”,<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> and all the compounds passed the filter (<a href="http://www.cbligand.org/PAINS/" class="extLink">http://www.cbligand.org/PAINS/</a>).</div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9"> Chemistry</h3><div class="NLM_p">The synthetic routes for the 2-chloroadenine derivatives are depicted in <a class="ref internalNav" href="#sch1" aria-label="Schemes 1">Schemes 1</a>–<a class="ref internalNav" href="#sch3" aria-label="3">3</a>. For the preparation of the target compounds <b>1a–i</b> (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>), intermediates <b>M3a–e</b> were synthesized by Suzuki coupling<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> between boric ester <b>M1</b> and aryl bromide <b>M2</b> or substitution with sodium alcoholate. Then, the bromination of <b>M3a–e</b> with PBr<sub>3</sub> gave the key intermediates <b>M4c–g</b>. The commercial intermediates <b>M4a–b</b> and the key intermediates <b>M4c–g</b> reacted with 2-chloro-9<i>H</i>-purin-6-amine using Cs<sub>2</sub>CO<sub>3</sub> as the base, yielding compounds <b>1a–f</b> and <b>1i</b>. Compounds <b>1e</b> and <b>1f</b> were reduced by Pd–C/H<sub>2</sub> to produce <b>1g</b> and <b>1h</b>.</div><div class="NLM_p">The synthetic routes for the preparation of compounds <b>2a–c</b> are shown in <a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>, which is similar to <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a> for the synthesis of compounds <b>1a–i</b>. <b>M5</b> was substituted with sodium alcoholate, followed by bromination with PBr<sub>3</sub> to yield the key intermediates <b>M7a–c</b>. Then, <b>M7a–c</b> were treated with 2-chloro-9<i>H</i>-purin-6-amine in the presence of Cs<sub>2</sub>CO<sub>3</sub> to obtain compounds <b>2a–c</b>.</div><div class="NLM_p last">As shown in <a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>, the key intermediate <b>M12</b> was synthesized by substitution with sodium alcoholate, Suzuki coupling<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> with pinacol vinylboronate, reduction with Pd–C/H<sub>2</sub>, and Wohl–Ziegler bromination<a onclick="showRef(event, 'ref34 ref35'); return false;" href="javascript:void(0);" class="ref ref34 ref35">(34,35)</a> with <i>N</i>-bromosuccinimide (NBS). Then, reaction of <b>M12</b> with 2-chloro-9<i>H</i>-purin-6-amine in the presence of Cs<sub>2</sub>CO<sub>3</sub> led to compound <b>3</b>. Racemate <b>3</b> was separated to both the (<i>R</i>)-isomer and (<i>S</i>)-isomer using a CHIRALFLASH IA column.</div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> Structure–Activity Relationships</h3><div class="NLM_p">We determined the inhibitory potencies of the compounds against PDE8A in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>, and the IC<sub>50</sub> values with standard deviation (SD) data are listed in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>.</div><div class="NLM_p">For compounds <b>1a–i</b>, different R<sub>1</sub> groups were introduced at the ortho position of the pyridine ring. When R<sub>1</sub> was a hydrogen atom (<b>1a</b>) or methyl group (<b>1b</b>), the compound exhibited weak inhibitory activity with an IC<sub>50</sub> value greater than 1 μM, indicating that an R<sub>1</sub> group with a small volume may not be suitable. Compounds <b>1c–i</b>, with larger volumes of R<sub>1</sub> groups, exhibited significant enhancement of the inhibitory potency against PDE8A. Among the ortho position-substituted compounds (<b>1a–i</b>), cyclopentyl-substituted compound <b>1g</b> (IC<sub>50</sub> = 0.046 μM) exhibited better inhibitory activity than other compounds.</div><div class="NLM_p">For compounds <b>2a–c</b>, different R<sub>2</sub> groups were introduced at the para position of the pyridine ring. Compared to compound <b>1a</b> with no substituent on the R<sub>2</sub> position, the inhibitory activities of all these three compounds were improved. Compound <b>2a</b> (R<sub>1</sub> = Cl) showed moderate inhibitory activity against PDE8A (IC<sub>50</sub> = 0.41 μM). A methoxyl group and 2,2-difluoroethoxy group were introduced on the para position to form compounds <b>2b</b> and <b>2c</b>. The inhibitory activity order of the substituents from high to low is −OCH<sub>2</sub>CHF<sub>2</sub> > −OCH<sub>3</sub>, implying that a certain length of R<sub>2</sub> group is favorable for the binding. Compared with compound <b>1i</b> with −OCH<sub>2</sub>CHF<sub>2</sub> at the ortho position, compound <b>2c</b> exhibited about 1.6-fold higher inhibitory activity than <b>1i</b> (0.36 vs 0.92 μM), implying that the substitution of −OCH<sub>2</sub>CHF<sub>2</sub> at the para position of pyridine is more beneficial to the inhibitory activity than that at the ortho position.</div><div class="NLM_p last">Based on the binding pattern of <b>2c</b>, we considered that the restriction of the active conformation is beneficial to inhibitory activity, and a methyl group was introduced to restrict the rotational freedom of the pyridin-2-yl methyl group of <b>2c</b> to obtain <b>3</b>. Notably, <b>3</b> showed approximately 13-fold higher inhibition than <b>2c</b> (0.026 vs 0.36 μM). We also obtained the two enantiomers of compound <b>3</b> (<b>3a</b> and <b>3b</b>), confirming that the (<i>S</i>)-isomer (<b>3a</b>) gave a better IC<sub>50</sub> value of 0.010 μM against PDE8A than <b>3b</b>. This improvement in affinity appears to be mainly due to the introduction of another methyl moiety at the R<sub>3</sub> position. In <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>, <b>3a</b> gave an IC<sub>50</sub> of 0.010 μM, similar to that (0.026 μM) of its racemic form <b>3</b>, while <b>3b</b> had an IC<sub>50</sub> of 2.8 μM, which suggested that the (<i>S</i>)-isomer significantly enhanced its inhibition with PDE8 compared to the (<i>R</i>)-isomer. In view of the more potent affinity against PDE8A, <b>3a</b> was used in the subsequent studies.</div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> Validation of the Key Tyr748 via the Cocrystal Structure</h3><div class="NLM_p">In <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>, the binding pattern of PDE8A with <b>3a</b> was revealed by the electron density maps of (Fo–Fc) of the X-ray crystal structure. It is clear that the adenine ring of <b>3a</b> is clamped tightly in the bay surrounded by Asn729, Gln778, and Phe781 because the amine of the adenine ring forms two H-bonds with the amide oxygen of the Gln778 side chain (3.5 Å) and Asn729 side chain (2.9 Å). Besides the π–π interactions with residues Phe781, the adenine ring of <b>3a</b> also forms a H-bond with the amide nitrogen of Gln778/Asn729 (3.5 Å to both nitrogens). Importantly, the pyridine ring forms a stronger H-bond of 2.7 Å with the hydroxyl group of Tyr748, which may account for the improvement of the selectivity index against PDE2A from 26-fold for clofarabine to 220-fold and validated that Tyr748 is a crucial residue for the discovery of potent PDE8A inhibitors.</div><figure id="fig3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01573/20201218/images/medium/jm0c01573_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01573/20201218/images/large/jm0c01573_0004.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Cocrystal structures of the PDE8A–<b>3a</b> complex. (A) Cartoon model for PDE8A in complex with <b>3a</b> (cyan sticks, PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=7CWG">7CWG</a>); the dotted lines represent H-bonds. (B) Electron density maps of (Fo–Fc) for PDE8A in complex with <b>3a</b> (cyan sticks). (C) Differences in the binding patterns between PDE8A–<b>3a</b> (cyan sticks) and PDE8A–IBMX (pink sticks, PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3ECN">3ECN</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01573/20201218/images/large/jm0c01573_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01573&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> Different Binding Patterns of <b>3a</b> from 3-Isobutyl-1-methylxanthine</h3><div class="NLM_p last">In <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>C, the planar xanthine core of 3-isobutyl-1-methylxanthine (IBMX) forms π–π stacking with the benzene ring of Phe781, and the carbonyl oxygen forms a week H-bond with the N atom of the Gln778 amide group at a distance of 3.4 Å, which is the only H-bond detected (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3ECN">3ECN</a>).<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> Unlike IBMX, <b>3a</b> shows much stronger interactions with three residues (Tyr748, Asn729, and Gln778) to form five H-bonds mentioned above as shown in <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>A. Among these, two H-bonds between <b>3a</b> and Asn729 are formed because the side chain undergoes the structural transformation with a Chi angle of 50.19° changed from −57.43° in the PDE8A–IBMX complex. It is noted that the pyridine of <b>3a</b> involved a strong H-bond of 2.7 Å with Tyr748, resulting in high selectivity over other PDEs, which is not observed in the crystal structure of PDE8A with bound IBMX. Additionally, the difluoroethoxyl side chain of <b>3a</b> induced a conformational change in Met670 (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>C).</div></div><div id="sec2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> Remarkable Selectivity Profile of Compound <b>3a</b></h3><div class="NLM_p">The selectivity profile (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>) of compound <b>3a</b> across PDE isoforms was determined. Its inhibitory affinities (IC<sub>50</sub>) against PDE1B, PDE3A, PDE5A1, PDE7A1, PDE9A2, and PDE11A4 were no less than 10 μM, and the IC<sub>50</sub> values against PDE2A, PDE4D2, and PDE10A were 220-fold, 710-fold, and 440-fold higher than those against PDE8A1, respectively. In short, the PDE8A inhibitor <b>3a</b> possesses higher selectivity properties than other PDE isoforms.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Selectivity Profile of <b>3a</b> across PDE Families</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">PDEs</th><th class="colsep0 rowsep0" align="center">IC<sub>50</sub> (μM)</th><th class="colsep0 rowsep0" align="center">selectivity (fold)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PDE8A1 (480–820)</td><td class="colsep0 rowsep0" align="left">0.010 ± 0.001</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PDE1B (146–506)</td><td class="colsep0 rowsep0" align="left">>10</td><td class="colsep0 rowsep0" align="left">>1000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PDE2A (580–919)</td><td class="colsep0 rowsep0" align="left">2.2 ± 0.1</td><td class="colsep0 rowsep0" align="left">220</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PDE3A (679–1087)</td><td class="colsep0 rowsep0" align="left">>10</td><td class="colsep0 rowsep0" align="left">>1000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PDE4D2 (86–413)</td><td class="colsep0 rowsep0" align="left">7.1 ± 0.3</td><td class="colsep0 rowsep0" align="left">710</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PDE5A1 (535–860)</td><td class="colsep0 rowsep0" align="left">>10</td><td class="colsep0 rowsep0" align="left">>1000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PDE7A1 (130–482)</td><td class="colsep0 rowsep0" align="left">>10</td><td class="colsep0 rowsep0" align="left">>1000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PDE9A2 (181–506)</td><td class="colsep0 rowsep0" align="left">>10</td><td class="colsep0 rowsep0" align="left">>1000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PDE10A (449–770)</td><td class="colsep0 rowsep0" align="left">4.4 ± 0.2</td><td class="colsep0 rowsep0" align="left">440</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PDE11A4 (588–911)</td><td class="colsep0 rowsep0" align="left">>10</td><td class="colsep0 rowsep0" align="left">>1000</td></tr></tbody></table></div></div></div><div id="sec2_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> Reasonable Druglike Profile</h3><div class="NLM_p">In view of its nanomolar inhibition against PDE8A and high selectivity across PDE isoforms, <b>3a</b> was further subjected to analysis of the water solubility, pharmacokinetic properties, human plasma protein binding rate, cytochrome P450 inhibition, human ether-a-go-go-related gene (hERG) inhibition, p<i>K</i><sub>a</sub>, log <i>P</i>, and blood–brain barrier (BBB) permeability to characterize its physicochemical properties.</div><div class="NLM_p">Oral administration (p.o.) of 10 mg/kg <b>3a</b> to SD rats resulted in a <i>C</i><sub>max</sub> of 1938 ng/mL, a <i>t</i><sub>1/2</sub> of 2.82 h, a <i>t</i><sub>max</sub> of 4.00 h, an AUC<sub>(0–∞)</sub> of 17,592 h·ng/mL, and an oral bioavailability of 47% (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>). Even after 24 h, its concentration in blood was over 30 ng/mL. The remarkable oral bioavailability and pharmacokinetic stability suggest that <b>3a</b> has the potential to be used as a lead compound for subsequent in vivo studies.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Pharmacokinetic Profile of <b>3a</b> in SD Rats</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center" char="±"><i>t</i><sub>1/2</sub> (h)</th><th class="colsep0 rowsep0" align="center" char="±"><i>T</i><sub>max</sub> (h)</th><th class="colsep0 rowsep0" align="center" char="±"><i>C</i><sub>max</sub> (ng/mL)</th><th class="colsep0 rowsep0" align="center" char="±">AUC<sub>(0–<i>t</i>)</sub> (h·ng/mL)</th><th class="colsep0 rowsep0" align="center" char="±">AUC<sub>(0–∞)</sub> (h·ng/mL)</th><th class="colsep0 rowsep0" align="center" char="±">MRT<sub>(0–<i>t</i>)</sub> (h)</th><th class="colsep0 rowsep0" align="center"><i>F</i> (%)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">i.v.</td><td class="colsep0 rowsep0" align="char" char="±">2.36 ± 0.39</td><td class="colsep0 rowsep0" align="char" char="±">0.14 ± 0.10</td><td class="colsep0 rowsep0" align="char" char="±">2192 ± 136</td><td class="colsep0 rowsep0" align="char" char="±">9410 ± 1157</td><td class="colsep0 rowsep0" align="char" char="±">9418 ± 1160</td><td class="colsep0 rowsep0" align="char" char="±">4.48 ± 0.25</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">p.o.</td><td class="colsep0 rowsep0" align="char" char="±">2.82 ± 0.45</td><td class="colsep0 rowsep0" align="char" char="±">4.00 ± 0.00</td><td class="colsep0 rowsep0" align="char" char="±">1938 ± 317</td><td class="colsep0 rowsep0" align="char" char="±">17,459 ± 2691</td><td class="colsep0 rowsep0" align="char" char="±">17,592 ± 2792</td><td class="colsep0 rowsep0" align="char" char="±">7.20 ± 0.25</td><td class="colsep0 rowsep0" align="left">47 ± 7</td></tr></tbody></table></div></div><div class="NLM_p">Other druglike profile evaluations of <b>3a</b> are shown in <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>, such as water solubility [0.108 mg/mL using the high-performance liquid chromatography (HPLC) method, pH 7.3], cytochrome P450 inhibition (IC<sub>50</sub> values >25 μM against CYP1A2, 2C9, 2C19, 2D6, and 3A4-M), hERG inhibition (IC<sub>50</sub> = 18 μM), and human plasma protein binding (PPB = 78%). Additionally, the values of p<i>K</i><sub>a</sub> and log <i>P</i> of <b>3a</b> are 3.69 and 3.84 (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01573/suppl_file/jm0c01573_si_002.pdf" class="ext-link">Figure S3</a>), respectively, which are in the proper range of druggability. Calculated by the standard curve in the parallel artificial membrane permeation assay (PAMPA),<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> its BBB permeability (<i>P</i><sub>e</sub> = 6.0 × 10<sup>–6</sup> cm/s) is greater than 3.6 × 10<sup>–6</sup> cm/s and classified into the CNS+ range (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01573/suppl_file/jm0c01573_si_002.pdf" class="ext-link">Table S2</a>), which suggests that <b>3a</b> is suitable for the in vivo VaD studies.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Druglike Profile of Compound <b>3a</b></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">content</th><th class="colsep0 rowsep0" align="center">value</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">water solubility (pH 7.3, HPLC method)</td><td class="colsep0 rowsep0" align="left">0.108 mg/mL</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="2" align="center">Pharmacokinetic Properties (p.o.)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> <i>t</i><sub>1/2</sub></td><td class="colsep0 rowsep0" align="left">2.82 h</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> <i>F</i></td><td class="colsep0 rowsep0" align="left">47%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">human plasma binding rate</td><td class="colsep0 rowsep0" align="left">78%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="2" align="center">Cytochrome P450 Inhibition (IC<sub>50</sub>)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> CYP1A2, 2C9, 2C19, 2D6, and 3A4-M</td><td class="colsep0 rowsep0" align="left">>25 μM</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">hERG inhibition (IC<sub>50</sub>)</td><td class="colsep0 rowsep0" align="left">18 μM</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">p<i>K</i><sub>a</sub></td><td class="colsep0 rowsep0" align="left">3.69</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">log <i>P</i></td><td class="colsep0 rowsep0" align="left">3.84</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">BBB permeability</td><td class="colsep0 rowsep0" align="left">6.0 ± 0.5 (×10<sup>–6</sup> cm/s)</td></tr></tbody></table></div></div></div><div id="sec2_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> Significant Pharmacodynamic Effects in the VaD Mice Model</h3><div class="NLM_p">To investigate whether compound <b>3a</b> could cause memory improvement in the VaD mice model, we used the Morris water maze (MWM) test and passive avoidance task. Mice by unilateral common carotid artery occlusion (UCCAO) were randomly assigned to three groups. Many studies suggest that donepezil was beneficial to treat cognitive impairment and memory deficits of VaD.<a onclick="showRef(event, 'ref38 ref39 ref40 ref41'); return false;" href="javascript:void(0);" class="ref ref38 ref39 ref40 ref41">(38−41)</a> Thus, donepezil was adopted as the positive control and to provide reference for the efficacy of compound <b>3a</b>. After 3 weeks of treatment with the vehicle (0.5% CMC–Na solution, p.o.) plus compound <b>3a</b> (3 mg/kg, p.o.) or donepezil (positive control, 1 mg/kg, p.o.), behavioral performance was evaluated. In the MWM test, the escape latency time (ELT) of each mouse to find the platform, the frequency of the platform site crossings, and the residence time in the platform were recorded on the spatial probe trial day to evaluate whether <b>3a</b> could improve the cognitive ability of each group.</div><div class="NLM_p">The pharmacodynamics results in <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a> indicate that the UCCAO mouse model was successfully established relative to the control group, which resulted in cognitive impairment in UCCAO-treated mice. Remarkably, daily administration of compound <b>3a</b> and donepezil to mice significantly decreased the ELT and increased the residence time in the platform area and the frequency of platform site crossings. Meanwhile, the therapeutic effects of compound <b>3a</b> and donepezil was nearly. These phenomena strongly suggested that <b>3a</b> could improve vascular cognitive impairment and enhance the spatial learning and memory capability of the UCCAO-treated mice.</div><figure id="fig4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01573/20201218/images/medium/jm0c01573_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01573/20201218/images/large/jm0c01573_0005.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Spatial learning and memory improvement of compound <b>3a</b> to UCCAO-treated mice after 3 weeks at the oral dose of 3 mg/kg. (A) ELT of UCCAO-treated mice in the spatial probe trial (s). (B) Frequency of the platform site crossings in the spatial probe trial (min<sup>–1</sup>). (C) Swimming time in the target area in the spatial probe trial (s). (D) Representative swimming trajectories of each group in the spatial probe trial. Donepezil (1 mg/kg, p.o.) was used as the positive control. Data are presented as the mean ± SEM. UCCAO-treated mice in each group, <i>n</i> = 9–12. #, <i>p</i> < 0.05 vs control; ##, <i>p</i> < 0.01 vs control; ###, <i>p</i> < 0.001 vs control; *, <i>p</i> < 0.05 vs model; **, <i>p</i> < 0.01 vs model.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01573/20201218/images/large/jm0c01573_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01573&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Moreover, the UCCAO-treated mice showed shortened avoidance latency and more error times in the passive avoidance test, while the trend improved in the <b>3a</b>- and donepezil-treated groups. Daily p.o. of <b>3a</b> and donepezil notably increased the avoidance latency and decreased the error times in the UCCAO-treated mice (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>). The results of behavioral performance demonstrated that this compound could efficiently improve cognitive impairment in the UCCAO-treated mice and enhance learning and memory, which identified a PDE8A inhibitor as a novel agent for the effective treatment of VaD.</div><figure id="fig5" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01573/20201218/images/medium/jm0c01573_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01573/20201218/images/large/jm0c01573_0006.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Therapeutic effects of compound <b>3a</b> on escaping reaction acquisition in the passive avoidance task in UCCAO mice. (A) Avoidance latency time of the passive avoidance task (s). (B) Error times of the passive avoidance task. Data are presented as the mean ± SEM. UCCAO-treated mice in each group, <i>n</i> = 9–12. #, <i>p</i> < 0.05 vs control; ##, <i>p</i> < 0.01 vs control; *, <i>p</i> < 0.05 vs model. (C) Body weight of different groups.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01573/20201218/images/large/jm0c01573_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01573&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i19">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_16005" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_16005" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">In summary, medicinal chemistry optimizations targeting Tyr748 in PDE8A identified the most potent inhibitor <b>3a</b> (IC<sub>50</sub> = 0.010 μM) with high selectivity across PDE isoforms and a reasonable druglike profile. The X-ray crystal structure of PDE8A–<b>3a</b> revealed the first binding pattern of a selective inhibitor with PDE8A after the report of PDE8A–IBMX (pan-PDE inhibitor) more than a decade ago, which may explain the improvement of the selectivity index of 220-fold against PDE2A compared to that of clofarabine (26-fold). Our work thus validated that Tyr748 is a crucial residue for the discovery of highly effective PDE8A inhibitors.</div><div class="NLM_p last">Furthermore, p.o. of <b>3a</b> caused comparable therapeutic effects to donepezil against VaD. These results suggest that selective PDE8A inhibitors could provide remarkable alternative compounds for the effective treatment of VaD.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i20">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_17520" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_17520" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> General Methods</h3><div class="NLM_p last">All the materials and reagents were bought from commercial agents (Bide, Energy and Meryer) without further purification. Chemical HG/T2354-92 silica gel (200–300 mesh, Haiyang) was used for chromatography, and silica gel plates with fluorescence F254 (0.25 mm, Huanghai) were used for thin-layer chromatography analysis. Reactions under anoxic stress were performed under argon. NMR spectra were recorded at room temperature on a Bruker Ascend 500, operating at 500 MHz for <sup>1</sup>H NMR and 126 MHz for <sup>13</sup>C NMR, or a Bruker Avance III, operating at 400 MHz for <sup>1</sup>H NMR and 101 MHz for <sup>13</sup>C NMR. The following abbreviations are used: s (singlet), br (broad signal), d (doublet), dd (doublet of doublets), t (triplet), q (quartet), and m (multiplet). Coupling constants are reported in hertz (Hz). High-resolution mass spectra were recorded on a MAT-95 spectrometer. The purity of targeted compounds was more than 95%, which was determined by reverse-phase HPLC analysis. HPLC instrument: SHIMADZU LC-20AT [column: Hypersil BDS C18, 5.0 μm, 4.6 × 150 mm (Elite)]; detector: SPD-20A UV/vis detector, UV detection at 254 nm; elution, CH<sub>3</sub>CN in water (60–70%, v/v); <i>T</i> = 25 °C; and flow rate = 1.0 mL/min.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> General Procedure for Synthesis of Intermediates <b>M3a–d</b></h3><div class="NLM_p">To the solution of <b>M1</b> (2.4 mmol) and <b>M2</b> (2 mmol) in 1,4-dioxane/H<sub>2</sub>O (4:1, 5 mL), K<sub>2</sub>CO<sub>3</sub> (4 mmol) and Pd(dppf)Cl<sub>2</sub>·CH<sub>2</sub>Cl<sub>2</sub> (0.4 mmol) were added. The mixture was stirred at 100 °C overnight under an atmosphere of Ar. After the mixture was cooled to room temperature (r.t.), it was diluted with water and extracted with ethyl acetate (EA) three times. The combined organic extracts were dried over anhydrous Na<sub>2</sub>SO<sub>4</sub> and concentrated to give a crude product, which was purified by silica gel column chromatography [petroleum ether (PE)/EA, 3:1] to get <b>M3a–d</b>.</div><div id="sec4_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i23" class="anchor-spacer"></div><h4 class="article-section__title" id="_i23"> (6-(Furan-2-yl)pyridin-2-yl)methanol (<b>M3a</b>)</h4><div class="NLM_p last">Yield: 83%. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 7.71 (t, <i>J</i> = 7.8 Hz, 1H), 7.60 (d, <i>J</i> = 7.8 Hz, 1H), 7.55–7.50 (m, 1H), 7.09 (dd, <i>J</i> = 4.0, 3.4 Hz, 2H), 6.54 (dd, <i>J</i> = 3.4, 1.8 Hz, 1H), 4.77 (d, <i>J</i> = 4.5 Hz, 2H), 3.88 (t, <i>J</i> = 4.9 Hz, 1H).</div></div><div id="sec4_2_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i24" class="anchor-spacer"></div><h4 class="article-section__title" id="_i24"> (6-(2-Fluorophenyl)pyridin-2-yl)methanol (<b>M3b</b>)</h4><div class="NLM_p last">Yield: 57%. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.01 (t, <i>J</i> = 7.9 Hz, 1H), 7.80–7.70 (m, 2H), 7.40 (dd, <i>J</i> = 13.2, 5.8 Hz, 1H), 7.29 (d, <i>J</i> = 7.5 Hz, 1H), 7.23–7.14 (m, 2H), 4.83 (s, 2H), 3.96 (s, 1H).</div></div><div id="sec4_2_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25"> (6-(Cyclopent-1-en-1-yl)pyridin-2-yl)methanol (<b>M3c</b>)</h4><div class="NLM_p last">Yield: 61%. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 7.61 (t, <i>J</i> = 7.7 Hz, 1H), 7.26 (s, 1H), 7.01 (d, <i>J</i> = 7.7 Hz, 1H), 6.66 (dd, <i>J</i> = 4.4, 2.3 Hz, 1H), 4.73 (s, 2H), 4.27 (s, 1H), 2.80 (ddd, <i>J</i> = 10.0, 4.6, 2.2 Hz, 2H), 2.59 (dtd, <i>J</i> = 10.1, 4.9, 2.4 Hz, 2H), 2.10–2.03 (m, 2H).</div></div><div id="sec4_2_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26"> (6-(3,6-Dihydro-2<i>H</i>-pyran-4-yl)pyridin-2-yl)methanol (<b>M3d</b>)</h4><div class="NLM_p last">Yield: 80%. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 7.66 (t, <i>J</i> = 7.7 Hz, 1H), 7.29 (d, <i>J</i> = 7.9 Hz, 1H), 7.08 (d, <i>J</i> = 7.6 Hz, 1H), 6.75 (ddd, <i>J</i> = 4.4, 3.0, 1.4 Hz, 1H), 4.75 (d, <i>J</i> = 4.3 Hz, 2H), 4.39 (dd, <i>J</i> = 5.3, 2.6 Hz, 2H), 4.08 (t, <i>J</i> = 4.5 Hz, 1H), 3.96 (t, <i>J</i> = 5.4 Hz, 2H), 2.66 (qd, <i>J</i> = 5.3, 2.4 Hz, 2H).</div></div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> Procedures for the Synthesis of Intermediate <b>M3e</b></h3><div class="NLM_p">Sodium 2,2-difluoroethanolate (6 mmol) was added to the solution of <b>M2</b> (3 mmol) in 2,2-difluoroethanol (3 mL). The mixture was stirred at 90 °C for 40 h. The mixture was diluted with water and extracted with dichloromethane (DCM) three times. The combined organic layers were dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, concentrated in vacuo, and purified by silica gel column chromatography (PE/EA, 5:1) to give <b>M3e</b>.</div><div id="sec4_3_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> (6-(2,2-Difluoroethoxy)pyridin-2-yl)methanol (<b>M3e</b>)</h4><div class="NLM_p last">Yield: 19%. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 7.62 (dd, <i>J</i> = 8.1, 7.5 Hz, 1H), 6.92 (dd, <i>J</i> = 7.3, 0.6 Hz, 1H), 6.73 (dd, <i>J</i> = 8.2, 0.5 Hz, 1H), 6.12 (tt, <i>J</i> = 55.4, 4.2 Hz, 1H), 4.68 (d, <i>J</i> = 5.2 Hz, 2H), 4.56 (td, <i>J</i> = 13.6, 4.2 Hz, 2H), 2.97 (t, <i>J</i> = 5.4 Hz, 1H).</div></div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> General Procedures for the Synthesis of Intermediates <b>M4c–g</b></h3><div class="NLM_p">PBr<sub>3</sub> (150 μL) was added dropwise to a stirred solution of <b>M3a–e</b> (2 mmol) in dry DCM (20 mL) at 0 °C. The reaction mixture was stirred for 4 h at r.t. and quenched by addition of a saturated solution of NaHCO<sub>3</sub> and DCM. The organic layer was dried over anhydrous Na<sub>2</sub>SO<sub>4</sub> and evaporated in vacuo to afford the crude product.</div><div id="sec4_4_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> 2-(Bromomethyl)-6-(furan-2-yl)pyridine (<b>M4c</b>)</h4><div class="NLM_p last">Yield: 73%. <sup>1</sup>H NMR (400 MHz, CDCl3): δ 7.71 (t, <i>J</i> = 7.8 Hz, 1H), 7.59 (d, <i>J</i> = 7.2 Hz, 1H), 7.54 (dd, <i>J</i> = 1.7, 0.7 Hz, 1H), 7.32 (dd, <i>J</i> = 7.7, 0.8 Hz, 1H), 7.09 (dd, <i>J</i> = 3.4, 0.7 Hz, 1H), 6.53 (dd, <i>J</i> = 3.4, 1.8 Hz, 1H), 4.57 (s, 2H).</div></div><div id="sec4_4_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> 2-(Bromomethyl)-6-(2-fluorophenyl)pyridine (<b>M4d</b>)</h4><div class="NLM_p last">Yield: 86%. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.03 (td, <i>J</i> = 7.9, 1.8 Hz, 1H), 7.75 (dt, <i>J</i> = 15.8, 8.0 Hz, 2H), 7.43 (d, <i>J</i> = 7.4 Hz, 1H), 7.41–7.35 (m, 1H), 7.28 (d, <i>J</i> = 8.5 Hz, 1H), 7.16 (dd, <i>J</i> = 11.4, 8.2 Hz, 1H), 4.63 (s, 2H).</div></div><div id="sec4_4_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32"> 2-(Bromomethyl)-6-(cyclopent-1-en-1-yl)pyridine (<b>M4e</b>)</h4><div class="NLM_p last">Yield: 84%. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 7.64 (t, <i>J</i> = 7.8 Hz, 1H), 7.30 (s, 1H), 7.25 (d, <i>J</i> = 7.8 Hz, 1H), 6.70–6.66 (m, 1H), 4.56 (s, 2H), 2.80 (ddd, <i>J</i> = 10.0, 4.6, 2.2 Hz, 2H), 2.59 (dtd, <i>J</i> = 10.1, 4.9, 2.4 Hz, 2H), 2.13–1.99 (m, 2H).</div></div><div id="sec4_4_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> 2-(Bromomethyl)-6-(3,6-dihydro-2<i>H</i>-pyran-4-yl)pyridine (<b>M4f</b>)</h4><div class="NLM_p last">Yield: 81%. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 7.67 (d, <i>J</i> = 7.8 Hz, 1H), 7.32 (d, <i>J</i> = 7.7 Hz, 1H), 7.28 (s, 1H), 6.75 (tt, <i>J</i> = 3.5, 1.8 Hz, 1H), 4.54 (s, 2H), 4.38 (dd, <i>J</i> = 5.6, 2.8 Hz, 2H), 3.94 (t, <i>J</i> = 5.5 Hz, 2H), 2.64 (td, <i>J</i> = 5.3, 2.6 Hz, 2H).</div></div><div id="sec4_4_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> 2-(Bromomethyl)-6-(2,2-difluoroethoxy)pyridine (<b>M4g</b>)</h4><div class="NLM_p last">Yield: 75%. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 7.60 (t, <i>J</i> = 7.7 Hz, 1H), 7.05 (d, <i>J</i> = 7.1 Hz, 1H), 6.74 (d, <i>J</i> = 8.2 Hz, 1H), 6.31–6.00 (m, 1H), 4.56 (td, <i>J</i> = 13.3, 3.7 Hz, 2H), 4.43 (s, 2H).</div></div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> General Procedures for the Synthesis of Compounds <b>1a–f</b> and <b>1i</b></h3><div class="NLM_p"><b>M4a–g</b> (1 mmol) and 2-chloro-9<i>H</i>-purin-6-amine (1 mmol) were dissolved in DMF. Cs<sub>2</sub>CO<sub>3</sub> (2 mmol) was added to the mixture and then stirred at 70 °C overnight. The mixture was diluted with water, extracted with EA, and washed with brine. The combined organic layers were dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, concentrated under reduced pressure, and purified by silica gel column chromatography or recrystallization to give <b>1a–f</b> and <b>1i</b> as a white or yellow solid.</div><div id="sec4_5_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36"> 2-Chloro-9-(pyridin-2-ylmethyl)-9<i>H</i>-purin-6-amine (<b>1a</b>)</h4><div class="NLM_p last">Yield: 58%. Purity: 98%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.55 (d, <i>J</i> = 4.7 Hz, 1H), 8.29 (s, 1H), 7.87 (d, <i>J</i> = 7.7 Hz, 1H), 7.81 (s, 2H), 7.38 (dd, <i>J</i> = 7.2, 5.1 Hz, 1H), 7.33 (d, <i>J</i> = 7.8 Hz, 1H), 5.52 (s, 2H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>): δ 157.2, 155.8, 153.5, 151.2, 149.8, 142.6, 137.7, 123.4, 122.0, 118.1, 48.1. HRMS (ESI-TOF) <i>m</i>/<i>z</i>: [M + H]<sup>+</sup> calcd for C<sub>11</sub>H<sub>9</sub>ClN<sub>6</sub>, 261.0650; found, 261.0646.</div></div><div id="sec4_5_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37"> 2-Chloro-9-((6-methylpyridin-2-yl)methyl)-9<i>H</i>-purin-6-amine (<b>1b</b>)</h4><div class="NLM_p last">Yield: 60%. Purity: 98%. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.02 (s, 1H), 7.70 (t, <i>J</i> = 7.9 Hz, 1H), 7.22 (d, <i>J</i> = 8.0 Hz, 2H), 5.39 (s, 2H), 2.56 (s, 3H). <sup>13</sup>C NMR (126 MHz, DMSO-<i>d</i><sub>6</sub>): δ 161.7, 158.3, 155.1, 153.3, 153.2, 147.5, 138.9, 123.6, 120.3, 110.9, 51.4, 24.0. HRMS (ESI-TOF) <i>m</i>/<i>z</i>: [M + H]<sup>+</sup> calcd for C<sub>12</sub>H<sub>11</sub>ClN<sub>6</sub>, 275.0806; found, 275.0801.</div></div><div id="sec4_5_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i38" class="anchor-spacer"></div><h4 class="article-section__title" id="_i38"> 2-Chloro-9-((6-(furan-2-yl)pyridin-2-yl)methyl)-9<i>H</i>-purin-6-amine (<b>1c</b>)</h4><div class="NLM_p last">Yield: 56%. Purity: 98%. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.08 (s, 1H), 7.71 (t, <i>J</i> = 7.8 Hz, 1H), 7.63 (d, <i>J</i> = 7.6 Hz, 1H), 7.55 (d, <i>J</i> = 1.0 Hz, 1H), 7.13 (d, <i>J</i> = 7.5 Hz, 1H), 7.03 (d, <i>J</i> = 3.1 Hz, 1H), 6.54 (dd, <i>J</i> = 3.4, 1.8 Hz, 1H), 6.04 (s, 2H), 5.48 (s, 2H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>): δ 156.2, 154.3, 154.3, 153.2, 151.3, 149.4, 143.6, 141.6, 137.9, 120.2, 118.1, 117.9, 112.1, 109.4, 48.6. HRMS (ESI-TOF) <i>m</i>/<i>z</i>: [M + H]<sup>+</sup> calcd for C<sub>15</sub>H<sub>11</sub>ClN<sub>6</sub>O, 327.0756; found, 327.0751.</div></div><div id="sec4_5_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i39" class="anchor-spacer"></div><h4 class="article-section__title" id="_i39"> 2-Chloro-9-((6-(2-fluorophenyl)pyridin-2-yl)methyl)-9<i>H</i>-purin-6-amine (<b>1d</b>)</h4><div class="NLM_p last">Yield: 61%. Purity: 99%. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.09 (s, 1H), 7.91 (td, <i>J</i> = 7.9, 1.8 Hz, 1H), 7.78–7.73 (m, 2H), 7.37–7.43 (m, 1H), 7.23–7.29 (m, 2H), 7.16 (ddd, <i>J</i> = 11.4, 8.2, 1.0 Hz, 1H), 6.09 (s, 2H), 5.52 (s, 2H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>): δ 160.6 (d, <i>J</i> = 250.4 Hz), 156.3, 154.3, 153.5, 151.3, 141.6, 137.7, 130.90 (d, <i>J</i><sub>C–F</sub> = 2.4 Hz), 130.8 (d, <i>J</i><sub>C–F</sub> = 8.7 Hz), 126.8, 124.6 (d, <i>J</i><sub>C–F</sub> = 3.2 Hz), 124.0 (d, <i>J</i><sub>C–F</sub> = 9.6 Hz), 120.9, 118.1, 116.4, 116.2, 48.7. HRMS (ESI-TOF) <i>m</i>/<i>z</i>: [M + H]<sup>+</sup> calcd for C<sub>17</sub>H<sub>12</sub>ClFN<sub>6</sub>, 355.0869; found, 355.0858.</div></div><div id="sec4_5_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i40" class="anchor-spacer"></div><h4 class="article-section__title" id="_i40"> 2-Chloro-9-((6-(cyclopent-1-en-1-yl)pyridin-2-yl)methyl)-9<i>H</i>-purin-6-amine (<b>1e</b>)</h4><div class="NLM_p last">Yield: 61%. Purity: 99%. <sup>1</sup>H NMR (400 MHz, MeOD): δ 8.20 (s, 1H), 7.68 (t, <i>J</i> = 7.8 Hz, 1H), 7.38 (d, <i>J</i> = 7.9 Hz, 1H), 7.12 (d, <i>J</i> = 7.7 Hz, 1H), 6.52–6.46 (m, 1H), 5.46 (s, 2H), 2.66 (ddt, <i>J</i> = 10.0, 7.6, 2.3 Hz, 2H), 2.52 (dtd, <i>J</i> = 10.2, 5.1, 2.5 Hz, 2H), 2.04–1.90 (m, 3H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>): δ 156.0, 155.3, 154.1, 153.6, 151.4, 143.1, 141.9, 137.2, 132.1, 119.7, 119.6, 118.1, 48.6, 33.5, 32.5, 23.3. HRMS (ESI-TOF) <i>m</i>/<i>z</i>: [M + H]<sup>+</sup> calcd for C<sub>16</sub>H<sub>15</sub>ClN<sub>6</sub>, 327.1119; found, 327.1117.</div></div><div id="sec4_5_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i41" class="anchor-spacer"></div><h4 class="article-section__title" id="_i41"> 2-Chloro-9-((6-(3,6-dihydro-2<i>H</i>-pyran-4-yl)pyridin-2-yl)methyl)-9<i>H</i>-purin-6-amine (<b>1f</b>)</h4><div class="NLM_p last">Yield: 55%. Purity: 99%. <sup>1</sup>H NMR (400 MHz, MeOD): δ 8.20 (s, 1H), 7.73 (t, <i>J</i> = 7.8 Hz, 1H), 7.43 (d, <i>J</i> = 8.0 Hz, 1H), 7.20 (d, <i>J</i> = 7.7 Hz, 1H), 6.61 (ddd, <i>J</i> = 4.3, 2.7, 1.5 Hz, 1H), 5.48 (s, 2H), 4.28 (dd, <i>J</i> = 5.5, 2.8 Hz, 2H), 3.85 (t, <i>J</i> = 5.5 Hz, 2H), 2.46 (ddt, <i>J</i> = 7.4, 4.7, 2.4 Hz, 2H). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>): δ 156.8, 156.1, 154.2, 153.4, 151.3, 141.7, 137.6, 133.8, 126.8, 120.3, 118.2, 118.1, 65.8, 64.4, 48.5, 25.7. HRMS (ESI-TOF) <i>m</i>/<i>z</i>: [M + H]<sup>+</sup> calcd for C<sub>16</sub>H<sub>15</sub>ClN<sub>6</sub>O, 343.1069; found, 343.1068.</div></div><div id="sec4_5_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i42" class="anchor-spacer"></div><h4 class="article-section__title" id="_i42"> 2-Chloro-9-((6-(2,2-difluoroethoxy)pyridin-2-yl)methyl)-9<i>H</i>-purin-6-amine (<b>1i</b>)</h4><div class="NLM_p last">Yield: 54%. Purity: 98%. <sup>1</sup>H NMR (400 MHz, MeOD): δ 8.20 (s, 1H), 7.70 (dd, <i>J</i> = 8.2, 7.4 Hz, 1H), 6.99 (d, <i>J</i> = 7.3 Hz, 1H), 6.76 (d, <i>J</i> = 8.3 Hz, 1H), 5.99 (tt, <i>J</i> = 55.6, 4.1 Hz, 1H), 5.42 (s, 2H), 4.31 (td, <i>J</i> = 13.9, 4.1 Hz, 2H). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>): δ 166.8, 162.0, 158.3, 158.3, 156.0, 147.3, 146.1, 122.8, 120.4, 119.0 (t, <i>J</i><sub>C–F</sub> = 239.1 Hz), 114.9, 68.6 (t, <i>J</i><sub>C–F</sub> = 27.7 Hz), 52.3. HRMS (ESI-TOF) <i>m</i>/<i>z</i>: [M + H]<sup>+</sup> calcd for C<sub>13</sub>H<sub>11</sub>ClF<sub>2</sub>N<sub>6</sub>O, 341.0724; found, 341.0721.</div></div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i43" class="anchor-spacer"></div><h3 class="article-section__title" id="_i43"> General Procedures for the Synthesis of Compounds <b>1g–h</b></h3><div class="NLM_p">10% Pd/C (10%, w/w) was added to the solution of <b>1e–f</b> (0.5 mmol) in MeOH/tetrahydrofuran (THF) (20 mL, 1:1, v/v). The reaction mixture was stirred at r.t. overnight under an atmosphere of H<sub>2</sub>. The mixture was then filtered through Celite, and the solvent was removed in vacuo to afford the crude product, which was purified by silica gel column chromatography to give <b>1g–h</b> as a white solid.</div><div id="sec4_6_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i44" class="anchor-spacer"></div><h4 class="article-section__title" id="_i44"> 2-Chloro-9-((6-cyclopentylpyridin-2-yl)methyl)-9<i>H</i>-purin-6-amine (<b>1g</b>)</h4><div class="NLM_p last">Yield: 83%. Purity: 96%. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.05 (s, 1H), 7.55 (t, <i>J</i> = 7.7 Hz, 1H), 7.10 (d, <i>J</i> = 7.7 Hz, 1H), 7.05 (d, <i>J</i> = 7.6 Hz, 1H), 5.96 (s, 2H), 5.40 (s, 2H), 3.20–3.09 (m, 1H), 2.07–1.99 (m, 2H), 1.79 (d, <i>J</i> = 2.6 Hz, 1H), 1.74–1.61 (m, 5H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>): δ 166.3, 156.2, 154.1, 153.4, 151.3, 141.7, 137.2, 121.2, 119.3, 118.0, 48.6, 47.6, 33.5, 25.8. HRMS (ESI-TOF) <i>m</i>/<i>z</i>: [M + H]<sup>+</sup> calcd for C<sub>16</sub>H<sub>17</sub>ClN<sub>6</sub>, 329.1276; found, 329.1279.</div></div><div id="sec4_6_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i45" class="anchor-spacer"></div><h4 class="article-section__title" id="_i45"> 2-Chloro-9-((6-(tetrahydro-2<i>H</i>-pyran-4-yl)pyridin-2-yl)methyl)-9<i>H</i>-purin-6-amine (<b>1h</b>)</h4><div class="NLM_p last">Yield: 88%. Purity: 99%. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.04 (s, 1H), 7.61 (t, <i>J</i> = 7.7 Hz, 1H), 7.11 (d, <i>J</i> = 7.7 Hz, 2H), 5.93 (s, 2H), 5.41 (s, 2H), 4.08 (ddd, <i>J</i> = 11.7, 4.0, 2.0 Hz, 2H), 3.54 (td, <i>J</i> = 11.5, 2.9 Hz, 2H), 2.91 (ddd, <i>J</i> = 15.6, 11.0, 4.6 Hz, 1H), 1.92–1.79 (m, 4H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>): δ 164.7, 156.3, 154.2, 153.8, 151.2, 141.6, 137.7, 120.5, 119.8, 118.1, 68.0, 48.6, 43.1, 32.2. HRMS (ESI-TOF) <i>m</i>/<i>z</i>: [M + H]<sup>+</sup> calcd for C<sub>16</sub>H<sub>17</sub>ClN<sub>6</sub>O, 345.1225; found, 345.1226.</div></div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i46" class="anchor-spacer"></div><h3 class="article-section__title" id="_i46"> General Procedures for the Synthesis of Intermediates <b>M6a–b</b></h3><div class="NLM_p"><b>M6a–b</b> were synthesized by the general procedure for the synthesis of <b>M3e</b>.</div><div id="sec4_7_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i47" class="anchor-spacer"></div><h4 class="article-section__title" id="_i47"> (4-Methoxypyridin-2-yl)methanol (<b>M6a</b>)</h4><div class="NLM_p last">Yield: 96%. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.37 (t, <i>J</i> = 4.9 Hz, 1H), 6.78 (d, <i>J</i> = 2.0 Hz, 1H), 6.74 (dd, <i>J</i> = 5.7, 2.4 Hz, 1H), 4.71 (s, 2H), 3.86 (s, 3H).</div></div><div id="sec4_7_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i48" class="anchor-spacer"></div><h4 class="article-section__title" id="_i48"> (4-(2,2-Difluoroethoxy)pyridin-2-yl)methanol (<b>M6b</b>)</h4><div class="NLM_p last">Yield: 36%. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.42 (d, <i>J</i> = 5.7 Hz, 1H), 6.85 (d, <i>J</i> = 2.3 Hz, 1H), 6.78 (dd, <i>J</i> = 5.7, 2.5 Hz, 1H), 6.12 (tt, <i>J</i> = 54.8, 4.0 Hz, 1H), 4.74 (s, 2H), 4.26 (td, <i>J</i> = 12.9, 4.0 Hz, 2H).</div></div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i49" class="anchor-spacer"></div><h3 class="article-section__title" id="_i49"> General Procedures for the Synthesis of Intermediates <b>M7a–c</b></h3><div class="NLM_p"><b>M7a–c</b> were synthesized by the general procedure for the synthesis of <b>M4c–g</b>.</div><div id="sec4_8_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i50" class="anchor-spacer"></div><h4 class="article-section__title" id="_i50"> 2-(Bromomethyl)-4-chloropyridine (<b>M7a</b>)</h4><div class="NLM_p last">Yield: 83%. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.48 (d, <i>J</i> = 5.3 Hz, 1H), 7.47 (d, <i>J</i> = 1.7 Hz, 1H), 7.24 (dd, <i>J</i> = 5.3, 1.8 Hz, 1H), 4.51 (s, 2H).</div></div><div id="sec4_8_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i51" class="anchor-spacer"></div><h4 class="article-section__title" id="_i51"> 2-(Bromomethyl)-4-methoxypyridine (<b>M7b</b>)</h4><div class="NLM_p last">Yield: 88%. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.41 (d, <i>J</i> = 5.8 Hz, 1H), 6.98 (d, <i>J</i> = 2.4 Hz, 1H), 6.76 (dd, <i>J</i> = 5.8, 2.4 Hz, 1H), 4.52 (s, 2H), 3.89 (s, 3H).</div></div><div id="sec4_8_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i52" class="anchor-spacer"></div><h4 class="article-section__title" id="_i52"> 2-(Bromomethyl)-4-(2,2-difluoroethoxy)pyridine (<b>M7c</b>)</h4><div class="NLM_p last">Yield: 81%. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.46 (d, <i>J</i> = 5.7 Hz, 1H), 7.02 (d, <i>J</i> = 2.3 Hz, 1H), 6.78 (dd, <i>J</i> = 5.7, 2.4 Hz, 1H), 6.13 (tt, <i>J</i> = 54.8, 4.0 Hz, 1H), 4.52 (s, 2H), 4.27 (td, <i>J</i> = 12.8, 4.0 Hz, 2H).</div></div></div><div id="sec4_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i53" class="anchor-spacer"></div><h3 class="article-section__title" id="_i53"> General Procedures for the Synthesis of Compounds <b>2a–c</b></h3><div class="NLM_p"><b>2a–c</b> were synthesized by the general procedure for the synthesis of <b>1a–f</b> and <b>1i</b>.</div><div id="sec4_9_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i54" class="anchor-spacer"></div><h4 class="article-section__title" id="_i54"> 2-Chloro-9-((4-chloropyridin-2-yl)methyl)-9<i>H</i>-purin-6-amine (<b>2a</b>)</h4><div class="NLM_p last">Yield: 52%. Purity: 98%. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.46 (d, <i>J</i> = 5.3 Hz, 1H), 7.98 (s, 1H), 7.28 (m, 2H), 6.02 (s, 2H), 5.43 (s, 2H). <sup>13</sup>C NMR (126 MHz, DMSO-<i>d</i><sub>6</sub>): δ 157.9, 157.2, 153.5, 151.3, 151.2, 144.1, 142.6, 123.6, 122.3, 118.1, 47.6. HRMS (ESI-TOF) <i>m</i>/<i>z</i>: [M + H]<sup>+</sup> calcd for C<sub>11</sub>H<sub>8</sub>Cl<sub>2</sub>N<sub>6</sub>, 295.0260; found, 295.0259.</div></div><div id="sec4_9_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i55" class="anchor-spacer"></div><h4 class="article-section__title" id="_i55"> 2-Chloro-9-((4-methoxypyridin-2-yl)methyl)-9<i>H</i>-purin-6-amine (<b>2b</b>)</h4><div class="NLM_p last">Yield: 55%. Purity: 98%. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.38 (d, <i>J</i> = 5.7 Hz, 1H), 7.98 (s, 1H), 6.85 (d, <i>J</i> = 2.3 Hz, 1H), 6.75 (dd, <i>J</i> = 5.8, 2.4 Hz, 1H), 5.80 (s, 2H), 5.38 (s, 2H), 3.83 (s, 3H). <sup>13</sup>C NMR (126 MHz, MeOD): δ 167.3, 156.7, 156.4, 154.0, 150.8, 150.4, 141.9, 117.4, 109.1, 108.7, 54.7, 47.7. HRMS (ESI-TOF) <i>m</i>/<i>z</i>: [M + H]<sup>+</sup> calcd for C<sub>12</sub>H<sub>11</sub>ClN<sub>6</sub>O, 291.0756; found, 291.0756.</div></div><div id="sec4_9_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i56" class="anchor-spacer"></div><h4 class="article-section__title" id="_i56"> 2-Chloro-9-((4-(2,2-difluoroethoxy)pyridin-2-yl)methyl)-9<i>H</i>-purin-6-amine (<b>2c</b>)</h4><div class="NLM_p last">Yield: 58%. Purity: 99%. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.43 (d, <i>J</i> = 5.7 Hz, 1H), 7.98 (s, 1H), 6.89 (d, <i>J</i> = 2.3 Hz, 1H), 6.78 (dd, <i>J</i> = 5.7, 2.4 Hz, 1H), 5.85–6.23 (m, 3H), 5.40 (s, 2H), 4.22 (td, <i>J</i> = 12.8, 4.0 Hz, 2H). <sup>13</sup>C NMR (126 MHz, MeOD): δ 165.4, 156.7, 156.7, 154.0, 150.8, 150.7, 142.0, 117.4, 113.5 (t, <i>J</i><sub>C–F</sub> = 239.7 Hz), 109.4, 109.0, 66.6 (t, <i>J</i><sub>C–F</sub> = 28.7 Hz), 47.7. HRMS (ESI-TOF) <i>m</i>/<i>z</i>: [M + H]<sup>+</sup> calcd for C<sub>13</sub>H<sub>11</sub>ClF<sub>2</sub>N<sub>6</sub>O, 341.0724; found, 341.0721.</div></div></div><div id="sec4_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i57" class="anchor-spacer"></div><h3 class="article-section__title" id="_i57"> Procedures for the Synthesis of Intermediate <b>M9</b></h3><div class="NLM_p"><b>M9</b> was synthesized by the general procedure for the synthesis of <b>M3e</b>.</div><div id="sec4_10_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i58" class="anchor-spacer"></div><h4 class="article-section__title" id="_i58"> 2-Chloro-4-(2,2-difluoroethoxy)pyridine (<b>M9</b>)</h4><div class="NLM_p last">Yield: 52%. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.25 (d, <i>J</i> = 5.8 Hz, 1H), 6.88 (d, <i>J</i> = 2.2 Hz, 1H), 6.80 (dd, <i>J</i> = 5.8, 2.0 Hz, 1H), 6.10 (tt, <i>J</i> = 54.8, 4.1 Hz, 1H), 4.24 (td, <i>J</i> = 12.8, 4.0 Hz, 2H).</div></div></div><div id="sec4_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i59" class="anchor-spacer"></div><h3 class="article-section__title" id="_i59"> Procedures for the Synthesis of Intermediate <b>M10</b></h3><div class="NLM_p"><b>M10</b> was synthesized by the general procedure for the synthesis of <b>M3a–e</b>.</div><div id="sec4_11_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i60" class="anchor-spacer"></div><h4 class="article-section__title" id="_i60"> 4-(2,2-Difluoroethoxy)-2-vinylpyridine (<b>M10</b>)</h4><div class="NLM_p last">Yield: 95%. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.44 (d, <i>J</i> = 5.7 Hz, 1H), 6.87 (d, <i>J</i> = 2.5 Hz, 1H), 5.96–6.26 (m, 2H), 6.26–5.95 (m, 2H), 5.50 (dd, <i>J</i> = 10.8, 1.1 Hz, 1H), 4.25 (td, <i>J</i> = 12.9, 4.1 Hz, 2H).</div></div></div><div id="sec4_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i61" class="anchor-spacer"></div><h3 class="article-section__title" id="_i61"> Procedures for the Synthesis of Intermediate <b>M11</b></h3><div class="NLM_p"><b>M11</b> was synthesized by the general procedure for the synthesis of <b>1g–h</b>.</div><div id="sec4_12_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i62" class="anchor-spacer"></div><h4 class="article-section__title" id="_i62"> 4-(2,2-Difluoroethoxy)-2-ethylpyridine (<b>M11</b>)</h4><div class="NLM_p last">Yield: 100%. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.41 (d, <i>J</i> = 5.7 Hz, 1H), 6.73 (d, <i>J</i> = 2.4 Hz, 1H), 6.68 (dd, <i>J</i> = 5.7, 2.5 Hz, 1H), 6.12 (tt, <i>J</i> = 54.9, 4.1 Hz, 1H), 4.24 (td, <i>J</i> = 12.9, 4.1 Hz, 2H), 2.82 (q, <i>J</i> = 7.6 Hz, 2H), 1.32 (t, <i>J</i> = 7.6 Hz, 3H).</div></div></div><div id="sec4_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i63" class="anchor-spacer"></div><h3 class="article-section__title" id="_i63"> Procedures for the Synthesis of Intermediate <b>M12</b></h3><div class="NLM_p">NBS (10 mmol) and 2,2′-azo-bis-isobutyronitrile (AIBN) (0.5 mmol) were added to the solution of <b>M11</b> (10 mmol) in CCl<sub>4</sub> (100 mL). The reaction mixture was stirred for 4 h at reflux under an atmosphere of Ar. The mixture was then filtered, concentrated, and purified by silica gel column chromatography (PE/EA, 5:1) to get <b>M12</b>.</div><div id="sec4_13_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i64" class="anchor-spacer"></div><h4 class="article-section__title" id="_i64"> 2-(1-Bromoethyl)-4-(2,2-difluoroethoxy)pyridine (<b>M12</b>)</h4><div class="NLM_p last">Yield: 81%. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 8.44 (d, <i>J</i> = 5.7 Hz, 1H), 7.01 (d, <i>J</i> = 2.4 Hz, 1H), 6.75 (dd, <i>J</i> = 5.7, 2.5 Hz, 1H), 6.11 (tt, <i>J</i> = 54.8, 4.0 Hz, 1H), 5.18 (q, <i>J</i> = 6.9 Hz, 1H), 4.26 (td, <i>J</i> = 12.8, 4.0 Hz, 2H), 2.06 (d, <i>J</i> = 6.9 Hz, 3H).</div></div></div><div id="sec4_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i65" class="anchor-spacer"></div><h3 class="article-section__title" id="_i65"> Procedures for the Synthesis of Compound <b>3</b></h3><div class="NLM_p"><b>3</b> was synthesized by the general procedure for the synthesis of <b>1a–f</b> and <b>1i</b>.</div><div id="sec4_14_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i66" class="anchor-spacer"></div><h4 class="article-section__title" id="_i66"> 2-Chloro-9-(1-(4-(2,2-difluoroethoxy)pyridin-2-yl)ethyl)-9<i>H</i>-purin-6-amine (<b>3</b>)</h4><div class="NLM_p last">Yield: 56%. Purity: 98%. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.45 (d, <i>J</i> = 5.7 Hz, 1H), 8.19 (s, 1H), 6.94 (d, <i>J</i> = 2.4 Hz, 1H), 6.77 (dd, <i>J</i> = 5.7, 2.5 Hz, 1H), 6.25–5.83 (m, 4H), 4.23 (td, <i>J</i> = 12.8, 4.0 Hz, 2H), 1.95 (d, <i>J</i> = 7.2 Hz, 3H). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>): δ 164.5, 160.2, 156.0, 153.9, 151.4, 150.9, 140.0, 118.1, 112.9 (t, <i>J</i><sub>C–F</sub> = 241.8 Hz), 109.4, 108.8, 84.5, 66.7 (t, <i>J</i><sub>C–F</sub> = 29.9 Hz), 54.7, 20.8. HRMS (ESI-TOF) <i>m</i>/<i>z</i>: [M + H]<sup>+</sup> calcd for C<sub>14</sub>H<sub>13</sub>ClF<sub>2</sub>N<sub>6</sub>O, 355.0880; found, 355.0877. Daicel CHIRALPAK AD-3 (0.46 cm × 25 cm); hexane/isopropanol = 55/45; flow rate = 1 mL/min; detection wavelength = 254 nm; <i>t</i><sub>1</sub> = 9.30 min, <b>(<i>S</i>)-3/3a</b>; <i>t</i><sub>2</sub> = 10.10 min, <b>(<i>R</i>)-3/3b</b>; <b>(<i>S</i>)-3</b>, [α]<sub class="stack">D</sub><sup class="stack">20</sup> −74.0 (<i>c</i> 0.1, CHCl<sub>3</sub>), ee > 99%; <b>(<i>R</i>)-3</b>, [α]<sub class="stack">D</sub><sup class="stack">20</sup> 74.0 (<i>c</i> 0.1, CHCl<sub>3</sub>), ee > 99%.</div></div></div><div id="sec4_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i67" class="anchor-spacer"></div><h3 class="article-section__title" id="_i67"> Molecular Docking</h3><div class="NLM_p last">The Surflex-Dock suite<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> of Tripos Sybyl-X.2.0 was used to predict the binding modes between designed compounds and PDE8A. The active site was represented by the ProtoMol, which was based on the bound ligand IBMX within PDE8A (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3ECN">3ECN</a>). The parameters of proto_bloat and proto_thresh were set to 0 and 0.5, respectively. In addition, other parameters were assigned default values. A total of 20 poses of each compound were generated for analysis.</div></div><div id="sec4_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i68" class="anchor-spacer"></div><h3 class="article-section__title" id="_i68"> Protein Expression and Purification</h3><div class="NLM_p">The recombinant pET15b-PDE8A1 plasmid (catalytic domain, 480–820) was subcloned and purified by protocols reported previously.<a onclick="showRef(event, 'ref36 ref43'); return false;" href="javascript:void(0);" class="ref ref36 ref43">(36,43)</a> The recombinant plasmid was transferred into the <i>Escherichia coli</i> strain BL21 (CodonPlus, DE3). Then, the <i>E. coli</i> cells carrying the plasmid grew in the 2 × YT medium (containing 100 mg/mL ampicillin, 50 mg/mL chloramphenicol, and 0.4% glucose) at 37 °C until OD<sub>600</sub> = 0.6–0.8, and then, 0.1 mM isopropyl-β-<span class="smallcaps smallerCapital">d</span>-thiogalactopyranoside was added to induce the PDE8A1 protein overexpression. The induced cells were collected after growing at 25 °C for another 20–24 h. The pellet from the frozen cells was denatured in the buffer of 7.8 M guanidine and 0.1 M Tris-HCl pH 8.0 overnight. A nickel nitriloacetic acid column (Qiagen) was used to purify the dissolved supernatant. The elution protein at a 30 μg/mL concentration was added dropwise into the refolding buffer under mild stir. The refolding was carried out at the 30 μg/mL protein concentration without shaking at 4 °C for 3 days. The recombinant PDE8A1 protein was purified using hydroxyapatite HTP GEL (Bio-Rad), a Q Sepharose column (GE Healthcare), and a gel filtration column Sephacryl S<sub>100</sub> (GE Healthcare). A typical batch of purification yielded 4–10 mg of the PDE8A1 protein from a 6 L cell culture medium. The PDE8A1 proteins had a purity greater than 95%, as shown by the sodium dodecyl sulfate gel. The proteins were used for the enzymatic activity assay of compounds, crystallization, and structure determination of PDE8A–clofarabine/<b>2a</b>/<b>3c</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01573/suppl_file/jm0c01573_si_002.pdf" class="ext-link">Table S3</a>).</div><div class="NLM_p">The fragments of PDE1B (146–506, delete 449–471), PDE2A (580–919), PDE3A (679–1087), PDE4D (86–413), PDE5A (535–860), PDE7A (130–482), PDE9A (181–506), and PDE10A (449–770) were purified by using similar protocols but without the denaturing and refolding processes as previously reported.<a onclick="showRef(event, 'ref15 ref30 ref44 ref45 ref46 ref47 ref48 ref49 ref50 ref51'); return false;" href="javascript:void(0);" class="ref ref15 ref30 ref44 ref45 ref46 ref47 ref48 ref49 ref50 ref51">(15,30,44−51)</a></div><div class="NLM_p last">The same procedures (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01573/suppl_file/jm0c01573_si_002.pdf" class="ext-link">Supporting Information</a>) for the enzymology and crystallization trials were performed as previous studies.<a onclick="showRef(event, 'ref15 ref30 ref44 ref45 ref46 ref47 ref48 ref49 ref50 ref51'); return false;" href="javascript:void(0);" class="ref ref15 ref30 ref44 ref45 ref46 ref47 ref48 ref49 ref50 ref51">(15,30,44−51)</a></div></div><div id="sec4_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i69" class="anchor-spacer"></div><h3 class="article-section__title" id="_i69"> Druglike Profile Determinations</h3><div class="NLM_p last">The same procedures for the druglike profile determinations such as pharmacokinetic properties, plasma protein binding rate, cytochrome P450 inhibition, hERG inhibition, p<i>K</i><sub>a</sub>, log <i>P</i>, and PAMPA–BBB (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01573/suppl_file/jm0c01573_si_002.pdf" class="ext-link">Supporting Information</a>) were performed as our previous studies.<a onclick="showRef(event, 'ref15 ref45 ref48 ref49 ref50 ref51 ref52'); return false;" href="javascript:void(0);" class="ref ref15 ref45 ref48 ref49 ref50 ref51 ref52">(15,45,48−52)</a></div></div><div id="sec4_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i70" class="anchor-spacer"></div><h3 class="article-section__title" id="_i70"> UCCAO Mouse Model of VaD and the MWM Test</h3><div class="NLM_p last">The same protocols as reported in our previous work have been performed<a onclick="showRef(event, 'ref15 ref51'); return false;" href="javascript:void(0);" class="ref ref15 ref51">(15,51)</a> (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01573/suppl_file/jm0c01573_si_002.pdf" class="ext-link">Supporting Information</a>) for the UCCAO mouse model of VaD and the MWM test. All animal care and experimental protocols were in accordance with the “Guide for the Care and Use of Laboratory Animals” (National Institutes of Health Publication, revised 1996, no. 86-23, Bethesda, MD) and approved by the Institutional Ethical Committee for Animal Research of Sun Yat-Sen University (IACUC number: SYSU-IACUC-2020-000292).</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i71"><a href="/doi/suppl/10.1021/acs.jmedchem.0c01573" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_78466" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_78466" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a href="/doi/10.1021/acs.jmedchem.0c01573?goto=supporting-info" class="ext-link">https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c01573</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Molecular formula strings and some data (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01573/suppl_file/jm0c01573_si_001.csv" class="ext-link">CSV</a>)</p></li><li><p class="inline">In vivo pharmacokinetics analysis; druglike profile of compound <b>3a</b>; PAMPA–BBB procedures; general procedures for crystallization trials; <sup>1</sup>H NMR, <sup>13</sup>C NMR, and high-resolution mass spectra data for targeted compounds; and purity of the tested compounds (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01573/suppl_file/jm0c01573_si_002.pdf" class="ext-link">PDF</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c01573/suppl_file/jm0c01573_si_001.csv">jm0c01573_si_001.csv (1.31 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c01573/suppl_file/jm0c01573_si_002.pdf">jm0c01573_si_002.pdf (3.33 MB)</a></li></ul></div></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">The atomic coordinates and structure factors have been deposited into the RCSB Protein Data Bank with accession numbers <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=7CWA">7CWA</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=7CWF">7CWF</a>, and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=7CWG">7CWG</a>. Authors will release the atomic coordinates and experimental data upon article publication.</p><div class="testing" data-doi="10.1021/acs.jmedchem.0c01573" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_61584" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_61584" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hai-Bin Luo</span> - <span class="hlFld-Affiliation affiliation">School
of Pharmaceutical Sciences, Sun Yat-Sen University, Guangzhou 510006, P. R. China</span>; 
    <span class="hlFld-Affiliation affiliation">Key
Laboratory of Tropical Biological Resources of Ministry of Education,
School of Life and Pharmaceutical Sciences, Hainan University, Haikou 570228, Hainan, China</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-2163-0509" title="Orcid link">http://orcid.org/0000-0002-2163-0509</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#bbd7ced4d3d98c8cfbd6dad2d795c8c2c8ce95dedfce95d8d5"><span class="__cf_email__" data-cfemail="e08c958f8882d7d7a08d81898cce93999395ce858495ce838e">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yadan Huang</span> - <span class="hlFld-Affiliation affiliation">School
of Pharmaceutical Sciences, Sun Yat-Sen University, Guangzhou 510006, P. R. China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Xu-Nian Wu</span> - <span class="hlFld-Affiliation affiliation">School
of Pharmaceutical Sciences, Sun Yat-Sen University, Guangzhou 510006, P. R. China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Qian Zhou</span> - <span class="hlFld-Affiliation affiliation">School
of Pharmaceutical Sciences, Sun Yat-Sen University, Guangzhou 510006, P. R. China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yinuo Wu</span> - <span class="hlFld-Affiliation affiliation">School
of Pharmaceutical Sciences, Sun Yat-Sen University, Guangzhou 510006, P. R. China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Dongxiao Zheng</span> - <span class="hlFld-Affiliation affiliation">Key
Laboratory of Tropical Biological Resources of Ministry of Education,
School of Life and Pharmaceutical Sciences, Hainan University, Haikou 570228, Hainan, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Zhe Li</span> - <span class="hlFld-Affiliation affiliation">School
of Pharmaceutical Sciences, Sun Yat-Sen University, Guangzhou 510006, P. R. China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lei Guo</span> - <span class="hlFld-Affiliation affiliation">School
of Pharmaceutical Sciences, Sun Yat-Sen University, Guangzhou 510006, P. R. China</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>Y.H., X.-N.W., and Q.Z. contributed equally.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ack1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i74">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_84001" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_84001" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">This work was supported by the National Natural Science Foundation of China (21877134, 22077143, and 81903542), the Science Foundation of Guangdong Province (2020A111128007, 2014A020210009, and 2018A030313215), the Science Foundation of Guangzhou City (201904020023), and the Fundamental Research Funds for the Central Universities (no. 20ykpy112). We sincerely thank the anonymous reviewers for their constructive comments on this paper.</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations</td></tr><tr><td class="NLM_term">PDE8A</td><td class="NLM_def"><p class="first last">phosphodiesterase 8A</p></td></tr><tr><td class="NLM_term">IC<sub>50</sub></td><td class="NLM_def"><p class="first last">half-inhibitory concentration</p></td></tr><tr><td class="NLM_term">IBMX</td><td class="NLM_def"><p class="first last">3-isobutyl-1-methylxanthine</p></td></tr><tr><td class="NLM_term">VaD</td><td class="NLM_def"><p class="first last">vascular dementia</p></td></tr><tr><td class="NLM_term">cAMP</td><td class="NLM_def"><p class="first last">cyclic adenosine 3′,5′-monophosphate</p></td></tr><tr><td class="NLM_term">cGMP</td><td class="NLM_def"><p class="first last">cyclic guanosine 3′,5′-monophosphate</p></td></tr><tr><td class="NLM_term">PDEs</td><td class="NLM_def"><p class="first last">phosphodiesterases</p></td></tr><tr><td class="NLM_term">FDA</td><td class="NLM_def"><p class="first last">Food and Drug Administration</p></td></tr><tr><td class="NLM_term">PDB</td><td class="NLM_def"><p class="first last">Protein Data Bank</p></td></tr><tr><td class="NLM_term">PAINS</td><td class="NLM_def"><p class="first last">pan-assay interference compounds</p></td></tr><tr><td class="NLM_term">NBS</td><td class="NLM_def"><p class="first last"><i>N</i>-bromosuccinimide</p></td></tr><tr><td class="NLM_term">SAR</td><td class="NLM_def"><p class="first last">structure–activity relationship</p></td></tr><tr><td class="NLM_term">SD</td><td class="NLM_def"><p class="first last">standard deviation/Sprague-Dawley</p></td></tr><tr><td class="NLM_term">hERG</td><td class="NLM_def"><p class="first last">human ether-a-go-go-related gene</p></td></tr><tr><td class="NLM_term"><i>t</i><sub>1/2</sub></td><td class="NLM_def"><p class="first last">half-time</p></td></tr><tr><td class="NLM_term"><i>T</i><sub>max</sub></td><td class="NLM_def"><p class="first last">peak time</p></td></tr><tr><td class="NLM_term"><i>C</i><sub>max</sub></td><td class="NLM_def"><p class="first last">peak concentration</p></td></tr><tr><td class="NLM_term">AUC</td><td class="NLM_def"><p class="first last">area under the curve</p></td></tr><tr><td class="NLM_term">MRT</td><td class="NLM_def"><p class="first last">mean residence time</p></td></tr><tr><td class="NLM_term"><i>F</i></td><td class="NLM_def"><p class="first last">bioavailability</p></td></tr><tr><td class="NLM_term">i.v.</td><td class="NLM_def"><p class="first last">intravenous administration</p></td></tr><tr><td class="NLM_term">p.o.</td><td class="NLM_def"><p class="first last">oral administration</p></td></tr><tr><td class="NLM_term">PD</td><td class="NLM_def"><p class="first last">pharmacodynamics</p></td></tr><tr><td class="NLM_term">HPLC</td><td class="NLM_def"><p class="first last">high-performance liquid chromatography</p></td></tr><tr><td class="NLM_term">CYP</td><td class="NLM_def"><p class="first last">cytochrome P450</p></td></tr><tr><td class="NLM_term">PPB</td><td class="NLM_def"><p class="first last">plasma protein binding</p></td></tr><tr><td class="NLM_term">BBB</td><td class="NLM_def"><p class="first last">blood–brain barrier</p></td></tr><tr><td class="NLM_term">PAMPA</td><td class="NLM_def"><p class="first last">parallel artificial membrane permeation assay</p></td></tr><tr><td class="NLM_term">CNS</td><td class="NLM_def"><p class="first last">central nervous system</p></td></tr><tr><td class="NLM_term">MWM</td><td class="NLM_def"><p class="first last">Morris water maze</p></td></tr><tr><td class="NLM_term">UCCAO</td><td class="NLM_def"><p class="first last">unilateral common carotid artery occlusion</p></td></tr><tr><td class="NLM_term">ELT</td><td class="NLM_def"><p class="first last">escape latency time</p></td></tr><tr><td class="NLM_term">SEM</td><td class="NLM_def"><p class="first last">standard error of the mean</p></td></tr><tr><td class="NLM_term">TLC</td><td class="NLM_def"><p class="first last">thin-layer chromatography</p></td></tr><tr><td class="NLM_term">HRMS</td><td class="NLM_def"><p class="first last">high-resolution mass spectrometry</p></td></tr><tr><td class="NLM_term">EA</td><td class="NLM_def"><p class="first last">ethyl acetate</p></td></tr><tr><td class="NLM_term">PE</td><td class="NLM_def"><p class="first last">petroleum ether</p></td></tr><tr><td class="NLM_term">DCM</td><td class="NLM_def"><p class="first last">dichloromethane</p></td></tr><tr><td class="NLM_term">DMF</td><td class="NLM_def"><p class="first last"><i>N</i>,<i>N</i>-dimethylformamide</p></td></tr><tr><td class="NLM_term">THF</td><td class="NLM_def"><p class="first last">tetrahydrofuran</p></td></tr><tr><td class="NLM_term">AIBN</td><td class="NLM_def"><p class="first last">2,2′-azo-bis-isobutyronitrile</p></td></tr><tr><td class="NLM_term">DMSO</td><td class="NLM_def"><p class="first last">dimethyl sulfoxide</p></td></tr><tr><td class="NLM_term">IPTG</td><td class="NLM_def"><p class="first last">isopropyl-β-<span class="smallcaps smallerCapital">d</span>-thiogalactopyranoside</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i76">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_75703" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_75703" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 52 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Conti, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beavo, J.</span></span> <span> </span><span class="NLM_article-title">Biochemistry and Physiology of Cyclic Nucleotide Phosphodiesterases: Essential Components in Cyclic Nucleotide Signaling</span>. <i>Annu. Rev. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>76</i></span>,  <span class="NLM_fpage">481</span>– <span class="NLM_lpage">511</span>, <span class="refDoi"> DOI: 10.1146/annurev.biochem.76.060305.150444</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=10.1146%2Fannurev.biochem.76.060305.150444" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=17376027" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtVehtb%252FE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=76&publication_year=2007&pages=481-511&author=M.+Contiauthor=J.+Beavo&title=Biochemistry+and+Physiology+of+Cyclic+Nucleotide+Phosphodiesterases%3A+Essential+Components+in+Cyclic+Nucleotide+Signaling&doi=10.1146%2Fannurev.biochem.76.060305.150444"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Biochemistry and physiology of cyclic nucleotide phosphodiesterases: essential components in cyclic nucleotide signaling</span></div><div class="casAuthors">Conti, Marco; Beavo, Joseph</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Biochemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">76</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">481-511</span>CODEN:
                <span class="NLM_cas:coden">ARBOAW</span>;
        ISSN:<span class="NLM_cas:issn">0066-4154</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review.  Although cyclic nucleotide phosphodiesterases (PDEs) were described soon after the discovery of cAMP, their complexity and functions in signaling is only recently beginning to become fully realized.  We now know that ≥100 different PDE proteins degrade cAMP and cGMP in eukaryotes.  A complex PDE gene organization and a large no. of PDE splicing variants serve to fine-tune cyclic nucleotide signals and contribute to specificity in signaling.  Here we review some of the major concepts related to our understanding of PDE function and regulation including: (1) the structure of catalytic and regulatory domains and arrangement in holoenzymes; (2) PDE integration into signaling complexes; (3) the nature and function of neg. and pos. feedback circuits that have been conserved in PDEs from prokaryotes to human; (4) the emerging assocn. of mutant PDE alleles with inherited diseases; and (5) the role of PDEs in generating subcellular signaling compartments.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrJviyUqGyR2rVg90H21EOLACvtfcHk0lgFCAI2W2HMXQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtVehtb%252FE&md5=4808b5e4b29337fab57e623d81a5f0f6</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1146%2Fannurev.biochem.76.060305.150444&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.biochem.76.060305.150444%26sid%3Dliteratum%253Aachs%26aulast%3DConti%26aufirst%3DM.%26aulast%3DBeavo%26aufirst%3DJ.%26atitle%3DBiochemistry%2520and%2520Physiology%2520of%2520Cyclic%2520Nucleotide%2520Phosphodiesterases%253A%2520Essential%2520Components%2520in%2520Cyclic%2520Nucleotide%2520Signaling%26jtitle%3DAnnu.%2520Rev.%2520Biochem.%26date%3D2007%26volume%3D76%26spage%3D481%26epage%3D511%26doi%3D10.1146%2Fannurev.biochem.76.060305.150444" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Francis, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blount, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corbin, J. D.</span></span> <span> </span><span class="NLM_article-title">Mammalian Cyclic Nucleotide Phosphodiesterases: Molecular Mechanisms and Physiological Functions</span>. <i>Physiol. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>91</i></span>,  <span class="NLM_fpage">651</span>– <span class="NLM_lpage">690</span>, <span class="refDoi"> DOI: 10.1152/physrev.00030.2010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=10.1152%2Fphysrev.00030.2010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=21527734" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=1%3ACAS%3A528%3ADC%252BC3MXns1Cms7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=91&publication_year=2011&pages=651-690&author=S.+H.+Francisauthor=M.+A.+Blountauthor=J.+D.+Corbin&title=Mammalian+Cyclic+Nucleotide+Phosphodiesterases%3A+Molecular+Mechanisms+and+Physiological+Functions&doi=10.1152%2Fphysrev.00030.2010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Mammalian cyclic nucleotide phosphodiesterases: molecular mechanisms and physiological functions</span></div><div class="casAuthors">Francis, Sharron H.; Blount, Mitsi A.; Corbin, Jackie D.</div><div class="citationInfo"><span class="NLM_cas:title">Physiological Reviews</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">91</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">651-690</span>CODEN:
                <span class="NLM_cas:coden">PHREA7</span>;
        ISSN:<span class="NLM_cas:issn">0031-9333</span>.
    
            (<span class="NLM_cas:orgname">American Physiological Society</span>)
        </div><div class="casAbstract">A review.  The superfamily of cyclic nucleotide (cN) phosphodiesterases (PDEs) is comprised of 11 families of enzymes.  PDEs break down cAMP and/or cGMP and are major determinants of cellular cN levels and, consequently, the actions of cN-signaling pathways.  PDEs exhibit a range of catalytic efficiencies for breakdown of cAMP and/or cGMP and are regulated by myriad processes including phosphorylation, cN binding to allosteric GAF domains, changes in expression levels, interaction with regulatory or anchoring proteins, and reversible translocation among subcellular compartments.  Selective PDE inhibitors are currently in clin. use for treatment of erectile dysfunction, pulmonary hypertension, intermittent claudication, and chronic pulmonary obstructive disease; many new inhibitors are being developed for treatment of these and other maladies.  Recently reported x-ray crystallog. structures have defined features that provide for specificity for cAMP or cGMP in PDE catalytic sites or their GAF domains, as well as mechanisms involved in catalysis, oligomerization, autoinhibition, and interactions with inhibitors.  In addn., major advances have been made in understanding the physiol. impact and the biochem. basis for selective localization and/or recruitment of specific PDE isoenzymes to particular subcellular compartments.  The many recent advances in understanding PDE structures, functions, and physiol. actions are discussed in this review.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrN99wWYsCXRbVg90H21EOLACvtfcHk0lh3t8nPB_bv_Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXns1Cms7o%253D&md5=4aae757704a6243c9aa2648c32d5c759</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1152%2Fphysrev.00030.2010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fphysrev.00030.2010%26sid%3Dliteratum%253Aachs%26aulast%3DFrancis%26aufirst%3DS.%2BH.%26aulast%3DBlount%26aufirst%3DM.%2BA.%26aulast%3DCorbin%26aufirst%3DJ.%2BD.%26atitle%3DMammalian%2520Cyclic%2520Nucleotide%2520Phosphodiesterases%253A%2520Molecular%2520Mechanisms%2520and%2520Physiological%2520Functions%26jtitle%3DPhysiol.%2520Rev.%26date%3D2011%26volume%3D91%26spage%3D651%26epage%3D690%26doi%3D10.1152%2Fphysrev.00030.2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Keravis, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lugnier, C.</span></span> <span> </span><span class="NLM_article-title">Cyclic Nucleotide Phosphodiesterase (PDE) Isozymes as Targets of the Intracellular Signalling Network: Benefits of PDE Inhibitors in Various Diseases and Perspectives for Future Therapeutic Developments</span>. <i>Br. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>165</i></span>,  <span class="NLM_fpage">1288</span>– <span class="NLM_lpage">1305</span>, <span class="refDoi"> DOI: 10.1111/j.1476-5381.2011.01729.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=10.1111%2Fj.1476-5381.2011.01729.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=22014080" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=1%3ACAS%3A528%3ADC%252BC38Xis1Ohtb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=165&publication_year=2012&pages=1288-1305&author=T.+Keravisauthor=C.+Lugnier&title=Cyclic+Nucleotide+Phosphodiesterase+%28PDE%29+Isozymes+as+Targets+of+the+Intracellular+Signalling+Network%3A+Benefits+of+PDE+Inhibitors+in+Various+Diseases+and+Perspectives+for+Future+Therapeutic+Developments&doi=10.1111%2Fj.1476-5381.2011.01729.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Cyclic nucleotide phosphodiesterase (PDE) isozymes as targets of the intracellular signalling network: benefits of PDE inhibitors in various diseases and perspectives for future therapeutic developments</span></div><div class="casAuthors">Keravis, Therese; Lugnier, Claire</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">165</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1288-1305</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  Cyclic nucleotide phosphodiesterases (PDEs) that specifically inactivate the intracellular messengers cAMP and cGMP in a compartmentalized manner represent an important enzyme class constituted by 11 gene-related families of isoenzymes (PDE1 to PDE11).  Downstream receptors, PDEs play a major role in controlling the signalosome at various levels of phosphorylations and protein/protein interactions.  Due to the multiplicity of isoenzymes, their various intracellular regulations and their different cellular and subcellular distributions, PDEs represent interesting targets in intracellular pathways.  Therefore, the investigation of PDE isoenzyme alterations related to various pathologies and the design of specific PDE inhibitors might lead to the development of new specific therapeutic strategies in numerous pathologies.  This manuscript (i) overviews the different PDEs including their endogenous regulations and their specific inhibitors; (ii) analyses the intracellular implications of PDEs in regulating signalling cascades in pathogenesis, exemplified by two diseases affecting cell cycle and proliferation; and (iii) discusses perspectives for future therapeutic developments.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqvr2jfPTxnY7Vg90H21EOLACvtfcHk0lh3t8nPB_bv_Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xis1Ohtb8%253D&md5=dbf5913bc6c973d0640258c51b7c481d</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1111%2Fj.1476-5381.2011.01729.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1476-5381.2011.01729.x%26sid%3Dliteratum%253Aachs%26aulast%3DKeravis%26aufirst%3DT.%26aulast%3DLugnier%26aufirst%3DC.%26atitle%3DCyclic%2520Nucleotide%2520Phosphodiesterase%2520%2528PDE%2529%2520Isozymes%2520as%2520Targets%2520of%2520the%2520Intracellular%2520Signalling%2520Network%253A%2520Benefits%2520of%2520PDE%2520Inhibitors%2520in%2520Various%2520Diseases%2520and%2520Perspectives%2520for%2520Future%2520Therapeutic%2520Developments%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2012%26volume%3D165%26spage%3D1288%26epage%3D1305%26doi%3D10.1111%2Fj.1476-5381.2011.01729.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Omori, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kotera, J.</span></span> <span> </span><span class="NLM_article-title">Overview of PDEs and Their Regulation</span>. <i>Circ. Res.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>100</i></span>,  <span class="NLM_fpage">309</span>– <span class="NLM_lpage">327</span>, <span class="refDoi"> DOI: 10.1161/01.res.0000256354.95791.f1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=10.1161%2F01.RES.0000256354.95791.f1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=17307970" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsF2kurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=2007&pages=309-327&author=K.+Omoriauthor=J.+Kotera&title=Overview+of+PDEs+and+Their+Regulation&doi=10.1161%2F01.res.0000256354.95791.f1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Overview of PDEs and their regulation</span></div><div class="casAuthors">Omori, Kenji; Kotera, Jun</div><div class="citationInfo"><span class="NLM_cas:title">Circulation Research</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">100</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">309-327</span>CODEN:
                <span class="NLM_cas:coden">CIRUAL</span>;
        ISSN:<span class="NLM_cas:issn">0009-7330</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">A review.  Contraction and relaxation of vascular smooth muscle and cardiac myocytes are key physiol. events in the cardiovascular system.  These events are regulated by 2nd messengers, cAMP and cGMP, in response to extracellular stimulants.  The strength of signal transduction is controlled by intracellular cyclic nucleotide concns., which are detd. by a balance in the prodn. and degrdn. of cAMP and cGMP.  The degrdn. of cyclic nucleotides is catalyzed by 3',5'-cyclic nucleotide phosphodiesterases (PDEs), and therefore regulation of PDEs hydrolytic activity is important for modulation of cellular functions.  Mammalian PDEs are composed of 21 genes and are categorized into 11 families based on sequence homol., enzymic properties, and sensitivity to inhibitors.  PDE families contain many splice variants that mostly are unique in tissue-expression patterns, gene regulation, enzymic regulation by phosphorylation and regulatory proteins, subcellular localization, and interaction with assocn. proteins.  Each unique variant is closely related to the regulation of a specific cellular signaling.  Thus, multiple PDEs function as a particular modulator of each cardiovascular function and regulate physiol. homeostasis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrctQ0OjiRTE7Vg90H21EOLACvtfcHk0liGsT1QuIoEdA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsF2kurY%253D&md5=932f5158c5ebdd9a75a41317b0b12955</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1161%2F01.RES.0000256354.95791.f1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252F01.RES.0000256354.95791.f1%26sid%3Dliteratum%253Aachs%26aulast%3DOmori%26aufirst%3DK.%26aulast%3DKotera%26aufirst%3DJ.%26atitle%3DOverview%2520of%2520PDEs%2520and%2520Their%2520Regulation%26jtitle%3DCirc.%2520Res.%26date%3D2007%26volume%3D100%26spage%3D309%26epage%3D327%26doi%3D10.1161%2F01.res.0000256354.95791.f1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pissarnitski, D.</span></span> <span> </span><span class="NLM_article-title">Phosphodiesterase 5 (PDE 5) Inhibitors for the Treatment of Male Erectile Disorder: Attaining Selectivity Versus PDE6</span>. <i>Med. Res. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">369</span>– <span class="NLM_lpage">395</span>, <span class="refDoi"> DOI: 10.1002/med.20053</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=10.1002%2Fmed.20053" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=16388517" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=1%3ACAS%3A528%3ADC%252BD28XksFSlsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2006&pages=369-395&author=D.+Pissarnitski&title=Phosphodiesterase+5+%28PDE+5%29+Inhibitors+for+the+Treatment+of+Male+Erectile+Disorder%3A+Attaining+Selectivity+Versus+PDE6&doi=10.1002%2Fmed.20053"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Phosphodiesterase 5 (PDE 5) inhibitors for the treatment of male erectile disorder: attaining selectivity versus PDE6</span></div><div class="casAuthors">Pissarnitski, Dmitri</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Research Reviews</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">369-395</span>CODEN:
                <span class="NLM_cas:coden">MRREDD</span>;
        ISSN:<span class="NLM_cas:issn">0198-6325</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review.  The role of phosphodiesterase type 5 (PDE5) in the mechanism of male erection has been well understood, and several drugs inhibiting this enzyme are being used for the treatment of erectile dysfunction (ED).  Discovery of inhibitors with improved selectivity vs. other PDE isoenzymes could lead to drugs with improved safety profile.  Achievement of selectivity vs. PDE6, co-inhibition of which results in disturbances of color perception, remains the most challenging aspect of current drug discovery programs.  The present review describes several case studies, where significant (>100 fold) selectivity vs. PDE6 has been attained via investigation of structure-activity relationships (SAR).  Special attention is given to the chem. routes leading to novel chemotypes and allowing efficient exploration of their SAR's.  Strategies for attaining inhibitor selectivity discussed below may be applicable for other drug discovery programs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo4b-KLkyrEO7Vg90H21EOLACvtfcHk0liGsT1QuIoEdA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XksFSlsLg%253D&md5=a272cd37ec48db5bdb7c8a0620f1cc9c</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1002%2Fmed.20053&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmed.20053%26sid%3Dliteratum%253Aachs%26aulast%3DPissarnitski%26aufirst%3DD.%26atitle%3DPhosphodiesterase%25205%2520%2528PDE%25205%2529%2520Inhibitors%2520for%2520the%2520Treatment%2520of%2520Male%2520Erectile%2520Disorder%253A%2520Attaining%2520Selectivity%2520Versus%2520PDE6%26jtitle%3DMed.%2520Res.%2520Rev.%26date%3D2006%26volume%3D26%26spage%3D369%26epage%3D395%26doi%3D10.1002%2Fmed.20053" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kokkonen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kass, D. A.</span></span> <span> </span><span class="NLM_article-title">Nanodomain Regulation of Cardiac Cyclic Nucleotide Signaling by Phosphodiesterases</span>. <i>Annu. Rev. Pharmacol. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">455</span>– <span class="NLM_lpage">479</span>, <span class="refDoi"> DOI: 10.1146/annurev-pharmtox-010716-104756</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=10.1146%2Fannurev-pharmtox-010716-104756" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=27732797" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhs1ykt7rN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2017&pages=455-479&author=K.+Kokkonenauthor=D.+A.+Kass&title=Nanodomain+Regulation+of+Cardiac+Cyclic+Nucleotide+Signaling+by+Phosphodiesterases&doi=10.1146%2Fannurev-pharmtox-010716-104756"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Nanodomain Regulation of Cardiac Cyclic Nucleotide Signaling by Phosphodiesterases</span></div><div class="casAuthors">Kokkonen, Kristen; Kass, David A.</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Pharmacology and Toxicology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">455-479</span>CODEN:
                <span class="NLM_cas:coden">ARPTDI</span>;
        ISSN:<span class="NLM_cas:issn">0362-1642</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews</span>)
        </div><div class="casAbstract">A review.  Cyclic nucleotide phosphodiesterases (PDEs) form an 11-member superfamily comprising 100 different isoforms that regulate the second messengers cyclic adenosine or guanosine 3',5'-monophosphate (cAMP or cGMP).  These PDE isoforms differ with respect to substrate selectivity and their localized control of cAMP and cGMP within nanodomains that target specific cellular pools and synthesis pathways for the cyclic nucleotides.  Seven PDE family members are physiol. relevant to regulating cardiac function, disease remodeling of the heart, or both: PDE1 and PDE2, both dual-substrate (cAMP and cGMP) esterases; PDE3, PDE4, and PDE8, which principally hydrolyze cAMP; and PDE5A and PDE9A, which target cGMP.  New insights regarding the different roles of PDEs in health and disease and their local signaling control are broadening the potential therapeutic utility for PDE-selective inhibitors.  In this review, we discuss these PDEs, focusing on the different mechanisms by which they control cardiac function in health and disease by regulating intracellular nanodomains.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGptHS7lTakIRrVg90H21EOLACvtfcHk0liGsT1QuIoEdA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhs1ykt7rN&md5=0bbfd7fecacc24ec40b76e7406495313</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1146%2Fannurev-pharmtox-010716-104756&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev-pharmtox-010716-104756%26sid%3Dliteratum%253Aachs%26aulast%3DKokkonen%26aufirst%3DK.%26aulast%3DKass%26aufirst%3DD.%2BA.%26atitle%3DNanodomain%2520Regulation%2520of%2520Cardiac%2520Cyclic%2520Nucleotide%2520Signaling%2520by%2520Phosphodiesterases%26jtitle%3DAnnu.%2520Rev.%2520Pharmacol.%2520Toxicol.%26date%3D2017%26volume%3D57%26spage%3D455%26epage%3D479%26doi%3D10.1146%2Fannurev-pharmtox-010716-104756" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Galiè, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghofrani, H. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Torbicki, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barst, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rubin, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Badesch, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fleming, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parpia, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burgess, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Branzi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grimminger, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurzyna, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simonneau, G.</span></span> <span> </span><span class="NLM_article-title">Sildenafil Citrate Therapy for Pulmonary Arterial Hypertension</span>. <i>N. Engl. J. Med.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>353</i></span>,  <span class="NLM_fpage">2148</span>– <span class="NLM_lpage">2157</span>, <span class="refDoi"> DOI: 10.1056/nejmoa050010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=10.1056%2FNEJMoa050010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=16291984" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht1ajtb%252FI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=353&publication_year=2005&pages=2148-2157&author=N.+Gali%C3%A8author=H.+A.+Ghofraniauthor=A.+Torbickiauthor=R.+J.+Barstauthor=L.+J.+Rubinauthor=D.+Badeschauthor=T.+Flemingauthor=T.+Parpiaauthor=G.+Burgessauthor=A.+Branziauthor=F.+Grimmingerauthor=M.+Kurzynaauthor=G.+Simonneau&title=Sildenafil+Citrate+Therapy+for+Pulmonary+Arterial+Hypertension&doi=10.1056%2Fnejmoa050010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Sildenafil citrate therapy for pulmonary arterial hypertension</span></div><div class="casAuthors">Galie, Nazzareno; Ghofrani, Hossein A.; Torbicki, Adam; Barst, Robyn J.; Rubin, Lewis J.; Badesch, David; Fleming, Thomas; Parpia, Tamiza; Burgess, Gary; Branzi, Angelo; Grimminger, Friedrich; Kurzyna, Marcin; Simonneau, Gerald</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">353</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">2148-2157</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">BACKGROUND: Sildenafil inhibits phosphodiesterase type 5, an enzyme that metabolizes cGMP, thereby enhancing the cGMP-mediated relaxation and growth inhibition of vascular smooth-muscle cells, including those in the lung.  METHODS: In this double-blind, placebo-controlled study, we randomly assigned 278 patients with symptomatic pulmonary arterial hypertension (either idiopathic or assocd. with connective-tissue disease or with repaired congenital systemic-to-pulmonary shunts) to placebo or sildenafil (20, 40, or 80 mg) orally three times daily for 12 wk.  The primary end point was the change from baseline to week 12 in the distance walked in six minutes.  The change in mean pulmonary-artery pressure and World Health Organization (WHO) functional class and the incidence of clin. worsening were also assessed, but the study was not powered to assess mortality.  Patients completing the 12-wk randomized study could enter a long-term extension study.  RESULTS: The distance walked in six minutes increased from baseline in all sildenafil groups; the mean placebo-cor. treatment effects were 45 m (+ 13.0 %), 46 m (+ 13.3 %), and 50 m (+ 14.7 %) for 20, 40, and 80 mg of sildenafil, resp. (P < 0.001 for all comparisons).  All sildenafil doses reduced the mean pulmonary-artery pressure (P = 0.04, P = 0.01, and P < 0.001, resp.), improved the WHO functional class (P = 0.003, P < 0.001, and P < 0.001, resp.), and were assocd. with side effects such as flushing, dyspepsia, and diarrhea.  The incidence of clin. worsening did not differ significantly between the patients treated with sildenafil and those treated with placebo.  Among the 222 patients completing one year of treatment with sildenafil monotherapy, the improvement from baseline at one year in the distance walked in six minutes was 51 m.  CONCLUSIONS: Sildenafil improves exercise capacity, WHO functional class, and hemodynamics in patients with symptomatic pulmonary arterial hypertension.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqdRmk6YHttM7Vg90H21EOLACvtfcHk0lg8sdwPv7Nc2Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht1ajtb%252FI&md5=98f9d612bdeb37178f0910263d9ca97f</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa050010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa050010%26sid%3Dliteratum%253Aachs%26aulast%3DGali%25C3%25A8%26aufirst%3DN.%26aulast%3DGhofrani%26aufirst%3DH.%2BA.%26aulast%3DTorbicki%26aufirst%3DA.%26aulast%3DBarst%26aufirst%3DR.%2BJ.%26aulast%3DRubin%26aufirst%3DL.%2BJ.%26aulast%3DBadesch%26aufirst%3DD.%26aulast%3DFleming%26aufirst%3DT.%26aulast%3DParpia%26aufirst%3DT.%26aulast%3DBurgess%26aufirst%3DG.%26aulast%3DBranzi%26aufirst%3DA.%26aulast%3DGrimminger%26aufirst%3DF.%26aulast%3DKurzyna%26aufirst%3DM.%26aulast%3DSimonneau%26aufirst%3DG.%26atitle%3DSildenafil%2520Citrate%2520Therapy%2520for%2520Pulmonary%2520Arterial%2520Hypertension%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2005%26volume%3D353%26spage%3D2148%26epage%3D2157%26doi%3D10.1056%2Fnejmoa050010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Baillie, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tejeda, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelly, M. P.</span></span> <span> </span><span class="NLM_article-title">Therapeutic Targeting of 3′,5′-Cyclic Nucleotide Phosphodiesterases: Inhibition and Beyond</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">770</span>– <span class="NLM_lpage">796</span>, <span class="refDoi"> DOI: 10.1038/s41573-019-0033-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=10.1038%2Fs41573-019-0033-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=31388135" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhsFamtLfF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2019&pages=770-796&author=G.+S.+Baillieauthor=G.+S.+Tejedaauthor=M.+P.+Kelly&title=Therapeutic+Targeting+of+3%E2%80%B2%2C5%E2%80%B2-Cyclic+Nucleotide+Phosphodiesterases%3A+Inhibition+and+Beyond&doi=10.1038%2Fs41573-019-0033-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Therapeutic targeting of 3',5'-cyclic nucleotide phosphodiesterases: inhibition and beyond</span></div><div class="casAuthors">Baillie, George S.; Tejeda, Gonzalo S.; Kelly, Michy P.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">770-796</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">A review.  Phosphodiesterases (PDEs), enzymes that degrade 3',5'-cyclic nucleotides, are being pursued as therapeutic targets for several diseases, including those affecting the nervous system, the cardiovascular system, fertility, immunity, cancer and metab.  Clin. development programs have focused exclusively on catalytic inhibition, which continues to be a strong focus of ongoing drug discovery efforts.  However, emerging evidence supports novel strategies to therapeutically target PDE function, including enhancing catalytic activity, normalizing altered compartmentalization and modulating post-translational modifications, as well as the potential use of PDEs as disease biomarkers.  Importantly, a more refined appreciation of the intramol. mechanisms regulating PDE function and trafficking is emerging, making these pioneering drug discovery efforts tractable.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_NtRRCDdas7Vg90H21EOLACvtfcHk0lg8sdwPv7Nc2Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhsFamtLfF&md5=f8a348c9c9e534227d60e4f635d90b25</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1038%2Fs41573-019-0033-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41573-019-0033-4%26sid%3Dliteratum%253Aachs%26aulast%3DBaillie%26aufirst%3DG.%2BS.%26aulast%3DTejeda%26aufirst%3DG.%2BS.%26aulast%3DKelly%26aufirst%3DM.%2BP.%26atitle%3DTherapeutic%2520Targeting%2520of%25203%25E2%2580%25B2%252C5%25E2%2580%25B2-Cyclic%2520Nucleotide%2520Phosphodiesterases%253A%2520Inhibition%2520and%2520Beyond%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2019%26volume%3D18%26spage%3D770%26epage%3D796%26doi%3D10.1038%2Fs41573-019-0033-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, N.</span></span> <span> </span><span class="NLM_article-title">Inhibitor of Phosphodiestearse-4 Improves Memory Deficits, Oxidative Stress, Neuroinflammation and Neuropathological Alterations in Mouse Models of Dementia of Alzheimer’s Type</span>. <i>Biomed. Pharmacother.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>88</i></span>,  <span class="NLM_fpage">698</span>– <span class="NLM_lpage">707</span>, <span class="refDoi"> DOI: 10.1016/j.biopha.2017.01.059</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=10.1016%2Fj.biopha.2017.01.059" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=28152479" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=1%3ACAS%3A528%3ADC%252BC2sXitVSlt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=88&publication_year=2017&pages=698-707&author=A.+Kumarauthor=N.+Singh&title=Inhibitor+of+Phosphodiestearse-4+Improves+Memory+Deficits%2C+Oxidative+Stress%2C+Neuroinflammation+and+Neuropathological+Alterations+in+Mouse+Models+of+Dementia+of+Alzheimer%E2%80%99s+Type&doi=10.1016%2Fj.biopha.2017.01.059"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibitor of Phosphodiestearse-4 improves memory deficits, oxidative stress, neuroinflammation and neuropathological alterations in mouse models of dementia of Alzheimer's Type</span></div><div class="casAuthors">Kumar, Amit; Singh, Nirmal</div><div class="citationInfo"><span class="NLM_cas:title">Biomedicine & Pharmacotherapy</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">88</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">698-707</span>CODEN:
                <span class="NLM_cas:coden">BIPHEX</span>;
        ISSN:<span class="NLM_cas:issn">0753-3322</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">The study investigates the potential of Rolipram a phosphodiesterase-4 inhibitor in cognitive deficits induced by streptozotocin (STZ, 3 mg/kg intracerebroventricularly) and natural ageing in mice.  Morris water maze (MWM) test was employed to evaluate learning and memory of the animals.  Extent of oxidative stress was measured by estg. the levels of brain glutathione (GSH) and thiobarbituric acid reactive species (TBARS).  Brain acetylcholinestrase (AChE) activity was also estd.  The brain activity of myeloperoxidase (MPO) was measured as a marker of inflammation.  STZ and ageing results in marked decline in MWM performance of the animals, reflecting impairment of learning and memory.  STZ treated mice and aged mice exhibited a marked accentuation of AChE activity, TBARS and MPO activity along with fall in GSH level.  Further the stained micrographs of STZ treated mice and aged mice indicate pathol. changes, severe neutrophilic infiltration and amyloid deposition.  Rolipram treatment significantly attenuated STZ induced and age related memory deficits, biochem. and histopathol. alterations.  The findings demonstrate the potential of Rolipram in memory dysfunctions which may probably be attributed to its anti-cholinesterase, anti-amyloid, anti-oxidative and anti-inflammatory effects.  The study concludes that PDE-4 can be explored as a potential therapeutic target in dementia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGolyQDD1R3sxrVg90H21EOLACvtfcHk0lg8sdwPv7Nc2Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXitVSlt7w%253D&md5=283d145e47d12940a38df6cfe8ae5b00</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2Fj.biopha.2017.01.059&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biopha.2017.01.059%26sid%3Dliteratum%253Aachs%26aulast%3DKumar%26aufirst%3DA.%26aulast%3DSingh%26aufirst%3DN.%26atitle%3DInhibitor%2520of%2520Phosphodiestearse-4%2520Improves%2520Memory%2520Deficits%252C%2520Oxidative%2520Stress%252C%2520Neuroinflammation%2520and%2520Neuropathological%2520Alterations%2520in%2520Mouse%2520Models%2520of%2520Dementia%2520of%2520Alzheimer%25E2%2580%2599s%2520Type%26jtitle%3DBiomed.%2520Pharmacother.%26date%3D2017%26volume%3D88%26spage%3D698%26epage%3D707%26doi%3D10.1016%2Fj.biopha.2017.01.059" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jabaris, S. G. S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sumathy, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Narayanan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thanikachalam, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Babu, C. S.</span></span> <span> </span><span class="NLM_article-title">Effects of Rolipram and Roflumilast, Phosphodiesterase-4 Inhibitors, on Hypertension-Induced Defects in Memory Function in Rats</span>. <i>Eur. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>746</i></span>,  <span class="NLM_fpage">138</span>– <span class="NLM_lpage">147</span>, <span class="refDoi"> DOI: 10.1016/j.ejphar.2014.10.039</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=10.1016%2Fj.ejphar.2014.10.039" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=25446433" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvFSmsLnO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=746&publication_year=2015&pages=138-147&author=S.+G.+S.+L.+Jabarisauthor=H.+Sumathyauthor=R.+S.+Kumarauthor=S.+Narayananauthor=S.+Thanikachalamauthor=C.+S.+Babu&title=Effects+of+Rolipram+and+Roflumilast%2C+Phosphodiesterase-4+Inhibitors%2C+on+Hypertension-Induced+Defects+in+Memory+Function+in+Rats&doi=10.1016%2Fj.ejphar.2014.10.039"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of rolipram and roflumilast, phosphodiesterase-4 inhibitors, on hypertension-induced defects in memory function in rats</span></div><div class="casAuthors">Jabaris, Sobhana George Sugin Lal; Sumathy, Haridass; Kumar, Ramadass Satiesh; Narayanan, Shridhar; Thanikachalam, Sadagopan; Babu, Chidambaram Saravana</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">746</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">138-147</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Hypertension (HT) is a prevailing risk factor for cognitive impairment, the most common cause of vascular dementia; yet, no possible mechanism underlying the cognitive impairment induced by hypertension has been identified so far.  Inhibition of PDE-4 has been shown to increase phosphorylation of cAMP-response element binding protein in the hippocampus and enhance the memory performance.  Here, we examd. the effects of PDE-4 inhibitors, rolipram and roflumilast, on the impairment of learning and memory obsd. in hypertensive rats.  We used 2k-1c hypertensive model to induce learning and memory defects.  In addn., mRNA expression of PDE-4 sub-types A-D was also assessed in the hippocampus tissue.  Systolic blood pressure (SBP) was measured by tail-cuff method was significantly increased in 2k-1c rats when compared to sham operated rats; this effect was reversed by clonidine, whereas, PDE-4 inhibitors did not.  PDE-4 inhibitors significantly reversed time induced memory deficit in novel object recognition task (NORT).  Further, the retention latency on the second day in the elevated plus maze model was significantly shortened after repeated administration of rolipram and roflumilast.  Plasma and brain concns. of rolipram, roflumilast and roflumilast N-oxide were also measured after the NORT and showed linear increase in plasma and brain concns.  The PDE4B and PDE4D gene expression was significantly enhanced in hypertensive rats compared with sham operated however PDE4A and PDE4C remained unaltered.  Repeated treatment with PDE-4 inhibitors caused down regulation of PDE4B and PDE4D in hypertensive rats.  These results suggest that inhibition of PDE-4 ameliorates HT-induced impairment of learning and memory functions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoKT6L29U_H4bVg90H21EOLACvtfcHk0lg8sdwPv7Nc2Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvFSmsLnO&md5=7a461c0debc0b3e2c32ec304846aed55</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2014.10.039&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2014.10.039%26sid%3Dliteratum%253Aachs%26aulast%3DJabaris%26aufirst%3DS.%2BG.%2BS.%2BL.%26aulast%3DSumathy%26aufirst%3DH.%26aulast%3DKumar%26aufirst%3DR.%2BS.%26aulast%3DNarayanan%26aufirst%3DS.%26aulast%3DThanikachalam%26aufirst%3DS.%26aulast%3DBabu%26aufirst%3DC.%2BS.%26atitle%3DEffects%2520of%2520Rolipram%2520and%2520Roflumilast%252C%2520Phosphodiesterase-4%2520Inhibitors%252C%2520on%2520Hypertension-Induced%2520Defects%2520in%2520Memory%2520Function%2520in%2520Rats%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2015%26volume%3D746%26spage%3D138%26epage%3D147%26doi%3D10.1016%2Fj.ejphar.2014.10.039" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Martinez, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gil, C.</span></span> <span> </span><span class="NLM_article-title">cAMP-Specific Phosphodiesterase Inhibitors: Promising Drugs for Inflammatory and Neurological Diseases</span>. <i>Expert Opin. Ther. Pat.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">1311</span>– <span class="NLM_lpage">1321</span>, <span class="refDoi"> DOI: 10.1517/13543776.2014.968127</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=10.1517%2F13543776.2014.968127" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=25284693" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvFejsr%252FN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2014&pages=1311-1321&author=A.+Martinezauthor=C.+Gil&title=cAMP-Specific+Phosphodiesterase+Inhibitors%3A+Promising+Drugs+for+Inflammatory+and+Neurological+Diseases&doi=10.1517%2F13543776.2014.968127"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">cAMP-specific phosphodiesterase inhibitors: promising drugs for inflammatory and neurological diseases</span></div><div class="casAuthors">Martinez, Ana; Gil, Carmen</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1311-1321</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">Introduction: PDEs are key enzymes in the adenosine and guanosine cyclic nucleotides (cAMP and cGMP) signaling cascade.  Their inhibition increases cyclic nucleotide levels inside the cell.  Thus, pharmacol. modulation of PDE activity can have profound effects on the function of cells and organ systems throughout the body.  Areas covered: Among the large PDE families, only PDE4, PDE7 and PDE8 are cAMP-specific hydrolyzing enzymes. cAMP is an important second messenger not only by its involvement in a vast no. of physiol. processes but also by activation of protein kinase A, exchange protein activated by cAMP (Epac) and cAMP response element-binding (CREB) or cyclic nucleotide-gated channels.  Clearly, such enzymes represent ideal drug targets for the pharmacol. treatment of many pathologies.  The discovery and development of small mols. targeting cAMP-specific PDEs reported in the last 5 years is the focus of the present review.  Expert opinion: The first PDE4 inhibitors recently reached the market, having avoided, by different strategies, their dose-limiting side effects (after more than two decades of drug development).  Meanwhile, new cAMP-specific PDE7 and PDE8 inhibitors emerged as effective and safe drugs for severe unmet diseases.  The therapeutic potential of these inhibitors will be tested in the near future, as many of these drug candidates are ready to start clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpPWFQGiKhADrVg90H21EOLACvtfcHk0lgU82osxdyY_w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvFejsr%252FN&md5=f9ef95eeccba94736c36de427c1715b0</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1517%2F13543776.2014.968127&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.2014.968127%26sid%3Dliteratum%253Aachs%26aulast%3DMartinez%26aufirst%3DA.%26aulast%3DGil%26aufirst%3DC.%26atitle%3DcAMP-Specific%2520Phosphodiesterase%2520Inhibitors%253A%2520Promising%2520Drugs%2520for%2520Inflammatory%2520and%2520Neurological%2520Diseases%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2014%26volume%3D24%26spage%3D1311%26epage%3D1321%26doi%3D10.1517%2F13543776.2014.968127" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rutten, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Basile, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prickaerts, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blokland, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vivian, J. A.</span></span> <span> </span><span class="NLM_article-title">Selective PDE Inhibitors Rolipram and Sildenafil Improve Object Retrieval Performance in Adult Cynomolgus Macaques</span>. <i>Psychopharmacology</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>196</i></span>,  <span class="NLM_fpage">643</span>– <span class="NLM_lpage">648</span>, <span class="refDoi"> DOI: 10.1007/s00213-007-0999-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=10.1007%2Fs00213-007-0999-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=18034336" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhvFyktbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=196&publication_year=2008&pages=643-648&author=K.+Ruttenauthor=J.+L.+Basileauthor=J.+Prickaertsauthor=A.+Bloklandauthor=J.+A.+Vivian&title=Selective+PDE+Inhibitors+Rolipram+and+Sildenafil+Improve+Object+Retrieval+Performance+in+Adult+Cynomolgus+Macaques&doi=10.1007%2Fs00213-007-0999-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Selective PDE inhibitors rolipram and sildenafil improve object retrieval performance in adult cynomolgus macaques</span></div><div class="casAuthors">Rutten, K.; Basile, J. L.; Prickaerts, J.; Blokland, A.; Vivian, J. A.</div><div class="citationInfo"><span class="NLM_cas:title">Psychopharmacology (Berlin, Germany)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">196</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">643-648</span>CODEN:
                <span class="NLM_cas:coden">PSCHDL</span>;
        ISSN:<span class="NLM_cas:issn">0033-3158</span>.
    
            (<span class="NLM_cas:orgname">Springer GmbH</span>)
        </div><div class="casAbstract">Rationale Selective phosphodiesterase (PDE) inhibitors improve the formation of hippocampus-dependent memories in several rodent models of cognition.  However, studies evaluating the effects of PDE inhibition on prefrontal cortex-dependent cognition and in monkeys are rare.  Objectives The present study investigates the effect of the PDE4 inhibitor rolipram and the PDE5 inhibitor sildenafil on object retrieval performance.  Object retrieval is a prefrontal cortical-mediated task, which is likely to capture attention and response inhibition.  Materials and methods The ability to retrieve a food reward from a clear box with an open side positioned in various orientations was assessed in adult male cynomolgus monkeys (Macaca fascicularis).  Results Rolipram (0.003-0.03 mg/kg, i.m. [i.m.]) and sildenafil (0.3-3 mg/kg, i.m.) dose-dependently increased correct first reaches during difficult trials, reaching significance at 0.01 and 1 mg/kg, resp.  For both drugs, correct reaches were increased approx. 20%; i.e., performance was improved from ∼50 to ∼70% correct.  Conclusions Both rolipram and sildenafil improved object retrieval performance, thus demonstrating the cognition-enhancing effects of PDE inhibition on a prefrontal task of executive function in monkeys.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrr2uGc94KR3rVg90H21EOLACvtfcHk0lgU82osxdyY_w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhvFyktbk%253D&md5=3f85149d89ef5eb0ebd4f6555df9bd0a</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1007%2Fs00213-007-0999-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00213-007-0999-1%26sid%3Dliteratum%253Aachs%26aulast%3DRutten%26aufirst%3DK.%26aulast%3DBasile%26aufirst%3DJ.%2BL.%26aulast%3DPrickaerts%26aufirst%3DJ.%26aulast%3DBlokland%26aufirst%3DA.%26aulast%3DVivian%26aufirst%3DJ.%2BA.%26atitle%3DSelective%2520PDE%2520Inhibitors%2520Rolipram%2520and%2520Sildenafil%2520Improve%2520Object%2520Retrieval%2520Performance%2520in%2520Adult%2520Cynomolgus%2520Macaques%26jtitle%3DPsychopharmacology%26date%3D2008%26volume%3D196%26spage%3D643%26epage%3D648%26doi%3D10.1007%2Fs00213-007-0999-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Monti, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berteotti, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Contestabile, A.</span></span> <span> </span><span class="NLM_article-title">Subchronic Rolipram Delivery Activates Hippocampal CREB and Arc, Enhances Retention and Slows down Extinction of Conditioned Fear</span>. <i>Neuropsychopharmacology</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>31</i></span>,  <span class="NLM_fpage">278</span>– <span class="NLM_lpage">286</span>, <span class="refDoi"> DOI: 10.1038/sj.npp.1300813</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=10.1038%2Fsj.npp.1300813" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=15988467" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=1%3ACAS%3A528%3ADC%252BD28XkvFymsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2006&pages=278-286&author=B.+Montiauthor=C.+Berteottiauthor=A.+Contestabile&title=Subchronic+Rolipram+Delivery+Activates+Hippocampal+CREB+and+Arc%2C+Enhances+Retention+and+Slows+down+Extinction+of+Conditioned+Fear&doi=10.1038%2Fsj.npp.1300813"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Subchronic Rolipram Delivery Activates Hippocampal CREB and Arc, Enhances Retention and Slows Down Extinction of Conditioned Fear</span></div><div class="casAuthors">Monti, Barbara; Berteotti, Chiara; Contestabile, Antonio</div><div class="citationInfo"><span class="NLM_cas:title">Neuropsychopharmacology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">278-286</span>CODEN:
                <span class="NLM_cas:coden">NEROEW</span>;
        ISSN:<span class="NLM_cas:issn">0893-133X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Rolipram, a type IV-specific phosphodiesterase inhibitor, is known to improve memory under various learning tasks.  Moreover, Rolipram treatments have been shown to increase expression and phosphorylation of a key factor for hippocampal memory consolidation, the cAMP-dependent response element-binding protein, CREB.  However, the exact correlation between hippocampal CREB phosphorylation and memory improvement induced by Rolipram has not yet been detd. in a CREB-dependent type of hippocampal-related learning in normogenic, intact rodents.  Here, we report that subchronic Rolipram delivery by using osmotic minipumps increased the basal rat hippocampal expression and phosphorylation of CREB, as well as the expression of the cAMP-dependent, memory-related protein, Arc.  In parallel, the same treatment improved memory consolidation of conditioned fear.  Furthermore, the increase of CREB phosphorylation and Arc expression consequent to the learning experience was enhanced in Rolipram-treated rats, compared to controls.  By evaluating the time course of memory extinction over 10 days after the initial learning test, we also obsd. significant slowing down of the memory extinction rate in Rolipram-treated rats.  This effect could be attributed to CREB phosphorylation and memory having been initially higher, as osmotic minipumps stopped to release Rolipram the first day after the initial learning test.  Our data define the conditions through which the pharmacol. manipulation of hippocampal CREB expression and activation result in memory amelioration in normogenic, intact animals.  These results are relevant for the study of mol. correlates of memory, and may also be important in view of the efforts to design new pharmacol. treatments, targeting the CREB pathway and leading to enhancement of learning and memory, even in the absence of patent neuropathol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoDGaiaPPepS7Vg90H21EOLACvtfcHk0lgU82osxdyY_w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XkvFymsQ%253D%253D&md5=2281024da42284207a9322c1f892430e</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1038%2Fsj.npp.1300813&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.npp.1300813%26sid%3Dliteratum%253Aachs%26aulast%3DMonti%26aufirst%3DB.%26aulast%3DBerteotti%26aufirst%3DC.%26aulast%3DContestabile%26aufirst%3DA.%26atitle%3DSubchronic%2520Rolipram%2520Delivery%2520Activates%2520Hippocampal%2520CREB%2520and%2520Arc%252C%2520Enhances%2520Retention%2520and%2520Slows%2520down%2520Extinction%2520of%2520Conditioned%2520Fear%26jtitle%3DNeuropsychopharmacology%26date%3D2006%26volume%3D31%26spage%3D278%26epage%3D286%26doi%3D10.1038%2Fsj.npp.1300813" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Guo, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zou, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, J.</span></span> <span> </span><span class="NLM_article-title">FFPM, a PDE4 Inhibitor, Reverses Learning and Memory Deficits in APP/PS1 Transgenic Mice via cAMP/PKA/CREB Signaling and anti-Inflammatory Effects</span>. <i>Neuropharmacology</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>116</i></span>,  <span class="NLM_fpage">260</span>– <span class="NLM_lpage">269</span>, <span class="refDoi"> DOI: 10.1016/j.neuropharm.2017.01.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=10.1016%2Fj.neuropharm.2017.01.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=28065587" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtFakt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=116&publication_year=2017&pages=260-269&author=H.+Guoauthor=Y.+Chengauthor=C.+Wangauthor=J.+Wuauthor=Z.+Zouauthor=B.+Niuauthor=H.+Yuauthor=H.+Wangauthor=J.+Xu&title=FFPM%2C+a+PDE4+Inhibitor%2C+Reverses+Learning+and+Memory+Deficits+in+APP%2FPS1+Transgenic+Mice+via+cAMP%2FPKA%2FCREB+Signaling+and+anti-Inflammatory+Effects&doi=10.1016%2Fj.neuropharm.2017.01.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">FFPM, a PDE4 inhibitor, reverses learning and memory deficits in APP/PS1 transgenic mice via cAMP/PKA/CREB signaling and anti-inflammatory effects</span></div><div class="casAuthors">Guo, Haibiao; Cheng, Yufang; Wang, Canmao; Wu, Jingang; Zou, Zhengqiang; Niu, Bo; Yu, Hui; Wang, Haitao; Xu, Jiangping</div><div class="citationInfo"><span class="NLM_cas:title">Neuropharmacology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">116</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">260-269</span>CODEN:
                <span class="NLM_cas:coden">NEPHBW</span>;
        ISSN:<span class="NLM_cas:issn">0028-3908</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Thus far, phosphodiesterase-4 (PDE4) inhibitors have not been approved for application in Alzheimer's disease (AD) in a clin. setting due to severe side effects, such as nausea and vomiting.  In this study, we investigated the effect of FFPM, a novel PDE4 inhibitor, on learning and memory abilities, as well as the underlying mechanism in the APP/PS1 mouse model of AD.  Pharmacokinetic studies have revealed that FFPM efficiently permeates into the brain, and reached peak values in plasma 2 h after orally dosing.  A 3-wk treatment with FFPM, at doses of 0.25 mg/kg and 0.5 mg/kg, significantly improved the learning and memory abilities of APP/PS1 transgenic mice in the Morris water maze and the Step-down passive avoidance task.  Interestingly, we found that while rolipram (0.5 mg/kg) reduced the duration of the α2 adrenergic receptor-mediated anesthesia induced by xylazine/ketamine, FFPM (0.5 mg/kg) or the vehicle did not have an evident effect.  FFPM increased the cAMP, PKA and CREB phosphorylation and BDNF levels, and reduced the NF-κB p65, iNOS, TNF-α and IL-1β levels in the hippocampi of APP/PS1 trangenic mice, as obsd. by ELISA and Western blot anal.  Taken together, our data demonstrated that the reversal effect of FFPM on cognitive deficits in APP/PS1 transgenic mice might be related to stimulation of the cAMP/PKA/CREB/BDNF pathway and anti-inflammatory effects.  Moreover, FFPM appears to have potential as an effective PDE4 inhibitor in AD treatment with little emetic potential.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqueQvekWB9CbVg90H21EOLACvtfcHk0lic_2je9FgVvw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtFakt70%253D&md5=024f56897208ce4c5c36e3a89d90c407</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2Fj.neuropharm.2017.01.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuropharm.2017.01.004%26sid%3Dliteratum%253Aachs%26aulast%3DGuo%26aufirst%3DH.%26aulast%3DCheng%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DC.%26aulast%3DWu%26aufirst%3DJ.%26aulast%3DZou%26aufirst%3DZ.%26aulast%3DNiu%26aufirst%3DB.%26aulast%3DYu%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DXu%26aufirst%3DJ.%26atitle%3DFFPM%252C%2520a%2520PDE4%2520Inhibitor%252C%2520Reverses%2520Learning%2520and%2520Memory%2520Deficits%2520in%2520APP%252FPS1%2520Transgenic%2520Mice%2520via%2520cAMP%252FPKA%252FCREB%2520Signaling%2520and%2520anti-Inflammatory%2520Effects%26jtitle%3DNeuropharmacology%26date%3D2017%26volume%3D116%26spage%3D260%26epage%3D269%26doi%3D10.1016%2Fj.neuropharm.2017.01.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Y.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, H.-B.</span></span> <span> </span><span class="NLM_article-title">Discovery and Optimization of α-Mangostin Derivatives as Novel PDE4 Inhibitors for the Treatment of Vascular Dementia</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>63</i></span>,  <span class="NLM_fpage">3370</span>– <span class="NLM_lpage">3380</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.0c00060</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.0c00060" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=1%3ACAS%3A528%3ADC%252BB3cXktlOgtbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2020&pages=3370-3380&author=J.+Liangauthor=Y.-Y.+Huangauthor=Q.+Zhouauthor=Y.+Gaoauthor=Z.+Liauthor=D.+Wuauthor=S.+Yuauthor=L.+Guoauthor=Z.+Chenauthor=L.+Huangauthor=S.+H.+Liangauthor=X.+Heauthor=R.+Wuauthor=H.-B.+Luo&title=Discovery+and+Optimization+of+%CE%B1-Mangostin+Derivatives+as+Novel+PDE4+Inhibitors+for+the+Treatment+of+Vascular+Dementia&doi=10.1021%2Facs.jmedchem.0c00060"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and Optimization of α-Mangostin Derivatives as Novel PDE4 Inhibitors for the Treatment of Vascular Dementia</span></div><div class="casAuthors">Liang, Jinhao; Huang, Yi-You; Zhou, Qian; Gao, Yuqi; Li, Zhe; Wu, Deyan; Yu, Si; Guo, Lei; Chen, Zhen; Huang, Ling; Liang, Steven H.; He, Xixin; Wu, Ruibo; Luo, Hai-Bin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">3370-3380</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">To validate PDE4 inhibitors as novel therapeutic agents against vascular dementia (VaD), 25 derivs. were discovered from the natural inhibitor α-mangostin (IC50 = 1.31 μM).  Hit-to-lead optimization identified a novel and selective PDE4 inhibitor 4e (IC50 = 17 nM), which adopted a different binding pattern from PDE4 inhibitors roflumilast and rolipram.  Oral administration of 4e at a dose of 10 mg/kg exhibited remarkable therapeutic effects in a VaD model and did not cause emesis to beagle dogs, indicating its potential as a novel anti-VaD agent.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpH4L06cQSRF7Vg90H21EOLACvtfcHk0lic_2je9FgVvw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXktlOgtbs%253D&md5=0b69626948b61a2b40d63b6762be855c</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.0c00060&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.0c00060%26sid%3Dliteratum%253Aachs%26aulast%3DLiang%26aufirst%3DJ.%26aulast%3DHuang%26aufirst%3DY.-Y.%26aulast%3DZhou%26aufirst%3DQ.%26aulast%3DGao%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DWu%26aufirst%3DD.%26aulast%3DYu%26aufirst%3DS.%26aulast%3DGuo%26aufirst%3DL.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DHuang%26aufirst%3DL.%26aulast%3DLiang%26aufirst%3DS.%2BH.%26aulast%3DHe%26aufirst%3DX.%26aulast%3DWu%26aufirst%3DR.%26aulast%3DLuo%26aufirst%3DH.-B.%26atitle%3DDiscovery%2520and%2520Optimization%2520of%2520%25CE%25B1-Mangostin%2520Derivatives%2520as%2520Novel%2520PDE4%2520Inhibitors%2520for%2520the%2520Treatment%2520of%2520Vascular%2520Dementia%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2020%26volume%3D63%26spage%3D3370%26epage%3D3380%26doi%3D10.1021%2Facs.jmedchem.0c00060" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Boswell-Smith, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spina, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Page, C. P.</span></span> <span> </span><span class="NLM_article-title">Phosphodiesterase Inhibitors</span>. <i>Br. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>147</i></span>,  <span class="NLM_fpage">S252</span>– <span class="NLM_lpage">S257</span>, <span class="refDoi"> DOI: 10.1038/sj.bjp.0706495</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=10.1038%2Fsj.bjp.0706495" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=16402111" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=1%3ACAS%3A528%3ADC%252BD28XisVCksw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=147&publication_year=2006&pages=S252-S257&author=V.+Boswell-Smithauthor=D.+Spinaauthor=C.+P.+Page&title=Phosphodiesterase+Inhibitors&doi=10.1038%2Fsj.bjp.0706495"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Phosphodiesterase inhibitors</span></div><div class="casAuthors">Boswell-Smith, Victoria; Spina, Domenico; Page, Clive P.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">147</span>
        (<span class="NLM_cas:issue">Suppl. 1</span>),
    <span class="NLM_cas:pages">S252-S257</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Phosphodiesterases are a diverse family of enzymes that hydrolyze cyclic nucleotides and thus play a key role in regulating intracellular levels of the second messengers cAMP and cGMP, and hence cell function.  Theophylline and papaverine have historically been used therapeutically and are known to be weak inhibitors of PDE, but to what extent this contributed toward their clin. efficacy was poorly defined.  However, the discovery of 11 isoenzyme families and our increased understanding of their function at the cell and mol. level provides an impetus for the development of isoenzyme selective inhibitors for the treatment of various diseases.  This review focuses on the development of PDE3 inhibitors for congestive heart failure, PDE4 inhibitors for inflammatory airways disease and most successfully, PDE5 inhibitors for erectile dysfunction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqImKBaZ--2N7Vg90H21EOLACvtfcHk0lhCdH4_X0wlgA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XisVCksw%253D%253D&md5=43dee6e45632455b864581e7a7e368e7</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjp.0706495&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjp.0706495%26sid%3Dliteratum%253Aachs%26aulast%3DBoswell-Smith%26aufirst%3DV.%26aulast%3DSpina%26aufirst%3DD.%26aulast%3DPage%26aufirst%3DC.%2BP.%26atitle%3DPhosphodiesterase%2520Inhibitors%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2006%26volume%3D147%26spage%3DS252%26epage%3DS257%26doi%3D10.1038%2Fsj.bjp.0706495" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vercambre, M.-N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berr, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ritchie, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, J. H.</span></span> <span> </span><span class="NLM_article-title">Caffeine and Cognitive Decline in Elderly Women at High Vascular Risk</span>. <i>J. Alzheimer’s Dis.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">413</span>– <span class="NLM_lpage">421</span>, <span class="refDoi"> DOI: 10.3233/jad-122371</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=10.3233%2FJAD-122371" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=23422357" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=1%3ACAS%3A528%3ADC%252BC3sXmt1Sisbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2013&pages=413-421&author=M.-N.+Vercambreauthor=C.+Berrauthor=K.+Ritchieauthor=J.+H.+Kang&title=Caffeine+and+Cognitive+Decline+in+Elderly+Women+at+High+Vascular+Risk&doi=10.3233%2Fjad-122371"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Caffeine and Cognitive Decline in Elderly Women at High Vascular Risk</span></div><div class="casAuthors">Vercambre, Marie-Noel; Berr, Claudine; Ritchie, Karen; Kang, Jae H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Alzheimer's Disease</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">413-421</span>CODEN:
                <span class="NLM_cas:coden">JADIF9</span>;
        ISSN:<span class="NLM_cas:issn">1387-2877</span>.
    
            (<span class="NLM_cas:orgname">IOS Press</span>)
        </div><div class="casAbstract">Background: Persons with vascular disorders are at higher risk of cognitive decline.  Objective: To det. whether caffeine may be assocd. with cognitive decline redn. in elderly at high vascular risk.  Methods: We included 2,475 women aged 65+ years in the Women's Antioxidant Cardiovascular Study, a randomized trial of antioxidants and B vitamins for cardiovascular disease secondary prevention.  We ascertained regular caffeine intake at baseline (1995-1996) using a validated 116 item-food frequency questionnaire.  From 1998-2000 to 2005-2006, we administered four telephone cognitive assessments at two-year intervals evaluating global cognition, verbal memory, and category fluency.  The primary outcome was the change in global cognitive score, which was the av. of the z-scores of all tests.  We used generalized linear models for repeated measures that were adjusted for various sociodemog., health, and lifestyle factors to evaluate the difference in cognitive decline rates across quintiles of caffeine intake.  Results: We obsd. significantly slower rates of cognitive decline with increasing caffeine intake (p-trend = 0.02).  The rate difference between the highest and lowest quintiles of usual caffeine intake (>371 vs. <30 mg/day) was equiv. to that obsd. between those who were 7 years apart in age (p = 0.006).  Consumption of caffeinated coffee was significantly related to slower cognitive decline (p-trend = 0.05), but not other caffeinated products (e.g., decaf, tea, cola, chocolate).  We conducted interaction analyses and obsd. stronger assocns. in women assigned to vitamin B supplementation (p-interaction = 0.02).  Conclusions: Caffeine intake was related to moderately better cognitive maintenance over 5 years in older women with vascular disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGryMo1SIfe3YbVg90H21EOLACvtfcHk0lhCdH4_X0wlgA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXmt1Sisbs%253D&md5=93f3a2500f2d46cf434ba86edc4205ac</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.3233%2FJAD-122371&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3233%252FJAD-122371%26sid%3Dliteratum%253Aachs%26aulast%3DVercambre%26aufirst%3DM.-N.%26aulast%3DBerr%26aufirst%3DC.%26aulast%3DRitchie%26aufirst%3DK.%26aulast%3DKang%26aufirst%3DJ.%2BH.%26atitle%3DCaffeine%2520and%2520Cognitive%2520Decline%2520in%2520Elderly%2520Women%2520at%2520High%2520Vascular%2520Risk%26jtitle%3DJ.%2520Alzheimer%25E2%2580%2599s%2520Dis.%26date%3D2013%26volume%3D35%26spage%3D413%26epage%3D421%26doi%3D10.3233%2Fjad-122371" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Driscoll, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shumaker, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Snively, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Margolis, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manson, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vitolins, M. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rossom, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Espeland, M. A.</span></span> <span> </span><span class="NLM_article-title">Relationships Between Caffeine Intake and Risk for Probable Dementia or Global Cognitive Impairment: The Women’s Health Initiative Memory Study</span>. <i>J. Gerontol., Ser. A</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>71</i></span>,  <span class="NLM_fpage">1596</span>– <span class="NLM_lpage">1602</span>, <span class="refDoi"> DOI: 10.1093/gerona/glw078</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=10.1093%2Fgerona%2Fglw078" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=27678290" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=1%3ACAS%3A528%3ADC%252BC1cXlsVCku7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2016&pages=1596-1602&author=I.+Driscollauthor=S.+A.+Shumakerauthor=B.+M.+Snivelyauthor=K.+L.+Margolisauthor=J.+E.+Mansonauthor=M.+Z.+Vitolinsauthor=R.+C.+Rossomauthor=M.+A.+Espeland&title=Relationships+Between+Caffeine+Intake+and+Risk+for+Probable+Dementia+or+Global+Cognitive+Impairment%3A+The+Women%E2%80%99s+Health+Initiative+Memory+Study&doi=10.1093%2Fgerona%2Fglw078"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Relationships between caffeine intake and risk for probable dementia or global cognitive impairment: the Women's Health Initiative Memory Study</span></div><div class="casAuthors">Driscoll, Ira; Shumaker, Sally A.; Snively, Beverly M.; Margolis, Karen L.; Manson, JoAnn E.; Vitolins, Mara Z.; Rossom, Rebecca C.; Espeland, Mark A.</div><div class="citationInfo"><span class="NLM_cas:title">Journals of Gerontology, Series A: Biological Sciences and Medical Sciences</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">71</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1596-1602</span>CODEN:
                <span class="NLM_cas:coden">JGASFW</span>;
        ISSN:<span class="NLM_cas:issn">1079-5006</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Background: Nonhuman studies suggest a protective effect of caffeine on cognition.  Although human literature remains less consistent, reviews suggest a possible favorable relationship between caffeine consumption and cognitive impairment or dementia.  We investigated the relationship between caffeine intake and incidence of cognitive impairment or probable dementia in women aged 65 and older from the Women's Health Initiative Memory Study.  Methods: All women with self-reported caffeine consumption at enrollment were included (N = 6,467).  In 10 years or less of follow-up with annual assessments of cognitive function, 388 of these women received a diagnosis of probable dementia based on a 4-phase protocol that included central adjudication.  We used proportional hazards regression to assess differences in the distributions of times until incidence of probable dementia or composite cognitive impairment among women grouped by baseline level of caffeine intake, adjusting for risk factors (hormone therapy, age, race, education, body mass index, sleep quality, depression, hypertension, prior cardiovascular disease, diabetes, smoking, and alc. consumption).  Results: Women consuming above median levels (mean intake = 261 mg) of caffeine intake for this group were less likely to develop incident dementia (hazard ratio = 0.74, 95% confidence interval [0.56, 0.99], p =.04) or any cognitive impairment (hazard ratio = 0.74, confidence interval [0.60, 0.91], p =.005) compared to those consuming below median amts. (mean intake = 64 mg) of caffeine for this group.  Conclusion: Our findings suggest lower odds of probable dementia or cognitive impairment in older women whose caffeine consumption was above median for this group and are consistent with the existing literature showing an inverse assocn. between caffeine intake and age-related cognitive impairment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoM5TuV7LvhJ7Vg90H21EOLACvtfcHk0lhCdH4_X0wlgA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXlsVCku7g%253D&md5=d869e20ebff561f178ee875f0a8bca3c</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1093%2Fgerona%2Fglw078&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fgerona%252Fglw078%26sid%3Dliteratum%253Aachs%26aulast%3DDriscoll%26aufirst%3DI.%26aulast%3DShumaker%26aufirst%3DS.%2BA.%26aulast%3DSnively%26aufirst%3DB.%2BM.%26aulast%3DMargolis%26aufirst%3DK.%2BL.%26aulast%3DManson%26aufirst%3DJ.%2BE.%26aulast%3DVitolins%26aufirst%3DM.%2BZ.%26aulast%3DRossom%26aufirst%3DR.%2BC.%26aulast%3DEspeland%26aufirst%3DM.%2BA.%26atitle%3DRelationships%2520Between%2520Caffeine%2520Intake%2520and%2520Risk%2520for%2520Probable%2520Dementia%2520or%2520Global%2520Cognitive%2520Impairment%253A%2520The%2520Women%25E2%2580%2599s%2520Health%2520Initiative%2520Memory%2520Study%26jtitle%3DJ.%2520Gerontol.%252C%2520Ser.%2520A%26date%3D2016%26volume%3D71%26spage%3D1596%26epage%3D1602%26doi%3D10.1093%2Fgerona%2Fglw078" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tsai, L.-C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, G. C.-K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nangle, S. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimizu-Albergine, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, G. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Storm, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beavo, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zweifel, L. S.</span></span> <span> </span><span class="NLM_article-title">Inactivation of Pde8b Enhances Memory, Motor Performance, and Protects against Age-Induced Motor Coordination Decay</span>. <i>Genes, Brain Behav.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">837</span>– <span class="NLM_lpage">847</span>, <span class="refDoi"> DOI: 10.1111/j.1601-183x.2012.00836.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=10.1111%2Fj.1601-183X.2012.00836.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=22925203" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvVOqtL7K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2012&pages=837-847&author=L.-C.+L.+Tsaiauthor=G.+C.-K.+Chanauthor=S.+N.+Nangleauthor=M.+Shimizu-Albergineauthor=G.+L.+Jonesauthor=D.+R.+Stormauthor=J.+A.+Beavoauthor=L.+S.+Zweifel&title=Inactivation+of+Pde8b+Enhances+Memory%2C+Motor+Performance%2C+and+Protects+against+Age-Induced+Motor+Coordination+Decay&doi=10.1111%2Fj.1601-183x.2012.00836.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Inactivation of Pde8b enhances memory, motor performance, and protects against age-induced motor coordination decay</span></div><div class="casAuthors">Tsai, L.-C. L.; Chan, G. C.-K.; Nangle, S. N.; Shimizu-Albergine, M.; Jones, G. L.; Storm, D. R.; Beavo, J. A.; Zweifel, L. S.</div><div class="citationInfo"><span class="NLM_cas:title">Genes, Brain and Behavior</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">837-847</span>CODEN:
                <span class="NLM_cas:coden">GBBEAO</span>;
        ISSN:<span class="NLM_cas:issn">1601-1848</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Phosphodiesterases (PDEs) are crit. regulatory enzymes in cyclic nucleotide signaling.  PDEs have diverse expression patterns within the central nervous system (CNS), show differing affinities for cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP), and regulate a vast array of behaviors.  Here, we investigated the expression profile of the PDE8 gene family members Pde8a and Pde8b in the mouse brain.  We find that Pde8a expression is largely absent in the CNS; by contrast, Pde8b is expressed in select regions of the hippocampus, ventral striatum, and cerebellum.  Behavioral anal. of mice with Pde8b gene inactivation (PDE8B KO) demonstrate an enhancement in contextual fear, spatial memory, performance in an appetitive instrumental conditioning task, motor-coordination, and have an attenuation of age-induced motor coordination decline.  In addn. to improvements obsd. in select behaviors, we find basal anxiety levels to be increased in PDE8B KO mice.  These findings indicate that selective antagonism of PDE8B may be an attractive target for enhancement of cognitive and motor functions; however, possible alterations in affective state will need to be weighed against potential therapeutic value.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr0KE_TSXpVG7Vg90H21EOLACvtfcHk0lgTT2c-1sARGg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvVOqtL7K&md5=9a273854e65eca00daba9e2236119260</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1111%2Fj.1601-183X.2012.00836.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1601-183X.2012.00836.x%26sid%3Dliteratum%253Aachs%26aulast%3DTsai%26aufirst%3DL.-C.%2BL.%26aulast%3DChan%26aufirst%3DG.%2BC.-K.%26aulast%3DNangle%26aufirst%3DS.%2BN.%26aulast%3DShimizu-Albergine%26aufirst%3DM.%26aulast%3DJones%26aufirst%3DG.%2BL.%26aulast%3DStorm%26aufirst%3DD.%2BR.%26aulast%3DBeavo%26aufirst%3DJ.%2BA.%26aulast%3DZweifel%26aufirst%3DL.%2BS.%26atitle%3DInactivation%2520of%2520Pde8b%2520Enhances%2520Memory%252C%2520Motor%2520Performance%252C%2520and%2520Protects%2520against%2520Age-Induced%2520Motor%2520Coordination%2520Decay%26jtitle%3DGenes%252C%2520Brain%2520Behav.%26date%3D2012%26volume%3D11%26spage%3D837%26epage%3D847%26doi%3D10.1111%2Fj.1601-183x.2012.00836.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Myers, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheewatrakoolpong, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Egan, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Billah, M. M.</span></span> <span> </span><span class="NLM_article-title">Expression, Purification, and Characterization of Human cAMP-Specific Phosphodiesterase (PDE4) Subtypes A, B, C, and D</span>. <i>Biochem. Biophys. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>234</i></span>,  <span class="NLM_fpage">320</span>– <span class="NLM_lpage">324</span>, <span class="refDoi"> DOI: 10.1006/bbrc.1997.6636</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=10.1006%2Fbbrc.1997.6636" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=9177268" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=1%3ACAS%3A528%3ADyaK2sXjsFCjtbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=234&publication_year=1997&pages=320-324&author=P.+Wangauthor=J.+G.+Myersauthor=P.+Wuauthor=B.+Cheewatrakoolpongauthor=R.+W.+Eganauthor=M.+M.+Billah&title=Expression%2C+Purification%2C+and+Characterization+of+Human+cAMP-Specific+Phosphodiesterase+%28PDE4%29+Subtypes+A%2C+B%2C+C%2C+and+D&doi=10.1006%2Fbbrc.1997.6636"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Expression, purification, and characterization of human cAMP-specific phosphodiesterase (PDE4) subtypes A, B, C, and D</span></div><div class="casAuthors">Wang, Peng; Myers, Joyce G.; Wu, Ping; Cheewatrakoolpong, Boonlert; Egan, Robert W.; Billah, M. Motasim</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical and Biophysical Research Communications</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">234</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">320-324</span>CODEN:
                <span class="NLM_cas:coden">BBRCA9</span>;
        ISSN:<span class="NLM_cas:issn">0006-291X</span>.
    
            (<span class="NLM_cas:orgname">Academic</span>)
        </div><div class="casAbstract">Although four members (A, B, C, and D) of the cAMP-specific phosphodiesterase (PDE4) family have been cloned by different groups, no study comparing the characteristics of purified human PDE4 subtypes has been published.  In this study, we have expressed human PDE4 A, B, C, and D in insect (SF9) cells by using the baculovirus expression system, purified the expressed proteins, and compared their characteristics.  The recombinant PDE4 subtypes all showed catalytic activity for cAMP with a Km of 1-5 -mM.  Vmax values differed significantly among these subtypes with the following order: C > B A > D.  PDE4 A, B, C, and D showed a very similar Mg2+ dependence profile.  PDE4 B and C showed similar pH profiles with the optimal pH being 8.0.  The pH profiles of PDE4 A and D were very different from each other and from those of B and C, with the optimal pH being 6.5 and 7.5, resp.  Furthermore, although PDE4 A, B, C, and D were all inhibited by the std. PDE4 inhibitors rolipram, Ro 20-1724, and etazolate, the inhibitory potency varied.  Thus, by several criteria including kinetics, pH dependency, and inhibitor sensitivity, various PDE4 subtypes differ significantly from one another.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoIN_kZyDyB2rVg90H21EOLACvtfcHk0lgTT2c-1sARGg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXjsFCjtbc%253D&md5=2bf67d38ba51a5ade5ce23cd6a75d6f8</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1006%2Fbbrc.1997.6636&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fbbrc.1997.6636%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DP.%26aulast%3DMyers%26aufirst%3DJ.%2BG.%26aulast%3DWu%26aufirst%3DP.%26aulast%3DCheewatrakoolpong%26aufirst%3DB.%26aulast%3DEgan%26aufirst%3DR.%2BW.%26aulast%3DBillah%26aufirst%3DM.%2BM.%26atitle%3DExpression%252C%2520Purification%252C%2520and%2520Characterization%2520of%2520Human%2520cAMP-Specific%2520Phosphodiesterase%2520%2528PDE4%2529%2520Subtypes%2520A%252C%2520B%252C%2520C%252C%2520and%2520D%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D1997%26volume%3D234%26spage%3D320%26epage%3D324%26doi%3D10.1006%2Fbbrc.1997.6636" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Soderling, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bayuga, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beavo, J. A.</span></span> <span> </span><span class="NLM_article-title">Cloning and Characterization of a cAMP-Specific Cyclic Nucleotide Phosphodiesterase</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>95</i></span>,  <span class="NLM_fpage">8991</span>– <span class="NLM_lpage">8996</span>, <span class="refDoi"> DOI: 10.1073/pnas.95.15.8991</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=10.1073%2Fpnas.95.15.8991" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=9671792" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=1%3ACAS%3A528%3ADyaK1cXkvFaltbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=1998&pages=8991-8996&author=S.+H.+Soderlingauthor=S.+J.+Bayugaauthor=J.+A.+Beavo&title=Cloning+and+Characterization+of+a+cAMP-Specific+Cyclic+Nucleotide+Phosphodiesterase&doi=10.1073%2Fpnas.95.15.8991"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Cloning and characterization of a cAMP-specific cyclic nucleotide phosphodiesterase</span></div><div class="casAuthors">Soderling, S. H.; Bayuga, S. J.; Beavo, J. A.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">95</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">8991-8996</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Cyclic nucleotide phosphodiesterases (PDEs) regulate intracellular levels of cAMP and cGMP by hydrolyzing them to their corresponding 5' monophosphates.  The authors report the cloning and characterization of a novel cAMP-specific PDE from mouse testis.  This unique phosphodiesterase contains a catalytic domain that overall shares <40% sequence identity to the catalytic domain of all other known PDEs.  Based on this limited homol., this new PDE clearly represents a previously unknown PDE gene family designated as PDE8.  The cDNA for PDE8 is 3678 nucleotides in length and is predicted to encode an 823 amino acid enzyme.  The cDNA includes a full ORF as it contains an in-frame stop codon before the start methionine.  PDE8 is specific for the hydrolysis of cAMP and has a Km of 0.15 μM.  Most common PDE inhibitors are ineffective antagonists of PDE8, including the nonspecific PDE inhibitor 3-isobutyl-1-methylxanthine.  Dipyridamole, however, an inhibitor that is generally considered to be relatively specific for the cGMP selective PDEs, does inhibit PDE8 with an IC50 of 4.5 μM.  Tissue distribution studies of 22 different mouse tissues indicates that PDE8 has highest expression in testis, followed by eye, liver, skeletal muscle, heart, 7-day embryo, kidney, ovary, and brain in decreasing order.  In situ hybridizations in testis, the tissue of highest expression, shows that PDE8 is expressed in the seminiferous epithelium in a stage-specific manner.  Highest levels of expression are seen in stages 7-12, with little or no expression in stages 1-6.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoQMKxo8j_cUbVg90H21EOLACvtfcHk0lgTT2c-1sARGg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXkvFaltbw%253D&md5=2a2da6944ca3140a1cf1479ab38cf2d6</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1073%2Fpnas.95.15.8991&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.95.15.8991%26sid%3Dliteratum%253Aachs%26aulast%3DSoderling%26aufirst%3DS.%2BH.%26aulast%3DBayuga%26aufirst%3DS.%2BJ.%26aulast%3DBeavo%26aufirst%3DJ.%2BA.%26atitle%3DCloning%2520and%2520Characterization%2520of%2520a%2520cAMP-Specific%2520Cyclic%2520Nucleotide%2520Phosphodiesterase%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1998%26volume%3D95%26spage%3D8991%26epage%3D8996%26doi%3D10.1073%2Fpnas.95.15.8991" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gamanuma, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuasa, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sasaki, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakurai, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kotera, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Omori, K.</span></span> <span> </span><span class="NLM_article-title">Comparison of Enzymatic Characterization and Gene Organization of Cyclic Nucleotide Phosphodiesterase 8 Family in Humans</span>. <i>Cell. Signalling</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">565</span>– <span class="NLM_lpage">574</span>, <span class="refDoi"> DOI: 10.1016/s0898-6568(02)00146-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=10.1016%2FS0898-6568%2802%2900146-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=12681444" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=1%3ACAS%3A528%3ADC%252BD3sXislemsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2003&pages=565-574&author=M.+Gamanumaauthor=K.+Yuasaauthor=T.+Sasakiauthor=N.+Sakuraiauthor=J.+Koteraauthor=K.+Omori&title=Comparison+of+Enzymatic+Characterization+and+Gene+Organization+of+Cyclic+Nucleotide+Phosphodiesterase+8+Family+in+Humans&doi=10.1016%2Fs0898-6568%2802%2900146-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Comparison of enzymatic characterization and gene organization of cyclic nucleotide phosphodiesterase 8 family in humans</span></div><div class="casAuthors">Gamanuma, Michiko; Yuasa, Keizo; Sasaki, Takashi; Sakurai, Naoki; Kotera, Jun; Omori, Kenji</div><div class="citationInfo"><span class="NLM_cas:title">Cellular Signalling</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">565-574</span>CODEN:
                <span class="NLM_cas:coden">CESIEY</span>;
        ISSN:<span class="NLM_cas:issn">0898-6568</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">Full-length cDNAs of human cyclic nucleotide phosphodiesterase 8B (PDE8B) were isolated.  Enzymic characteristics of a dominant variant encoding a protein of 885 residues (PDE8B1) were compared with those of PDE8A1.  The recombinant PDE8A1 and PDE8B1 proteins of an entire form were produced in both cytosolic and membrane fractions of the transfected COS cells.  The human PDE8B1 was a high-affinity cAMP-PDE with Km value of 101±12 nM for cAMP, which is greater than that of PDE8A1 (40±1 nM).  Relative Vmax value of PDE8A1 was 57±8% compared with that of PDE8B1 (100±12%).  Although PDE8A1 was moderately inhibited by dipyridamole with IC50 value of 8±2 μM, the compd. antagonized the PDE8B1 activity at three-fold higher concn. (IC50=23±2 μM).  The human PDE8B gene was composed of 22 exons, spanning over 217 kb.  Although overall sequence identity between PDE8A1 and PDE8B1 was 68%, positions of junctions of each exon between the PDE8A1 and PDE8B1 sequences were well matched, indicating evolutionary relatedness of both genes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp35CEEyORktrVg90H21EOLACvtfcHk0ljxKzuJBjRLNQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXislemsbs%253D&md5=c47dd94b28601e42b6b9353401b92fe4</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2FS0898-6568%2802%2900146-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0898-6568%252802%252900146-8%26sid%3Dliteratum%253Aachs%26aulast%3DGamanuma%26aufirst%3DM.%26aulast%3DYuasa%26aufirst%3DK.%26aulast%3DSasaki%26aufirst%3DT.%26aulast%3DSakurai%26aufirst%3DN.%26aulast%3DKotera%26aufirst%3DJ.%26aulast%3DOmori%26aufirst%3DK.%26atitle%3DComparison%2520of%2520Enzymatic%2520Characterization%2520and%2520Gene%2520Organization%2520of%2520Cyclic%2520Nucleotide%2520Phosphodiesterase%25208%2520Family%2520in%2520Humans%26jtitle%3DCell.%2520Signalling%26date%3D2003%26volume%3D15%26spage%3D565%26epage%3D574%26doi%3D10.1016%2Fs0898-6568%2802%2900146-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fisher, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pillar, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">St. Denis, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, J. B.</span></span> <span> </span><span class="NLM_article-title">Isolation and Characterization of PDE8A, a Novel Human cAMP-Specific Phosphodiesterase</span>. <i>Biochem. Biophys. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>246</i></span>,  <span class="NLM_fpage">570</span>– <span class="NLM_lpage">577</span>, <span class="refDoi"> DOI: 10.1006/bbrc.1998.8684</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=10.1006%2Fbbrc.1998.8684" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=9618252" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=1%3ACAS%3A528%3ADyaK1cXjsFyjsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=246&publication_year=1998&pages=570-577&author=D.+A.+Fisherauthor=J.+F.+Smithauthor=J.+S.+Pillarauthor=S.+H.+St.+Denisauthor=J.+B.+Cheng&title=Isolation+and+Characterization+of+PDE8A%2C+a+Novel+Human+cAMP-Specific+Phosphodiesterase&doi=10.1006%2Fbbrc.1998.8684"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Isolation and characterization of PDE8A, a novel human cAMP-specific phosphodiesterase'</span></div><div class="casAuthors">Fisher, Douglas A.; Smith, James F.; Pillar, Joann S.; St. Denis, Suzanne H.; Cheng, John B.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical and Biophysical Research Communications</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">246</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">570-577</span>CODEN:
                <span class="NLM_cas:coden">BBRCA9</span>;
        ISSN:<span class="NLM_cas:issn">0006-291X</span>.
    
            (<span class="NLM_cas:orgname">Academic Press</span>)
        </div><div class="casAbstract">As part of our efforts to understand the regulation of intracellular cAMP and to generate new targets for pharmacol. intervention, the authors have cloned and characterized the first isoenzyme in a new family of cyclic nucleotide phosphodiesterases, PDE8A.  PDE8A is most similar to PDE4 (38.5% amino acid identity in the catalytic domain), but is clearly not a member of any of the seven known PDE families.  The authors report the cloning of human cDNA encoding the C-terminal 713 amino acids of the protein, including a 283 amino acid region located near the C-terminus that is homologous to the ∼270 amino acid catalytic domain of other PDEs.  In addn., the authors found cDNA sequences consistent with alternative 5' mRNA splicing analogous to that seen in other PDE genes.  PDE8A is expressed in a wide variety of tissues as a ∼4.5 kb mRNA, with highest levels in testis, ovary, small intestine, and colon.  The C-terminal 545 amino acids of PDE8A (the region shared among all splice variants) were expressed in baculovirus.  Kinetic anal. of the baculovirus expressed enzyme shows it to be a very high affinity cAMP specific PDE with a Km of 55 nM for cAMP and 124 μM for cGMP.  The Vmax (150 pmol/min/μg recombinant enzyme) is about 10 times slower than that of PDE 4.  The cAMP hydrolytic activity of PDE8A is not modulated by cGMP at concns. up to 100 μM.  The enzyme requires the presence of at least 1 mM Mn2+ or Mg2+ for maximal activity in vitro, while 100 mM Ca2+ restores only about 20% activity.  PDE8A is insensitive (up to 100 μM) to a variety of PDE inhibitors including rolipram, zaprinast, vinpocetine, SKF-94120, and IBMX, but is inhibited (IC50 = 9 μM) by the PDE inhibitor dipyridamole.  To give PDE8A a descriptive name that distinguishes it from the other two known high affinity cAMP-specific phosphodiesterases (PDE4 and PDE7), the authors denote PDE8A as the high affinity cAMP-specific and IBMX-insensitive PDE.  (c) 1998 Academic Press.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp-MkMna8TGZ7Vg90H21EOLACvtfcHk0ljxKzuJBjRLNQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXjsFyjsL0%253D&md5=e11a53c2ca696c384c7d11e870760c7e</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1006%2Fbbrc.1998.8684&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fbbrc.1998.8684%26sid%3Dliteratum%253Aachs%26aulast%3DFisher%26aufirst%3DD.%2BA.%26aulast%3DSmith%26aufirst%3DJ.%2BF.%26aulast%3DPillar%26aufirst%3DJ.%2BS.%26aulast%3DSt.%2BDenis%26aufirst%3DS.%2BH.%26aulast%3DCheng%26aufirst%3DJ.%2BB.%26atitle%3DIsolation%2520and%2520Characterization%2520of%2520PDE8A%252C%2520a%2520Novel%2520Human%2520cAMP-Specific%2520Phosphodiesterase%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D1998%26volume%3D246%26spage%3D570%26epage%3D577%26doi%3D10.1006%2Fbbrc.1998.8684" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Snyder, H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corriveau, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Craft, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Faber, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greenberg, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knopman, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lamb, B. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montine, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nedergaard, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schaffer, C. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schneider, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wellington, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilcock, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zipfel, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zlokovic, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bain, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bosetti, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galis, Z. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koroshetz, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carrillo, M. C.</span></span> <span> </span><span class="NLM_article-title">Vascular Contributions to Cognitive Impairment and Dementia Including Alzheimer’s Disease</span>. <i>Alzheimer’s Dementia</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">710</span>– <span class="NLM_lpage">717</span>, <span class="refDoi"> DOI: 10.1016/j.jalz.2014.10.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=10.1016%2Fj.jalz.2014.10.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=25510382" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=1%3ACAS%3A280%3ADC%252BC2MznslKktQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2015&pages=710-717&author=H.+M.+Snyderauthor=R.+A.+Corriveauauthor=S.+Craftauthor=J.+E.+Faberauthor=S.+M.+Greenbergauthor=D.+Knopmanauthor=B.+T.+Lambauthor=T.+J.+Montineauthor=M.+Nedergaardauthor=C.+B.+Schafferauthor=J.+A.+Schneiderauthor=C.+Wellingtonauthor=D.+M.+Wilcockauthor=G.+J.+Zipfelauthor=B.+Zlokovicauthor=L.+J.+Bainauthor=F.+Bosettiauthor=Z.+S.+Galisauthor=W.+Koroshetzauthor=M.+C.+Carrillo&title=Vascular+Contributions+to+Cognitive+Impairment+and+Dementia+Including+Alzheimer%E2%80%99s+Disease&doi=10.1016%2Fj.jalz.2014.10.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Vascular contributions to cognitive impairment and dementia including Alzheimer's disease</span></div><div class="casAuthors">Snyder Heather M; Corriveau Roderick A; Bosetti Francesca; Koroshetz Walter; Craft Suzanne; Faber James E; Greenberg Steven M; Knopman David; Lamb Bruce T; Montine Thomas J; Nedergaard Maiken; Schaffer Chris B; Schneider Julie A; Wellington Cheryl; Wilcock Donna M; Zipfel Gregory J; Zlokovic Berislav; Bain Lisa J; Galis Zorina S; Carrillo Maria C</div><div class="citationInfo"><span class="NLM_cas:title">Alzheimer's & dementia : the journal of the Alzheimer's Association</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">710-7</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Scientific evidence continues to demonstrate the linkage of vascular contributions to cognitive impairment and dementia such as Alzheimer's disease.  In December, 2013, the Alzheimer's Association, with scientific input from the National Institute of Neurological Disorders and Stroke and the National Heart, Lung and Blood Institute from the National Institutes of Health, convened scientific experts to discuss the research gaps in our understanding of how vascular factors contribute to Alzheimer's disease and related dementia.  This manuscript summarizes the meeting and the resultant discussion, including an outline of next steps needed to move this area of research forward.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQra8xm-3FgJ9LIORRPd5lbfW6udTcc2ebn_UzLIGqbO7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2MznslKktQ%253D%253D&md5=16f91243764ad9e8a617ae7625150c51</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2Fj.jalz.2014.10.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jalz.2014.10.008%26sid%3Dliteratum%253Aachs%26aulast%3DSnyder%26aufirst%3DH.%2BM.%26aulast%3DCorriveau%26aufirst%3DR.%2BA.%26aulast%3DCraft%26aufirst%3DS.%26aulast%3DFaber%26aufirst%3DJ.%2BE.%26aulast%3DGreenberg%26aufirst%3DS.%2BM.%26aulast%3DKnopman%26aufirst%3DD.%26aulast%3DLamb%26aufirst%3DB.%2BT.%26aulast%3DMontine%26aufirst%3DT.%2BJ.%26aulast%3DNedergaard%26aufirst%3DM.%26aulast%3DSchaffer%26aufirst%3DC.%2BB.%26aulast%3DSchneider%26aufirst%3DJ.%2BA.%26aulast%3DWellington%26aufirst%3DC.%26aulast%3DWilcock%26aufirst%3DD.%2BM.%26aulast%3DZipfel%26aufirst%3DG.%2BJ.%26aulast%3DZlokovic%26aufirst%3DB.%26aulast%3DBain%26aufirst%3DL.%2BJ.%26aulast%3DBosetti%26aufirst%3DF.%26aulast%3DGalis%26aufirst%3DZ.%2BS.%26aulast%3DKoroshetz%26aufirst%3DW.%26aulast%3DCarrillo%26aufirst%3DM.%2BC.%26atitle%3DVascular%2520Contributions%2520to%2520Cognitive%2520Impairment%2520and%2520Dementia%2520Including%2520Alzheimer%25E2%2580%2599s%2520Disease%26jtitle%3DAlzheimer%25E2%2580%2599s%2520Dementia%26date%3D2015%26volume%3D11%26spage%3D710%26epage%3D717%26doi%3D10.1016%2Fj.jalz.2014.10.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Demirbas, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wyman, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimizu-Albergine, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cakici, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beavo, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffman, C. S.</span></span> <span> </span><span class="NLM_article-title">A Yeast-Based Chemical Screen Identifies a PDE Inhibitor that Elevates Steroidogenesis in Mouse Leydig Cells via PDE8 and PDE4 Inhibition</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>8</i></span>, <span class="NLM_elocation-id">e71279</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0071279</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=10.1371%2Fjournal.pone.0071279" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=23967182" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtleru7jO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&author=D.+Demirbasauthor=A.+R.+Wymanauthor=M.+Shimizu-Albergineauthor=O.+Cakiciauthor=J.+A.+Beavoauthor=C.+S.+Hoffman&title=A+Yeast-Based+Chemical+Screen+Identifies+a+PDE+Inhibitor+that+Elevates+Steroidogenesis+in+Mouse+Leydig+Cells+via+PDE8+and+PDE4+Inhibition&doi=10.1371%2Fjournal.pone.0071279"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">A yeast-based chemical screen identifies a PDE inhibitor that elevates steroidogenesis in mouse leydig cells via PDE8 and PDE4 inhibition</span></div><div class="casAuthors">Demirbas, Didem; Wyman, Arlene R.; Shimizu-Albergine, Masami; Cakici, Ozgur; Beavo, Joseph A.; Hoffman, Charles S.</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">e71279</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">A cell-based high-throughput screen (HTS) was developed to detect phosphodiesterase 8 (PDE8) and PDE4/8 combination inhibitors.  By replacing the Schizosaccharomyces pombe PDE gene with the murine PDE8A1 gene in strains lacking adenylyl cyclase, we generated strains whose protein kinase A (PKA)-stimulated growth in 5-fluoro orotic acid (5FOA) medium reflects PDE8 activity.  From our previously-identified PDE4 and PDE7 inhibitors, we identified a PDE4/8 inhibitor that allowed us to optimize screening conditions.  Of 222,711 compds. screened, ∼0.2% displayed composite Z scores of >20.  Addnl. yeast-based assays using the most effective 367 compds. identified 30 candidates for further characterization.  Among these, compd. BC8-15 displayed the lowest IC50 value for both PDE4 and PDE8 inhibition in in vitro enzyme assays.  This compd. also displays significant activity against PDE10A and PDE11A.  BC8-15 elevates steroidogenesis in mouse Leydig cells as a single pharmacol. agent.  Assays using BC8-15 and two structural derivs. support a model in which PDE8 is a primary regulator of testosterone prodn. by Leydig cells, with an addnl. role for PDE4 in this process.  BC8-15, BC8-15A and BC8-15C, which are com. available compds., display distinct patterns of activity against PDE4, PDE8, PDE10A and PDE11A, representing a chem. toolkit that could be used to examine the biol. roles of these enzymes in cell culture systems.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGquVl5cz94TT7Vg90H21EOLACvtfcHk0ljTCtvagp8kjA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtleru7jO&md5=9734250e3b8c50bf60b41b1bd13d66c2</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0071279&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0071279%26sid%3Dliteratum%253Aachs%26aulast%3DDemirbas%26aufirst%3DD.%26aulast%3DWyman%26aufirst%3DA.%2BR.%26aulast%3DShimizu-Albergine%26aufirst%3DM.%26aulast%3DCakici%26aufirst%3DO.%26aulast%3DBeavo%26aufirst%3DJ.%2BA.%26aulast%3DHoffman%26aufirst%3DC.%2BS.%26atitle%3DA%2520Yeast-Based%2520Chemical%2520Screen%2520Identifies%2520a%2520PDE%2520Inhibitor%2520that%2520Elevates%2520Steroidogenesis%2520in%2520Mouse%2520Leydig%2520Cells%2520via%2520PDE8%2520and%2520PDE4%2520Inhibition%26jtitle%3DPLoS%2520One%26date%3D2013%26volume%3D8%26doi%3D10.1371%2Fjournal.pone.0071279" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">DeNinno, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wright, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Visser, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Etienne, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moore, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olson, T. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rocke, B. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andrews, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zarbo, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Millham, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boscoe, B. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boyer, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doran, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Houseknecht, K. L.</span></span> <span> </span><span class="NLM_article-title">1,5-Substituted Nipecotic Amides: Selective PDE8 Inhibitors Displaying Diastereomer-Dependent Microsomal Stability</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">3095</span>– <span class="NLM_lpage">3098</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2011.03.022</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=10.1016%2Fj.bmcl.2011.03.022" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=21459572" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=1%3ACAS%3A528%3ADC%252BC3MXlsVClsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=3095-3098&author=M.+P.+DeNinnoauthor=S.+W.+Wrightauthor=M.+S.+Visserauthor=J.+B.+Etienneauthor=D.+E.+Mooreauthor=T.+V.+Olsonauthor=B.+N.+Rockeauthor=M.+P.+Andrewsauthor=C.+Zarboauthor=M.+L.+Millhamauthor=B.+P.+Boscoeauthor=D.+D.+Boyerauthor=S.+D.+Doranauthor=K.+L.+Houseknecht&title=1%2C5-Substituted+Nipecotic+Amides%3A+Selective+PDE8+Inhibitors+Displaying+Diastereomer-Dependent+Microsomal+Stability&doi=10.1016%2Fj.bmcl.2011.03.022"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">1,5-Substituted nipecotic amides: Selective PDE8 inhibitors displaying diastereomer-dependent microsomal stability</span></div><div class="casAuthors">DeNinno, Michael P.; Wright, Stephen W.; Visser, Michael S.; Etienne, John B.; Moore, Dianna E.; Olson, Thanh V.; Rocke, Benjamin N.; Andrews, Melissa P.; Zarbo, Cynthia; Millham, Michele L.; Boscoe, Brian P.; Boyer, David D.; Doran, Shawn D.; Houseknecht, Karen L.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">3095-3098</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The first highly potent and selective PDE8 inhibitors are disclosed.  The initial tetrahydroisoquinoline hit was transformed into a nipecotic amide series in order to address a reactive metabolite issue.  Redn. of lipophilicity to address metabolic liabilities uncovered an interesting diastereomer-dependent trend in turnover by human microsomes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqD21pbH0ParbVg90H21EOLACvtfcHk0ljTCtvagp8kjA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXlsVClsr0%253D&md5=1d85b5911aadbbe17a7ff6e85596adc1</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2011.03.022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2011.03.022%26sid%3Dliteratum%253Aachs%26aulast%3DDeNinno%26aufirst%3DM.%2BP.%26aulast%3DWright%26aufirst%3DS.%2BW.%26aulast%3DVisser%26aufirst%3DM.%2BS.%26aulast%3DEtienne%26aufirst%3DJ.%2BB.%26aulast%3DMoore%26aufirst%3DD.%2BE.%26aulast%3DOlson%26aufirst%3DT.%2BV.%26aulast%3DRocke%26aufirst%3DB.%2BN.%26aulast%3DAndrews%26aufirst%3DM.%2BP.%26aulast%3DZarbo%26aufirst%3DC.%26aulast%3DMillham%26aufirst%3DM.%2BL.%26aulast%3DBoscoe%26aufirst%3DB.%2BP.%26aulast%3DBoyer%26aufirst%3DD.%2BD.%26aulast%3DDoran%26aufirst%3DS.%2BD.%26aulast%3DHouseknecht%26aufirst%3DK.%2BL.%26atitle%3D1%252C5-Substituted%2520Nipecotic%2520Amides%253A%2520Selective%2520PDE8%2520Inhibitors%2520Displaying%2520Diastereomer-Dependent%2520Microsomal%2520Stability%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D3095%26epage%3D3098%26doi%3D10.1016%2Fj.bmcl.2011.03.022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">DeNinno, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wright, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Etienne, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olson, T. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rocke, B. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corbett, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kung, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DiRico, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andrews, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Millham, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parker, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Esler, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Volkenburg, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boyer, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Houseknecht, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doran, S. D.</span></span> <span> </span><span class="NLM_article-title">Discovery of Triazolopyrimidine-Based PDE8B Inhibitors: Exceptionally Ligand-Efficient and Lipophilic Ligand-Efficient Compounds for the Treatment of Diabetes</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">5721</span>– <span class="NLM_lpage">5726</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2012.06.079</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=10.1016%2Fj.bmcl.2012.06.079" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=22858141" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtFCgsrvO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=5721-5726&author=M.+P.+DeNinnoauthor=S.+W.+Wrightauthor=J.+B.+Etienneauthor=T.+V.+Olsonauthor=B.+N.+Rockeauthor=J.+W.+Corbettauthor=D.+W.+Kungauthor=K.+J.+DiRicoauthor=K.+M.+Andrewsauthor=M.+L.+Millhamauthor=J.+C.+Parkerauthor=W.+Eslerauthor=M.+van+Volkenburgauthor=D.+D.+Boyerauthor=K.+L.+Houseknechtauthor=S.+D.+Doran&title=Discovery+of+Triazolopyrimidine-Based+PDE8B+Inhibitors%3A+Exceptionally+Ligand-Efficient+and+Lipophilic+Ligand-Efficient+Compounds+for+the+Treatment+of+Diabetes&doi=10.1016%2Fj.bmcl.2012.06.079"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of triazolopyrimidine-based PDE8B inhibitors: Exceptionally ligand-efficient and lipophilic ligand-efficient compounds for the treatment of diabetes</span></div><div class="casAuthors">DeNinno, Michael P.; Wright, Stephen W.; Etienne, John B.; Olson, Thanh V.; Rocke, Benjamin N.; Corbett, Jeffrey W.; Kung, Daniel W.; DiRico, Kenneth J.; Andrews, Kim M.; Millham, Michele L.; Parker, Janice C.; Esler, William; van Volkenburg, Maria; Boyer, David D.; Houseknecht, Karen L.; Doran, Shawn D.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">5721-5726</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">PDE8B is a cAMP-specific isoform of the broader class of phosphodiesterases (PDEs).  As no selective PDE8B inhibitors had been reported, a high throughput screen was run with the goal of identifying selective tools for exploring the potential therapeutic utility of PDE8B inhibition.  Of the numerous hits, one was particularly attractive since it was amenable to rapid deconstruction leading to inhibitors with very high ligand efficiency and lipophilic ligand efficiency.  Triazolopyrimidines of formula I were prepd. and showed promised PDE8B inhibitory activity.  These triazolopyrimidines were optimized for potency, selectivity and ADME properties ultimately leading to compd. II.  Compd. II was highly potent and selective with good bioavailability (IC50 1.5 nM) and advanced into pre-clin. development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqqk21AAzYE67Vg90H21EOLACvtfcHk0lgGtC0RmsjSaw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtFCgsrvO&md5=7a5e3f3f39c63e304d5b958d4550745c</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2012.06.079&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2012.06.079%26sid%3Dliteratum%253Aachs%26aulast%3DDeNinno%26aufirst%3DM.%2BP.%26aulast%3DWright%26aufirst%3DS.%2BW.%26aulast%3DEtienne%26aufirst%3DJ.%2BB.%26aulast%3DOlson%26aufirst%3DT.%2BV.%26aulast%3DRocke%26aufirst%3DB.%2BN.%26aulast%3DCorbett%26aufirst%3DJ.%2BW.%26aulast%3DKung%26aufirst%3DD.%2BW.%26aulast%3DDiRico%26aufirst%3DK.%2BJ.%26aulast%3DAndrews%26aufirst%3DK.%2BM.%26aulast%3DMillham%26aufirst%3DM.%2BL.%26aulast%3DParker%26aufirst%3DJ.%2BC.%26aulast%3DEsler%26aufirst%3DW.%26aulast%3Dvan%2BVolkenburg%26aufirst%3DM.%26aulast%3DBoyer%26aufirst%3DD.%2BD.%26aulast%3DHouseknecht%26aufirst%3DK.%2BL.%26aulast%3DDoran%26aufirst%3DS.%2BD.%26atitle%3DDiscovery%2520of%2520Triazolopyrimidine-Based%2520PDE8B%2520Inhibitors%253A%2520Exceptionally%2520Ligand-Efficient%2520and%2520Lipophilic%2520Ligand-Efficient%2520Compounds%2520for%2520the%2520Treatment%2520of%2520Diabetes%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D5721%26epage%3D5726%26doi%3D10.1016%2Fj.bmcl.2012.06.079" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fisher, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pillar, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">St. Denis, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, J. B.</span></span> <span> </span><span class="NLM_article-title">Isolation and Characterization of PDE9A, a Novel Human cGMP-Specific Phosphodiesterase</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>273</i></span>,  <span class="NLM_fpage">15559</span>– <span class="NLM_lpage">15564</span>, <span class="refDoi"> DOI: 10.1074/jbc.273.25.15559</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=10.1074%2Fjbc.273.25.15559" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=9624146" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=1%3ACAS%3A528%3ADyaK1cXktVSmtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=273&publication_year=1998&pages=15559-15564&author=D.+A.+Fisherauthor=J.+F.+Smithauthor=J.+S.+Pillarauthor=S.+H.+St.+Denisauthor=J.+B.+Cheng&title=Isolation+and+Characterization+of+PDE9A%2C+a+Novel+Human+cGMP-Specific+Phosphodiesterase&doi=10.1074%2Fjbc.273.25.15559"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Isolation and characterization of PDE9A, a novel human cGMP-specific phosphodiesterase</span></div><div class="casAuthors">Fisher, Douglas A.; Smith, James F.; Pillar, Joann S.; Denis, Suzanne H. St.; Cheng, John B.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">273</span>
        (<span class="NLM_cas:issue">25</span>),
    <span class="NLM_cas:pages">15559-15564</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The authors have cloned and characterized the first human isoenzyme in a new family of cyclic nucleotide phosphodiesterases, PDE9A.  By sequence homol. in the catalytic domain, PDE9A is almost equidistant from all eight known mammalian PDE families but is most similar to PDE8A (34% amino acid identity) and least like PDE5A (28% amino acid identity).  The authors report the cloning of human cDNA encoding a full-length protein of 593 amino acids, including a 261-amino acid region located near the C terminus that is homologous to the ∼270-amino acid catalytic domain of other PDEs.  PDE9A is expressed in all eight tissues examd. as a ∼2.0-kilobase mRNA, with highest levels in spleen, small intestine, and brain.  The full-length PDE9A was expressed in baculovirus fused to an N-terminal 9-amino acid FLAG tag.  Kinetic anal. of the baculovirus-expressed enzyme shows it to be a very high affinity cGMP-specific PDE with a Km of 170 nM for cGMP and 230 μM for cAMP.  The Km for cGMP makes PDE9A one of the highest affinity PDEs known.  The Vmax for cGMP (4.9 nmol/min/μg recombinant enzyme) is about twice as fast as that of PDE4 for cAMP.  The enzyme is about twice as active in vitro in 1-10 mM Mn2+ than in the same concn. of Mg2+ or Ca2+.  PDE9A is insensitive (up to 100 μM) to a variety of PDE inhibitors including rolipram, vinpocetine, SKF-94120, dipyridamole, and 3-isobutyl-1-methyl-xanthine but is inhibited (IC50 = 35 μM) by zaprinast, a PDE5 inhibitor.  PDE9A lacks a region homologous to the allosteric cGMP-binding regulatory regions found in the cGMP-binding PDEs: PDE2, PDE5, and PDE6.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo9pa9zyPPt1rVg90H21EOLACvtfcHk0lgGtC0RmsjSaw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXktVSmtbk%253D&md5=c3ff4e1180aecf32fe9b856946853c37</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1074%2Fjbc.273.25.15559&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.273.25.15559%26sid%3Dliteratum%253Aachs%26aulast%3DFisher%26aufirst%3DD.%2BA.%26aulast%3DSmith%26aufirst%3DJ.%2BF.%26aulast%3DPillar%26aufirst%3DJ.%2BS.%26aulast%3DSt.%2BDenis%26aufirst%3DS.%2BH.%26aulast%3DCheng%26aufirst%3DJ.%2BB.%26atitle%3DIsolation%2520and%2520Characterization%2520of%2520PDE9A%252C%2520a%2520Novel%2520Human%2520cGMP-Specific%2520Phosphodiesterase%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1998%26volume%3D273%26spage%3D15559%26epage%3D15564%26doi%3D10.1074%2Fjbc.273.25.15559" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Meng, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hou, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shao, Y.-X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, P.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cai, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, H.-B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wan, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ke, H.</span></span> <span> </span><span class="NLM_article-title">Structure-Based Discovery of Highly Selective Phosphodiesterase-9A Inhibitors and Implications for Inhibitor Design</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">8549</span>– <span class="NLM_lpage">8558</span>, <span class="refDoi"> DOI: 10.1021/jm301189c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm301189c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtlGktbzJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=8549-8558&author=F.+Mengauthor=J.+Houauthor=Y.-X.+Shaoauthor=P.-Y.+Wuauthor=M.+Huangauthor=X.+Zhuauthor=Y.+Caiauthor=Z.+Liauthor=J.+Xuauthor=P.+Liuauthor=H.-B.+Luoauthor=Y.+Wanauthor=H.+Ke&title=Structure-Based+Discovery+of+Highly+Selective+Phosphodiesterase-9A+Inhibitors+and+Implications+for+Inhibitor+Design&doi=10.1021%2Fjm301189c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Based Discovery of Highly Selective Phosphodiesterase-9A Inhibitors and Implications for Inhibitor Design</span></div><div class="casAuthors">Meng, Fei; Hou, Jing; Shao, Yong-Xian; Wu, Pei-Ying; Huang, Manna; Zhu, Xinhai; Cai, Yonghong; Li, Zhe; Xu, Jie; Liu, Peiqing; Luo, Hai-Bin; Wan, Yiqian; Ke, Hengming</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">8549-8558</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A new series of phosphodiesterase-9 (PDE9) inhibitors that contain a scaffold of 6-amino-pyrazolopyrimidinone have been discovered by a combination of structure-based design and computational docking.  This procedure significantly saved the load of chem. synthesis and is an effective method for the discovery of inhibitors.  The best compd. 28 (I) has an IC50 of 21 nM and 3.3 μM, resp., for PDE9 and PDE5 and about 3 orders of magnitude of selectivity against other PDE families.  The crystal structure of the PDE9 catalytic domain in complex with 28 has been detd. and shows a hydrogen bond between 28 and Tyr424.  This hydrogen bond may account for the 860-fold selectivity of 28 against PDE1B, in comparison with about 30-fold selectivity of BAY73-6691.  Thus, our studies suggest that Tyr424, a unique residue of PDE8 and PDE9, is a potential target for improvement of selectivity of PDE9 inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrXPtJ-cQVCabVg90H21EOLACvtfcHk0likCdhBCBuR2Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtlGktbzJ&md5=ed8c37d784c80b040c51c9e2b40e2d99</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Fjm301189c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301189c%26sid%3Dliteratum%253Aachs%26aulast%3DMeng%26aufirst%3DF.%26aulast%3DHou%26aufirst%3DJ.%26aulast%3DShao%26aufirst%3DY.-X.%26aulast%3DWu%26aufirst%3DP.-Y.%26aulast%3DHuang%26aufirst%3DM.%26aulast%3DZhu%26aufirst%3DX.%26aulast%3DCai%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DXu%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DP.%26aulast%3DLuo%26aufirst%3DH.-B.%26aulast%3DWan%26aufirst%3DY.%26aulast%3DKe%26aufirst%3DH.%26atitle%3DStructure-Based%2520Discovery%2520of%2520Highly%2520Selective%2520Phosphodiesterase-9A%2520Inhibitors%2520and%2520Implications%2520for%2520Inhibitor%2520Design%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D8549%26epage%3D8558%26doi%3D10.1021%2Fjm301189c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shao, Y.-x.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cui, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, L.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cai, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wan, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ke, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, H.-B.</span></span> <span> </span><span class="NLM_article-title">Discovery of a Phosphodiesterase 9A Inhibitor as a Potential Hypoglycemic Agent</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">10304</span>– <span class="NLM_lpage">10313</span>, <span class="refDoi"> DOI: 10.1021/jm500836h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm500836h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitVSju73E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=10304-10313&author=Y.-x.+Shaoauthor=M.+Huangauthor=W.+Cuiauthor=L.-J.+Fengauthor=Y.+Wuauthor=Y.+Caiauthor=Z.+Liauthor=X.+Zhuauthor=P.+Liuauthor=Y.+Wanauthor=H.+Keauthor=H.-B.+Luo&title=Discovery+of+a+Phosphodiesterase+9A+Inhibitor+as+a+Potential+Hypoglycemic+Agent&doi=10.1021%2Fjm500836h"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a Phosphodiesterase 9A Inhibitor as a Potential Hypoglycemic Agent</span></div><div class="casAuthors">Shao, Yong-xian; Huang, Manna; Cui, Wenjun; Feng, Ling-Jun; Wu, Yinuo; Cai, Yinghong; Li, Zhe; Zhu, Xinhai; Liu, Peiqing; Wan, Yiqian; Ke, Hengming; Luo, Hai-Bin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">10304-10313</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Phosphodiesterase 9 (PDE9) inhibitors have been studied as potential therapeutics for treatment of diabetes and Alzheimer's disease.  Here we report a potent PDE9 inhibitor 3r that has an IC50 of 0.6 nM and >150-fold selectivity over other PDEs.  The HepG2 cell-based assay shows that 3r inhibits the mRNA expression of phosphoenolpyruvate carboxykinase and glucose 6-phosphatase.  These activities of 3r, together with the reasonable pharmacokinetic properties and no acute toxicity at 1200 mg/kg dosage, suggest its potential as a hypoglycemic agent.  The crystal structure of PDE9-3r reveals significantly different conformation and hydrogen bonding pattern of 3r from those of previously published 28s.  Both 3r and 28s form a hydrogen bond with Tyr424, a unique PDE9 residue (except for PDE8), but 3r shows an addnl. hydrogen bond with Ala452.  This structure information might be useful for design of PDE9 inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo41BAQ4bJwqbVg90H21EOLACvtfcHk0likCdhBCBuR2Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitVSju73E&md5=71b59f683cfbd1b6620d507e654e231f</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Fjm500836h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm500836h%26sid%3Dliteratum%253Aachs%26aulast%3DShao%26aufirst%3DY.-x.%26aulast%3DHuang%26aufirst%3DM.%26aulast%3DCui%26aufirst%3DW.%26aulast%3DFeng%26aufirst%3DL.-J.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DCai%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DZhu%26aufirst%3DX.%26aulast%3DLiu%26aufirst%3DP.%26aulast%3DWan%26aufirst%3DY.%26aulast%3DKe%26aufirst%3DH.%26aulast%3DLuo%26aufirst%3DH.-B.%26atitle%3DDiscovery%2520of%2520a%2520Phosphodiesterase%25209A%2520Inhibitor%2520as%2520a%2520Potential%2520Hypoglycemic%2520Agent%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D10304%26epage%3D10313%26doi%3D10.1021%2Fjm500836h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mao, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, H.-B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span> <span> </span><span class="NLM_article-title">Discovery of Novel Purine Nucleoside Derivatives as Phosphodiesterase 2 (PDE2) inhibitors: Structure-Based Virtual Screening, Optimization and Biological Evaluation</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">119</span>– <span class="NLM_lpage">133</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2017.11.022</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=10.1016%2Fj.bmc.2017.11.022" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=29174506" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvVKhsrjK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2018&pages=119-133&author=X.+Qiuauthor=Y.+Huangauthor=D.+Wuauthor=F.+Maoauthor=J.+Zhuauthor=W.+Yanauthor=H.-B.+Luoauthor=J.+Li&title=Discovery+of+Novel+Purine+Nucleoside+Derivatives+as+Phosphodiesterase+2+%28PDE2%29+inhibitors%3A+Structure-Based+Virtual+Screening%2C+Optimization+and+Biological+Evaluation&doi=10.1016%2Fj.bmc.2017.11.022"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of novel purine nucleoside derivatives as phosphodiesterase 2 (PDE2) inhibitors: Structure-based virtual screening, optimization and biological evaluation</span></div><div class="casAuthors">Qiu, Xiaoxia; Huang, Yiyou; Wu, Deyan; Mao, Fei; Zhu, Jin; Yan, Wenzhong; Luo, Hai-Bin; Li, Jian</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">119-133</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Phosphodiesterase 2 (PDE2) has received much attention for the potential treatment of the central nervous system (CNS) disorders and pulmonary hypertension.  Herein, we identified that clofarabine (4), an FDA-approved drug, displayed potential PDE2 inhibitory activity (IC50=3.12±0.67μM) by structure-based virtual screening and bioassay.  Considering the potential therapeutic benefit of PDE2, a series of purine nucleoside derivs. based on the structure and binding mode of 4 were designed, synthesized and evaluated, which led to the discovery of the best compd. 14e with a significant improvement of inhibitory potency (IC50=0.32±0.04μM).  Further mol. docking and mol. dynamic (MD) simulations studies revealed that 5'-benzyl group of 14e could interact with the unique hydrophobic pocket of PDE2 by forming extra van der Waals interactions with hydrophobic residues such as Leu770, Thr768, Thr805 and Leu809, which might contribute to its enhancement of PDE2 inhibition.  These potential compds. reported in this article and the valuable structure-activity relationships (SARs) might bring significant instruction for further development of potent PDE2 inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqskipWtgMkULVg90H21EOLACvtfcHk0likCdhBCBuR2Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvVKhsrjK&md5=ac48f4d93e5d13d4098858cb57717d28</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2017.11.022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2017.11.022%26sid%3Dliteratum%253Aachs%26aulast%3DQiu%26aufirst%3DX.%26aulast%3DHuang%26aufirst%3DY.%26aulast%3DWu%26aufirst%3DD.%26aulast%3DMao%26aufirst%3DF.%26aulast%3DZhu%26aufirst%3DJ.%26aulast%3DYan%26aufirst%3DW.%26aulast%3DLuo%26aufirst%3DH.-B.%26aulast%3DLi%26aufirst%3DJ.%26atitle%3DDiscovery%2520of%2520Novel%2520Purine%2520Nucleoside%2520Derivatives%2520as%2520Phosphodiesterase%25202%2520%2528PDE2%2529%2520inhibitors%253A%2520Structure-Based%2520Virtual%2520Screening%252C%2520Optimization%2520and%2520Biological%2520Evaluation%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2018%26volume%3D26%26spage%3D119%26epage%3D133%26doi%3D10.1016%2Fj.bmc.2017.11.022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Baell, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holloway, G. A.</span></span> <span> </span><span class="NLM_article-title">New Substructure Filters for Removal of Pan Assay Interference Compounds (PAINS) from Screening Libraries and for their Exclusion in Bioassays</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">2719</span>– <span class="NLM_lpage">2740</span>, <span class="refDoi"> DOI: 10.1021/jm901137j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm901137j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsF2qsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=2719-2740&author=J.+B.+Baellauthor=G.+A.+Holloway&title=New+Substructure+Filters+for+Removal+of+Pan+Assay+Interference+Compounds+%28PAINS%29+from+Screening+Libraries+and+for+their+Exclusion+in+Bioassays&doi=10.1021%2Fjm901137j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">New Substructure Filters for Removal of Pan Assay Interference Compounds (PAINS) from Screening Libraries and for Their Exclusion in Bioassays</span></div><div class="casAuthors">Baell, Jonathan B.; Holloway, Georgina A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2719-2740</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">This report describes a no. of substructural features which can help to identify compds. that appear as frequent hitters (promiscuous compds.) in many biochem. high throughput screens.  The compds. identified by such substructural features are not recognized by filters commonly used to identify reactive compds.  Even though these substructural features were identified using only one assay detection technol., such compds. have been reported to be active from many different assays.  In fact, these compds. are increasingly prevalent in the literature as potential starting points for further exploration, whereas they may not be.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGro_JARcceWjLVg90H21EOLACvtfcHk0lhfcBwLnNI8AQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsF2qsLw%253D&md5=fbf397aa4910753c550425708c866fd2</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Fjm901137j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901137j%26sid%3Dliteratum%253Aachs%26aulast%3DBaell%26aufirst%3DJ.%2BB.%26aulast%3DHolloway%26aufirst%3DG.%2BA.%26atitle%3DNew%2520Substructure%2520Filters%2520for%2520Removal%2520of%2520Pan%2520Assay%2520Interference%2520Compounds%2520%2528PAINS%2529%2520from%2520Screening%2520Libraries%2520and%2520for%2520their%2520Exclusion%2520in%2520Bioassays%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D2719%26epage%3D2740%26doi%3D10.1021%2Fjm901137j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Miyaura, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, A.</span></span> <span> </span><span class="NLM_article-title">Palladium-Catalyzed Cross-Coupling Reactions of Organoboron Compounds</span>. <i>Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>95</i></span>,  <span class="NLM_fpage">2457</span>– <span class="NLM_lpage">2483</span>, <span class="refDoi"> DOI: 10.1021/cr00039a007</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cr00039a007" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=1%3ACAS%3A528%3ADyaK2MXoslGiurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=1995&pages=2457-2483&author=N.+Miyauraauthor=A.+Suzuki&title=Palladium-Catalyzed+Cross-Coupling+Reactions+of+Organoboron+Compounds&doi=10.1021%2Fcr00039a007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Palladium-Catalyzed Cross-Coupling Reactions of Organoboron Compounds</span></div><div class="casAuthors">Miyaura, Norio; Suzuki, Akira</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, D. C.)</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">95</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2457-83</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review with >250 refs. including title reactions and their mechanisms, prepn. of organoboron reagents, alkoxycarbonylation and dimerization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqHwupBJT1UCbVg90H21EOLACvtfcHk0lhfcBwLnNI8AQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXoslGiurg%253D&md5=d127b414a75161652876eebc3ed0c486</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1021%2Fcr00039a007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr00039a007%26sid%3Dliteratum%253Aachs%26aulast%3DMiyaura%26aufirst%3DN.%26aulast%3DSuzuki%26aufirst%3DA.%26atitle%3DPalladium-Catalyzed%2520Cross-Coupling%2520Reactions%2520of%2520Organoboron%2520Compounds%26jtitle%3DChem.%2520Rev.%26date%3D1995%26volume%3D95%26spage%3D2457%26epage%3D2483%26doi%3D10.1021%2Fcr00039a007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wohl, A.</span></span> <span> </span><span class="NLM_article-title">Bromierung ungesättigter Verbindungen mit N-Brom-acetamid, ein Beitrag zur Lehre vom Verlauf chemischer Vorgänge</span>. <i>Ber. Dtsch. Chem. Ges.</i> <span class="NLM_year" style="font-weight: bold;">1919</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">51</span>– <span class="NLM_lpage">63</span>, <span class="refDoi"> DOI: 10.1002/cber.19190520109</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=10.1002%2Fcber.19190520109" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=1%3ACAS%3A528%3ADyaC1MXot1ek" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=1919&pages=51-63&author=A.+Wohl&title=Bromierung+unges%C3%A4ttigter+Verbindungen+mit+N-Brom-acetamid%2C+ein+Beitrag+zur+Lehre+vom+Verlauf+chemischer+Vorg%C3%A4nge&doi=10.1002%2Fcber.19190520109"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Bromination of unsaturated compounds with N-bromoacetamide, a contribution to the study of the course of chemical processes</span></div><div class="casAuthors">Wohl, A.</div><div class="citationInfo"><span class="NLM_cas:title">Berichte der Deutschen Chemischen Gesellschaft [Abteilung] B: Abhandlungen</span>
        (<span class="NLM_cas:date">1919</span>),
    <span class="NLM_cas:volume">52B</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">51-63</span>CODEN:
                <span class="NLM_cas:coden">BDCBAD</span>;
        ISSN:<span class="NLM_cas:issn">0365-9488</span>.
    </div><div class="casAbstract">It has now become quite widely accepted that substitution reactions are often preceded by addition reactions and the present investigation was carried out in the course of a search for reactions which would make it possible to decide with certainty whether there is really a primary addition and, if so, whether it is molecular or atomic.  W. found, e. g., that the reaction Me2C:CMe2 + AcNHBr (a) → Me2C:CMeCH2Br + AcNH2 occurs under such conditions (good cooling in Et2O or Me2CO) that the (a) is not dissociated at all or only to a very minute extent; no HBr can be detected.  This reaction can in no way be explained as taking place by addition of the residues Br and AcNH of the (a) to the two C atoms of the double bond, for an acetylated bromoamine would split off HBr and not AcNH2.  Moreover, the behavior of (a) towards Me2C:CHMe (see below) also shows that the Br does not combine with either of the unsatd.  C atoms.  There, therefore, remains but one possibility, that the primary addition occurs through subsidiary valences on (a) and one or both of the trivalent C atoms and the resulting unstable structure with the loosest union between Br and N then loses AcNH, forming AcNH2 with the most labile H atom after the Br and this H atom, obeying the law of neutralization, have exchanged places.  According to W.'s views, the high additive power of (a) depends on the union, the spatial proximity, of the two fields of affinity of the unsatd. negative atoms -N.dbd.Br.dbd., just like H2N.dbd..O.dbd.H, H2N.dbd..N.dbd.H2, HO.N.dbd.O.dbd., (HO)2S.dbd.O.dbd., HN.dbd.:C.dbd., etc. Compds. without this union, like the hydrazonium salts, H2NNMe3I, are quite indifferent, e. g., towards aldehydes.  Me2C:CHMe and (a) under such conditions (sufficient diln. and cooling) that AcNH2 seps. and the Br deriv. remains in soln. give exclusively a di-Br compd. C5H8Br2.  If, however, equimol. amts. of Me2C:CHMe and (a) are brought together in cold Et2O they combine and sep. practically quant. as an oil which, when the Et2O is poured off, undergoes an energetic reaction just like when Me2C:CHMe and (a) are brought together without a diluent.  It is, therefore, not the addition product stable at low temps. which dets. the course of the substitution reaction but some part of it (which could not be isolated) in the mixt. formed when the temp. is raised.  In the substitution reaction it is one of the primary H atoms, not the tertiary atom, which is replaced.  The primary addition is, therefore, detd. by the co´operation of the Br-N secondary valences and the C double bond, and the further course of the reaction by the mobility of the H atoms; according to the well-known rule, the double bond loosens the H on the adjacent C atom.  In harmony with these views it was found that (a) does not attack compds. satd. in the usual sense (except Me3CBr) and a series of compds. unsatd. in the ordinary sense but lacking the conditions of easy addition or of mobile H atoms (EtBr, iso-PrBr, (CH2Br)2, PhCH2Br and CH2(CO2Et)2 in the first group and C2H4, C2H2, maleic and fumaric acids, PhCH:CHCO2H, PhCH:CHCO2Et and PhCH:CHCHO in the second group).  Malonic ester, in spite of the mobile H atoms, lacks a grouping appropriate for the primary addition; this, however, is present in the deriv.  EtO2CCH2CONH2 which in Me3CO smoothly forms the compd. EtO2CCHBrCONH2, the transient yellow color appearing during the course of its prepn. indicating the formation of a Br-N compd. with pentavalent N in which the migration of the Br from N to C occurs by intramol. substitution.  The indifference of the other compds. of the second group is easily explained by the absence of a reactively influenced H atom.  On the other hand, AcCH2CO2Et, PhOH and, to a less marked degree, PhOMe react with (a) just like Me2C:CMe2 and Me2C:CHMe.  The same is true of Me3CBr, PhCH:CH2, MeCH:CHCO2H, NCCH2CO2Et, AcH, HCO2H and HCO2Et.  The (a) used was recrystd. from C6H6, m. 108° and was colorless; as diluents were used Et2O (in which it is not sol. but dissolves as the reaction proceeds and AcNH2 seps.) or Me2CO which dissolves (a) readily without being itself markedly brominated in the cold.  In general, as soon as the starch-iodide reaction was no longer given, the AcNH2, was removed, after addition of Et2O, by shaking with Na2CO3 and washing with H2O and the H2O-insol. layer was dried with Na2SO4 and fractionated in vacuo.  Without a diluent (a) acts on easily brominated compds. with much evolution of heat, darkening and violent decompn., the unattacked (a) itself being thereby decompd. with liberation of Br.  From 10 g. cold Me2C:CHMe treated with four 10-g. portions of (a) in 60 cc. Me2CO was obtained 9 g. of a compound, C5H8Br2 (b) (found 69.74% Br; calcd., 70.14), b12 54-5°, decolorizes KMnO4 and Br-H2O in alc.; no mono-Br deriv. is formed, even when a large excess of Me2C:CHMe is used (20 g. to 20 of Br). Me2C:CBrMe, prepd. by Bauer's method (Bull. soc. chim. 2, 149(1860)) but from pure Me2C:CHMe instead of amylene, b766 119-20°; it reacts much more slowly than Me2C:CHMe with (a); 14.9 g. added at room temp. to 13.8 g. (a) in 60 cc. Me2CO and allowed to stand 24 hrs. without cooling, gave, besides unchanged Me2C:CBrMe, a fraction b25 96-8° with 69.43% Br.  This dibromotrimethylethylene partly polymerizes on cooling and unlike (b) has an intense odor and attacks the eyes.  From 10 g. Me2C:CMe2 in 36 cc. cold Et2O and 16 g. (a) is obtained about 3 g. of not quite pure bromotetramethylethylene (found 46.3% Br; calcd. 49.0%), b15, 60-90°, decolorizes KMnO4, easily decomps. and polymerizes.  Me3CBr (37 g.) in 10 cc. cold Et2O slowly treated with 37 g. (a) yields 7 g. Me2C(CH2Br)Br, b36 60-1°, b. 149°.  From 44.3 g. PhOH in 145 cc. cold Et2O treated at 12 hr. intervals With, 20, 20 and 25 g. (a) is obtained p-BrC6H4OH, m. 64°, b21 1.39°, b, 236°.  PhOMe (10.8 g.) and 13.8 g. (a) in 65 cc. Me2CO after 24 hrs. at room temp. gave 17 g. p-BrC6H4OMe, m. 11-1.5°, b. 215°.  AcCH2CO2Et (21.7 g.) in 100 cc. cold Et2O treated in the course of 1 day with 8 + 8 + 7 g. (a) yields 15 g. AcCHBrCO2Et, b18 106-8°.  From 2 g. EtO2CCH2CONH2 (prepd. by heating EtO2CCH2C(OEt):NH.HCl at 125-30°) in 5 cc. cold Me2CO, slowly treated with 2 g. (a) in 5 cc. Me2CO and allowed to stand 24 hrs. to disappearance of the yellow color and the starch-iodide reaction, is obtained a mixt. of AcNH2 and EtO2CCHBrCONH2</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprQjLugWJXH7Vg90H21EOLACvtfcHk0lhfcBwLnNI8AQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaC1MXot1ek&md5=d796a70a33b020369681c460b7d278f0</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1002%2Fcber.19190520109&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcber.19190520109%26sid%3Dliteratum%253Aachs%26aulast%3DWohl%26aufirst%3DA.%26atitle%3DBromierung%2520unges%25C3%25A4ttigter%2520Verbindungen%2520mit%2520N-Brom-acetamid%252C%2520ein%2520Beitrag%2520zur%2520Lehre%2520vom%2520Verlauf%2520chemischer%2520Vorg%25C3%25A4nge%26jtitle%3DBer.%2520Dtsch.%2520Chem.%2520Ges.%26date%3D1919%26volume%3D52%26spage%3D51%26epage%3D63%26doi%3D10.1002%2Fcber.19190520109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ziegler, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schenck, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krockow, E. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siebert, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wenz, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weber, H.</span></span> <span> </span><span class="NLM_article-title">Die Synthese des Cantharidins</span>. <i>Justus Liebigs Ann. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1942</span>,  <span class="NLM_volume"><i>551</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">79</span>, <span class="refDoi"> DOI: 10.1002/jlac.19425510102</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=10.1002%2Fjlac.19425510102" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=1%3ACAS%3A528%3ADyaH3sXjtlKisQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=551&publication_year=1942&pages=1-79&author=K.+Zieglerauthor=G.+Schenckauthor=E.+W.+Krockowauthor=A.+Siebertauthor=A.+Wenzauthor=H.+Weber&title=Die+Synthese+des+Cantharidins&doi=10.1002%2Fjlac.19425510102"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of cantharidin</span></div><div class="casAuthors">Ziegler, K.; Schenck, G.; Krockow, E. W.; Siebert, A.; Wenz, A.; Weber, H.</div><div class="citationInfo"><span class="NLM_cas:title">Justus Liebigs Annalen der Chemie</span>
        (<span class="NLM_cas:date">1942</span>),
    <span class="NLM_cas:volume">551</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1-79</span>CODEN:
                <span class="NLM_cas:coden">JLACBF</span>;
        ISSN:<span class="NLM_cas:issn">0075-4617</span>.
    </div><div class="casAbstract">Di-Me 3,6-endomethylenehexahydrophthalate (21.2 g.), shaken 24 h. at room temp. with 800 cc. 0.3 N Ph3CNa in ether, the soln. cooled in ice-salt, treated with 45 g. MeI (better with 28 cc. Me2SO4), shaken 12 h. at room temp., the residue hydrolyzed by refluxing with 50 g. KOH in 250 cc. MeOH for 72 h. and fractionated with Na2CO3 or better by boiling with 1 l. and then with 0.5 l. petr. ether (60-80°), gives as the sol. portion 62% of cis-1,2-dimethyl-3,6-endomethylenehexahydrophthalic anhydride (methylenecantharidin), m. 206° (Me ester of the acid, m. 57°), and 1.5 g. of the trans-acid (trans-methylenecantharidic acid), m. 320-3° (Me ester, m. 44°); the anhydride does not appear to be formed.  Various attempts to methylate di-Me norcantharidate were not successful.  Fumaronitrile (I) results in 68% yield from 50 g. of the diamide, 250 g. p-MeC6H4-SO2Cl and 600 cc. dry C5H5N on boiling exactly 20 min., distn. of 350 cc. C5H5N, addn. of 50 cc. H2O, extn. with ether, removal of the ether and crystn. of the I.  (CH2:CH)2 (0.3 mol) and 0.2 mol I in 50 cc. PhMe, heated 24 h. at 100°, give 25% of trans-4,5-dicyanocyclohexene (II), b15 166-70°, m. 125°; considerable rubberlike polymer is formed; the use of 20 g. (CH2:CH)2 and 1.9 g.  I in 30 cc. PhMe gives 70% of II but it is difficult to purify.  The passage of (CH2:CH)2 into 33 g. I in 25 cc. PhMe at 131° (bath temp. 170-80°) during 76 h. gives 34% absorption; repetition 3 times (73 h., 118 h. and 165 h.) gives 76% pure II.  This is not methylated smoothly.  1,2-Dimethyl-1,2,3,6-tetrahydrophthalic anhydride (III), m. 101°, results in 50% yield by passage of (CH2:CH)2 into a boiling soln. of 50 g. dimethylmaleic anhydride (IV) and 25 cc. decalin for 720 h. (8 passages) or in 60% yield by carrying out the reaction in a 3-1. Cu autoclave with 185 g. IV and 80 g. (CH2:CH)2 at 160° for 26 h. (the flask is of sufficient size so that most of the (CH2:CH)2 remains in the gaseous phase).  The crude III (202 g.) is purified by heating with 160 g. KOH in 2 l. H2O in a current of steam, clarifying with charcoal, pptg. with concd. HCl and extg. with C6H6 for 24 h.; this gives 50-60 g. of IV and 80-5 g. of the acid corresponding to III, distg. at 265-9°; a better purifn. is effected by soln. in AcOH and adding dropwise and with cooling 115 g. Br, giving 183 g. of the dibromide (V), m. 181°; boiling 210 g. with 90 g. Zn in 900 cc. MeOH for 2 h. gives 90% of III.  III. is stable at 400°; it is hydrolyzed by alkali to the acid, m. 200° (formation of III); III also results slowly on heating the acid with H2O.  Catalytic redn. of III gives desoxycantharidin (VA) (Gadamer, C. A. 9, 2084), m. 129°; the acid m. 180°; characteristic is the rapid formation of the anhydride on boiling with H2O.  The characteristic instability of cantharidindicarboxylic acids is the result of the presence of the bridge.  V (17 g.), added in small portions to 15 g. NaOH in 50 cc. boiling H2O, gives a mixt., sepd. by extn. with petr. ether into an ethylene oxide (VI) or keto anhydride (VII), m. 182°, and the corresponding acid, m. 178°.  V (20 g.) and 50 g. Me3N, heated 20 h. at 100°, give large amts. of non-volatile products and about 10% of 1,2-dimethyl-1,2-dihydrophthalic anhydride (VIII), b2 112°, m. 70°.  The corresponding acid m. 158° (formation of VIII).  Catalytic redn. of VIII gives VA.  VIII yields 30% of a dibromide, m. 126°, and a more-sol. product (m. p. not given); this loses only 1 Br with AgNO3 in EtOH or with aq. Me2CO.  VIII and NH3 at 250° give dehydrocantharidinimide, m. 136°.  III (18 g.) and 18 g. powd. (CH2CO)2NBr in 80 cc. CCl4, heated 5 h., give 24-5 g. of a mixt. of 6-bromo-1,2-dimethyl-1,2,3,6-tetrahydrophthalic anhydride (IX), sepd. into a small amt. of an isomer, m. 106°, and a larger amt. of an isomer, m. 72°; the latter spontaneously loses HBr.  On heating at 150° and then at 180° IX gives VIII, the yield depending on the exptl. conditions.  IX (51 g.) and 170 cc. 20% NaOH, boiled 20 min. and repeatedly crystd. from H2O, give isocantharic acid Nr.  2 (X), m. 204-6°; this liberates CO2 from Na2CO2 and is unsatd. toward KMnO4; Me ester, m. 72°; if the crude product is boiled with AcCl for 5 h., there results 1,2-dimethyl-6-acetoxy-1, ,2,3,6-tetrahydrophthalic anhydride, b. 310°, m. 101.5-2°; this also results on warming 15 g. III, 22 g. SeO2 and 37 cc. Ac2O for 48 h. at 60°.  Catalytic redn. of X gives dihydrocantharic acid, m. 263° (di-Me ester (XI), m. 58-60°).  The Me ester of X and (CH2CO)2NBr give a Br deriv., m. 166°; catalytic redn. gives XI, m. 65°.  The nonvolatile fraction from the prepn. of VIII (100 g.) in 200 cc. H2O, dropped into a boiling soln. of 40 g. NaOH in 200 cc. H2O, the soln. acidified and extd. with ether, gives pseudocantharic acid (XII), m. 187°; Me ester, m. 100°; catalytic redn. gives the dihydro deriv., m. 270-3°.  IV (100 g.) and 127 g. cyclohexadiene (best result if dissolved in an equal vol. of C6H6), heated 3 days at 170-80°, the cryst. reaction product distd. with steam and crystd. from AcOH or decalin, or soln. in warm alkali, pptn. with acid and crystn. from AcOH, give 87.5% of 1,2-dimethyl-3,6-endovinylenehexahydrophthalic anhydride (XIII), m. 263.5°.  Mixing a soln. of 10 g. XII in 70 cc. 4 N NaOH and 150 cc. H2O at 0° and a NaOBr soln. prepd. from 30 cc. 4 N NaOH and 30 g. ice with 2.6 cc. Br at -3 to -5° with cooling gives, after 5 min., 10-11 g. of a Na salt; acidification with H2SO4 and crystn. from EtOH give the bromolactonic acid (XIV), C12H15O4Br, m. 231-2° (decompn.); Me ester, m. 164-5°.  The Na salt boiled with H2O, EtOH or Me2CO gives the dilactone, C12H14O4, m. about 375°; it is stable to KMnO4 and insol. in Na2CO3; boiling with 10 parts of 2 N NaOH gives the hydroxylactonic acid (XV), whose Me ester m. 177-8°; heating the acid above 260° gives the dilactone; XV results on boiling XIV with 2 N KMnO4.  Oxidn. of XIII in 4 mols. of 2 N NaOH with KMnO4 gives 1,2-dimethyl-3,6-endo(dihydroxyethylene)hexahydrophthalic anhydride [3,6-endo(dihydroxyethylene)desoxycantharidin] (XVI), m. 303°; Me2CO contg. concd. H2SO4 gives the dimethylmethylene ether, C15H20O5, m. 214-15°.  HNO3 (d. 1.5) converts XIII into a dinitrate, m. 157-8°; 20 g. XIII, heated with 40 cc. HNO3 (d. 1.4) and 40 cc. H2O for 15 min. at 100°, gives 3,6-endo.ovrddot.oxalyldesoxycantharidic acid (4,5-diketo-3,6-endoethylene-1,2-dimethylhexahydrophthalic acid) C12H14O6; from H2O it seps. in a colorless form (XVII), turns yellow at 260°, m. 315-20° (slow heating), 338-40° (decompn.) in a bath heated to 330°; yellow di-Me ester, m. 173-4°; Ac2O gives the yellow anhydride, with the same m. p. as the acids; on standing in air it spontaneously absorbs H2O and forms XVII.  The crude oxidn. product of XIII with dil. HNO3, evapd. with HNO3 (d. 1.5), gives 1,2-dimethylcyclohexane-cis-1,2,3,6-tetracarboxylic dianhydride (XVIII), m. 245-6°; boiling H2O slowly dissolves XVIII and careful evapn. gives the acid.  XVIII and CH2N2 in ether contg. some H2O, on standing 2-3 days, give the cis-tetra-Me ester, m. 108-9°; in Me2CO contg. H2O, CH2N2, acting 3 days, gives the di-Me ester, m. 156°, which with CH2N2 in ether gives the tetra-Me ester.  Neutralization of XVIII with 2 N MeONa (to phenolphthalein), addn. of HCl to Congo-red reaction and reaction with CH2N2 gives the tetra-Me ester, whereas evapn. of the soln. to dryness and treatment of the residue with Me2SO4-NaOH under strictly defined conditions gives tetra-Me 1,2-dimethylcyclohexane-1,2-cis-3,6-trans-tetracarboxylate (XIX), m. 111-12°.  XIX boiled with 5-6 parts of 2.6 N MeOH-KOH for 20-5 min. gives the trans-1,2-di-Me ester (XX), with 1 mol. H2O (lost at 120°), m. 208°; this also results by the acid hydrolysis (20.2% HCl) of XIX or of the cis-tetra-Me ester.  The Ag salt of XX and Br in CCl4 give acidic products (XXI) (extd. from ether by Na2CO3) and Me epihydrobromocantharate, m. 115-16°; boiling with 6-7 parts of 48% HBr for 1.5 h. gives the acid (XXII), with 1 mol. H2O, m. 185-6°; heating the acid over a free flame gives HBr, cantharic acid and cantharidin.  XXI contains 4-bromo-2,3-carbomethoxy-2,3-dimethylcyclohexane-1-carboxylic acid, m. 119°, and the ester lactone C11H13O5(OMe), m. 184-5°; hydrolysis of the lactone with 48% HBr gives the lactonedicarboxylic acid (XXIII), m. 296-7°, with a noticeable change in structure at 205-20°; Ac2O gives the anhydride (XXIV), m. 296-7°.  The configuration of cantharidin is discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpy7hYVkjr6wLVg90H21EOLACvtfcHk0lgndkOiHmiotw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaH3sXjtlKisQ%253D%253D&md5=e48588ac81b8488c9bbe36e21f223322</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1002%2Fjlac.19425510102&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjlac.19425510102%26sid%3Dliteratum%253Aachs%26aulast%3DZiegler%26aufirst%3DK.%26aulast%3DSchenck%26aufirst%3DG.%26aulast%3DKrockow%26aufirst%3DE.%2BW.%26aulast%3DSiebert%26aufirst%3DA.%26aulast%3DWenz%26aufirst%3DA.%26aulast%3DWeber%26aufirst%3DH.%26atitle%3DDie%2520Synthese%2520des%2520Cantharidins%26jtitle%3DJustus%2520Liebigs%2520Ann.%2520Chem.%26date%3D1942%26volume%3D551%26spage%3D1%26epage%3D79%26doi%3D10.1002%2Fjlac.19425510102" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cai, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robinson, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ke, H.</span></span> <span> </span><span class="NLM_article-title">Kinetic and Structural Studies of Phosphodiesterase-8A and Implication on the Inhibitor Selectivity</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>47</i></span>,  <span class="NLM_fpage">12760</span>– <span class="NLM_lpage">12768</span>, <span class="refDoi"> DOI: 10.1021/bi801487x</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi801487x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtlaktb3P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2008&pages=12760-12768&author=H.+Wangauthor=Z.+Yanauthor=S.+Yangauthor=J.+Caiauthor=H.+Robinsonauthor=H.+Ke&title=Kinetic+and+Structural+Studies+of+Phosphodiesterase-8A+and+Implication+on+the+Inhibitor+Selectivity&doi=10.1021%2Fbi801487x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Kinetic and Structural Studies of Phosphodiesterase-8A and Implication on the Inhibitor Selectivity</span></div><div class="casAuthors">Wang, Huanchen; Yan, Zier; Yang, Serena; Cai, Jiwen; Robinson, Howard; Ke, Hengming</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">48</span>),
    <span class="NLM_cas:pages">12760-12768</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Cyclic nucleotide phosphodiesterase-8 (PDE8) is a family of cAMP-specific enzymes and plays important roles in many biol. processes, including T-cell activation, testosterone prodn., adrenocortical hyperplasia, and thyroid function.  However, no PDE8 selective inhibitors are available for trial treatment of human diseases.  Here we report kinetic properties of the highly active PDE8A1 catalytic domain prepd. from refolding and its crystal structures in the unliganded and 3-isobutyl-1-methylxanthine (IBMX) bound forms at 1.9 and 2.1 Å resolns., resp.  The PDE8A1 catalytic domain has a Km of 1.8 μM, Vmax of 6.1 μmol/min/mg, a kcat of 4.0 s-1 for cAMP, and a Km of 1.6 mM, Vmax of 2.5 μmol/min/mg, a kcat of 1.6 s-1 for cGMP, thus indicating that the substrate specificity of PDE8 is dominated by Km.  The structure of the PDE8A1 catalytic domain has similar topol. as those of other PDE families but contains two extra helixes around Asn685-Thr710.  Since this fragment is distant from the active site of the enzyme, its impact on the catalysis is unclear.  The PDE8A1 catalytic domain is insensitive to the IBMX inhibition (IC50 = 700 μM).  The unfavorable interaction of IBMX in the PDE8A1-IBMX structure suggests an important role of Tyr748 in the inhibitor binding.  Indeed, the mutation of Tyr748 to phenylalanine increases the PDE8A1 sensitivity to several nonselective or family selective PDE inhibitors.  Thus, the structural and mutagenesis studies provide not only insight into the enzymic properties but also guidelines for design of PDE8 selective inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpqkXukMGQCC7Vg90H21EOLACvtfcHk0lgndkOiHmiotw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtlaktb3P&md5=6cb6b603ec147d1bd4ec7a7f7c493d59</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1021%2Fbi801487x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi801487x%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DH.%26aulast%3DYan%26aufirst%3DZ.%26aulast%3DYang%26aufirst%3DS.%26aulast%3DCai%26aufirst%3DJ.%26aulast%3DRobinson%26aufirst%3DH.%26aulast%3DKe%26aufirst%3DH.%26atitle%3DKinetic%2520and%2520Structural%2520Studies%2520of%2520Phosphodiesterase-8A%2520and%2520Implication%2520on%2520the%2520Inhibitor%2520Selectivity%26jtitle%3DBiochemistry%26date%3D2008%26volume%3D47%26spage%3D12760%26epage%3D12768%26doi%3D10.1021%2Fbi801487x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Di, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kerns, E. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McConnell, O. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carter, G. T.</span></span> <span> </span><span class="NLM_article-title">High Throughput Artificial Membrane Permeability Assay for Blood-Brain Barrier</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">223</span>– <span class="NLM_lpage">232</span>, <span class="refDoi"> DOI: 10.1016/s0223-5234(03)00012-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=10.1016%2FS0223-5234%2803%2900012-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=12667689" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=1%3ACAS%3A528%3ADC%252BD3sXitlKju7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2003&pages=223-232&author=L.+Diauthor=E.+H.+Kernsauthor=K.+Fanauthor=O.+J.+McConnellauthor=G.+T.+Carter&title=High+Throughput+Artificial+Membrane+Permeability+Assay+for+Blood-Brain+Barrier&doi=10.1016%2Fs0223-5234%2803%2900012-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">High throughput artificial membrane permeability assay for blood-brain barrier</span></div><div class="casAuthors">Di, Li; Kerns, Edward H.; Fan, Kristi; McConnell, Oliver J.; Carter, Guy T.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">223-232</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Editions Scientifiques et Medicales Elsevier</span>)
        </div><div class="casAbstract">The recent advances in high throughput screening for biol. activities and combinatorial chem. have greatly expanded the no. of drug candidates.  Rapid screening for BBB penetration potential early in drug discovery programs provides important information for compd. selection and guidance of synthesis for desirable CNS properties.  In this paper, we discuss a modification of the parallel artificial membrane permeation assay (PAMPA) for the prediction of blood-brain barrier penetration (PAMPA-BBB).  The assay was developed with 30 structurally diverse com. drugs and validated with 14 Wyeth Research compds.  The PAMPA-BBB assay has the advantages of: predicting passive blood-brain barrier penetration with high success, high throughput, low cost, and reproducibility.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZCg9Ka4mziLVg90H21EOLACvtfcHk0lgndkOiHmiotw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXitlKju7c%253D&md5=d228d5808ba8df23deed92c5e2bf3863</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1016%2FS0223-5234%2803%2900012-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0223-5234%252803%252900012-6%26sid%3Dliteratum%253Aachs%26aulast%3DDi%26aufirst%3DL.%26aulast%3DKerns%26aufirst%3DE.%2BH.%26aulast%3DFan%26aufirst%3DK.%26aulast%3DMcConnell%26aufirst%3DO.%2BJ.%26aulast%3DCarter%26aufirst%3DG.%2BT.%26atitle%3DHigh%2520Throughput%2520Artificial%2520Membrane%2520Permeability%2520Assay%2520for%2520Blood-Brain%2520Barrier%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2003%26volume%3D38%26spage%3D223%26epage%3D232%26doi%3D10.1016%2Fs0223-5234%2803%2900012-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Farooq, M. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Min, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goshgarian, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gorelick, P. B.</span></span> <span> </span><span class="NLM_article-title">Pharmacotherapy for Vascular Cognitive Impairment</span>. <i>CNS Drugs</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>31</i></span>,  <span class="NLM_fpage">759</span>– <span class="NLM_lpage">776</span>, <span class="refDoi"> DOI: 10.1007/s40263-017-0459-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=10.1007%2Fs40263-017-0459-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=28786085" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtlaku7vM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2017&pages=759-776&author=M.+U.+Farooqauthor=J.+Minauthor=C.+Goshgarianauthor=P.+B.+Gorelick&title=Pharmacotherapy+for+Vascular+Cognitive+Impairment&doi=10.1007%2Fs40263-017-0459-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacotherapy for Vascular Cognitive Impairment</span></div><div class="casAuthors">Farooq, Muhammad U.; Min, Jiangyong; Goshgarian, Christopher; Gorelick, Philip B.</div><div class="citationInfo"><span class="NLM_cas:title">CNS Drugs</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">759-776</span>CODEN:
                <span class="NLM_cas:coden">CNDREF</span>;
        ISSN:<span class="NLM_cas:issn">1172-7047</span>.
    
            (<span class="NLM_cas:orgname">Springer International Publishing AG</span>)
        </div><div class="casAbstract">A review.  Vascular cognitive impairment (VCI) is the second most common type of dementia after Alzheimer's disease (AD).  Stroke and cardiovascular risk factors have been linked to both AD and VCI and potentially can affect cognitive function in mid and later life.  Various pharmacol. agents, including donepezil, galantamine, and memantine, approved for the treatment of AD have shown modest cognitive benefits in patients with vascular dementia (VaD).  However, their functional and global benefits have been inconsistent.  Donepezil has shown some cognitive benefit in patients with VaD only, and galantamine has shown some benefit in mixed dementia (AD/VaD).  The benefits of other drugs such as rivastigmine, memantine, nimodipine, and piracetam are not clear.  Some other supplements and herbal therapies, such as citicoline, actovegin, huperzine A, and vinpocetine, have also been studied in patients with VaD, but their beneficial effects are not well established.  Non-drug therapies and lifestyle modifications such as diet, exercise, and vascular risk factor control are important in the management of VCI and should not be ignored.  However, there is a need for more robust clin. trials focusing on executive function and other cognitive measures and incorporation of newer imaging modalities to provide addnl. evidence about the utility of these strategies in patients with VCI.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoOL6PkMSfYd7Vg90H21EOLACvtfcHk0lgndkOiHmiotw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtlaku7vM&md5=50bb4f3b295af1b7a0d16d81b8c0f5e4</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1007%2Fs40263-017-0459-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs40263-017-0459-3%26sid%3Dliteratum%253Aachs%26aulast%3DFarooq%26aufirst%3DM.%2BU.%26aulast%3DMin%26aufirst%3DJ.%26aulast%3DGoshgarian%26aufirst%3DC.%26aulast%3DGorelick%26aufirst%3DP.%2BB.%26atitle%3DPharmacotherapy%2520for%2520Vascular%2520Cognitive%2520Impairment%26jtitle%3DCNS%2520Drugs%26date%3D2017%26volume%3D31%26spage%3D759%26epage%3D776%26doi%3D10.1007%2Fs40263-017-0459-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bhatia, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, N.</span></span> <span> </span><span class="NLM_article-title">Tadalafil Ameliorates Memory Deficits, Oxidative Stress, Endothelial Dysfunction and Neuropathological Changes in Rat Model of Hyperhomocysteinemia Induced Vascular Dementia</span>. <i>Int. J. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">13</span>, <span class="refDoi"> DOI: 10.1080/00207454.2020.1817009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=10.1080%2F00207454.2020.1817009" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2020&pages=1-13&author=P.+Bhatiaauthor=N.+Singh&title=Tadalafil+Ameliorates+Memory+Deficits%2C+Oxidative+Stress%2C+Endothelial+Dysfunction+and+Neuropathological+Changes+in+Rat+Model+of+Hyperhomocysteinemia+Induced+Vascular+Dementia&doi=10.1080%2F00207454.2020.1817009"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1080%2F00207454.2020.1817009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F00207454.2020.1817009%26sid%3Dliteratum%253Aachs%26aulast%3DBhatia%26aufirst%3DP.%26aulast%3DSingh%26aufirst%3DN.%26atitle%3DTadalafil%2520Ameliorates%2520Memory%2520Deficits%252C%2520Oxidative%2520Stress%252C%2520Endothelial%2520Dysfunction%2520and%2520Neuropathological%2520Changes%2520in%2520Rat%2520Model%2520of%2520Hyperhomocysteinemia%2520Induced%2520Vascular%2520Dementia%26jtitle%3DInt.%2520J.%2520Neurosci.%26date%3D2020%26spage%3D1%26epage%3D13%26doi%3D10.1080%2F00207454.2020.1817009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jian, W.-X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhan, J.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chu, S.-F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, N.-H.</span></span> <span> </span><span class="NLM_article-title">Donepezil Attenuates Vascular Dementia in Rats through Increasing BDNF Induced by Reducing HDAC6 Nuclear Translocation</span>. <i>Acta Pharmacol. Sin.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>41</i></span>,  <span class="NLM_fpage">588</span>– <span class="NLM_lpage">598</span>, <span class="refDoi"> DOI: 10.1038/s41401-019-0334-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=10.1038%2Fs41401-019-0334-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=31913348" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=1%3ACAS%3A528%3ADC%252BB3cXlslejtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2020&pages=588-598&author=W.-X.+Jianauthor=Z.+Zhangauthor=J.-H.+Zhanauthor=S.-F.+Chuauthor=Y.+Pengauthor=M.+Zhaoauthor=Q.+Wangauthor=N.-H.+Chen&title=Donepezil+Attenuates+Vascular+Dementia+in+Rats+through+Increasing+BDNF+Induced+by+Reducing+HDAC6+Nuclear+Translocation&doi=10.1038%2Fs41401-019-0334-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Donepezil attenuates vascular dementia in rats through increasing BDNF induced by reducing HDAC6 nuclear translocation</span></div><div class="casAuthors">Jian, Wen-xuan; Zhang, Zhao; Zhan, Jia-hong; Chu, Shi-feng; Peng, Ye; Zhao, Ming; Wang, Qi; Chen, Nai-hong</div><div class="citationInfo"><span class="NLM_cas:title">Acta Pharmacologica Sinica</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">588-598</span>CODEN:
                <span class="NLM_cas:coden">APSCG5</span>;
        ISSN:<span class="NLM_cas:issn">1671-4083</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Vascular dementia (VD) is the second most common dementia disease after Alzheimer's diseases (AD) in the world.  Donepezil is used to treat mild to moderate AD, and it has been shown to treat cognitive impairment and memory deficits caused by VD.  However, the action mechanism of donepezil against VD has not been clarified.  In this study, a bilateral common carotid artery occlusion (BCCAO) model was established in rats to simulate the pathol. of VD.  Two weeks after the surgery, the rats were administered donepezil (10 mg.kg-1.d-1, ig) for 3 wk, and then subjected to behavioral tests.  We showed that donepezil treatment significantly improved the performance of BCCAO rats in Morris Water Mazes test and Step-down test.  Furthermore, we showed that donepezil treatment significantly attenuated neurodegeneration and restored the synapse dendritic spines d. in cortex and hippocampus.  We revealed that donepezil treatment significantly increased BDNF expression in cortex and hippocampus.  Interestingly, donepezil treatment significantly decreased nuclear translocation of HDAC6 and the binding between HDAC6 and BDNF promoter IV in cortex, but not in the hippocampus.  The attenuated neurodegeneration by donepezil in cortex and hippocampus might due to the reduced ROS levels and increased phosphorylation of AMPK, whereas increased phosphorylation of AKT was only detected in cortex.  In conclusion, our results demonstrate that donepezil attenuates neurodegeneration in cortex and hippocampus via increasing BDNF expression; the regulation of donepezil on HDAC6 occurred in cortex, but not in the hippocampus.  This study further clarifies the pharmacol. mechanism of donepezil, while also emphasizes the promising epigenetic regulation of HDAC6.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrTRc2zIX7VObVg90H21EOLACvtfcHk0lhV_31Qd1M3Wg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXlslejtw%253D%253D&md5=c7a27dad86c11efa1f1866770c4c03a3</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1038%2Fs41401-019-0334-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41401-019-0334-5%26sid%3Dliteratum%253Aachs%26aulast%3DJian%26aufirst%3DW.-X.%26aulast%3DZhang%26aufirst%3DZ.%26aulast%3DZhan%26aufirst%3DJ.-H.%26aulast%3DChu%26aufirst%3DS.-F.%26aulast%3DPeng%26aufirst%3DY.%26aulast%3DZhao%26aufirst%3DM.%26aulast%3DWang%26aufirst%3DQ.%26aulast%3DChen%26aufirst%3DN.-H.%26atitle%3DDonepezil%2520Attenuates%2520Vascular%2520Dementia%2520in%2520Rats%2520through%2520Increasing%2520BDNF%2520Induced%2520by%2520Reducing%2520HDAC6%2520Nuclear%2520Translocation%26jtitle%3DActa%2520Pharmacol.%2520Sin.%26date%3D2020%26volume%3D41%26spage%3D588%26epage%3D598%26doi%3D10.1038%2Fs41401-019-0334-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sun, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ge, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qin, Y.</span></span> <span> </span><span class="NLM_article-title"><span class="smallcaps smallerCapital">dl</span>-3-<i>n</i>-Butylphthalide Regulates Cholinergic Dysfunction in Chronic Cerebral Hypoperfusion Rats</span>. <i>J. Int. Med. Res.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>48</i></span>,  <span class="NLM_fpage">0300060520936177</span>, <span class="refDoi"> DOI: 10.1177/0300060520936177</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=10.1177%2F0300060520936177" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=32644834" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2020&pages=0300060520936177&author=Y.+Sunauthor=Z.+Zhaoauthor=Q.+Liauthor=C.+Wangauthor=X.+Geauthor=X.+Wangauthor=G.+Wangauthor=Y.+Qin&title=dl-3-n-Butylphthalide+Regulates+Cholinergic+Dysfunction+in+Chronic+Cerebral+Hypoperfusion+Rats&doi=10.1177%2F0300060520936177"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1177%2F0300060520936177&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F0300060520936177%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DY.%26aulast%3DZhao%26aufirst%3DZ.%26aulast%3DLi%26aufirst%3DQ.%26aulast%3DWang%26aufirst%3DC.%26aulast%3DGe%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DG.%26aulast%3DQin%26aufirst%3DY.%26atitle%3Ddl-3-n-Butylphthalide%2520Regulates%2520Cholinergic%2520Dysfunction%2520in%2520Chronic%2520Cerebral%2520Hypoperfusion%2520Rats%26jtitle%3DJ.%2520Int.%2520Med.%2520Res.%26date%3D2020%26volume%3D48%26spage%3D0300060520936177%26doi%3D10.1177%2F0300060520936177" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jain, A. N.</span></span> <span> </span><span class="NLM_article-title">Surflex: Fully Automatic Flexible Molecular Docking Using a Molecular Similarity-Based Search Engine</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">499</span>– <span class="NLM_lpage">511</span>, <span class="refDoi"> DOI: 10.1021/jm020406h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm020406h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=1%3ACAS%3A528%3ADC%252BD3sXkvFKjsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=499-511&author=A.+N.+Jain&title=Surflex%3A+Fully+Automatic+Flexible+Molecular+Docking+Using+a+Molecular+Similarity-Based+Search+Engine&doi=10.1021%2Fjm020406h"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Surflex: fully automatic flexible molecular docking using a molecular similarity-based search engine</span></div><div class="casAuthors">Jain, Ajay N.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">499-511</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Surflex is a fully automatic flexible mol. docking algorithm that combines the scoring function from the Hammerhead docking system with a search engine that relies on a surface-based mol. similarity method as a means to rapidly generate suitable putative poses for mol. fragments.  Results are presented evaluating reliability and accuracy of dockings compared with crystallog. exptl. results on 81 protein/ligand pairs of substantial structural diversity.  In over 80% of the complexes, Surflex's highest scoring docked pose was within 2.5 Å root-mean-square deviation (rmsd), with over 90% of the complexes having one of the top ranked poses within 2.5 Å rmsd.  Results are also presented assessing Surflex's utility as a screening tool on two protein targets (thymidine kinase and estrogen receptor) using data sets on which competing methods were run.  Performance of Surflex was significantly better, with true pos. rates of greater than 80% at false pos. rates of less than 1%.  Docking time was roughly linear in no. of rotatable bonds, beginning with a few seconds for rigid mols. and adding approx. 10 s per rotatable bond.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrawn5WHbx5p7Vg90H21EOLACvtfcHk0lhV_31Qd1M3Wg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXkvFKjsA%253D%253D&md5=67a08aafeadf69101d56b2f60a922359</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1021%2Fjm020406h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm020406h%26sid%3Dliteratum%253Aachs%26aulast%3DJain%26aufirst%3DA.%2BN.%26atitle%3DSurflex%253A%2520Fully%2520Automatic%2520Flexible%2520Molecular%2520Docking%2520Using%2520a%2520Molecular%2520Similarity-Based%2520Search%2520Engine%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26spage%3D499%26epage%3D511%26doi%3D10.1021%2Fjm020406h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yan, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cai, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ke, H.</span></span> <span> </span><span class="NLM_article-title">Refolding and Kinetic Characterization of the Phosphodiesterase-8A Catalytic Domain</span>. <i>Protein Expression Purif.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>64</i></span>,  <span class="NLM_fpage">82</span>– <span class="NLM_lpage">88</span>, <span class="refDoi"> DOI: 10.1016/j.pep.2008.10.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=10.1016%2Fj.pep.2008.10.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=18984055" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsFansrvN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2009&pages=82-88&author=Z.+Yanauthor=H.+Wangauthor=J.+Caiauthor=H.+Ke&title=Refolding+and+Kinetic+Characterization+of+the+Phosphodiesterase-8A+Catalytic+Domain&doi=10.1016%2Fj.pep.2008.10.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Refolding and kinetic characterization of the phosphodiesterase-8A catalytic domain</span></div><div class="casAuthors">Yan, Zier; Wang, Huanchen; Cai, Jiwen; Ke, Hengming</div><div class="citationInfo"><span class="NLM_cas:title">Protein Expression & Purification</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">64</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">82-88</span>CODEN:
                <span class="NLM_cas:coden">PEXPEJ</span>;
        ISSN:<span class="NLM_cas:issn">1046-5928</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Cyclic nucleotide phosphodiesterase-8 (PDE8) hydrolyzes the second messenger cAMP and is involved in many biol. processes such as testosterone prodn.  Although the bacterial and mammalian expression systems have been extensively tried, prodn. of large quantity of sol. and active PDE8 remains to be a major hurdle for pharmacol. and structural studies.  Reported here is a detailed protocol of refolding and purifn. of large quantity of the PDE8A1 catalytic domain (residues 480-820) and kinetic characterization of the refolded protein.  This protocol yielded about 8 mg of the PDE8A catalytic domain from 2 l Escherichia coli culture, which has at least 40-fold higher activity than those reported in literature.  The PDE8A1 catalytic domain has kcat of 4.0 s-1 for Mn2+ and 2.9 s-1 for Mg2+, and the Km values of 1-1.8 μM.  In addn., the PDE8A1 (205-820) fragment that contains both PAS and catalytic domains was expressed in E. coli and refolded.  This PDE8A1 (205-820) fragment has kcat of 1.1 s-1 and Km of 0.28 μM, but aggregated at high concn.  The Km of PDE8A1 (205-820) is 2- to 7-fold higher than the Km values of 40-150 nM for the full-length PDE8s in literature, but about 6-fold lower than that of the catalytic domain.  Thus, the Km difference likely implies an allosteric regulation of the PDE8A activity by its PAS domain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpptbTvyV50hrVg90H21EOLACvtfcHk0lhg_Bhb7otPUA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsFansrvN&md5=0e059481f27093b8393de0fe4378cc85</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1016%2Fj.pep.2008.10.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pep.2008.10.005%26sid%3Dliteratum%253Aachs%26aulast%3DYan%26aufirst%3DZ.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DCai%26aufirst%3DJ.%26aulast%3DKe%26aufirst%3DH.%26atitle%3DRefolding%2520and%2520Kinetic%2520Characterization%2520of%2520the%2520Phosphodiesterase-8A%2520Catalytic%2520Domain%26jtitle%3DProtein%2520Expression%2520Purif.%26date%3D2009%26volume%3D64%26spage%3D82%26epage%3D88%26doi%3D10.1016%2Fj.pep.2008.10.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cai, Y.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, Y.-K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shao, Y.-X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, H.-B.</span></span> <span> </span><span class="NLM_article-title">Identification of Novel Phosphodiesterase-4D Inhibitors Prescreened by Molecular Dynamics-Augmented Modeling and Validated by Bioassay</span>. <i>J. Chem. Inf. Model.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">972</span>– <span class="NLM_lpage">981</span>, <span class="refDoi"> DOI: 10.1021/ci400063s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ci400063s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=1%3ACAS%3A528%3ADC%252BC3sXktlersrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2013&pages=972-981&author=Z.+Liauthor=Y.-H.+Caiauthor=Y.-K.+Chengauthor=X.+Luauthor=Y.-X.+Shaoauthor=X.+Liauthor=M.+Liuauthor=P.+Liuauthor=H.-B.+Luo&title=Identification+of+Novel+Phosphodiesterase-4D+Inhibitors+Prescreened+by+Molecular+Dynamics-Augmented+Modeling+and+Validated+by+Bioassay&doi=10.1021%2Fci400063s"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of Novel Phosphodiesterase-4D Inhibitors Prescreened by Molecular Dynamics-Augmented Modeling and Validated by Bioassay</span></div><div class="casAuthors">Li, Zhe; Cai, Ying-Hong; Cheng, Yuen-Kit; Lu, Xiao; Shao, Yong-Xian; Li, Xingshu; Liu, Ming; Liu, Peiqing; Luo, Hai-Bin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">972-981</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Phosphodiesterase-4D (PDE4D) has been proved to be a potential therapeutic target against strokes.  In the present study, a procedure of integrating pharmacophore, mol. docking, mol. dynamics (MD) simulations, binding free energy calcns., and finally validation with bioassay was developed and described to search for novel PDE4D inhibitors from the SPECS database.  Among the 29 compds. selected by our MD-augmented strategy, 15 hits were found with IC50 between 1.9 and 50 μM (a hit rate of 52%) and 6 potent hits showed IC50 less than 10 μM, which suggested that MD simulations can explore the intermol. interactions of PDE4D-inhibitor complexes more precisely and thus significantly enhanced the hit rate of this screening.  The effective and efficient integrated procedures described in this study could be readily applied to screening studies toward other drug targets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoV8kRufl7wP7Vg90H21EOLACvtfcHk0lhg_Bhb7otPUA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXktlersrs%253D&md5=f35d422becdcfaafa25eb5fbd9631f72</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1021%2Fci400063s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci400063s%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DCai%26aufirst%3DY.-H.%26aulast%3DCheng%26aufirst%3DY.-K.%26aulast%3DLu%26aufirst%3DX.%26aulast%3DShao%26aufirst%3DY.-X.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DLiu%26aufirst%3DM.%26aulast%3DLiu%26aufirst%3DP.%26aulast%3DLuo%26aufirst%3DH.-B.%26atitle%3DIdentification%2520of%2520Novel%2520Phosphodiesterase-4D%2520Inhibitors%2520Prescreened%2520by%2520Molecular%2520Dynamics-Augmented%2520Modeling%2520and%2520Validated%2520by%2520Bioassay%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2013%26volume%3D53%26spage%3D972%26epage%3D981%26doi%3D10.1021%2Fci400063s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Y.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geng, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, H.-B.</span></span> <span> </span><span class="NLM_article-title">Optimization of Chromeno[2,3-c]pyrrol-9(2<i>H</i>)-ones as Highly Potent, Selective, and Orally Bioavailable PDE5 Inhibitors: Structure–Activity Relationship, X-ray Crystal Structure, and Pharmacodynamic Effect on Pulmonary Arterial Hypertension</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">8468</span>– <span class="NLM_lpage">8473</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b01209</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b01209" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhsFyqtLfO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=8468-8473&author=D.+Wuauthor=Y.+Huangauthor=Y.+Chenauthor=Y.-Y.+Huangauthor=H.+Gengauthor=T.+Zhangauthor=C.+Zhangauthor=Z.+Liauthor=L.+Guoauthor=J.+Chenauthor=H.-B.+Luo&title=Optimization+of+Chromeno%5B2%2C3-c%5Dpyrrol-9%282H%29-ones+as+Highly+Potent%2C+Selective%2C+and+Orally+Bioavailable+PDE5+Inhibitors%3A+Structure%E2%80%93Activity+Relationship%2C+X-ray+Crystal+Structure%2C+and+Pharmacodynamic+Effect+on+Pulmonary+Arterial+Hypertension&doi=10.1021%2Facs.jmedchem.8b01209"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Optimization of Chromeno[2,3-c]pyrrol-9(2H)-ones as Highly Potent, Selective, and Orally Bioavailable PDE5 Inhibitors: Structure-Activity Relationship, X-ray Crystal Structure, and Pharmacodynamic Effect on Pulmonary Arterial Hypertension</span></div><div class="casAuthors">Wu, Deyan; Huang, Yadan; Chen, Yiping; Huang, Yi-You; Geng, Haiju; Zhang, Tianhua; Zhang, Chen; Li, Zhe; Guo, Lei; Chen, Jianwen; Luo, Hai-Bin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">8468-8473</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">To further explore the structure-activity relationship around the chromeno[2,3-c]pyrrol-9(2H)-one scaffold, 19 derivs. as inhibitors against PDE5 were discovered.  The most potent inhibitor 3 has an IC50 of 0.32 nM with remarkable selectivity and druglike profile.  Oral administration of 3 (1.25 mg/kg) caused comparable therapeutic effects to sildenafil (10.0 mg/kg) against pulmonary arterial hypertension.  Further, different binding patterns from sildenafil were revealed in cocrystal structures, which provide structural templates for discovery of highly potent PDE5 inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrpoBU299FP4bVg90H21EOLACvtfcHk0lhg_Bhb7otPUA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhsFyqtLfO&md5=68091f0dd4d25dc79ac8ffb2f02832d9</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b01209&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b01209%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DD.%26aulast%3DHuang%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DHuang%26aufirst%3DY.-Y.%26aulast%3DGeng%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DT.%26aulast%3DZhang%26aufirst%3DC.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DGuo%26aufirst%3DL.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DLuo%26aufirst%3DH.-B.%26atitle%3DOptimization%2520of%2520Chromeno%255B2%252C3-c%255Dpyrrol-9%25282H%2529-ones%2520as%2520Highly%2520Potent%252C%2520Selective%252C%2520and%2520Orally%2520Bioavailable%2520PDE5%2520Inhibitors%253A%2520Structure%25E2%2580%2593Activity%2520Relationship%252C%2520X-ray%2520Crystal%2520Structure%252C%2520and%2520Pharmacodynamic%2520Effect%2520on%2520Pulmonary%2520Arterial%2520Hypertension%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D8468%26epage%3D8473%26doi%3D10.1021%2Facs.jmedchem.8b01209" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robinson, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ke, H.</span></span> <span> </span><span class="NLM_article-title">Multiple Elements Jointly Determine Inhibitor Selectivity of Cyclic Nucleotide Phosphodiesterases 4 and 7</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>280</i></span>,  <span class="NLM_fpage">30949</span>– <span class="NLM_lpage">30955</span>, <span class="refDoi"> DOI: 10.1074/jbc.m504398200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=10.1074%2Fjbc.M504398200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=15994308" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=1%3ACAS%3A528%3ADC%252BD2MXpsVCmt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=280&publication_year=2005&pages=30949-30955&author=H.+Wangauthor=Y.+Liuauthor=Y.+Chenauthor=H.+Robinsonauthor=H.+Ke&title=Multiple+Elements+Jointly+Determine+Inhibitor+Selectivity+of+Cyclic+Nucleotide+Phosphodiesterases+4+and+7&doi=10.1074%2Fjbc.m504398200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Multiple Elements Jointly Determine Inhibitor Selectivity of Cyclic Nucleotide Phosphodiesterases 4 and 7</span></div><div class="casAuthors">Wang, Huanchen; Liu, Yudong; Chen, Yuxiang; Robinson, Howard; Ke, Hengming</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">280</span>
        (<span class="NLM_cas:issue">35</span>),
    <span class="NLM_cas:pages">30949-30955</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Phosphodiesterase (PDE) inhibitors have been widely studied as therapeutics for treatment of human diseases.  However, the mechanism by which each PDE family recognizes selectively a category of inhibitors remains a puzzle.  Here we report the crystal structure of PDE7A1 catalytic domain in complex with non-selective inhibitor 3-isobutyl-1-methylxanthine and kinetic anal. on the mutants of PDE7A1 and PDE4D2.  Our studies suggest at least three elements play crit. roles in inhibitor selectivity: 1) the conformation and position of an invariant glutamine, 2) the natures of scaffolding residues, and 3) residues that alter shape and size of the binding pocket.  Kinetic anal. shows that single PDE7 to PDE4 mutations increase the sensitivity of PDE7 to PDE4 inhibitors but are not sufficient to render the engineered enzymes comparable with the wild types.  The triple S373Y/S377T/I412S mutation of PDE7A1 produces a PDE4-like enzyme, implying that multiple elements must work together to det. inhibitor selectivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp3hRnOJlxTlrVg90H21EOLACvtfcHk0lgmQnIoXvzwsQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXpsVCmt7k%253D&md5=306c19c96f9841d1f5b55d63729b9870</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M504398200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M504398200%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DH.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DRobinson%26aufirst%3DH.%26aulast%3DKe%26aufirst%3DH.%26atitle%3DMultiple%2520Elements%2520Jointly%2520Determine%2520Inhibitor%2520Selectivity%2520of%2520Cyclic%2520Nucleotide%2520Phosphodiesterases%25204%2520and%25207%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2005%26volume%3D280%26spage%3D30949%26epage%3D30955%26doi%3D10.1074%2Fjbc.m504398200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Park, S.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahmad, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Philp, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baar, K.</span></span> <span> </span><span class="NLM_article-title">Resveratrol Ameliorates Aging-Related Metabolic Phenotypes by Inhibiting cAMP Phosphodiesterases</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>148</i></span>,  <span class="NLM_fpage">421</span>– <span class="NLM_lpage">433</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2012.01.017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=10.1016%2Fj.cell.2012.01.017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=22304913" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvFakurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=148&publication_year=2012&pages=421-433&author=S.-J.+Parkauthor=F.+Ahmadauthor=A.+Philpauthor=K.+Baar&title=Resveratrol+Ameliorates+Aging-Related+Metabolic+Phenotypes+by+Inhibiting+cAMP+Phosphodiesterases&doi=10.1016%2Fj.cell.2012.01.017"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Resveratrol Ameliorates Aging-Related Metabolic Phenotypes by Inhibiting cAMP Phosphodiesterases</span></div><div class="casAuthors">Park, Sung-Jun; Ahmad, Faiyaz; Philp, Andrew; Baar, Keith; Williams, Tishan; Luo, Haibin; Ke, Hengming; Rehmann, Holger; Taussig, Ronald; Brown, Alexandra L.; Kim, Myung K.; Beaven, Michael A.; Burgin, Alex B.; Manganiello, Vincent; Chung, Jay H.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">148</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">421-433</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Resveratrol, a polyphenol in red wine, has been reported as a calorie restriction mimetic with potential antiaging and antidiabetogenic properties.  It is widely consumed as a nutritional supplement, but its mechanism of action remains a mystery.  Here, we report that the metabolic effects of resveratrol result from competitive inhibition of cAMP-degrading phosphodiesterases, leading to elevated cAMP levels.  The resulting activation of Epac1, a cAMP effector protein, increases intracellular Ca2+ levels and activates the CamKKβ-AMPK pathway via phospholipase C and the ryanodine receptor Ca2+-release channel.  As a consequence, resveratrol increases NAD+ and the activity of Sirt1.  Inhibiting PDE4 with rolipram reproduces all of the metabolic benefits of resveratrol, including prevention of diet-induced obesity and an increase in mitochondrial function, phys. stamina, and glucose tolerance in mice.  Therefore, administration of PDE4 inhibitors may also protect against and ameliorate the symptoms of metabolic diseases assocd. with aging.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo8zHottwfaS7Vg90H21EOLACvtfcHk0lgmQnIoXvzwsQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvFakurc%253D&md5=6e8e92e1140c0c63c0fc92314e0f0c5c</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2012.01.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2012.01.017%26sid%3Dliteratum%253Aachs%26aulast%3DPark%26aufirst%3DS.-J.%26aulast%3DAhmad%26aufirst%3DF.%26aulast%3DPhilp%26aufirst%3DA.%26aulast%3DBaar%26aufirst%3DK.%26atitle%3DResveratrol%2520Ameliorates%2520Aging-Related%2520Metabolic%2520Phenotypes%2520by%2520Inhibiting%2520cAMP%2520Phosphodiesterases%26jtitle%3DCell%26date%3D2012%26volume%3D148%26spage%3D421%26epage%3D433%26doi%3D10.1016%2Fj.cell.2012.01.017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geng, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lai, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, H.-B.</span></span> <span> </span><span class="NLM_article-title">Discovery and Optimization of Chromeno[2,3-c]pyrrol-9(2H)-ones as Novel Selective and Orally Bioavailable Phosphodiesterase 5 Inhibitors for the Treatment of Pulmonary Arterial Hypertension</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">6622</span>– <span class="NLM_lpage">6637</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00523</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00523" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtFCju7bL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=6622-6637&author=D.+Wuauthor=T.+Zhangauthor=Y.+Chenauthor=Y.+Huangauthor=H.+Gengauthor=Y.+Yuauthor=C.+Zhangauthor=Z.+Laiauthor=Y.+Wuauthor=X.+Guoauthor=J.+Chenauthor=H.-B.+Luo&title=Discovery+and+Optimization+of+Chromeno%5B2%2C3-c%5Dpyrrol-9%282H%29-ones+as+Novel+Selective+and+Orally+Bioavailable+Phosphodiesterase+5+Inhibitors+for+the+Treatment+of+Pulmonary+Arterial+Hypertension&doi=10.1021%2Facs.jmedchem.7b00523"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and Optimization of Chromeno[2,3-c]pyrrol-9(2H)-ones as Novel Selective and Orally Bioavailable Phosphodiesterase 5 Inhibitors for the Treatment of Pulmonary Arterial Hypertension</span></div><div class="casAuthors">Wu, Deyan; Zhang, Tianhua; Chen, Yiping; Huang, Yadan; Geng, Haiju; Yu, Yanfa; Zhang, Chen; Lai, Zengwei; Wu, Yinuo; Guo, Xiaolei; Chen, Jianwen; Luo, Hai-Bin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">6622-6637</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Phosphodiesterase 5 (PDE5) inhibitors have been used as clin. agents to treat erectile dysfunction and pulmonary arterial hypertension (PAH).  Herein, the authors detail the discovery of a novel series of chromeno[2,3-c]pyrrol-9(2H)-one derivs. as selective and orally bioavailable inhibitors against phosphodiesterase 5.  Medicinal chem. optimization resulted in compd. 2 (3-(benzo[d][1,3]dioxol-5-ylmethyl)-1-(thiazol-2-yl)chromeno[2,3-c]pyrrol-9(2H)-one), which exhibits a desirable inhibitory potency of 5.6 nM with remarkable selectivity as well as excellent pharmacokinetic properties and an oral bioavailability of 63.4%.  In addn., oral administration of 2 at a dose of 5.0 mg/kg caused better pharmacodynamics effects on both mPAP (mean pulmonary artery pressure) and RVHI (index of right ventricle hypertrophy) than sildenafil citrate at a dose of 10.0 mg/kg.  These activities along with its reasonable druglike properties, such as human liver microsomal stability, cytochrome inhibition, hERG inhibition, and pharmacol. safety, indicate that 2 is a potential candidate for the treatment of PAH.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrWWPn7AuEJbbVg90H21EOLACvtfcHk0lgmQnIoXvzwsQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtFCju7bL&md5=b12716eb2b3e9ee0616300e4a788acfd</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00523&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00523%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DD.%26aulast%3DZhang%26aufirst%3DT.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DHuang%26aufirst%3DY.%26aulast%3DGeng%26aufirst%3DH.%26aulast%3DYu%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DC.%26aulast%3DLai%26aufirst%3DZ.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DGuo%26aufirst%3DX.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DLuo%26aufirst%3DH.-B.%26atitle%3DDiscovery%2520and%2520Optimization%2520of%2520Chromeno%255B2%252C3-c%255Dpyrrol-9%25282H%2529-ones%2520as%2520Novel%2520Selective%2520and%2520Orally%2520Bioavailable%2520Phosphodiesterase%25205%2520Inhibitors%2520for%2520the%2520Treatment%2520of%2520Pulmonary%2520Arterial%2520Hypertension%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D6622%26epage%3D6637%26doi%3D10.1021%2Facs.jmedchem.7b00523" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Y.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, Y.-F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, H.-B.</span></span> <span> </span><span class="NLM_article-title">Validation of Phosphodiesterase-10 as a Novel Target for Pulmonary Arterial Hypertension via Highly Selective and Subnanomolar Inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">3707</span>– <span class="NLM_lpage">3721</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.9b00224</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.9b00224" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=1%3ACAS%3A528%3ADC%252BC1MXlt1yks7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2019&pages=3707-3721&author=Y.-Y.+Huangauthor=Y.-F.+Yuauthor=C.+Zhangauthor=Y.+Chenauthor=Q.+Zhouauthor=Z.+Liauthor=S.+Zhouauthor=Z.+Liauthor=L.+Guoauthor=D.+Wuauthor=Y.+Wuauthor=H.-B.+Luo&title=Validation+of+Phosphodiesterase-10+as+a+Novel+Target+for+Pulmonary+Arterial+Hypertension+via+Highly+Selective+and+Subnanomolar+Inhibitors&doi=10.1021%2Facs.jmedchem.9b00224"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Validation of Phosphodiesterase-10 as a Novel Target for Pulmonary Arterial Hypertension via Highly Selective and Subnanomolar Inhibitors</span></div><div class="casAuthors">Huang, Yi-You; Yu, Yan-Fa; Zhang, Chen; Chen, Yiping; Zhou, Qian; Li, Zhuoming; Zhou, Sihang; Li, Zhe; Guo, Lei; Wu, Deyan; Wu, Yinuo; Luo, Hai-Bin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">3707-3721</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Pulmonary arterial hypertension (PAH) causes pathol. increase in pulmonary vascular resistance, leading to right-heart failure and eventual death.  Previously, phosphodiesterase-10 (PDE10) was reported to be a promising target for PAH based on the studies with a nonselective PDE inhibitor papaverine, but little progress has been made to confirm the practical application of PDE10 inhibitors.  To validate whether PAH is ameliorated by PDE10 inhibition rather than other PDE isoforms, here we report an integrated strategy to discover highly selective PDE10 inhibitors as chem. probes.  Structural optimization resulted in a PDE10 inhibitor 2b with subnanomolar affinity and good selectivity of >45 000-fold against other PDEs.  The cocrystal structure of the PDE10-2b complex revealed an important H-bond interaction between 2b and Tyr693.  Finally, compd. 2b significantly decreased the arterial pressure in PAH rats and thus validated the potential of PDE10 as a novel anti-PAH target.  These findings suggest that PDE10 inhibition may be a viable treatment option for PAH.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqBy0isM1x_z7Vg90H21EOLACvtfcHk0liydpppsvd_lQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXlt1yks7Y%253D&md5=eb543109abd51256d9216dc4ad3ed6fa</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.9b00224&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.9b00224%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DY.-Y.%26aulast%3DYu%26aufirst%3DY.-F.%26aulast%3DZhang%26aufirst%3DC.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DZhou%26aufirst%3DQ.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DZhou%26aufirst%3DS.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DGuo%26aufirst%3DL.%26aulast%3DWu%26aufirst%3DD.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DLuo%26aufirst%3DH.-B.%26atitle%3DValidation%2520of%2520Phosphodiesterase-10%2520as%2520a%2520Novel%2520Target%2520for%2520Pulmonary%2520Arterial%2520Hypertension%2520via%2520Highly%2520Selective%2520and%2520Subnanomolar%2520Inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2019%26volume%3D62%26spage%3D3707%26epage%3D3721%26doi%3D10.1021%2Facs.jmedchem.9b00224" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Y.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, H.-B.</span></span> <span> </span><span class="NLM_article-title">Discovery of Highly Selective and Orally Available Benzimidazole-Based Phosphodiesterase 10 Inhibitors with Improved Solubility and Pharmacokinetic Properties for Treatment of Pulmonary Arterial Hypertension</span>. <i>Acta Pharm. Sin. B</i> <span class="NLM_year" style="font-weight: bold;">2020</span>, <span class="refDoi"> DOI: 10.1016/j.apsb.2020.04.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=10.1016%2Fj.apsb.2020.04.003" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2020&author=Y.+Yangauthor=S.+Zhangauthor=Q.+Zhouauthor=C.+Zhangauthor=Y.+Gaoauthor=H.+Wangauthor=Z.+Liauthor=D.+Wuauthor=Y.+Wuauthor=Y.-Y.+Huangauthor=L.+Guoauthor=H.-B.+Luo&title=Discovery+of+Highly+Selective+and+Orally+Available+Benzimidazole-Based+Phosphodiesterase+10+Inhibitors+with+Improved+Solubility+and+Pharmacokinetic+Properties+for+Treatment+of+Pulmonary+Arterial+Hypertension&doi=10.1016%2Fj.apsb.2020.04.003"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1016%2Fj.apsb.2020.04.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.apsb.2020.04.003%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DS.%26aulast%3DZhou%26aufirst%3DQ.%26aulast%3DZhang%26aufirst%3DC.%26aulast%3DGao%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DWu%26aufirst%3DD.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DHuang%26aufirst%3DY.-Y.%26aulast%3DGuo%26aufirst%3DL.%26aulast%3DLuo%26aufirst%3DH.-B.%26atitle%3DDiscovery%2520of%2520Highly%2520Selective%2520and%2520Orally%2520Available%2520Benzimidazole-Based%2520Phosphodiesterase%252010%2520Inhibitors%2520with%2520Improved%2520Solubility%2520and%2520Pharmacokinetic%2520Properties%2520for%2520Treatment%2520of%2520Pulmonary%2520Arterial%2520Hypertension%26jtitle%3DActa%2520Pharm.%2520Sin.%2520B%26date%3D2020%26doi%3D10.1016%2Fj.apsb.2020.04.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, Y.-F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geng, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tian, Y.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J.-W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, H.-B.</span></span> <span> </span><span class="NLM_article-title">Discovery of Potent, Selective, and Orally Bioavailable Inhibitors against Phosphodiesterase-9, a Novel Target for the Treatment of Vascular Dementia</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">4218</span>– <span class="NLM_lpage">4224</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b01041</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b01041" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=1%3ACAS%3A528%3ADC%252BC1MXmtVCjtr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2019&pages=4218-4224&author=Y.+Wuauthor=Q.+Zhouauthor=T.+Zhangauthor=Z.+Liauthor=Y.-P.+Chenauthor=P.+Zhangauthor=Y.-F.+Yuauthor=H.+Gengauthor=Y.-J.+Tianauthor=C.+Zhangauthor=Y.+Wangauthor=J.-W.+Chenauthor=Y.+Chenauthor=H.-B.+Luo&title=Discovery+of+Potent%2C+Selective%2C+and+Orally+Bioavailable+Inhibitors+against+Phosphodiesterase-9%2C+a+Novel+Target+for+the+Treatment+of+Vascular+Dementia&doi=10.1021%2Facs.jmedchem.8b01041"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Potent, Selective, and Orally Bioavailable Inhibitors against Phosphodiesterase-9, a Novel Target for the Treatment of Vascular Dementia</span></div><div class="casAuthors">Wu, Yinuo; Zhou, Qian; Zhang, Tianhua; Li, Zhe; Chen, Yi-Ping; Zhang, Pei; Yu, Yan-Fa; Geng, Haiju; Tian, Yi-Jing; Zhang, Chen; Wang, Yu; Chen, Jian-Wen; Chen, Yan; Luo, Hai-Bin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">4218-4224</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">To identify phosphodiesterase-9 (PDE9) as a novel target for the treatment of vascular dementia (VaD), a series of pyrazolopyrimidinone analogs were discovered based on a hit 1.  Hit-to-lead optimization resulted in a potent inhibitor 2 with excellent selectivity and physicochem. properties to enable in vivo studies.  Oral administration of 2 (5.0 mg/kg) caused notable therapeutic effects in the VaD mouse model, providing a promising lead or chem. probe for investigating the biol. functions of PDE9 inhibition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrh0_gKOVCmpLVg90H21EOLACvtfcHk0liydpppsvd_lQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXmtVCjtr0%253D&md5=383a19c865240aa6b6e2ec97308da917</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b01041&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b01041%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DY.%26aulast%3DZhou%26aufirst%3DQ.%26aulast%3DZhang%26aufirst%3DT.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DChen%26aufirst%3DY.-P.%26aulast%3DZhang%26aufirst%3DP.%26aulast%3DYu%26aufirst%3DY.-F.%26aulast%3DGeng%26aufirst%3DH.%26aulast%3DTian%26aufirst%3DY.-J.%26aulast%3DZhang%26aufirst%3DC.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DJ.-W.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DLuo%26aufirst%3DH.-B.%26atitle%3DDiscovery%2520of%2520Potent%252C%2520Selective%252C%2520and%2520Orally%2520Bioavailable%2520Inhibitors%2520against%2520Phosphodiesterase-9%252C%2520a%2520Novel%2520Target%2520for%2520the%2520Treatment%2520of%2520Vascular%2520Dementia%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2019%26volume%3D62%26spage%3D4218%26epage%3D4224%26doi%3D10.1021%2Facs.jmedchem.8b01041" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, H.-B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span> <span> </span><span class="NLM_article-title">Design, Synthesis, and Evaluation of Multitarget-Directed Resveratrol Derivatives for the Treatment of Alzheimer’s Disease</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">5843</span>– <span class="NLM_lpage">5859</span>, <span class="refDoi"> DOI: 10.1021/jm400567s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm400567s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtVWhtrrK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=5843-5859&author=C.+Luauthor=Y.+Guoauthor=J.+Yanauthor=Z.+Luoauthor=H.-B.+Luoauthor=M.+Yanauthor=L.+Huangauthor=X.+Li&title=Design%2C+Synthesis%2C+and+Evaluation+of+Multitarget-Directed+Resveratrol+Derivatives+for+the+Treatment+of+Alzheimer%E2%80%99s+Disease&doi=10.1021%2Fjm400567s"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Design, Synthesis, and Evaluation of Multitarget-Directed Resveratrol Derivatives for the Treatment of Alzheimer's Disease</span></div><div class="casAuthors">Lu, Chuanjun; Guo, Yueyan; Yan, Jun; Luo, Zonghua; Luo, Hai-Bin; Yan, Ming; Huang, Ling; Li, Xingshu</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">5843-5859</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A series of multitarget-directed resveratrol derivs. was designed and synthesized for the treatment of Alzheimer's disease (AD).  In vitro studies indicated that most of the target compds. exhibit significant inhibition of self-induced β-amyloid (Aβ) aggregation and Cu(II)-induced Aβ1-42 aggregation and acted as potential antioxidants and biometal chelators.  In particular, compds. I (R = Me) (II) and I (R = H) (III) are potential lead compds. for AD therapy (II, IC50 = 7.56 μM and III, IC50 = 6.51 μM for self-induced Aβ aggregation; the oxygen radical absorbance capacity assay using fluorescein (ORAC-FL) values are 4.72 and 4.70, resp.).  Moreover, these compds. are capable of disassembling the highly structured Aβ fibrils generated by self- and Cu(II)-induced Aβ aggregation.  Furthermore, II crossed the blood-brain barrier (BBB) in vitro and did not exhibit any acute toxicity in mice at doses of up to 2000 mg/kg.  Taken together, the data indicate that II is a very promising lead compd. for AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpxibZnQJ-ZTLVg90H21EOLACvtfcHk0liTF7E7ZTZA3g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtVWhtrrK&md5=58824e2df9bdc9fc4216ac9cbeafc87c</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1021%2Fjm400567s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400567s%26sid%3Dliteratum%253Aachs%26aulast%3DLu%26aufirst%3DC.%26aulast%3DGuo%26aufirst%3DY.%26aulast%3DYan%26aufirst%3DJ.%26aulast%3DLuo%26aufirst%3DZ.%26aulast%3DLuo%26aufirst%3DH.-B.%26aulast%3DYan%26aufirst%3DM.%26aulast%3DHuang%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DX.%26atitle%3DDesign%252C%2520Synthesis%252C%2520and%2520Evaluation%2520of%2520Multitarget-Directed%2520Resveratrol%2520Derivatives%2520for%2520the%2520Treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520Disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D5843%26epage%3D5859%26doi%3D10.1021%2Fjm400567s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 1 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Paul M.  Epstein</span>, <span class="hlFld-ContribAuthor ">Chaitali  Basole</span>, <span class="hlFld-ContribAuthor ">Stefan  Brocke</span>. </span><span class="cited-content_cbyCitation_article-title">The Role of PDE8 in T Cell Recruitment and Function in Inflammation. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Cell and Developmental Biology</span><span> <strong>2021,</strong> <em>9 </em><a href="https://doi.org/10.3389/fcell.2021.636778" title="DOI URL">https://doi.org/10.3389/fcell.2021.636778</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fcell.2021.636778&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffcell.2021.636778%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Cell%2520and%2520Developmental%2520Biology%26atitle%3DThe%252BRole%252Bof%252BPDE8%252Bin%252BT%252BCell%252BRecruitment%252Band%252BFunction%252Bin%252BInflammation%26aulast%3DEpstein%26aufirst%3DPaul%2BM.%26date%3D2021%26date%3D2021%26volume%3D9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01573/20201218/images/medium/jm0c01573_0012.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01573/20201218/images/large/jm0c01573_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01573&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01573/20201218/images/medium/jm0c01573_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01573/20201218/images/large/jm0c01573_0002.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structure-based optimizations of 2-chloroadenine derivatives as novel PDE8A inhibitors with improved potency and selectivity by targeting Tyr748. (A) Sequence alignment of the residues in the active site across PDE families. (B) Two rounds of structural optimizations based on clofarabine resulted in the highly potent PDE8A inhibitor <b>3a</b>. The PDB IDs are <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=7CWA">7CWA</a> and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=7CWF">7CWF</a> for the crystal structures of the PDE8A–clofarabine and PDE8A–<b>2c</b> complexes (see their binding patterns in high resolution in <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>), respectively.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01573/20201218/images/large/jm0c01573_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01573&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01573/20201218/images/medium/jm0c01573_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01573/20201218/images/large/jm0c01573_0003.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Structure-based optimization of selective PDE8A inhibitors. (A) Cartoon presentation of clofarabine binding to the active pocket of PDE8A (green sticks, PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=7CWA">7CWA</a>). (B) Design of a scaffold that may potentially form a H-bond with Tyr748 and fit tightly to the PDE8A pocket. (C) Cartoon presentation of <b>2c</b> binding to the pocket of PDE8A (purple sticks, PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=7CWF">7CWF</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01573/20201218/images/large/jm0c01573_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01573&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01573/20201218/images/medium/jm0c01573_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01573/20201218/images/large/jm0c01573_0007.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthetic Route for Compounds <b>1a–i</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01573/20201218/images/large/jm0c01573_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01573&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) boric ester or boric acid derivatives (<b>M1</b>), Pd(dppf)Cl<sub>2</sub>·CH<sub>2</sub>Cl<sub>2</sub>, K<sub>2</sub>CO<sub>3</sub>, 1,4-dioxane/H<sub>2</sub>O, 100 °C, overnight; (b) sodium 2,2-difluoroethanolate, 2,2-difluoroethanol, reflux, 16 h; (c) PBr<sub>3</sub>, DCM, 0 °C to r.t., 4 h; (d) 2-chloro-9<i>H</i>-purin-6-amine, Cs<sub>2</sub>CO<sub>3</sub>, DMF, 70 °C, overnight; (e) Pd/C, H<sub>2</sub>, MeOH/THF, r.t., overnight.</p></p></figure><figure data-id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01573/20201218/images/medium/jm0c01573_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01573/20201218/images/large/jm0c01573_0008.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthetic Route for Compounds <b>2a–c</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01573/20201218/images/large/jm0c01573_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01573&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) sodium methoxide or sodium 2,2-difluoroethanolate, MeOH or 2,2-difluoroethanol, reflux, 16 h; (b) PBr<sub>3</sub>, DCM, 0 °C to r.t., 4 h; (c) 2-chloro-9<i>H</i>-purin-6-amine, Cs<sub>2</sub>CO<sub>3</sub>, DMF, 70 °C, overnight.</p></p></figure><figure data-id="sch3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01573/20201218/images/medium/jm0c01573_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01573/20201218/images/large/jm0c01573_0009.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthetic Route for Compounds <b>3</b>, <b>3a</b>, and <b>3b</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01573/20201218/images/large/jm0c01573_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01573&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) sodium 2,2-difluoroethanolate, 2,2-difluoroethanol, reflux, 16 h; (b) pinacol vinylboronate, Pd(dppf)Cl<sub>2</sub>·CH<sub>2</sub>Cl<sub>2</sub>, K<sub>2</sub>CO<sub>3</sub>, 1,4-dioxane/H<sub>2</sub>O, 100 °C, overnight; (c) Pd/C, H<sub>2</sub>, MeOH/THF, r.t., overnight; (d) NBS, AIBN, CCl<sub>4</sub>, reflux, 4 h; (e) 2-chloro-9<i>H</i>-purin-6-amine, Cs<sub>2</sub>CO<sub>3</sub>, DMF, 70 °C, overnight; (f) chiral separation, CHIRALFLASH IA column, DCM/THF 99:1, 12 mL/min.</p></p></figure><figure data-id="fig3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01573/20201218/images/medium/jm0c01573_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01573/20201218/images/large/jm0c01573_0004.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Cocrystal structures of the PDE8A–<b>3a</b> complex. (A) Cartoon model for PDE8A in complex with <b>3a</b> (cyan sticks, PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=7CWG">7CWG</a>); the dotted lines represent H-bonds. (B) Electron density maps of (Fo–Fc) for PDE8A in complex with <b>3a</b> (cyan sticks). (C) Differences in the binding patterns between PDE8A–<b>3a</b> (cyan sticks) and PDE8A–IBMX (pink sticks, PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3ECN">3ECN</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01573/20201218/images/large/jm0c01573_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01573&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01573/20201218/images/medium/jm0c01573_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01573/20201218/images/large/jm0c01573_0005.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Spatial learning and memory improvement of compound <b>3a</b> to UCCAO-treated mice after 3 weeks at the oral dose of 3 mg/kg. (A) ELT of UCCAO-treated mice in the spatial probe trial (s). (B) Frequency of the platform site crossings in the spatial probe trial (min<sup>–1</sup>). (C) Swimming time in the target area in the spatial probe trial (s). (D) Representative swimming trajectories of each group in the spatial probe trial. Donepezil (1 mg/kg, p.o.) was used as the positive control. Data are presented as the mean ± SEM. UCCAO-treated mice in each group, <i>n</i> = 9–12. #, <i>p</i> < 0.05 vs control; ##, <i>p</i> < 0.01 vs control; ###, <i>p</i> < 0.001 vs control; *, <i>p</i> < 0.05 vs model; **, <i>p</i> < 0.01 vs model.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01573/20201218/images/large/jm0c01573_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01573&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01573/20201218/images/medium/jm0c01573_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01573/20201218/images/large/jm0c01573_0006.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Therapeutic effects of compound <b>3a</b> on escaping reaction acquisition in the passive avoidance task in UCCAO mice. (A) Avoidance latency time of the passive avoidance task (s). (B) Error times of the passive avoidance task. Data are presented as the mean ± SEM. UCCAO-treated mice in each group, <i>n</i> = 9–12. #, <i>p</i> < 0.05 vs control; ##, <i>p</i> < 0.01 vs control; *, <i>p</i> < 0.05 vs model. (C) Body weight of different groups.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01573/20201218/images/large/jm0c01573_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01573&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i76">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_67564" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_67564" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 52 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Conti, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beavo, J.</span></span> <span> </span><span class="NLM_article-title">Biochemistry and Physiology of Cyclic Nucleotide Phosphodiesterases: Essential Components in Cyclic Nucleotide Signaling</span>. <i>Annu. Rev. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>76</i></span>,  <span class="NLM_fpage">481</span>– <span class="NLM_lpage">511</span>, <span class="refDoi"> DOI: 10.1146/annurev.biochem.76.060305.150444</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=10.1146%2Fannurev.biochem.76.060305.150444" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=17376027" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtVehtb%252FE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=76&publication_year=2007&pages=481-511&author=M.+Contiauthor=J.+Beavo&title=Biochemistry+and+Physiology+of+Cyclic+Nucleotide+Phosphodiesterases%3A+Essential+Components+in+Cyclic+Nucleotide+Signaling&doi=10.1146%2Fannurev.biochem.76.060305.150444"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Biochemistry and physiology of cyclic nucleotide phosphodiesterases: essential components in cyclic nucleotide signaling</span></div><div class="casAuthors">Conti, Marco; Beavo, Joseph</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Biochemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">76</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">481-511</span>CODEN:
                <span class="NLM_cas:coden">ARBOAW</span>;
        ISSN:<span class="NLM_cas:issn">0066-4154</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review.  Although cyclic nucleotide phosphodiesterases (PDEs) were described soon after the discovery of cAMP, their complexity and functions in signaling is only recently beginning to become fully realized.  We now know that ≥100 different PDE proteins degrade cAMP and cGMP in eukaryotes.  A complex PDE gene organization and a large no. of PDE splicing variants serve to fine-tune cyclic nucleotide signals and contribute to specificity in signaling.  Here we review some of the major concepts related to our understanding of PDE function and regulation including: (1) the structure of catalytic and regulatory domains and arrangement in holoenzymes; (2) PDE integration into signaling complexes; (3) the nature and function of neg. and pos. feedback circuits that have been conserved in PDEs from prokaryotes to human; (4) the emerging assocn. of mutant PDE alleles with inherited diseases; and (5) the role of PDEs in generating subcellular signaling compartments.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrJviyUqGyR2rVg90H21EOLACvtfcHk0lj4dv4y5h9VnA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtVehtb%252FE&md5=4808b5e4b29337fab57e623d81a5f0f6</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1146%2Fannurev.biochem.76.060305.150444&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.biochem.76.060305.150444%26sid%3Dliteratum%253Aachs%26aulast%3DConti%26aufirst%3DM.%26aulast%3DBeavo%26aufirst%3DJ.%26atitle%3DBiochemistry%2520and%2520Physiology%2520of%2520Cyclic%2520Nucleotide%2520Phosphodiesterases%253A%2520Essential%2520Components%2520in%2520Cyclic%2520Nucleotide%2520Signaling%26jtitle%3DAnnu.%2520Rev.%2520Biochem.%26date%3D2007%26volume%3D76%26spage%3D481%26epage%3D511%26doi%3D10.1146%2Fannurev.biochem.76.060305.150444" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Francis, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blount, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corbin, J. D.</span></span> <span> </span><span class="NLM_article-title">Mammalian Cyclic Nucleotide Phosphodiesterases: Molecular Mechanisms and Physiological Functions</span>. <i>Physiol. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>91</i></span>,  <span class="NLM_fpage">651</span>– <span class="NLM_lpage">690</span>, <span class="refDoi"> DOI: 10.1152/physrev.00030.2010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=10.1152%2Fphysrev.00030.2010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=21527734" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=1%3ACAS%3A528%3ADC%252BC3MXns1Cms7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=91&publication_year=2011&pages=651-690&author=S.+H.+Francisauthor=M.+A.+Blountauthor=J.+D.+Corbin&title=Mammalian+Cyclic+Nucleotide+Phosphodiesterases%3A+Molecular+Mechanisms+and+Physiological+Functions&doi=10.1152%2Fphysrev.00030.2010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Mammalian cyclic nucleotide phosphodiesterases: molecular mechanisms and physiological functions</span></div><div class="casAuthors">Francis, Sharron H.; Blount, Mitsi A.; Corbin, Jackie D.</div><div class="citationInfo"><span class="NLM_cas:title">Physiological Reviews</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">91</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">651-690</span>CODEN:
                <span class="NLM_cas:coden">PHREA7</span>;
        ISSN:<span class="NLM_cas:issn">0031-9333</span>.
    
            (<span class="NLM_cas:orgname">American Physiological Society</span>)
        </div><div class="casAbstract">A review.  The superfamily of cyclic nucleotide (cN) phosphodiesterases (PDEs) is comprised of 11 families of enzymes.  PDEs break down cAMP and/or cGMP and are major determinants of cellular cN levels and, consequently, the actions of cN-signaling pathways.  PDEs exhibit a range of catalytic efficiencies for breakdown of cAMP and/or cGMP and are regulated by myriad processes including phosphorylation, cN binding to allosteric GAF domains, changes in expression levels, interaction with regulatory or anchoring proteins, and reversible translocation among subcellular compartments.  Selective PDE inhibitors are currently in clin. use for treatment of erectile dysfunction, pulmonary hypertension, intermittent claudication, and chronic pulmonary obstructive disease; many new inhibitors are being developed for treatment of these and other maladies.  Recently reported x-ray crystallog. structures have defined features that provide for specificity for cAMP or cGMP in PDE catalytic sites or their GAF domains, as well as mechanisms involved in catalysis, oligomerization, autoinhibition, and interactions with inhibitors.  In addn., major advances have been made in understanding the physiol. impact and the biochem. basis for selective localization and/or recruitment of specific PDE isoenzymes to particular subcellular compartments.  The many recent advances in understanding PDE structures, functions, and physiol. actions are discussed in this review.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrN99wWYsCXRbVg90H21EOLACvtfcHk0ljx8zbpTVlMgg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXns1Cms7o%253D&md5=4aae757704a6243c9aa2648c32d5c759</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1152%2Fphysrev.00030.2010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fphysrev.00030.2010%26sid%3Dliteratum%253Aachs%26aulast%3DFrancis%26aufirst%3DS.%2BH.%26aulast%3DBlount%26aufirst%3DM.%2BA.%26aulast%3DCorbin%26aufirst%3DJ.%2BD.%26atitle%3DMammalian%2520Cyclic%2520Nucleotide%2520Phosphodiesterases%253A%2520Molecular%2520Mechanisms%2520and%2520Physiological%2520Functions%26jtitle%3DPhysiol.%2520Rev.%26date%3D2011%26volume%3D91%26spage%3D651%26epage%3D690%26doi%3D10.1152%2Fphysrev.00030.2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Keravis, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lugnier, C.</span></span> <span> </span><span class="NLM_article-title">Cyclic Nucleotide Phosphodiesterase (PDE) Isozymes as Targets of the Intracellular Signalling Network: Benefits of PDE Inhibitors in Various Diseases and Perspectives for Future Therapeutic Developments</span>. <i>Br. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>165</i></span>,  <span class="NLM_fpage">1288</span>– <span class="NLM_lpage">1305</span>, <span class="refDoi"> DOI: 10.1111/j.1476-5381.2011.01729.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=10.1111%2Fj.1476-5381.2011.01729.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=22014080" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=1%3ACAS%3A528%3ADC%252BC38Xis1Ohtb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=165&publication_year=2012&pages=1288-1305&author=T.+Keravisauthor=C.+Lugnier&title=Cyclic+Nucleotide+Phosphodiesterase+%28PDE%29+Isozymes+as+Targets+of+the+Intracellular+Signalling+Network%3A+Benefits+of+PDE+Inhibitors+in+Various+Diseases+and+Perspectives+for+Future+Therapeutic+Developments&doi=10.1111%2Fj.1476-5381.2011.01729.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Cyclic nucleotide phosphodiesterase (PDE) isozymes as targets of the intracellular signalling network: benefits of PDE inhibitors in various diseases and perspectives for future therapeutic developments</span></div><div class="casAuthors">Keravis, Therese; Lugnier, Claire</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">165</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1288-1305</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  Cyclic nucleotide phosphodiesterases (PDEs) that specifically inactivate the intracellular messengers cAMP and cGMP in a compartmentalized manner represent an important enzyme class constituted by 11 gene-related families of isoenzymes (PDE1 to PDE11).  Downstream receptors, PDEs play a major role in controlling the signalosome at various levels of phosphorylations and protein/protein interactions.  Due to the multiplicity of isoenzymes, their various intracellular regulations and their different cellular and subcellular distributions, PDEs represent interesting targets in intracellular pathways.  Therefore, the investigation of PDE isoenzyme alterations related to various pathologies and the design of specific PDE inhibitors might lead to the development of new specific therapeutic strategies in numerous pathologies.  This manuscript (i) overviews the different PDEs including their endogenous regulations and their specific inhibitors; (ii) analyses the intracellular implications of PDEs in regulating signalling cascades in pathogenesis, exemplified by two diseases affecting cell cycle and proliferation; and (iii) discusses perspectives for future therapeutic developments.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqvr2jfPTxnY7Vg90H21EOLACvtfcHk0ljx8zbpTVlMgg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xis1Ohtb8%253D&md5=dbf5913bc6c973d0640258c51b7c481d</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1111%2Fj.1476-5381.2011.01729.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1476-5381.2011.01729.x%26sid%3Dliteratum%253Aachs%26aulast%3DKeravis%26aufirst%3DT.%26aulast%3DLugnier%26aufirst%3DC.%26atitle%3DCyclic%2520Nucleotide%2520Phosphodiesterase%2520%2528PDE%2529%2520Isozymes%2520as%2520Targets%2520of%2520the%2520Intracellular%2520Signalling%2520Network%253A%2520Benefits%2520of%2520PDE%2520Inhibitors%2520in%2520Various%2520Diseases%2520and%2520Perspectives%2520for%2520Future%2520Therapeutic%2520Developments%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2012%26volume%3D165%26spage%3D1288%26epage%3D1305%26doi%3D10.1111%2Fj.1476-5381.2011.01729.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Omori, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kotera, J.</span></span> <span> </span><span class="NLM_article-title">Overview of PDEs and Their Regulation</span>. <i>Circ. Res.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>100</i></span>,  <span class="NLM_fpage">309</span>– <span class="NLM_lpage">327</span>, <span class="refDoi"> DOI: 10.1161/01.res.0000256354.95791.f1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=10.1161%2F01.RES.0000256354.95791.f1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=17307970" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsF2kurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=2007&pages=309-327&author=K.+Omoriauthor=J.+Kotera&title=Overview+of+PDEs+and+Their+Regulation&doi=10.1161%2F01.res.0000256354.95791.f1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Overview of PDEs and their regulation</span></div><div class="casAuthors">Omori, Kenji; Kotera, Jun</div><div class="citationInfo"><span class="NLM_cas:title">Circulation Research</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">100</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">309-327</span>CODEN:
                <span class="NLM_cas:coden">CIRUAL</span>;
        ISSN:<span class="NLM_cas:issn">0009-7330</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">A review.  Contraction and relaxation of vascular smooth muscle and cardiac myocytes are key physiol. events in the cardiovascular system.  These events are regulated by 2nd messengers, cAMP and cGMP, in response to extracellular stimulants.  The strength of signal transduction is controlled by intracellular cyclic nucleotide concns., which are detd. by a balance in the prodn. and degrdn. of cAMP and cGMP.  The degrdn. of cyclic nucleotides is catalyzed by 3',5'-cyclic nucleotide phosphodiesterases (PDEs), and therefore regulation of PDEs hydrolytic activity is important for modulation of cellular functions.  Mammalian PDEs are composed of 21 genes and are categorized into 11 families based on sequence homol., enzymic properties, and sensitivity to inhibitors.  PDE families contain many splice variants that mostly are unique in tissue-expression patterns, gene regulation, enzymic regulation by phosphorylation and regulatory proteins, subcellular localization, and interaction with assocn. proteins.  Each unique variant is closely related to the regulation of a specific cellular signaling.  Thus, multiple PDEs function as a particular modulator of each cardiovascular function and regulate physiol. homeostasis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrctQ0OjiRTE7Vg90H21EOLACvtfcHk0ljx8zbpTVlMgg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsF2kurY%253D&md5=932f5158c5ebdd9a75a41317b0b12955</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1161%2F01.RES.0000256354.95791.f1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252F01.RES.0000256354.95791.f1%26sid%3Dliteratum%253Aachs%26aulast%3DOmori%26aufirst%3DK.%26aulast%3DKotera%26aufirst%3DJ.%26atitle%3DOverview%2520of%2520PDEs%2520and%2520Their%2520Regulation%26jtitle%3DCirc.%2520Res.%26date%3D2007%26volume%3D100%26spage%3D309%26epage%3D327%26doi%3D10.1161%2F01.res.0000256354.95791.f1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pissarnitski, D.</span></span> <span> </span><span class="NLM_article-title">Phosphodiesterase 5 (PDE 5) Inhibitors for the Treatment of Male Erectile Disorder: Attaining Selectivity Versus PDE6</span>. <i>Med. Res. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">369</span>– <span class="NLM_lpage">395</span>, <span class="refDoi"> DOI: 10.1002/med.20053</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=10.1002%2Fmed.20053" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=16388517" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=1%3ACAS%3A528%3ADC%252BD28XksFSlsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2006&pages=369-395&author=D.+Pissarnitski&title=Phosphodiesterase+5+%28PDE+5%29+Inhibitors+for+the+Treatment+of+Male+Erectile+Disorder%3A+Attaining+Selectivity+Versus+PDE6&doi=10.1002%2Fmed.20053"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Phosphodiesterase 5 (PDE 5) inhibitors for the treatment of male erectile disorder: attaining selectivity versus PDE6</span></div><div class="casAuthors">Pissarnitski, Dmitri</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Research Reviews</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">369-395</span>CODEN:
                <span class="NLM_cas:coden">MRREDD</span>;
        ISSN:<span class="NLM_cas:issn">0198-6325</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review.  The role of phosphodiesterase type 5 (PDE5) in the mechanism of male erection has been well understood, and several drugs inhibiting this enzyme are being used for the treatment of erectile dysfunction (ED).  Discovery of inhibitors with improved selectivity vs. other PDE isoenzymes could lead to drugs with improved safety profile.  Achievement of selectivity vs. PDE6, co-inhibition of which results in disturbances of color perception, remains the most challenging aspect of current drug discovery programs.  The present review describes several case studies, where significant (>100 fold) selectivity vs. PDE6 has been attained via investigation of structure-activity relationships (SAR).  Special attention is given to the chem. routes leading to novel chemotypes and allowing efficient exploration of their SAR's.  Strategies for attaining inhibitor selectivity discussed below may be applicable for other drug discovery programs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo4b-KLkyrEO7Vg90H21EOLACvtfcHk0lhtfcImbJHV0w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XksFSlsLg%253D&md5=a272cd37ec48db5bdb7c8a0620f1cc9c</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1002%2Fmed.20053&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmed.20053%26sid%3Dliteratum%253Aachs%26aulast%3DPissarnitski%26aufirst%3DD.%26atitle%3DPhosphodiesterase%25205%2520%2528PDE%25205%2529%2520Inhibitors%2520for%2520the%2520Treatment%2520of%2520Male%2520Erectile%2520Disorder%253A%2520Attaining%2520Selectivity%2520Versus%2520PDE6%26jtitle%3DMed.%2520Res.%2520Rev.%26date%3D2006%26volume%3D26%26spage%3D369%26epage%3D395%26doi%3D10.1002%2Fmed.20053" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kokkonen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kass, D. A.</span></span> <span> </span><span class="NLM_article-title">Nanodomain Regulation of Cardiac Cyclic Nucleotide Signaling by Phosphodiesterases</span>. <i>Annu. Rev. Pharmacol. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">455</span>– <span class="NLM_lpage">479</span>, <span class="refDoi"> DOI: 10.1146/annurev-pharmtox-010716-104756</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=10.1146%2Fannurev-pharmtox-010716-104756" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=27732797" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhs1ykt7rN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2017&pages=455-479&author=K.+Kokkonenauthor=D.+A.+Kass&title=Nanodomain+Regulation+of+Cardiac+Cyclic+Nucleotide+Signaling+by+Phosphodiesterases&doi=10.1146%2Fannurev-pharmtox-010716-104756"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Nanodomain Regulation of Cardiac Cyclic Nucleotide Signaling by Phosphodiesterases</span></div><div class="casAuthors">Kokkonen, Kristen; Kass, David A.</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Pharmacology and Toxicology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">455-479</span>CODEN:
                <span class="NLM_cas:coden">ARPTDI</span>;
        ISSN:<span class="NLM_cas:issn">0362-1642</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews</span>)
        </div><div class="casAbstract">A review.  Cyclic nucleotide phosphodiesterases (PDEs) form an 11-member superfamily comprising 100 different isoforms that regulate the second messengers cyclic adenosine or guanosine 3',5'-monophosphate (cAMP or cGMP).  These PDE isoforms differ with respect to substrate selectivity and their localized control of cAMP and cGMP within nanodomains that target specific cellular pools and synthesis pathways for the cyclic nucleotides.  Seven PDE family members are physiol. relevant to regulating cardiac function, disease remodeling of the heart, or both: PDE1 and PDE2, both dual-substrate (cAMP and cGMP) esterases; PDE3, PDE4, and PDE8, which principally hydrolyze cAMP; and PDE5A and PDE9A, which target cGMP.  New insights regarding the different roles of PDEs in health and disease and their local signaling control are broadening the potential therapeutic utility for PDE-selective inhibitors.  In this review, we discuss these PDEs, focusing on the different mechanisms by which they control cardiac function in health and disease by regulating intracellular nanodomains.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGptHS7lTakIRrVg90H21EOLACvtfcHk0lhtfcImbJHV0w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhs1ykt7rN&md5=0bbfd7fecacc24ec40b76e7406495313</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1146%2Fannurev-pharmtox-010716-104756&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev-pharmtox-010716-104756%26sid%3Dliteratum%253Aachs%26aulast%3DKokkonen%26aufirst%3DK.%26aulast%3DKass%26aufirst%3DD.%2BA.%26atitle%3DNanodomain%2520Regulation%2520of%2520Cardiac%2520Cyclic%2520Nucleotide%2520Signaling%2520by%2520Phosphodiesterases%26jtitle%3DAnnu.%2520Rev.%2520Pharmacol.%2520Toxicol.%26date%3D2017%26volume%3D57%26spage%3D455%26epage%3D479%26doi%3D10.1146%2Fannurev-pharmtox-010716-104756" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Galiè, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghofrani, H. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Torbicki, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barst, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rubin, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Badesch, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fleming, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parpia, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burgess, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Branzi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grimminger, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurzyna, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simonneau, G.</span></span> <span> </span><span class="NLM_article-title">Sildenafil Citrate Therapy for Pulmonary Arterial Hypertension</span>. <i>N. Engl. J. Med.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>353</i></span>,  <span class="NLM_fpage">2148</span>– <span class="NLM_lpage">2157</span>, <span class="refDoi"> DOI: 10.1056/nejmoa050010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=10.1056%2FNEJMoa050010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=16291984" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht1ajtb%252FI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=353&publication_year=2005&pages=2148-2157&author=N.+Gali%C3%A8author=H.+A.+Ghofraniauthor=A.+Torbickiauthor=R.+J.+Barstauthor=L.+J.+Rubinauthor=D.+Badeschauthor=T.+Flemingauthor=T.+Parpiaauthor=G.+Burgessauthor=A.+Branziauthor=F.+Grimmingerauthor=M.+Kurzynaauthor=G.+Simonneau&title=Sildenafil+Citrate+Therapy+for+Pulmonary+Arterial+Hypertension&doi=10.1056%2Fnejmoa050010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Sildenafil citrate therapy for pulmonary arterial hypertension</span></div><div class="casAuthors">Galie, Nazzareno; Ghofrani, Hossein A.; Torbicki, Adam; Barst, Robyn J.; Rubin, Lewis J.; Badesch, David; Fleming, Thomas; Parpia, Tamiza; Burgess, Gary; Branzi, Angelo; Grimminger, Friedrich; Kurzyna, Marcin; Simonneau, Gerald</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">353</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">2148-2157</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">BACKGROUND: Sildenafil inhibits phosphodiesterase type 5, an enzyme that metabolizes cGMP, thereby enhancing the cGMP-mediated relaxation and growth inhibition of vascular smooth-muscle cells, including those in the lung.  METHODS: In this double-blind, placebo-controlled study, we randomly assigned 278 patients with symptomatic pulmonary arterial hypertension (either idiopathic or assocd. with connective-tissue disease or with repaired congenital systemic-to-pulmonary shunts) to placebo or sildenafil (20, 40, or 80 mg) orally three times daily for 12 wk.  The primary end point was the change from baseline to week 12 in the distance walked in six minutes.  The change in mean pulmonary-artery pressure and World Health Organization (WHO) functional class and the incidence of clin. worsening were also assessed, but the study was not powered to assess mortality.  Patients completing the 12-wk randomized study could enter a long-term extension study.  RESULTS: The distance walked in six minutes increased from baseline in all sildenafil groups; the mean placebo-cor. treatment effects were 45 m (+ 13.0 %), 46 m (+ 13.3 %), and 50 m (+ 14.7 %) for 20, 40, and 80 mg of sildenafil, resp. (P < 0.001 for all comparisons).  All sildenafil doses reduced the mean pulmonary-artery pressure (P = 0.04, P = 0.01, and P < 0.001, resp.), improved the WHO functional class (P = 0.003, P < 0.001, and P < 0.001, resp.), and were assocd. with side effects such as flushing, dyspepsia, and diarrhea.  The incidence of clin. worsening did not differ significantly between the patients treated with sildenafil and those treated with placebo.  Among the 222 patients completing one year of treatment with sildenafil monotherapy, the improvement from baseline at one year in the distance walked in six minutes was 51 m.  CONCLUSIONS: Sildenafil improves exercise capacity, WHO functional class, and hemodynamics in patients with symptomatic pulmonary arterial hypertension.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqdRmk6YHttM7Vg90H21EOLACvtfcHk0lhtfcImbJHV0w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht1ajtb%252FI&md5=98f9d612bdeb37178f0910263d9ca97f</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa050010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa050010%26sid%3Dliteratum%253Aachs%26aulast%3DGali%25C3%25A8%26aufirst%3DN.%26aulast%3DGhofrani%26aufirst%3DH.%2BA.%26aulast%3DTorbicki%26aufirst%3DA.%26aulast%3DBarst%26aufirst%3DR.%2BJ.%26aulast%3DRubin%26aufirst%3DL.%2BJ.%26aulast%3DBadesch%26aufirst%3DD.%26aulast%3DFleming%26aufirst%3DT.%26aulast%3DParpia%26aufirst%3DT.%26aulast%3DBurgess%26aufirst%3DG.%26aulast%3DBranzi%26aufirst%3DA.%26aulast%3DGrimminger%26aufirst%3DF.%26aulast%3DKurzyna%26aufirst%3DM.%26aulast%3DSimonneau%26aufirst%3DG.%26atitle%3DSildenafil%2520Citrate%2520Therapy%2520for%2520Pulmonary%2520Arterial%2520Hypertension%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2005%26volume%3D353%26spage%3D2148%26epage%3D2157%26doi%3D10.1056%2Fnejmoa050010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Baillie, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tejeda, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelly, M. P.</span></span> <span> </span><span class="NLM_article-title">Therapeutic Targeting of 3′,5′-Cyclic Nucleotide Phosphodiesterases: Inhibition and Beyond</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">770</span>– <span class="NLM_lpage">796</span>, <span class="refDoi"> DOI: 10.1038/s41573-019-0033-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=10.1038%2Fs41573-019-0033-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=31388135" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhsFamtLfF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2019&pages=770-796&author=G.+S.+Baillieauthor=G.+S.+Tejedaauthor=M.+P.+Kelly&title=Therapeutic+Targeting+of+3%E2%80%B2%2C5%E2%80%B2-Cyclic+Nucleotide+Phosphodiesterases%3A+Inhibition+and+Beyond&doi=10.1038%2Fs41573-019-0033-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Therapeutic targeting of 3',5'-cyclic nucleotide phosphodiesterases: inhibition and beyond</span></div><div class="casAuthors">Baillie, George S.; Tejeda, Gonzalo S.; Kelly, Michy P.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">770-796</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">A review.  Phosphodiesterases (PDEs), enzymes that degrade 3',5'-cyclic nucleotides, are being pursued as therapeutic targets for several diseases, including those affecting the nervous system, the cardiovascular system, fertility, immunity, cancer and metab.  Clin. development programs have focused exclusively on catalytic inhibition, which continues to be a strong focus of ongoing drug discovery efforts.  However, emerging evidence supports novel strategies to therapeutically target PDE function, including enhancing catalytic activity, normalizing altered compartmentalization and modulating post-translational modifications, as well as the potential use of PDEs as disease biomarkers.  Importantly, a more refined appreciation of the intramol. mechanisms regulating PDE function and trafficking is emerging, making these pioneering drug discovery efforts tractable.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_NtRRCDdas7Vg90H21EOLACvtfcHk0liJbBqUbTRjFg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhsFamtLfF&md5=f8a348c9c9e534227d60e4f635d90b25</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1038%2Fs41573-019-0033-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41573-019-0033-4%26sid%3Dliteratum%253Aachs%26aulast%3DBaillie%26aufirst%3DG.%2BS.%26aulast%3DTejeda%26aufirst%3DG.%2BS.%26aulast%3DKelly%26aufirst%3DM.%2BP.%26atitle%3DTherapeutic%2520Targeting%2520of%25203%25E2%2580%25B2%252C5%25E2%2580%25B2-Cyclic%2520Nucleotide%2520Phosphodiesterases%253A%2520Inhibition%2520and%2520Beyond%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2019%26volume%3D18%26spage%3D770%26epage%3D796%26doi%3D10.1038%2Fs41573-019-0033-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, N.</span></span> <span> </span><span class="NLM_article-title">Inhibitor of Phosphodiestearse-4 Improves Memory Deficits, Oxidative Stress, Neuroinflammation and Neuropathological Alterations in Mouse Models of Dementia of Alzheimer’s Type</span>. <i>Biomed. Pharmacother.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>88</i></span>,  <span class="NLM_fpage">698</span>– <span class="NLM_lpage">707</span>, <span class="refDoi"> DOI: 10.1016/j.biopha.2017.01.059</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=10.1016%2Fj.biopha.2017.01.059" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=28152479" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=1%3ACAS%3A528%3ADC%252BC2sXitVSlt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=88&publication_year=2017&pages=698-707&author=A.+Kumarauthor=N.+Singh&title=Inhibitor+of+Phosphodiestearse-4+Improves+Memory+Deficits%2C+Oxidative+Stress%2C+Neuroinflammation+and+Neuropathological+Alterations+in+Mouse+Models+of+Dementia+of+Alzheimer%E2%80%99s+Type&doi=10.1016%2Fj.biopha.2017.01.059"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibitor of Phosphodiestearse-4 improves memory deficits, oxidative stress, neuroinflammation and neuropathological alterations in mouse models of dementia of Alzheimer's Type</span></div><div class="casAuthors">Kumar, Amit; Singh, Nirmal</div><div class="citationInfo"><span class="NLM_cas:title">Biomedicine & Pharmacotherapy</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">88</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">698-707</span>CODEN:
                <span class="NLM_cas:coden">BIPHEX</span>;
        ISSN:<span class="NLM_cas:issn">0753-3322</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">The study investigates the potential of Rolipram a phosphodiesterase-4 inhibitor in cognitive deficits induced by streptozotocin (STZ, 3 mg/kg intracerebroventricularly) and natural ageing in mice.  Morris water maze (MWM) test was employed to evaluate learning and memory of the animals.  Extent of oxidative stress was measured by estg. the levels of brain glutathione (GSH) and thiobarbituric acid reactive species (TBARS).  Brain acetylcholinestrase (AChE) activity was also estd.  The brain activity of myeloperoxidase (MPO) was measured as a marker of inflammation.  STZ and ageing results in marked decline in MWM performance of the animals, reflecting impairment of learning and memory.  STZ treated mice and aged mice exhibited a marked accentuation of AChE activity, TBARS and MPO activity along with fall in GSH level.  Further the stained micrographs of STZ treated mice and aged mice indicate pathol. changes, severe neutrophilic infiltration and amyloid deposition.  Rolipram treatment significantly attenuated STZ induced and age related memory deficits, biochem. and histopathol. alterations.  The findings demonstrate the potential of Rolipram in memory dysfunctions which may probably be attributed to its anti-cholinesterase, anti-amyloid, anti-oxidative and anti-inflammatory effects.  The study concludes that PDE-4 can be explored as a potential therapeutic target in dementia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGolyQDD1R3sxrVg90H21EOLACvtfcHk0liJbBqUbTRjFg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXitVSlt7w%253D&md5=283d145e47d12940a38df6cfe8ae5b00</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2Fj.biopha.2017.01.059&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biopha.2017.01.059%26sid%3Dliteratum%253Aachs%26aulast%3DKumar%26aufirst%3DA.%26aulast%3DSingh%26aufirst%3DN.%26atitle%3DInhibitor%2520of%2520Phosphodiestearse-4%2520Improves%2520Memory%2520Deficits%252C%2520Oxidative%2520Stress%252C%2520Neuroinflammation%2520and%2520Neuropathological%2520Alterations%2520in%2520Mouse%2520Models%2520of%2520Dementia%2520of%2520Alzheimer%25E2%2580%2599s%2520Type%26jtitle%3DBiomed.%2520Pharmacother.%26date%3D2017%26volume%3D88%26spage%3D698%26epage%3D707%26doi%3D10.1016%2Fj.biopha.2017.01.059" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jabaris, S. G. S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sumathy, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Narayanan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thanikachalam, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Babu, C. S.</span></span> <span> </span><span class="NLM_article-title">Effects of Rolipram and Roflumilast, Phosphodiesterase-4 Inhibitors, on Hypertension-Induced Defects in Memory Function in Rats</span>. <i>Eur. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>746</i></span>,  <span class="NLM_fpage">138</span>– <span class="NLM_lpage">147</span>, <span class="refDoi"> DOI: 10.1016/j.ejphar.2014.10.039</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=10.1016%2Fj.ejphar.2014.10.039" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=25446433" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvFSmsLnO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=746&publication_year=2015&pages=138-147&author=S.+G.+S.+L.+Jabarisauthor=H.+Sumathyauthor=R.+S.+Kumarauthor=S.+Narayananauthor=S.+Thanikachalamauthor=C.+S.+Babu&title=Effects+of+Rolipram+and+Roflumilast%2C+Phosphodiesterase-4+Inhibitors%2C+on+Hypertension-Induced+Defects+in+Memory+Function+in+Rats&doi=10.1016%2Fj.ejphar.2014.10.039"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of rolipram and roflumilast, phosphodiesterase-4 inhibitors, on hypertension-induced defects in memory function in rats</span></div><div class="casAuthors">Jabaris, Sobhana George Sugin Lal; Sumathy, Haridass; Kumar, Ramadass Satiesh; Narayanan, Shridhar; Thanikachalam, Sadagopan; Babu, Chidambaram Saravana</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">746</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">138-147</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Hypertension (HT) is a prevailing risk factor for cognitive impairment, the most common cause of vascular dementia; yet, no possible mechanism underlying the cognitive impairment induced by hypertension has been identified so far.  Inhibition of PDE-4 has been shown to increase phosphorylation of cAMP-response element binding protein in the hippocampus and enhance the memory performance.  Here, we examd. the effects of PDE-4 inhibitors, rolipram and roflumilast, on the impairment of learning and memory obsd. in hypertensive rats.  We used 2k-1c hypertensive model to induce learning and memory defects.  In addn., mRNA expression of PDE-4 sub-types A-D was also assessed in the hippocampus tissue.  Systolic blood pressure (SBP) was measured by tail-cuff method was significantly increased in 2k-1c rats when compared to sham operated rats; this effect was reversed by clonidine, whereas, PDE-4 inhibitors did not.  PDE-4 inhibitors significantly reversed time induced memory deficit in novel object recognition task (NORT).  Further, the retention latency on the second day in the elevated plus maze model was significantly shortened after repeated administration of rolipram and roflumilast.  Plasma and brain concns. of rolipram, roflumilast and roflumilast N-oxide were also measured after the NORT and showed linear increase in plasma and brain concns.  The PDE4B and PDE4D gene expression was significantly enhanced in hypertensive rats compared with sham operated however PDE4A and PDE4C remained unaltered.  Repeated treatment with PDE-4 inhibitors caused down regulation of PDE4B and PDE4D in hypertensive rats.  These results suggest that inhibition of PDE-4 ameliorates HT-induced impairment of learning and memory functions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoKT6L29U_H4bVg90H21EOLACvtfcHk0liJbBqUbTRjFg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvFSmsLnO&md5=7a461c0debc0b3e2c32ec304846aed55</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2014.10.039&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2014.10.039%26sid%3Dliteratum%253Aachs%26aulast%3DJabaris%26aufirst%3DS.%2BG.%2BS.%2BL.%26aulast%3DSumathy%26aufirst%3DH.%26aulast%3DKumar%26aufirst%3DR.%2BS.%26aulast%3DNarayanan%26aufirst%3DS.%26aulast%3DThanikachalam%26aufirst%3DS.%26aulast%3DBabu%26aufirst%3DC.%2BS.%26atitle%3DEffects%2520of%2520Rolipram%2520and%2520Roflumilast%252C%2520Phosphodiesterase-4%2520Inhibitors%252C%2520on%2520Hypertension-Induced%2520Defects%2520in%2520Memory%2520Function%2520in%2520Rats%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2015%26volume%3D746%26spage%3D138%26epage%3D147%26doi%3D10.1016%2Fj.ejphar.2014.10.039" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Martinez, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gil, C.</span></span> <span> </span><span class="NLM_article-title">cAMP-Specific Phosphodiesterase Inhibitors: Promising Drugs for Inflammatory and Neurological Diseases</span>. <i>Expert Opin. Ther. Pat.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">1311</span>– <span class="NLM_lpage">1321</span>, <span class="refDoi"> DOI: 10.1517/13543776.2014.968127</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=10.1517%2F13543776.2014.968127" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=25284693" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvFejsr%252FN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2014&pages=1311-1321&author=A.+Martinezauthor=C.+Gil&title=cAMP-Specific+Phosphodiesterase+Inhibitors%3A+Promising+Drugs+for+Inflammatory+and+Neurological+Diseases&doi=10.1517%2F13543776.2014.968127"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">cAMP-specific phosphodiesterase inhibitors: promising drugs for inflammatory and neurological diseases</span></div><div class="casAuthors">Martinez, Ana; Gil, Carmen</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1311-1321</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">Introduction: PDEs are key enzymes in the adenosine and guanosine cyclic nucleotides (cAMP and cGMP) signaling cascade.  Their inhibition increases cyclic nucleotide levels inside the cell.  Thus, pharmacol. modulation of PDE activity can have profound effects on the function of cells and organ systems throughout the body.  Areas covered: Among the large PDE families, only PDE4, PDE7 and PDE8 are cAMP-specific hydrolyzing enzymes. cAMP is an important second messenger not only by its involvement in a vast no. of physiol. processes but also by activation of protein kinase A, exchange protein activated by cAMP (Epac) and cAMP response element-binding (CREB) or cyclic nucleotide-gated channels.  Clearly, such enzymes represent ideal drug targets for the pharmacol. treatment of many pathologies.  The discovery and development of small mols. targeting cAMP-specific PDEs reported in the last 5 years is the focus of the present review.  Expert opinion: The first PDE4 inhibitors recently reached the market, having avoided, by different strategies, their dose-limiting side effects (after more than two decades of drug development).  Meanwhile, new cAMP-specific PDE7 and PDE8 inhibitors emerged as effective and safe drugs for severe unmet diseases.  The therapeutic potential of these inhibitors will be tested in the near future, as many of these drug candidates are ready to start clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpPWFQGiKhADrVg90H21EOLACvtfcHk0ljdAkS09PEY6Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvFejsr%252FN&md5=f9ef95eeccba94736c36de427c1715b0</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1517%2F13543776.2014.968127&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.2014.968127%26sid%3Dliteratum%253Aachs%26aulast%3DMartinez%26aufirst%3DA.%26aulast%3DGil%26aufirst%3DC.%26atitle%3DcAMP-Specific%2520Phosphodiesterase%2520Inhibitors%253A%2520Promising%2520Drugs%2520for%2520Inflammatory%2520and%2520Neurological%2520Diseases%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2014%26volume%3D24%26spage%3D1311%26epage%3D1321%26doi%3D10.1517%2F13543776.2014.968127" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rutten, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Basile, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prickaerts, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blokland, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vivian, J. A.</span></span> <span> </span><span class="NLM_article-title">Selective PDE Inhibitors Rolipram and Sildenafil Improve Object Retrieval Performance in Adult Cynomolgus Macaques</span>. <i>Psychopharmacology</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>196</i></span>,  <span class="NLM_fpage">643</span>– <span class="NLM_lpage">648</span>, <span class="refDoi"> DOI: 10.1007/s00213-007-0999-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=10.1007%2Fs00213-007-0999-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=18034336" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhvFyktbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=196&publication_year=2008&pages=643-648&author=K.+Ruttenauthor=J.+L.+Basileauthor=J.+Prickaertsauthor=A.+Bloklandauthor=J.+A.+Vivian&title=Selective+PDE+Inhibitors+Rolipram+and+Sildenafil+Improve+Object+Retrieval+Performance+in+Adult+Cynomolgus+Macaques&doi=10.1007%2Fs00213-007-0999-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Selective PDE inhibitors rolipram and sildenafil improve object retrieval performance in adult cynomolgus macaques</span></div><div class="casAuthors">Rutten, K.; Basile, J. L.; Prickaerts, J.; Blokland, A.; Vivian, J. A.</div><div class="citationInfo"><span class="NLM_cas:title">Psychopharmacology (Berlin, Germany)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">196</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">643-648</span>CODEN:
                <span class="NLM_cas:coden">PSCHDL</span>;
        ISSN:<span class="NLM_cas:issn">0033-3158</span>.
    
            (<span class="NLM_cas:orgname">Springer GmbH</span>)
        </div><div class="casAbstract">Rationale Selective phosphodiesterase (PDE) inhibitors improve the formation of hippocampus-dependent memories in several rodent models of cognition.  However, studies evaluating the effects of PDE inhibition on prefrontal cortex-dependent cognition and in monkeys are rare.  Objectives The present study investigates the effect of the PDE4 inhibitor rolipram and the PDE5 inhibitor sildenafil on object retrieval performance.  Object retrieval is a prefrontal cortical-mediated task, which is likely to capture attention and response inhibition.  Materials and methods The ability to retrieve a food reward from a clear box with an open side positioned in various orientations was assessed in adult male cynomolgus monkeys (Macaca fascicularis).  Results Rolipram (0.003-0.03 mg/kg, i.m. [i.m.]) and sildenafil (0.3-3 mg/kg, i.m.) dose-dependently increased correct first reaches during difficult trials, reaching significance at 0.01 and 1 mg/kg, resp.  For both drugs, correct reaches were increased approx. 20%; i.e., performance was improved from ∼50 to ∼70% correct.  Conclusions Both rolipram and sildenafil improved object retrieval performance, thus demonstrating the cognition-enhancing effects of PDE inhibition on a prefrontal task of executive function in monkeys.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrr2uGc94KR3rVg90H21EOLACvtfcHk0ljdAkS09PEY6Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhvFyktbk%253D&md5=3f85149d89ef5eb0ebd4f6555df9bd0a</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1007%2Fs00213-007-0999-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00213-007-0999-1%26sid%3Dliteratum%253Aachs%26aulast%3DRutten%26aufirst%3DK.%26aulast%3DBasile%26aufirst%3DJ.%2BL.%26aulast%3DPrickaerts%26aufirst%3DJ.%26aulast%3DBlokland%26aufirst%3DA.%26aulast%3DVivian%26aufirst%3DJ.%2BA.%26atitle%3DSelective%2520PDE%2520Inhibitors%2520Rolipram%2520and%2520Sildenafil%2520Improve%2520Object%2520Retrieval%2520Performance%2520in%2520Adult%2520Cynomolgus%2520Macaques%26jtitle%3DPsychopharmacology%26date%3D2008%26volume%3D196%26spage%3D643%26epage%3D648%26doi%3D10.1007%2Fs00213-007-0999-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Monti, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berteotti, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Contestabile, A.</span></span> <span> </span><span class="NLM_article-title">Subchronic Rolipram Delivery Activates Hippocampal CREB and Arc, Enhances Retention and Slows down Extinction of Conditioned Fear</span>. <i>Neuropsychopharmacology</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>31</i></span>,  <span class="NLM_fpage">278</span>– <span class="NLM_lpage">286</span>, <span class="refDoi"> DOI: 10.1038/sj.npp.1300813</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=10.1038%2Fsj.npp.1300813" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=15988467" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=1%3ACAS%3A528%3ADC%252BD28XkvFymsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2006&pages=278-286&author=B.+Montiauthor=C.+Berteottiauthor=A.+Contestabile&title=Subchronic+Rolipram+Delivery+Activates+Hippocampal+CREB+and+Arc%2C+Enhances+Retention+and+Slows+down+Extinction+of+Conditioned+Fear&doi=10.1038%2Fsj.npp.1300813"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Subchronic Rolipram Delivery Activates Hippocampal CREB and Arc, Enhances Retention and Slows Down Extinction of Conditioned Fear</span></div><div class="casAuthors">Monti, Barbara; Berteotti, Chiara; Contestabile, Antonio</div><div class="citationInfo"><span class="NLM_cas:title">Neuropsychopharmacology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">278-286</span>CODEN:
                <span class="NLM_cas:coden">NEROEW</span>;
        ISSN:<span class="NLM_cas:issn">0893-133X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Rolipram, a type IV-specific phosphodiesterase inhibitor, is known to improve memory under various learning tasks.  Moreover, Rolipram treatments have been shown to increase expression and phosphorylation of a key factor for hippocampal memory consolidation, the cAMP-dependent response element-binding protein, CREB.  However, the exact correlation between hippocampal CREB phosphorylation and memory improvement induced by Rolipram has not yet been detd. in a CREB-dependent type of hippocampal-related learning in normogenic, intact rodents.  Here, we report that subchronic Rolipram delivery by using osmotic minipumps increased the basal rat hippocampal expression and phosphorylation of CREB, as well as the expression of the cAMP-dependent, memory-related protein, Arc.  In parallel, the same treatment improved memory consolidation of conditioned fear.  Furthermore, the increase of CREB phosphorylation and Arc expression consequent to the learning experience was enhanced in Rolipram-treated rats, compared to controls.  By evaluating the time course of memory extinction over 10 days after the initial learning test, we also obsd. significant slowing down of the memory extinction rate in Rolipram-treated rats.  This effect could be attributed to CREB phosphorylation and memory having been initially higher, as osmotic minipumps stopped to release Rolipram the first day after the initial learning test.  Our data define the conditions through which the pharmacol. manipulation of hippocampal CREB expression and activation result in memory amelioration in normogenic, intact animals.  These results are relevant for the study of mol. correlates of memory, and may also be important in view of the efforts to design new pharmacol. treatments, targeting the CREB pathway and leading to enhancement of learning and memory, even in the absence of patent neuropathol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoDGaiaPPepS7Vg90H21EOLACvtfcHk0ljdAkS09PEY6Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XkvFymsQ%253D%253D&md5=2281024da42284207a9322c1f892430e</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1038%2Fsj.npp.1300813&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.npp.1300813%26sid%3Dliteratum%253Aachs%26aulast%3DMonti%26aufirst%3DB.%26aulast%3DBerteotti%26aufirst%3DC.%26aulast%3DContestabile%26aufirst%3DA.%26atitle%3DSubchronic%2520Rolipram%2520Delivery%2520Activates%2520Hippocampal%2520CREB%2520and%2520Arc%252C%2520Enhances%2520Retention%2520and%2520Slows%2520down%2520Extinction%2520of%2520Conditioned%2520Fear%26jtitle%3DNeuropsychopharmacology%26date%3D2006%26volume%3D31%26spage%3D278%26epage%3D286%26doi%3D10.1038%2Fsj.npp.1300813" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Guo, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zou, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, J.</span></span> <span> </span><span class="NLM_article-title">FFPM, a PDE4 Inhibitor, Reverses Learning and Memory Deficits in APP/PS1 Transgenic Mice via cAMP/PKA/CREB Signaling and anti-Inflammatory Effects</span>. <i>Neuropharmacology</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>116</i></span>,  <span class="NLM_fpage">260</span>– <span class="NLM_lpage">269</span>, <span class="refDoi"> DOI: 10.1016/j.neuropharm.2017.01.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=10.1016%2Fj.neuropharm.2017.01.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=28065587" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtFakt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=116&publication_year=2017&pages=260-269&author=H.+Guoauthor=Y.+Chengauthor=C.+Wangauthor=J.+Wuauthor=Z.+Zouauthor=B.+Niuauthor=H.+Yuauthor=H.+Wangauthor=J.+Xu&title=FFPM%2C+a+PDE4+Inhibitor%2C+Reverses+Learning+and+Memory+Deficits+in+APP%2FPS1+Transgenic+Mice+via+cAMP%2FPKA%2FCREB+Signaling+and+anti-Inflammatory+Effects&doi=10.1016%2Fj.neuropharm.2017.01.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">FFPM, a PDE4 inhibitor, reverses learning and memory deficits in APP/PS1 transgenic mice via cAMP/PKA/CREB signaling and anti-inflammatory effects</span></div><div class="casAuthors">Guo, Haibiao; Cheng, Yufang; Wang, Canmao; Wu, Jingang; Zou, Zhengqiang; Niu, Bo; Yu, Hui; Wang, Haitao; Xu, Jiangping</div><div class="citationInfo"><span class="NLM_cas:title">Neuropharmacology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">116</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">260-269</span>CODEN:
                <span class="NLM_cas:coden">NEPHBW</span>;
        ISSN:<span class="NLM_cas:issn">0028-3908</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Thus far, phosphodiesterase-4 (PDE4) inhibitors have not been approved for application in Alzheimer's disease (AD) in a clin. setting due to severe side effects, such as nausea and vomiting.  In this study, we investigated the effect of FFPM, a novel PDE4 inhibitor, on learning and memory abilities, as well as the underlying mechanism in the APP/PS1 mouse model of AD.  Pharmacokinetic studies have revealed that FFPM efficiently permeates into the brain, and reached peak values in plasma 2 h after orally dosing.  A 3-wk treatment with FFPM, at doses of 0.25 mg/kg and 0.5 mg/kg, significantly improved the learning and memory abilities of APP/PS1 transgenic mice in the Morris water maze and the Step-down passive avoidance task.  Interestingly, we found that while rolipram (0.5 mg/kg) reduced the duration of the α2 adrenergic receptor-mediated anesthesia induced by xylazine/ketamine, FFPM (0.5 mg/kg) or the vehicle did not have an evident effect.  FFPM increased the cAMP, PKA and CREB phosphorylation and BDNF levels, and reduced the NF-κB p65, iNOS, TNF-α and IL-1β levels in the hippocampi of APP/PS1 trangenic mice, as obsd. by ELISA and Western blot anal.  Taken together, our data demonstrated that the reversal effect of FFPM on cognitive deficits in APP/PS1 transgenic mice might be related to stimulation of the cAMP/PKA/CREB/BDNF pathway and anti-inflammatory effects.  Moreover, FFPM appears to have potential as an effective PDE4 inhibitor in AD treatment with little emetic potential.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqueQvekWB9CbVg90H21EOLACvtfcHk0liD89djduixnw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtFakt70%253D&md5=024f56897208ce4c5c36e3a89d90c407</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2Fj.neuropharm.2017.01.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuropharm.2017.01.004%26sid%3Dliteratum%253Aachs%26aulast%3DGuo%26aufirst%3DH.%26aulast%3DCheng%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DC.%26aulast%3DWu%26aufirst%3DJ.%26aulast%3DZou%26aufirst%3DZ.%26aulast%3DNiu%26aufirst%3DB.%26aulast%3DYu%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DXu%26aufirst%3DJ.%26atitle%3DFFPM%252C%2520a%2520PDE4%2520Inhibitor%252C%2520Reverses%2520Learning%2520and%2520Memory%2520Deficits%2520in%2520APP%252FPS1%2520Transgenic%2520Mice%2520via%2520cAMP%252FPKA%252FCREB%2520Signaling%2520and%2520anti-Inflammatory%2520Effects%26jtitle%3DNeuropharmacology%26date%3D2017%26volume%3D116%26spage%3D260%26epage%3D269%26doi%3D10.1016%2Fj.neuropharm.2017.01.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Y.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, H.-B.</span></span> <span> </span><span class="NLM_article-title">Discovery and Optimization of α-Mangostin Derivatives as Novel PDE4 Inhibitors for the Treatment of Vascular Dementia</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>63</i></span>,  <span class="NLM_fpage">3370</span>– <span class="NLM_lpage">3380</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.0c00060</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.0c00060" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=1%3ACAS%3A528%3ADC%252BB3cXktlOgtbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2020&pages=3370-3380&author=J.+Liangauthor=Y.-Y.+Huangauthor=Q.+Zhouauthor=Y.+Gaoauthor=Z.+Liauthor=D.+Wuauthor=S.+Yuauthor=L.+Guoauthor=Z.+Chenauthor=L.+Huangauthor=S.+H.+Liangauthor=X.+Heauthor=R.+Wuauthor=H.-B.+Luo&title=Discovery+and+Optimization+of+%CE%B1-Mangostin+Derivatives+as+Novel+PDE4+Inhibitors+for+the+Treatment+of+Vascular+Dementia&doi=10.1021%2Facs.jmedchem.0c00060"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and Optimization of α-Mangostin Derivatives as Novel PDE4 Inhibitors for the Treatment of Vascular Dementia</span></div><div class="casAuthors">Liang, Jinhao; Huang, Yi-You; Zhou, Qian; Gao, Yuqi; Li, Zhe; Wu, Deyan; Yu, Si; Guo, Lei; Chen, Zhen; Huang, Ling; Liang, Steven H.; He, Xixin; Wu, Ruibo; Luo, Hai-Bin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">3370-3380</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">To validate PDE4 inhibitors as novel therapeutic agents against vascular dementia (VaD), 25 derivs. were discovered from the natural inhibitor α-mangostin (IC50 = 1.31 μM).  Hit-to-lead optimization identified a novel and selective PDE4 inhibitor 4e (IC50 = 17 nM), which adopted a different binding pattern from PDE4 inhibitors roflumilast and rolipram.  Oral administration of 4e at a dose of 10 mg/kg exhibited remarkable therapeutic effects in a VaD model and did not cause emesis to beagle dogs, indicating its potential as a novel anti-VaD agent.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpH4L06cQSRF7Vg90H21EOLACvtfcHk0liD89djduixnw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXktlOgtbs%253D&md5=0b69626948b61a2b40d63b6762be855c</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.0c00060&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.0c00060%26sid%3Dliteratum%253Aachs%26aulast%3DLiang%26aufirst%3DJ.%26aulast%3DHuang%26aufirst%3DY.-Y.%26aulast%3DZhou%26aufirst%3DQ.%26aulast%3DGao%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DWu%26aufirst%3DD.%26aulast%3DYu%26aufirst%3DS.%26aulast%3DGuo%26aufirst%3DL.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DHuang%26aufirst%3DL.%26aulast%3DLiang%26aufirst%3DS.%2BH.%26aulast%3DHe%26aufirst%3DX.%26aulast%3DWu%26aufirst%3DR.%26aulast%3DLuo%26aufirst%3DH.-B.%26atitle%3DDiscovery%2520and%2520Optimization%2520of%2520%25CE%25B1-Mangostin%2520Derivatives%2520as%2520Novel%2520PDE4%2520Inhibitors%2520for%2520the%2520Treatment%2520of%2520Vascular%2520Dementia%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2020%26volume%3D63%26spage%3D3370%26epage%3D3380%26doi%3D10.1021%2Facs.jmedchem.0c00060" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Boswell-Smith, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spina, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Page, C. P.</span></span> <span> </span><span class="NLM_article-title">Phosphodiesterase Inhibitors</span>. <i>Br. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>147</i></span>,  <span class="NLM_fpage">S252</span>– <span class="NLM_lpage">S257</span>, <span class="refDoi"> DOI: 10.1038/sj.bjp.0706495</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=10.1038%2Fsj.bjp.0706495" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=16402111" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=1%3ACAS%3A528%3ADC%252BD28XisVCksw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=147&publication_year=2006&pages=S252-S257&author=V.+Boswell-Smithauthor=D.+Spinaauthor=C.+P.+Page&title=Phosphodiesterase+Inhibitors&doi=10.1038%2Fsj.bjp.0706495"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Phosphodiesterase inhibitors</span></div><div class="casAuthors">Boswell-Smith, Victoria; Spina, Domenico; Page, Clive P.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">147</span>
        (<span class="NLM_cas:issue">Suppl. 1</span>),
    <span class="NLM_cas:pages">S252-S257</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Phosphodiesterases are a diverse family of enzymes that hydrolyze cyclic nucleotides and thus play a key role in regulating intracellular levels of the second messengers cAMP and cGMP, and hence cell function.  Theophylline and papaverine have historically been used therapeutically and are known to be weak inhibitors of PDE, but to what extent this contributed toward their clin. efficacy was poorly defined.  However, the discovery of 11 isoenzyme families and our increased understanding of their function at the cell and mol. level provides an impetus for the development of isoenzyme selective inhibitors for the treatment of various diseases.  This review focuses on the development of PDE3 inhibitors for congestive heart failure, PDE4 inhibitors for inflammatory airways disease and most successfully, PDE5 inhibitors for erectile dysfunction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqImKBaZ--2N7Vg90H21EOLACvtfcHk0ljA8gR7aQqkLA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XisVCksw%253D%253D&md5=43dee6e45632455b864581e7a7e368e7</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjp.0706495&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjp.0706495%26sid%3Dliteratum%253Aachs%26aulast%3DBoswell-Smith%26aufirst%3DV.%26aulast%3DSpina%26aufirst%3DD.%26aulast%3DPage%26aufirst%3DC.%2BP.%26atitle%3DPhosphodiesterase%2520Inhibitors%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2006%26volume%3D147%26spage%3DS252%26epage%3DS257%26doi%3D10.1038%2Fsj.bjp.0706495" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vercambre, M.-N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berr, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ritchie, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, J. H.</span></span> <span> </span><span class="NLM_article-title">Caffeine and Cognitive Decline in Elderly Women at High Vascular Risk</span>. <i>J. Alzheimer’s Dis.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">413</span>– <span class="NLM_lpage">421</span>, <span class="refDoi"> DOI: 10.3233/jad-122371</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=10.3233%2FJAD-122371" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=23422357" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=1%3ACAS%3A528%3ADC%252BC3sXmt1Sisbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2013&pages=413-421&author=M.-N.+Vercambreauthor=C.+Berrauthor=K.+Ritchieauthor=J.+H.+Kang&title=Caffeine+and+Cognitive+Decline+in+Elderly+Women+at+High+Vascular+Risk&doi=10.3233%2Fjad-122371"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Caffeine and Cognitive Decline in Elderly Women at High Vascular Risk</span></div><div class="casAuthors">Vercambre, Marie-Noel; Berr, Claudine; Ritchie, Karen; Kang, Jae H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Alzheimer's Disease</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">413-421</span>CODEN:
                <span class="NLM_cas:coden">JADIF9</span>;
        ISSN:<span class="NLM_cas:issn">1387-2877</span>.
    
            (<span class="NLM_cas:orgname">IOS Press</span>)
        </div><div class="casAbstract">Background: Persons with vascular disorders are at higher risk of cognitive decline.  Objective: To det. whether caffeine may be assocd. with cognitive decline redn. in elderly at high vascular risk.  Methods: We included 2,475 women aged 65+ years in the Women's Antioxidant Cardiovascular Study, a randomized trial of antioxidants and B vitamins for cardiovascular disease secondary prevention.  We ascertained regular caffeine intake at baseline (1995-1996) using a validated 116 item-food frequency questionnaire.  From 1998-2000 to 2005-2006, we administered four telephone cognitive assessments at two-year intervals evaluating global cognition, verbal memory, and category fluency.  The primary outcome was the change in global cognitive score, which was the av. of the z-scores of all tests.  We used generalized linear models for repeated measures that were adjusted for various sociodemog., health, and lifestyle factors to evaluate the difference in cognitive decline rates across quintiles of caffeine intake.  Results: We obsd. significantly slower rates of cognitive decline with increasing caffeine intake (p-trend = 0.02).  The rate difference between the highest and lowest quintiles of usual caffeine intake (>371 vs. <30 mg/day) was equiv. to that obsd. between those who were 7 years apart in age (p = 0.006).  Consumption of caffeinated coffee was significantly related to slower cognitive decline (p-trend = 0.05), but not other caffeinated products (e.g., decaf, tea, cola, chocolate).  We conducted interaction analyses and obsd. stronger assocns. in women assigned to vitamin B supplementation (p-interaction = 0.02).  Conclusions: Caffeine intake was related to moderately better cognitive maintenance over 5 years in older women with vascular disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGryMo1SIfe3YbVg90H21EOLACvtfcHk0ljA8gR7aQqkLA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXmt1Sisbs%253D&md5=93f3a2500f2d46cf434ba86edc4205ac</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.3233%2FJAD-122371&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3233%252FJAD-122371%26sid%3Dliteratum%253Aachs%26aulast%3DVercambre%26aufirst%3DM.-N.%26aulast%3DBerr%26aufirst%3DC.%26aulast%3DRitchie%26aufirst%3DK.%26aulast%3DKang%26aufirst%3DJ.%2BH.%26atitle%3DCaffeine%2520and%2520Cognitive%2520Decline%2520in%2520Elderly%2520Women%2520at%2520High%2520Vascular%2520Risk%26jtitle%3DJ.%2520Alzheimer%25E2%2580%2599s%2520Dis.%26date%3D2013%26volume%3D35%26spage%3D413%26epage%3D421%26doi%3D10.3233%2Fjad-122371" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Driscoll, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shumaker, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Snively, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Margolis, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manson, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vitolins, M. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rossom, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Espeland, M. A.</span></span> <span> </span><span class="NLM_article-title">Relationships Between Caffeine Intake and Risk for Probable Dementia or Global Cognitive Impairment: The Women’s Health Initiative Memory Study</span>. <i>J. Gerontol., Ser. A</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>71</i></span>,  <span class="NLM_fpage">1596</span>– <span class="NLM_lpage">1602</span>, <span class="refDoi"> DOI: 10.1093/gerona/glw078</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=10.1093%2Fgerona%2Fglw078" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=27678290" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=1%3ACAS%3A528%3ADC%252BC1cXlsVCku7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2016&pages=1596-1602&author=I.+Driscollauthor=S.+A.+Shumakerauthor=B.+M.+Snivelyauthor=K.+L.+Margolisauthor=J.+E.+Mansonauthor=M.+Z.+Vitolinsauthor=R.+C.+Rossomauthor=M.+A.+Espeland&title=Relationships+Between+Caffeine+Intake+and+Risk+for+Probable+Dementia+or+Global+Cognitive+Impairment%3A+The+Women%E2%80%99s+Health+Initiative+Memory+Study&doi=10.1093%2Fgerona%2Fglw078"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Relationships between caffeine intake and risk for probable dementia or global cognitive impairment: the Women's Health Initiative Memory Study</span></div><div class="casAuthors">Driscoll, Ira; Shumaker, Sally A.; Snively, Beverly M.; Margolis, Karen L.; Manson, JoAnn E.; Vitolins, Mara Z.; Rossom, Rebecca C.; Espeland, Mark A.</div><div class="citationInfo"><span class="NLM_cas:title">Journals of Gerontology, Series A: Biological Sciences and Medical Sciences</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">71</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1596-1602</span>CODEN:
                <span class="NLM_cas:coden">JGASFW</span>;
        ISSN:<span class="NLM_cas:issn">1079-5006</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Background: Nonhuman studies suggest a protective effect of caffeine on cognition.  Although human literature remains less consistent, reviews suggest a possible favorable relationship between caffeine consumption and cognitive impairment or dementia.  We investigated the relationship between caffeine intake and incidence of cognitive impairment or probable dementia in women aged 65 and older from the Women's Health Initiative Memory Study.  Methods: All women with self-reported caffeine consumption at enrollment were included (N = 6,467).  In 10 years or less of follow-up with annual assessments of cognitive function, 388 of these women received a diagnosis of probable dementia based on a 4-phase protocol that included central adjudication.  We used proportional hazards regression to assess differences in the distributions of times until incidence of probable dementia or composite cognitive impairment among women grouped by baseline level of caffeine intake, adjusting for risk factors (hormone therapy, age, race, education, body mass index, sleep quality, depression, hypertension, prior cardiovascular disease, diabetes, smoking, and alc. consumption).  Results: Women consuming above median levels (mean intake = 261 mg) of caffeine intake for this group were less likely to develop incident dementia (hazard ratio = 0.74, 95% confidence interval [0.56, 0.99], p =.04) or any cognitive impairment (hazard ratio = 0.74, confidence interval [0.60, 0.91], p =.005) compared to those consuming below median amts. (mean intake = 64 mg) of caffeine for this group.  Conclusion: Our findings suggest lower odds of probable dementia or cognitive impairment in older women whose caffeine consumption was above median for this group and are consistent with the existing literature showing an inverse assocn. between caffeine intake and age-related cognitive impairment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoM5TuV7LvhJ7Vg90H21EOLACvtfcHk0ljA8gR7aQqkLA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXlsVCku7g%253D&md5=d869e20ebff561f178ee875f0a8bca3c</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1093%2Fgerona%2Fglw078&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fgerona%252Fglw078%26sid%3Dliteratum%253Aachs%26aulast%3DDriscoll%26aufirst%3DI.%26aulast%3DShumaker%26aufirst%3DS.%2BA.%26aulast%3DSnively%26aufirst%3DB.%2BM.%26aulast%3DMargolis%26aufirst%3DK.%2BL.%26aulast%3DManson%26aufirst%3DJ.%2BE.%26aulast%3DVitolins%26aufirst%3DM.%2BZ.%26aulast%3DRossom%26aufirst%3DR.%2BC.%26aulast%3DEspeland%26aufirst%3DM.%2BA.%26atitle%3DRelationships%2520Between%2520Caffeine%2520Intake%2520and%2520Risk%2520for%2520Probable%2520Dementia%2520or%2520Global%2520Cognitive%2520Impairment%253A%2520The%2520Women%25E2%2580%2599s%2520Health%2520Initiative%2520Memory%2520Study%26jtitle%3DJ.%2520Gerontol.%252C%2520Ser.%2520A%26date%3D2016%26volume%3D71%26spage%3D1596%26epage%3D1602%26doi%3D10.1093%2Fgerona%2Fglw078" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tsai, L.-C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, G. C.-K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nangle, S. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimizu-Albergine, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, G. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Storm, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beavo, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zweifel, L. S.</span></span> <span> </span><span class="NLM_article-title">Inactivation of Pde8b Enhances Memory, Motor Performance, and Protects against Age-Induced Motor Coordination Decay</span>. <i>Genes, Brain Behav.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">837</span>– <span class="NLM_lpage">847</span>, <span class="refDoi"> DOI: 10.1111/j.1601-183x.2012.00836.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=10.1111%2Fj.1601-183X.2012.00836.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=22925203" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvVOqtL7K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2012&pages=837-847&author=L.-C.+L.+Tsaiauthor=G.+C.-K.+Chanauthor=S.+N.+Nangleauthor=M.+Shimizu-Albergineauthor=G.+L.+Jonesauthor=D.+R.+Stormauthor=J.+A.+Beavoauthor=L.+S.+Zweifel&title=Inactivation+of+Pde8b+Enhances+Memory%2C+Motor+Performance%2C+and+Protects+against+Age-Induced+Motor+Coordination+Decay&doi=10.1111%2Fj.1601-183x.2012.00836.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Inactivation of Pde8b enhances memory, motor performance, and protects against age-induced motor coordination decay</span></div><div class="casAuthors">Tsai, L.-C. L.; Chan, G. C.-K.; Nangle, S. N.; Shimizu-Albergine, M.; Jones, G. L.; Storm, D. R.; Beavo, J. A.; Zweifel, L. S.</div><div class="citationInfo"><span class="NLM_cas:title">Genes, Brain and Behavior</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">837-847</span>CODEN:
                <span class="NLM_cas:coden">GBBEAO</span>;
        ISSN:<span class="NLM_cas:issn">1601-1848</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Phosphodiesterases (PDEs) are crit. regulatory enzymes in cyclic nucleotide signaling.  PDEs have diverse expression patterns within the central nervous system (CNS), show differing affinities for cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP), and regulate a vast array of behaviors.  Here, we investigated the expression profile of the PDE8 gene family members Pde8a and Pde8b in the mouse brain.  We find that Pde8a expression is largely absent in the CNS; by contrast, Pde8b is expressed in select regions of the hippocampus, ventral striatum, and cerebellum.  Behavioral anal. of mice with Pde8b gene inactivation (PDE8B KO) demonstrate an enhancement in contextual fear, spatial memory, performance in an appetitive instrumental conditioning task, motor-coordination, and have an attenuation of age-induced motor coordination decline.  In addn. to improvements obsd. in select behaviors, we find basal anxiety levels to be increased in PDE8B KO mice.  These findings indicate that selective antagonism of PDE8B may be an attractive target for enhancement of cognitive and motor functions; however, possible alterations in affective state will need to be weighed against potential therapeutic value.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr0KE_TSXpVG7Vg90H21EOLACvtfcHk0lhw16Nd8KDQDQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvVOqtL7K&md5=9a273854e65eca00daba9e2236119260</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1111%2Fj.1601-183X.2012.00836.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1601-183X.2012.00836.x%26sid%3Dliteratum%253Aachs%26aulast%3DTsai%26aufirst%3DL.-C.%2BL.%26aulast%3DChan%26aufirst%3DG.%2BC.-K.%26aulast%3DNangle%26aufirst%3DS.%2BN.%26aulast%3DShimizu-Albergine%26aufirst%3DM.%26aulast%3DJones%26aufirst%3DG.%2BL.%26aulast%3DStorm%26aufirst%3DD.%2BR.%26aulast%3DBeavo%26aufirst%3DJ.%2BA.%26aulast%3DZweifel%26aufirst%3DL.%2BS.%26atitle%3DInactivation%2520of%2520Pde8b%2520Enhances%2520Memory%252C%2520Motor%2520Performance%252C%2520and%2520Protects%2520against%2520Age-Induced%2520Motor%2520Coordination%2520Decay%26jtitle%3DGenes%252C%2520Brain%2520Behav.%26date%3D2012%26volume%3D11%26spage%3D837%26epage%3D847%26doi%3D10.1111%2Fj.1601-183x.2012.00836.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Myers, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheewatrakoolpong, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Egan, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Billah, M. M.</span></span> <span> </span><span class="NLM_article-title">Expression, Purification, and Characterization of Human cAMP-Specific Phosphodiesterase (PDE4) Subtypes A, B, C, and D</span>. <i>Biochem. Biophys. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>234</i></span>,  <span class="NLM_fpage">320</span>– <span class="NLM_lpage">324</span>, <span class="refDoi"> DOI: 10.1006/bbrc.1997.6636</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=10.1006%2Fbbrc.1997.6636" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=9177268" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=1%3ACAS%3A528%3ADyaK2sXjsFCjtbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=234&publication_year=1997&pages=320-324&author=P.+Wangauthor=J.+G.+Myersauthor=P.+Wuauthor=B.+Cheewatrakoolpongauthor=R.+W.+Eganauthor=M.+M.+Billah&title=Expression%2C+Purification%2C+and+Characterization+of+Human+cAMP-Specific+Phosphodiesterase+%28PDE4%29+Subtypes+A%2C+B%2C+C%2C+and+D&doi=10.1006%2Fbbrc.1997.6636"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Expression, purification, and characterization of human cAMP-specific phosphodiesterase (PDE4) subtypes A, B, C, and D</span></div><div class="casAuthors">Wang, Peng; Myers, Joyce G.; Wu, Ping; Cheewatrakoolpong, Boonlert; Egan, Robert W.; Billah, M. Motasim</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical and Biophysical Research Communications</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">234</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">320-324</span>CODEN:
                <span class="NLM_cas:coden">BBRCA9</span>;
        ISSN:<span class="NLM_cas:issn">0006-291X</span>.
    
            (<span class="NLM_cas:orgname">Academic</span>)
        </div><div class="casAbstract">Although four members (A, B, C, and D) of the cAMP-specific phosphodiesterase (PDE4) family have been cloned by different groups, no study comparing the characteristics of purified human PDE4 subtypes has been published.  In this study, we have expressed human PDE4 A, B, C, and D in insect (SF9) cells by using the baculovirus expression system, purified the expressed proteins, and compared their characteristics.  The recombinant PDE4 subtypes all showed catalytic activity for cAMP with a Km of 1-5 -mM.  Vmax values differed significantly among these subtypes with the following order: C > B A > D.  PDE4 A, B, C, and D showed a very similar Mg2+ dependence profile.  PDE4 B and C showed similar pH profiles with the optimal pH being 8.0.  The pH profiles of PDE4 A and D were very different from each other and from those of B and C, with the optimal pH being 6.5 and 7.5, resp.  Furthermore, although PDE4 A, B, C, and D were all inhibited by the std. PDE4 inhibitors rolipram, Ro 20-1724, and etazolate, the inhibitory potency varied.  Thus, by several criteria including kinetics, pH dependency, and inhibitor sensitivity, various PDE4 subtypes differ significantly from one another.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoIN_kZyDyB2rVg90H21EOLACvtfcHk0lgwHRMoBXWeBg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXjsFCjtbc%253D&md5=2bf67d38ba51a5ade5ce23cd6a75d6f8</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1006%2Fbbrc.1997.6636&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fbbrc.1997.6636%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DP.%26aulast%3DMyers%26aufirst%3DJ.%2BG.%26aulast%3DWu%26aufirst%3DP.%26aulast%3DCheewatrakoolpong%26aufirst%3DB.%26aulast%3DEgan%26aufirst%3DR.%2BW.%26aulast%3DBillah%26aufirst%3DM.%2BM.%26atitle%3DExpression%252C%2520Purification%252C%2520and%2520Characterization%2520of%2520Human%2520cAMP-Specific%2520Phosphodiesterase%2520%2528PDE4%2529%2520Subtypes%2520A%252C%2520B%252C%2520C%252C%2520and%2520D%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D1997%26volume%3D234%26spage%3D320%26epage%3D324%26doi%3D10.1006%2Fbbrc.1997.6636" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Soderling, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bayuga, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beavo, J. A.</span></span> <span> </span><span class="NLM_article-title">Cloning and Characterization of a cAMP-Specific Cyclic Nucleotide Phosphodiesterase</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>95</i></span>,  <span class="NLM_fpage">8991</span>– <span class="NLM_lpage">8996</span>, <span class="refDoi"> DOI: 10.1073/pnas.95.15.8991</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=10.1073%2Fpnas.95.15.8991" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=9671792" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=1%3ACAS%3A528%3ADyaK1cXkvFaltbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=1998&pages=8991-8996&author=S.+H.+Soderlingauthor=S.+J.+Bayugaauthor=J.+A.+Beavo&title=Cloning+and+Characterization+of+a+cAMP-Specific+Cyclic+Nucleotide+Phosphodiesterase&doi=10.1073%2Fpnas.95.15.8991"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Cloning and characterization of a cAMP-specific cyclic nucleotide phosphodiesterase</span></div><div class="casAuthors">Soderling, S. H.; Bayuga, S. J.; Beavo, J. A.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">95</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">8991-8996</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Cyclic nucleotide phosphodiesterases (PDEs) regulate intracellular levels of cAMP and cGMP by hydrolyzing them to their corresponding 5' monophosphates.  The authors report the cloning and characterization of a novel cAMP-specific PDE from mouse testis.  This unique phosphodiesterase contains a catalytic domain that overall shares <40% sequence identity to the catalytic domain of all other known PDEs.  Based on this limited homol., this new PDE clearly represents a previously unknown PDE gene family designated as PDE8.  The cDNA for PDE8 is 3678 nucleotides in length and is predicted to encode an 823 amino acid enzyme.  The cDNA includes a full ORF as it contains an in-frame stop codon before the start methionine.  PDE8 is specific for the hydrolysis of cAMP and has a Km of 0.15 μM.  Most common PDE inhibitors are ineffective antagonists of PDE8, including the nonspecific PDE inhibitor 3-isobutyl-1-methylxanthine.  Dipyridamole, however, an inhibitor that is generally considered to be relatively specific for the cGMP selective PDEs, does inhibit PDE8 with an IC50 of 4.5 μM.  Tissue distribution studies of 22 different mouse tissues indicates that PDE8 has highest expression in testis, followed by eye, liver, skeletal muscle, heart, 7-day embryo, kidney, ovary, and brain in decreasing order.  In situ hybridizations in testis, the tissue of highest expression, shows that PDE8 is expressed in the seminiferous epithelium in a stage-specific manner.  Highest levels of expression are seen in stages 7-12, with little or no expression in stages 1-6.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoQMKxo8j_cUbVg90H21EOLACvtfcHk0lgwHRMoBXWeBg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXkvFaltbw%253D&md5=2a2da6944ca3140a1cf1479ab38cf2d6</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1073%2Fpnas.95.15.8991&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.95.15.8991%26sid%3Dliteratum%253Aachs%26aulast%3DSoderling%26aufirst%3DS.%2BH.%26aulast%3DBayuga%26aufirst%3DS.%2BJ.%26aulast%3DBeavo%26aufirst%3DJ.%2BA.%26atitle%3DCloning%2520and%2520Characterization%2520of%2520a%2520cAMP-Specific%2520Cyclic%2520Nucleotide%2520Phosphodiesterase%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1998%26volume%3D95%26spage%3D8991%26epage%3D8996%26doi%3D10.1073%2Fpnas.95.15.8991" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gamanuma, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuasa, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sasaki, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakurai, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kotera, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Omori, K.</span></span> <span> </span><span class="NLM_article-title">Comparison of Enzymatic Characterization and Gene Organization of Cyclic Nucleotide Phosphodiesterase 8 Family in Humans</span>. <i>Cell. Signalling</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">565</span>– <span class="NLM_lpage">574</span>, <span class="refDoi"> DOI: 10.1016/s0898-6568(02)00146-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=10.1016%2FS0898-6568%2802%2900146-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=12681444" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=1%3ACAS%3A528%3ADC%252BD3sXislemsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2003&pages=565-574&author=M.+Gamanumaauthor=K.+Yuasaauthor=T.+Sasakiauthor=N.+Sakuraiauthor=J.+Koteraauthor=K.+Omori&title=Comparison+of+Enzymatic+Characterization+and+Gene+Organization+of+Cyclic+Nucleotide+Phosphodiesterase+8+Family+in+Humans&doi=10.1016%2Fs0898-6568%2802%2900146-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Comparison of enzymatic characterization and gene organization of cyclic nucleotide phosphodiesterase 8 family in humans</span></div><div class="casAuthors">Gamanuma, Michiko; Yuasa, Keizo; Sasaki, Takashi; Sakurai, Naoki; Kotera, Jun; Omori, Kenji</div><div class="citationInfo"><span class="NLM_cas:title">Cellular Signalling</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">565-574</span>CODEN:
                <span class="NLM_cas:coden">CESIEY</span>;
        ISSN:<span class="NLM_cas:issn">0898-6568</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">Full-length cDNAs of human cyclic nucleotide phosphodiesterase 8B (PDE8B) were isolated.  Enzymic characteristics of a dominant variant encoding a protein of 885 residues (PDE8B1) were compared with those of PDE8A1.  The recombinant PDE8A1 and PDE8B1 proteins of an entire form were produced in both cytosolic and membrane fractions of the transfected COS cells.  The human PDE8B1 was a high-affinity cAMP-PDE with Km value of 101±12 nM for cAMP, which is greater than that of PDE8A1 (40±1 nM).  Relative Vmax value of PDE8A1 was 57±8% compared with that of PDE8B1 (100±12%).  Although PDE8A1 was moderately inhibited by dipyridamole with IC50 value of 8±2 μM, the compd. antagonized the PDE8B1 activity at three-fold higher concn. (IC50=23±2 μM).  The human PDE8B gene was composed of 22 exons, spanning over 217 kb.  Although overall sequence identity between PDE8A1 and PDE8B1 was 68%, positions of junctions of each exon between the PDE8A1 and PDE8B1 sequences were well matched, indicating evolutionary relatedness of both genes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp35CEEyORktrVg90H21EOLACvtfcHk0lgwHRMoBXWeBg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXislemsbs%253D&md5=c47dd94b28601e42b6b9353401b92fe4</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2FS0898-6568%2802%2900146-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0898-6568%252802%252900146-8%26sid%3Dliteratum%253Aachs%26aulast%3DGamanuma%26aufirst%3DM.%26aulast%3DYuasa%26aufirst%3DK.%26aulast%3DSasaki%26aufirst%3DT.%26aulast%3DSakurai%26aufirst%3DN.%26aulast%3DKotera%26aufirst%3DJ.%26aulast%3DOmori%26aufirst%3DK.%26atitle%3DComparison%2520of%2520Enzymatic%2520Characterization%2520and%2520Gene%2520Organization%2520of%2520Cyclic%2520Nucleotide%2520Phosphodiesterase%25208%2520Family%2520in%2520Humans%26jtitle%3DCell.%2520Signalling%26date%3D2003%26volume%3D15%26spage%3D565%26epage%3D574%26doi%3D10.1016%2Fs0898-6568%2802%2900146-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fisher, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pillar, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">St. Denis, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, J. B.</span></span> <span> </span><span class="NLM_article-title">Isolation and Characterization of PDE8A, a Novel Human cAMP-Specific Phosphodiesterase</span>. <i>Biochem. Biophys. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>246</i></span>,  <span class="NLM_fpage">570</span>– <span class="NLM_lpage">577</span>, <span class="refDoi"> DOI: 10.1006/bbrc.1998.8684</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=10.1006%2Fbbrc.1998.8684" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=9618252" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=1%3ACAS%3A528%3ADyaK1cXjsFyjsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=246&publication_year=1998&pages=570-577&author=D.+A.+Fisherauthor=J.+F.+Smithauthor=J.+S.+Pillarauthor=S.+H.+St.+Denisauthor=J.+B.+Cheng&title=Isolation+and+Characterization+of+PDE8A%2C+a+Novel+Human+cAMP-Specific+Phosphodiesterase&doi=10.1006%2Fbbrc.1998.8684"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Isolation and characterization of PDE8A, a novel human cAMP-specific phosphodiesterase'</span></div><div class="casAuthors">Fisher, Douglas A.; Smith, James F.; Pillar, Joann S.; St. Denis, Suzanne H.; Cheng, John B.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical and Biophysical Research Communications</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">246</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">570-577</span>CODEN:
                <span class="NLM_cas:coden">BBRCA9</span>;
        ISSN:<span class="NLM_cas:issn">0006-291X</span>.
    
            (<span class="NLM_cas:orgname">Academic Press</span>)
        </div><div class="casAbstract">As part of our efforts to understand the regulation of intracellular cAMP and to generate new targets for pharmacol. intervention, the authors have cloned and characterized the first isoenzyme in a new family of cyclic nucleotide phosphodiesterases, PDE8A.  PDE8A is most similar to PDE4 (38.5% amino acid identity in the catalytic domain), but is clearly not a member of any of the seven known PDE families.  The authors report the cloning of human cDNA encoding the C-terminal 713 amino acids of the protein, including a 283 amino acid region located near the C-terminus that is homologous to the ∼270 amino acid catalytic domain of other PDEs.  In addn., the authors found cDNA sequences consistent with alternative 5' mRNA splicing analogous to that seen in other PDE genes.  PDE8A is expressed in a wide variety of tissues as a ∼4.5 kb mRNA, with highest levels in testis, ovary, small intestine, and colon.  The C-terminal 545 amino acids of PDE8A (the region shared among all splice variants) were expressed in baculovirus.  Kinetic anal. of the baculovirus expressed enzyme shows it to be a very high affinity cAMP specific PDE with a Km of 55 nM for cAMP and 124 μM for cGMP.  The Vmax (150 pmol/min/μg recombinant enzyme) is about 10 times slower than that of PDE 4.  The cAMP hydrolytic activity of PDE8A is not modulated by cGMP at concns. up to 100 μM.  The enzyme requires the presence of at least 1 mM Mn2+ or Mg2+ for maximal activity in vitro, while 100 mM Ca2+ restores only about 20% activity.  PDE8A is insensitive (up to 100 μM) to a variety of PDE inhibitors including rolipram, zaprinast, vinpocetine, SKF-94120, and IBMX, but is inhibited (IC50 = 9 μM) by the PDE inhibitor dipyridamole.  To give PDE8A a descriptive name that distinguishes it from the other two known high affinity cAMP-specific phosphodiesterases (PDE4 and PDE7), the authors denote PDE8A as the high affinity cAMP-specific and IBMX-insensitive PDE.  (c) 1998 Academic Press.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp-MkMna8TGZ7Vg90H21EOLACvtfcHk0ljHnn0JZWLcqw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXjsFyjsL0%253D&md5=e11a53c2ca696c384c7d11e870760c7e</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1006%2Fbbrc.1998.8684&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fbbrc.1998.8684%26sid%3Dliteratum%253Aachs%26aulast%3DFisher%26aufirst%3DD.%2BA.%26aulast%3DSmith%26aufirst%3DJ.%2BF.%26aulast%3DPillar%26aufirst%3DJ.%2BS.%26aulast%3DSt.%2BDenis%26aufirst%3DS.%2BH.%26aulast%3DCheng%26aufirst%3DJ.%2BB.%26atitle%3DIsolation%2520and%2520Characterization%2520of%2520PDE8A%252C%2520a%2520Novel%2520Human%2520cAMP-Specific%2520Phosphodiesterase%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D1998%26volume%3D246%26spage%3D570%26epage%3D577%26doi%3D10.1006%2Fbbrc.1998.8684" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Snyder, H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corriveau, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Craft, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Faber, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greenberg, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knopman, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lamb, B. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montine, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nedergaard, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schaffer, C. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schneider, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wellington, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilcock, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zipfel, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zlokovic, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bain, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bosetti, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galis, Z. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koroshetz, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carrillo, M. C.</span></span> <span> </span><span class="NLM_article-title">Vascular Contributions to Cognitive Impairment and Dementia Including Alzheimer’s Disease</span>. <i>Alzheimer’s Dementia</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">710</span>– <span class="NLM_lpage">717</span>, <span class="refDoi"> DOI: 10.1016/j.jalz.2014.10.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=10.1016%2Fj.jalz.2014.10.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=25510382" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=1%3ACAS%3A280%3ADC%252BC2MznslKktQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2015&pages=710-717&author=H.+M.+Snyderauthor=R.+A.+Corriveauauthor=S.+Craftauthor=J.+E.+Faberauthor=S.+M.+Greenbergauthor=D.+Knopmanauthor=B.+T.+Lambauthor=T.+J.+Montineauthor=M.+Nedergaardauthor=C.+B.+Schafferauthor=J.+A.+Schneiderauthor=C.+Wellingtonauthor=D.+M.+Wilcockauthor=G.+J.+Zipfelauthor=B.+Zlokovicauthor=L.+J.+Bainauthor=F.+Bosettiauthor=Z.+S.+Galisauthor=W.+Koroshetzauthor=M.+C.+Carrillo&title=Vascular+Contributions+to+Cognitive+Impairment+and+Dementia+Including+Alzheimer%E2%80%99s+Disease&doi=10.1016%2Fj.jalz.2014.10.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Vascular contributions to cognitive impairment and dementia including Alzheimer's disease</span></div><div class="casAuthors">Snyder Heather M; Corriveau Roderick A; Bosetti Francesca; Koroshetz Walter; Craft Suzanne; Faber James E; Greenberg Steven M; Knopman David; Lamb Bruce T; Montine Thomas J; Nedergaard Maiken; Schaffer Chris B; Schneider Julie A; Wellington Cheryl; Wilcock Donna M; Zipfel Gregory J; Zlokovic Berislav; Bain Lisa J; Galis Zorina S; Carrillo Maria C</div><div class="citationInfo"><span class="NLM_cas:title">Alzheimer's & dementia : the journal of the Alzheimer's Association</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">710-7</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Scientific evidence continues to demonstrate the linkage of vascular contributions to cognitive impairment and dementia such as Alzheimer's disease.  In December, 2013, the Alzheimer's Association, with scientific input from the National Institute of Neurological Disorders and Stroke and the National Heart, Lung and Blood Institute from the National Institutes of Health, convened scientific experts to discuss the research gaps in our understanding of how vascular factors contribute to Alzheimer's disease and related dementia.  This manuscript summarizes the meeting and the resultant discussion, including an outline of next steps needed to move this area of research forward.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQra8xm-3FgJ9LIORRPd5lbfW6udTcc2eYhrrlOsdVv7rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2MznslKktQ%253D%253D&md5=16f91243764ad9e8a617ae7625150c51</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2Fj.jalz.2014.10.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jalz.2014.10.008%26sid%3Dliteratum%253Aachs%26aulast%3DSnyder%26aufirst%3DH.%2BM.%26aulast%3DCorriveau%26aufirst%3DR.%2BA.%26aulast%3DCraft%26aufirst%3DS.%26aulast%3DFaber%26aufirst%3DJ.%2BE.%26aulast%3DGreenberg%26aufirst%3DS.%2BM.%26aulast%3DKnopman%26aufirst%3DD.%26aulast%3DLamb%26aufirst%3DB.%2BT.%26aulast%3DMontine%26aufirst%3DT.%2BJ.%26aulast%3DNedergaard%26aufirst%3DM.%26aulast%3DSchaffer%26aufirst%3DC.%2BB.%26aulast%3DSchneider%26aufirst%3DJ.%2BA.%26aulast%3DWellington%26aufirst%3DC.%26aulast%3DWilcock%26aufirst%3DD.%2BM.%26aulast%3DZipfel%26aufirst%3DG.%2BJ.%26aulast%3DZlokovic%26aufirst%3DB.%26aulast%3DBain%26aufirst%3DL.%2BJ.%26aulast%3DBosetti%26aufirst%3DF.%26aulast%3DGalis%26aufirst%3DZ.%2BS.%26aulast%3DKoroshetz%26aufirst%3DW.%26aulast%3DCarrillo%26aufirst%3DM.%2BC.%26atitle%3DVascular%2520Contributions%2520to%2520Cognitive%2520Impairment%2520and%2520Dementia%2520Including%2520Alzheimer%25E2%2580%2599s%2520Disease%26jtitle%3DAlzheimer%25E2%2580%2599s%2520Dementia%26date%3D2015%26volume%3D11%26spage%3D710%26epage%3D717%26doi%3D10.1016%2Fj.jalz.2014.10.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Demirbas, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wyman, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimizu-Albergine, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cakici, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beavo, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffman, C. S.</span></span> <span> </span><span class="NLM_article-title">A Yeast-Based Chemical Screen Identifies a PDE Inhibitor that Elevates Steroidogenesis in Mouse Leydig Cells via PDE8 and PDE4 Inhibition</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>8</i></span>, <span class="NLM_elocation-id">e71279</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0071279</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=10.1371%2Fjournal.pone.0071279" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=23967182" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtleru7jO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&author=D.+Demirbasauthor=A.+R.+Wymanauthor=M.+Shimizu-Albergineauthor=O.+Cakiciauthor=J.+A.+Beavoauthor=C.+S.+Hoffman&title=A+Yeast-Based+Chemical+Screen+Identifies+a+PDE+Inhibitor+that+Elevates+Steroidogenesis+in+Mouse+Leydig+Cells+via+PDE8+and+PDE4+Inhibition&doi=10.1371%2Fjournal.pone.0071279"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">A yeast-based chemical screen identifies a PDE inhibitor that elevates steroidogenesis in mouse leydig cells via PDE8 and PDE4 inhibition</span></div><div class="casAuthors">Demirbas, Didem; Wyman, Arlene R.; Shimizu-Albergine, Masami; Cakici, Ozgur; Beavo, Joseph A.; Hoffman, Charles S.</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">e71279</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">A cell-based high-throughput screen (HTS) was developed to detect phosphodiesterase 8 (PDE8) and PDE4/8 combination inhibitors.  By replacing the Schizosaccharomyces pombe PDE gene with the murine PDE8A1 gene in strains lacking adenylyl cyclase, we generated strains whose protein kinase A (PKA)-stimulated growth in 5-fluoro orotic acid (5FOA) medium reflects PDE8 activity.  From our previously-identified PDE4 and PDE7 inhibitors, we identified a PDE4/8 inhibitor that allowed us to optimize screening conditions.  Of 222,711 compds. screened, ∼0.2% displayed composite Z scores of >20.  Addnl. yeast-based assays using the most effective 367 compds. identified 30 candidates for further characterization.  Among these, compd. BC8-15 displayed the lowest IC50 value for both PDE4 and PDE8 inhibition in in vitro enzyme assays.  This compd. also displays significant activity against PDE10A and PDE11A.  BC8-15 elevates steroidogenesis in mouse Leydig cells as a single pharmacol. agent.  Assays using BC8-15 and two structural derivs. support a model in which PDE8 is a primary regulator of testosterone prodn. by Leydig cells, with an addnl. role for PDE4 in this process.  BC8-15, BC8-15A and BC8-15C, which are com. available compds., display distinct patterns of activity against PDE4, PDE8, PDE10A and PDE11A, representing a chem. toolkit that could be used to examine the biol. roles of these enzymes in cell culture systems.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGquVl5cz94TT7Vg90H21EOLACvtfcHk0ljHnn0JZWLcqw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtleru7jO&md5=9734250e3b8c50bf60b41b1bd13d66c2</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0071279&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0071279%26sid%3Dliteratum%253Aachs%26aulast%3DDemirbas%26aufirst%3DD.%26aulast%3DWyman%26aufirst%3DA.%2BR.%26aulast%3DShimizu-Albergine%26aufirst%3DM.%26aulast%3DCakici%26aufirst%3DO.%26aulast%3DBeavo%26aufirst%3DJ.%2BA.%26aulast%3DHoffman%26aufirst%3DC.%2BS.%26atitle%3DA%2520Yeast-Based%2520Chemical%2520Screen%2520Identifies%2520a%2520PDE%2520Inhibitor%2520that%2520Elevates%2520Steroidogenesis%2520in%2520Mouse%2520Leydig%2520Cells%2520via%2520PDE8%2520and%2520PDE4%2520Inhibition%26jtitle%3DPLoS%2520One%26date%3D2013%26volume%3D8%26doi%3D10.1371%2Fjournal.pone.0071279" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">DeNinno, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wright, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Visser, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Etienne, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moore, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olson, T. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rocke, B. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andrews, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zarbo, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Millham, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boscoe, B. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boyer, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doran, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Houseknecht, K. L.</span></span> <span> </span><span class="NLM_article-title">1,5-Substituted Nipecotic Amides: Selective PDE8 Inhibitors Displaying Diastereomer-Dependent Microsomal Stability</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">3095</span>– <span class="NLM_lpage">3098</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2011.03.022</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=10.1016%2Fj.bmcl.2011.03.022" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=21459572" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=1%3ACAS%3A528%3ADC%252BC3MXlsVClsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=3095-3098&author=M.+P.+DeNinnoauthor=S.+W.+Wrightauthor=M.+S.+Visserauthor=J.+B.+Etienneauthor=D.+E.+Mooreauthor=T.+V.+Olsonauthor=B.+N.+Rockeauthor=M.+P.+Andrewsauthor=C.+Zarboauthor=M.+L.+Millhamauthor=B.+P.+Boscoeauthor=D.+D.+Boyerauthor=S.+D.+Doranauthor=K.+L.+Houseknecht&title=1%2C5-Substituted+Nipecotic+Amides%3A+Selective+PDE8+Inhibitors+Displaying+Diastereomer-Dependent+Microsomal+Stability&doi=10.1016%2Fj.bmcl.2011.03.022"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">1,5-Substituted nipecotic amides: Selective PDE8 inhibitors displaying diastereomer-dependent microsomal stability</span></div><div class="casAuthors">DeNinno, Michael P.; Wright, Stephen W.; Visser, Michael S.; Etienne, John B.; Moore, Dianna E.; Olson, Thanh V.; Rocke, Benjamin N.; Andrews, Melissa P.; Zarbo, Cynthia; Millham, Michele L.; Boscoe, Brian P.; Boyer, David D.; Doran, Shawn D.; Houseknecht, Karen L.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">3095-3098</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The first highly potent and selective PDE8 inhibitors are disclosed.  The initial tetrahydroisoquinoline hit was transformed into a nipecotic amide series in order to address a reactive metabolite issue.  Redn. of lipophilicity to address metabolic liabilities uncovered an interesting diastereomer-dependent trend in turnover by human microsomes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqD21pbH0ParbVg90H21EOLACvtfcHk0lgeR-OD3-Aebg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXlsVClsr0%253D&md5=1d85b5911aadbbe17a7ff6e85596adc1</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2011.03.022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2011.03.022%26sid%3Dliteratum%253Aachs%26aulast%3DDeNinno%26aufirst%3DM.%2BP.%26aulast%3DWright%26aufirst%3DS.%2BW.%26aulast%3DVisser%26aufirst%3DM.%2BS.%26aulast%3DEtienne%26aufirst%3DJ.%2BB.%26aulast%3DMoore%26aufirst%3DD.%2BE.%26aulast%3DOlson%26aufirst%3DT.%2BV.%26aulast%3DRocke%26aufirst%3DB.%2BN.%26aulast%3DAndrews%26aufirst%3DM.%2BP.%26aulast%3DZarbo%26aufirst%3DC.%26aulast%3DMillham%26aufirst%3DM.%2BL.%26aulast%3DBoscoe%26aufirst%3DB.%2BP.%26aulast%3DBoyer%26aufirst%3DD.%2BD.%26aulast%3DDoran%26aufirst%3DS.%2BD.%26aulast%3DHouseknecht%26aufirst%3DK.%2BL.%26atitle%3D1%252C5-Substituted%2520Nipecotic%2520Amides%253A%2520Selective%2520PDE8%2520Inhibitors%2520Displaying%2520Diastereomer-Dependent%2520Microsomal%2520Stability%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D3095%26epage%3D3098%26doi%3D10.1016%2Fj.bmcl.2011.03.022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">DeNinno, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wright, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Etienne, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olson, T. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rocke, B. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corbett, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kung, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DiRico, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andrews, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Millham, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parker, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Esler, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Volkenburg, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boyer, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Houseknecht, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doran, S. D.</span></span> <span> </span><span class="NLM_article-title">Discovery of Triazolopyrimidine-Based PDE8B Inhibitors: Exceptionally Ligand-Efficient and Lipophilic Ligand-Efficient Compounds for the Treatment of Diabetes</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">5721</span>– <span class="NLM_lpage">5726</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2012.06.079</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=10.1016%2Fj.bmcl.2012.06.079" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=22858141" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtFCgsrvO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=5721-5726&author=M.+P.+DeNinnoauthor=S.+W.+Wrightauthor=J.+B.+Etienneauthor=T.+V.+Olsonauthor=B.+N.+Rockeauthor=J.+W.+Corbettauthor=D.+W.+Kungauthor=K.+J.+DiRicoauthor=K.+M.+Andrewsauthor=M.+L.+Millhamauthor=J.+C.+Parkerauthor=W.+Eslerauthor=M.+van+Volkenburgauthor=D.+D.+Boyerauthor=K.+L.+Houseknechtauthor=S.+D.+Doran&title=Discovery+of+Triazolopyrimidine-Based+PDE8B+Inhibitors%3A+Exceptionally+Ligand-Efficient+and+Lipophilic+Ligand-Efficient+Compounds+for+the+Treatment+of+Diabetes&doi=10.1016%2Fj.bmcl.2012.06.079"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of triazolopyrimidine-based PDE8B inhibitors: Exceptionally ligand-efficient and lipophilic ligand-efficient compounds for the treatment of diabetes</span></div><div class="casAuthors">DeNinno, Michael P.; Wright, Stephen W.; Etienne, John B.; Olson, Thanh V.; Rocke, Benjamin N.; Corbett, Jeffrey W.; Kung, Daniel W.; DiRico, Kenneth J.; Andrews, Kim M.; Millham, Michele L.; Parker, Janice C.; Esler, William; van Volkenburg, Maria; Boyer, David D.; Houseknecht, Karen L.; Doran, Shawn D.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">5721-5726</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">PDE8B is a cAMP-specific isoform of the broader class of phosphodiesterases (PDEs).  As no selective PDE8B inhibitors had been reported, a high throughput screen was run with the goal of identifying selective tools for exploring the potential therapeutic utility of PDE8B inhibition.  Of the numerous hits, one was particularly attractive since it was amenable to rapid deconstruction leading to inhibitors with very high ligand efficiency and lipophilic ligand efficiency.  Triazolopyrimidines of formula I were prepd. and showed promised PDE8B inhibitory activity.  These triazolopyrimidines were optimized for potency, selectivity and ADME properties ultimately leading to compd. II.  Compd. II was highly potent and selective with good bioavailability (IC50 1.5 nM) and advanced into pre-clin. development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqqk21AAzYE67Vg90H21EOLACvtfcHk0lgeR-OD3-Aebg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtFCgsrvO&md5=7a5e3f3f39c63e304d5b958d4550745c</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2012.06.079&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2012.06.079%26sid%3Dliteratum%253Aachs%26aulast%3DDeNinno%26aufirst%3DM.%2BP.%26aulast%3DWright%26aufirst%3DS.%2BW.%26aulast%3DEtienne%26aufirst%3DJ.%2BB.%26aulast%3DOlson%26aufirst%3DT.%2BV.%26aulast%3DRocke%26aufirst%3DB.%2BN.%26aulast%3DCorbett%26aufirst%3DJ.%2BW.%26aulast%3DKung%26aufirst%3DD.%2BW.%26aulast%3DDiRico%26aufirst%3DK.%2BJ.%26aulast%3DAndrews%26aufirst%3DK.%2BM.%26aulast%3DMillham%26aufirst%3DM.%2BL.%26aulast%3DParker%26aufirst%3DJ.%2BC.%26aulast%3DEsler%26aufirst%3DW.%26aulast%3Dvan%2BVolkenburg%26aufirst%3DM.%26aulast%3DBoyer%26aufirst%3DD.%2BD.%26aulast%3DHouseknecht%26aufirst%3DK.%2BL.%26aulast%3DDoran%26aufirst%3DS.%2BD.%26atitle%3DDiscovery%2520of%2520Triazolopyrimidine-Based%2520PDE8B%2520Inhibitors%253A%2520Exceptionally%2520Ligand-Efficient%2520and%2520Lipophilic%2520Ligand-Efficient%2520Compounds%2520for%2520the%2520Treatment%2520of%2520Diabetes%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D5721%26epage%3D5726%26doi%3D10.1016%2Fj.bmcl.2012.06.079" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fisher, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pillar, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">St. Denis, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, J. B.</span></span> <span> </span><span class="NLM_article-title">Isolation and Characterization of PDE9A, a Novel Human cGMP-Specific Phosphodiesterase</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>273</i></span>,  <span class="NLM_fpage">15559</span>– <span class="NLM_lpage">15564</span>, <span class="refDoi"> DOI: 10.1074/jbc.273.25.15559</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=10.1074%2Fjbc.273.25.15559" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=9624146" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=1%3ACAS%3A528%3ADyaK1cXktVSmtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=273&publication_year=1998&pages=15559-15564&author=D.+A.+Fisherauthor=J.+F.+Smithauthor=J.+S.+Pillarauthor=S.+H.+St.+Denisauthor=J.+B.+Cheng&title=Isolation+and+Characterization+of+PDE9A%2C+a+Novel+Human+cGMP-Specific+Phosphodiesterase&doi=10.1074%2Fjbc.273.25.15559"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Isolation and characterization of PDE9A, a novel human cGMP-specific phosphodiesterase</span></div><div class="casAuthors">Fisher, Douglas A.; Smith, James F.; Pillar, Joann S.; Denis, Suzanne H. St.; Cheng, John B.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">273</span>
        (<span class="NLM_cas:issue">25</span>),
    <span class="NLM_cas:pages">15559-15564</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The authors have cloned and characterized the first human isoenzyme in a new family of cyclic nucleotide phosphodiesterases, PDE9A.  By sequence homol. in the catalytic domain, PDE9A is almost equidistant from all eight known mammalian PDE families but is most similar to PDE8A (34% amino acid identity) and least like PDE5A (28% amino acid identity).  The authors report the cloning of human cDNA encoding a full-length protein of 593 amino acids, including a 261-amino acid region located near the C terminus that is homologous to the ∼270-amino acid catalytic domain of other PDEs.  PDE9A is expressed in all eight tissues examd. as a ∼2.0-kilobase mRNA, with highest levels in spleen, small intestine, and brain.  The full-length PDE9A was expressed in baculovirus fused to an N-terminal 9-amino acid FLAG tag.  Kinetic anal. of the baculovirus-expressed enzyme shows it to be a very high affinity cGMP-specific PDE with a Km of 170 nM for cGMP and 230 μM for cAMP.  The Km for cGMP makes PDE9A one of the highest affinity PDEs known.  The Vmax for cGMP (4.9 nmol/min/μg recombinant enzyme) is about twice as fast as that of PDE4 for cAMP.  The enzyme is about twice as active in vitro in 1-10 mM Mn2+ than in the same concn. of Mg2+ or Ca2+.  PDE9A is insensitive (up to 100 μM) to a variety of PDE inhibitors including rolipram, vinpocetine, SKF-94120, dipyridamole, and 3-isobutyl-1-methyl-xanthine but is inhibited (IC50 = 35 μM) by zaprinast, a PDE5 inhibitor.  PDE9A lacks a region homologous to the allosteric cGMP-binding regulatory regions found in the cGMP-binding PDEs: PDE2, PDE5, and PDE6.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo9pa9zyPPt1rVg90H21EOLACvtfcHk0lgeR-OD3-Aebg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXktVSmtbk%253D&md5=c3ff4e1180aecf32fe9b856946853c37</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1074%2Fjbc.273.25.15559&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.273.25.15559%26sid%3Dliteratum%253Aachs%26aulast%3DFisher%26aufirst%3DD.%2BA.%26aulast%3DSmith%26aufirst%3DJ.%2BF.%26aulast%3DPillar%26aufirst%3DJ.%2BS.%26aulast%3DSt.%2BDenis%26aufirst%3DS.%2BH.%26aulast%3DCheng%26aufirst%3DJ.%2BB.%26atitle%3DIsolation%2520and%2520Characterization%2520of%2520PDE9A%252C%2520a%2520Novel%2520Human%2520cGMP-Specific%2520Phosphodiesterase%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1998%26volume%3D273%26spage%3D15559%26epage%3D15564%26doi%3D10.1074%2Fjbc.273.25.15559" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Meng, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hou, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shao, Y.-X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, P.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cai, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, H.-B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wan, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ke, H.</span></span> <span> </span><span class="NLM_article-title">Structure-Based Discovery of Highly Selective Phosphodiesterase-9A Inhibitors and Implications for Inhibitor Design</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">8549</span>– <span class="NLM_lpage">8558</span>, <span class="refDoi"> DOI: 10.1021/jm301189c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm301189c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtlGktbzJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=8549-8558&author=F.+Mengauthor=J.+Houauthor=Y.-X.+Shaoauthor=P.-Y.+Wuauthor=M.+Huangauthor=X.+Zhuauthor=Y.+Caiauthor=Z.+Liauthor=J.+Xuauthor=P.+Liuauthor=H.-B.+Luoauthor=Y.+Wanauthor=H.+Ke&title=Structure-Based+Discovery+of+Highly+Selective+Phosphodiesterase-9A+Inhibitors+and+Implications+for+Inhibitor+Design&doi=10.1021%2Fjm301189c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Based Discovery of Highly Selective Phosphodiesterase-9A Inhibitors and Implications for Inhibitor Design</span></div><div class="casAuthors">Meng, Fei; Hou, Jing; Shao, Yong-Xian; Wu, Pei-Ying; Huang, Manna; Zhu, Xinhai; Cai, Yonghong; Li, Zhe; Xu, Jie; Liu, Peiqing; Luo, Hai-Bin; Wan, Yiqian; Ke, Hengming</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">8549-8558</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A new series of phosphodiesterase-9 (PDE9) inhibitors that contain a scaffold of 6-amino-pyrazolopyrimidinone have been discovered by a combination of structure-based design and computational docking.  This procedure significantly saved the load of chem. synthesis and is an effective method for the discovery of inhibitors.  The best compd. 28 (I) has an IC50 of 21 nM and 3.3 μM, resp., for PDE9 and PDE5 and about 3 orders of magnitude of selectivity against other PDE families.  The crystal structure of the PDE9 catalytic domain in complex with 28 has been detd. and shows a hydrogen bond between 28 and Tyr424.  This hydrogen bond may account for the 860-fold selectivity of 28 against PDE1B, in comparison with about 30-fold selectivity of BAY73-6691.  Thus, our studies suggest that Tyr424, a unique residue of PDE8 and PDE9, is a potential target for improvement of selectivity of PDE9 inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrXPtJ-cQVCabVg90H21EOLACvtfcHk0ljv1uZiZegZVA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtlGktbzJ&md5=ed8c37d784c80b040c51c9e2b40e2d99</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Fjm301189c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301189c%26sid%3Dliteratum%253Aachs%26aulast%3DMeng%26aufirst%3DF.%26aulast%3DHou%26aufirst%3DJ.%26aulast%3DShao%26aufirst%3DY.-X.%26aulast%3DWu%26aufirst%3DP.-Y.%26aulast%3DHuang%26aufirst%3DM.%26aulast%3DZhu%26aufirst%3DX.%26aulast%3DCai%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DXu%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DP.%26aulast%3DLuo%26aufirst%3DH.-B.%26aulast%3DWan%26aufirst%3DY.%26aulast%3DKe%26aufirst%3DH.%26atitle%3DStructure-Based%2520Discovery%2520of%2520Highly%2520Selective%2520Phosphodiesterase-9A%2520Inhibitors%2520and%2520Implications%2520for%2520Inhibitor%2520Design%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D8549%26epage%3D8558%26doi%3D10.1021%2Fjm301189c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shao, Y.-x.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cui, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, L.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cai, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wan, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ke, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, H.-B.</span></span> <span> </span><span class="NLM_article-title">Discovery of a Phosphodiesterase 9A Inhibitor as a Potential Hypoglycemic Agent</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">10304</span>– <span class="NLM_lpage">10313</span>, <span class="refDoi"> DOI: 10.1021/jm500836h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm500836h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitVSju73E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=10304-10313&author=Y.-x.+Shaoauthor=M.+Huangauthor=W.+Cuiauthor=L.-J.+Fengauthor=Y.+Wuauthor=Y.+Caiauthor=Z.+Liauthor=X.+Zhuauthor=P.+Liuauthor=Y.+Wanauthor=H.+Keauthor=H.-B.+Luo&title=Discovery+of+a+Phosphodiesterase+9A+Inhibitor+as+a+Potential+Hypoglycemic+Agent&doi=10.1021%2Fjm500836h"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a Phosphodiesterase 9A Inhibitor as a Potential Hypoglycemic Agent</span></div><div class="casAuthors">Shao, Yong-xian; Huang, Manna; Cui, Wenjun; Feng, Ling-Jun; Wu, Yinuo; Cai, Yinghong; Li, Zhe; Zhu, Xinhai; Liu, Peiqing; Wan, Yiqian; Ke, Hengming; Luo, Hai-Bin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">10304-10313</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Phosphodiesterase 9 (PDE9) inhibitors have been studied as potential therapeutics for treatment of diabetes and Alzheimer's disease.  Here we report a potent PDE9 inhibitor 3r that has an IC50 of 0.6 nM and >150-fold selectivity over other PDEs.  The HepG2 cell-based assay shows that 3r inhibits the mRNA expression of phosphoenolpyruvate carboxykinase and glucose 6-phosphatase.  These activities of 3r, together with the reasonable pharmacokinetic properties and no acute toxicity at 1200 mg/kg dosage, suggest its potential as a hypoglycemic agent.  The crystal structure of PDE9-3r reveals significantly different conformation and hydrogen bonding pattern of 3r from those of previously published 28s.  Both 3r and 28s form a hydrogen bond with Tyr424, a unique PDE9 residue (except for PDE8), but 3r shows an addnl. hydrogen bond with Ala452.  This structure information might be useful for design of PDE9 inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo41BAQ4bJwqbVg90H21EOLACvtfcHk0ljv1uZiZegZVA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitVSju73E&md5=71b59f683cfbd1b6620d507e654e231f</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Fjm500836h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm500836h%26sid%3Dliteratum%253Aachs%26aulast%3DShao%26aufirst%3DY.-x.%26aulast%3DHuang%26aufirst%3DM.%26aulast%3DCui%26aufirst%3DW.%26aulast%3DFeng%26aufirst%3DL.-J.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DCai%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DZhu%26aufirst%3DX.%26aulast%3DLiu%26aufirst%3DP.%26aulast%3DWan%26aufirst%3DY.%26aulast%3DKe%26aufirst%3DH.%26aulast%3DLuo%26aufirst%3DH.-B.%26atitle%3DDiscovery%2520of%2520a%2520Phosphodiesterase%25209A%2520Inhibitor%2520as%2520a%2520Potential%2520Hypoglycemic%2520Agent%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D10304%26epage%3D10313%26doi%3D10.1021%2Fjm500836h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mao, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, H.-B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span> <span> </span><span class="NLM_article-title">Discovery of Novel Purine Nucleoside Derivatives as Phosphodiesterase 2 (PDE2) inhibitors: Structure-Based Virtual Screening, Optimization and Biological Evaluation</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">119</span>– <span class="NLM_lpage">133</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2017.11.022</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=10.1016%2Fj.bmc.2017.11.022" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=29174506" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvVKhsrjK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2018&pages=119-133&author=X.+Qiuauthor=Y.+Huangauthor=D.+Wuauthor=F.+Maoauthor=J.+Zhuauthor=W.+Yanauthor=H.-B.+Luoauthor=J.+Li&title=Discovery+of+Novel+Purine+Nucleoside+Derivatives+as+Phosphodiesterase+2+%28PDE2%29+inhibitors%3A+Structure-Based+Virtual+Screening%2C+Optimization+and+Biological+Evaluation&doi=10.1016%2Fj.bmc.2017.11.022"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of novel purine nucleoside derivatives as phosphodiesterase 2 (PDE2) inhibitors: Structure-based virtual screening, optimization and biological evaluation</span></div><div class="casAuthors">Qiu, Xiaoxia; Huang, Yiyou; Wu, Deyan; Mao, Fei; Zhu, Jin; Yan, Wenzhong; Luo, Hai-Bin; Li, Jian</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">119-133</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Phosphodiesterase 2 (PDE2) has received much attention for the potential treatment of the central nervous system (CNS) disorders and pulmonary hypertension.  Herein, we identified that clofarabine (4), an FDA-approved drug, displayed potential PDE2 inhibitory activity (IC50=3.12±0.67μM) by structure-based virtual screening and bioassay.  Considering the potential therapeutic benefit of PDE2, a series of purine nucleoside derivs. based on the structure and binding mode of 4 were designed, synthesized and evaluated, which led to the discovery of the best compd. 14e with a significant improvement of inhibitory potency (IC50=0.32±0.04μM).  Further mol. docking and mol. dynamic (MD) simulations studies revealed that 5'-benzyl group of 14e could interact with the unique hydrophobic pocket of PDE2 by forming extra van der Waals interactions with hydrophobic residues such as Leu770, Thr768, Thr805 and Leu809, which might contribute to its enhancement of PDE2 inhibition.  These potential compds. reported in this article and the valuable structure-activity relationships (SARs) might bring significant instruction for further development of potent PDE2 inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqskipWtgMkULVg90H21EOLACvtfcHk0lj1cfU6kD_rig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvVKhsrjK&md5=ac48f4d93e5d13d4098858cb57717d28</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2017.11.022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2017.11.022%26sid%3Dliteratum%253Aachs%26aulast%3DQiu%26aufirst%3DX.%26aulast%3DHuang%26aufirst%3DY.%26aulast%3DWu%26aufirst%3DD.%26aulast%3DMao%26aufirst%3DF.%26aulast%3DZhu%26aufirst%3DJ.%26aulast%3DYan%26aufirst%3DW.%26aulast%3DLuo%26aufirst%3DH.-B.%26aulast%3DLi%26aufirst%3DJ.%26atitle%3DDiscovery%2520of%2520Novel%2520Purine%2520Nucleoside%2520Derivatives%2520as%2520Phosphodiesterase%25202%2520%2528PDE2%2529%2520inhibitors%253A%2520Structure-Based%2520Virtual%2520Screening%252C%2520Optimization%2520and%2520Biological%2520Evaluation%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2018%26volume%3D26%26spage%3D119%26epage%3D133%26doi%3D10.1016%2Fj.bmc.2017.11.022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Baell, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holloway, G. A.</span></span> <span> </span><span class="NLM_article-title">New Substructure Filters for Removal of Pan Assay Interference Compounds (PAINS) from Screening Libraries and for their Exclusion in Bioassays</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">2719</span>– <span class="NLM_lpage">2740</span>, <span class="refDoi"> DOI: 10.1021/jm901137j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm901137j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsF2qsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=2719-2740&author=J.+B.+Baellauthor=G.+A.+Holloway&title=New+Substructure+Filters+for+Removal+of+Pan+Assay+Interference+Compounds+%28PAINS%29+from+Screening+Libraries+and+for+their+Exclusion+in+Bioassays&doi=10.1021%2Fjm901137j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">New Substructure Filters for Removal of Pan Assay Interference Compounds (PAINS) from Screening Libraries and for Their Exclusion in Bioassays</span></div><div class="casAuthors">Baell, Jonathan B.; Holloway, Georgina A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2719-2740</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">This report describes a no. of substructural features which can help to identify compds. that appear as frequent hitters (promiscuous compds.) in many biochem. high throughput screens.  The compds. identified by such substructural features are not recognized by filters commonly used to identify reactive compds.  Even though these substructural features were identified using only one assay detection technol., such compds. have been reported to be active from many different assays.  In fact, these compds. are increasingly prevalent in the literature as potential starting points for further exploration, whereas they may not be.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGro_JARcceWjLVg90H21EOLACvtfcHk0lj1cfU6kD_rig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsF2qsLw%253D&md5=fbf397aa4910753c550425708c866fd2</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Fjm901137j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901137j%26sid%3Dliteratum%253Aachs%26aulast%3DBaell%26aufirst%3DJ.%2BB.%26aulast%3DHolloway%26aufirst%3DG.%2BA.%26atitle%3DNew%2520Substructure%2520Filters%2520for%2520Removal%2520of%2520Pan%2520Assay%2520Interference%2520Compounds%2520%2528PAINS%2529%2520from%2520Screening%2520Libraries%2520and%2520for%2520their%2520Exclusion%2520in%2520Bioassays%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D2719%26epage%3D2740%26doi%3D10.1021%2Fjm901137j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Miyaura, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, A.</span></span> <span> </span><span class="NLM_article-title">Palladium-Catalyzed Cross-Coupling Reactions of Organoboron Compounds</span>. <i>Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>95</i></span>,  <span class="NLM_fpage">2457</span>– <span class="NLM_lpage">2483</span>, <span class="refDoi"> DOI: 10.1021/cr00039a007</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cr00039a007" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=1%3ACAS%3A528%3ADyaK2MXoslGiurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=1995&pages=2457-2483&author=N.+Miyauraauthor=A.+Suzuki&title=Palladium-Catalyzed+Cross-Coupling+Reactions+of+Organoboron+Compounds&doi=10.1021%2Fcr00039a007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Palladium-Catalyzed Cross-Coupling Reactions of Organoboron Compounds</span></div><div class="casAuthors">Miyaura, Norio; Suzuki, Akira</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, D. C.)</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">95</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2457-83</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review with >250 refs. including title reactions and their mechanisms, prepn. of organoboron reagents, alkoxycarbonylation and dimerization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqHwupBJT1UCbVg90H21EOLACvtfcHk0lj1cfU6kD_rig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXoslGiurg%253D&md5=d127b414a75161652876eebc3ed0c486</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1021%2Fcr00039a007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr00039a007%26sid%3Dliteratum%253Aachs%26aulast%3DMiyaura%26aufirst%3DN.%26aulast%3DSuzuki%26aufirst%3DA.%26atitle%3DPalladium-Catalyzed%2520Cross-Coupling%2520Reactions%2520of%2520Organoboron%2520Compounds%26jtitle%3DChem.%2520Rev.%26date%3D1995%26volume%3D95%26spage%3D2457%26epage%3D2483%26doi%3D10.1021%2Fcr00039a007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wohl, A.</span></span> <span> </span><span class="NLM_article-title">Bromierung ungesättigter Verbindungen mit N-Brom-acetamid, ein Beitrag zur Lehre vom Verlauf chemischer Vorgänge</span>. <i>Ber. Dtsch. Chem. Ges.</i> <span class="NLM_year" style="font-weight: bold;">1919</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">51</span>– <span class="NLM_lpage">63</span>, <span class="refDoi"> DOI: 10.1002/cber.19190520109</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=10.1002%2Fcber.19190520109" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=1%3ACAS%3A528%3ADyaC1MXot1ek" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=1919&pages=51-63&author=A.+Wohl&title=Bromierung+unges%C3%A4ttigter+Verbindungen+mit+N-Brom-acetamid%2C+ein+Beitrag+zur+Lehre+vom+Verlauf+chemischer+Vorg%C3%A4nge&doi=10.1002%2Fcber.19190520109"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Bromination of unsaturated compounds with N-bromoacetamide, a contribution to the study of the course of chemical processes</span></div><div class="casAuthors">Wohl, A.</div><div class="citationInfo"><span class="NLM_cas:title">Berichte der Deutschen Chemischen Gesellschaft [Abteilung] B: Abhandlungen</span>
        (<span class="NLM_cas:date">1919</span>),
    <span class="NLM_cas:volume">52B</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">51-63</span>CODEN:
                <span class="NLM_cas:coden">BDCBAD</span>;
        ISSN:<span class="NLM_cas:issn">0365-9488</span>.
    </div><div class="casAbstract">It has now become quite widely accepted that substitution reactions are often preceded by addition reactions and the present investigation was carried out in the course of a search for reactions which would make it possible to decide with certainty whether there is really a primary addition and, if so, whether it is molecular or atomic.  W. found, e. g., that the reaction Me2C:CMe2 + AcNHBr (a) → Me2C:CMeCH2Br + AcNH2 occurs under such conditions (good cooling in Et2O or Me2CO) that the (a) is not dissociated at all or only to a very minute extent; no HBr can be detected.  This reaction can in no way be explained as taking place by addition of the residues Br and AcNH of the (a) to the two C atoms of the double bond, for an acetylated bromoamine would split off HBr and not AcNH2.  Moreover, the behavior of (a) towards Me2C:CHMe (see below) also shows that the Br does not combine with either of the unsatd.  C atoms.  There, therefore, remains but one possibility, that the primary addition occurs through subsidiary valences on (a) and one or both of the trivalent C atoms and the resulting unstable structure with the loosest union between Br and N then loses AcNH, forming AcNH2 with the most labile H atom after the Br and this H atom, obeying the law of neutralization, have exchanged places.  According to W.'s views, the high additive power of (a) depends on the union, the spatial proximity, of the two fields of affinity of the unsatd. negative atoms -N.dbd.Br.dbd., just like H2N.dbd..O.dbd.H, H2N.dbd..N.dbd.H2, HO.N.dbd.O.dbd., (HO)2S.dbd.O.dbd., HN.dbd.:C.dbd., etc. Compds. without this union, like the hydrazonium salts, H2NNMe3I, are quite indifferent, e. g., towards aldehydes.  Me2C:CHMe and (a) under such conditions (sufficient diln. and cooling) that AcNH2 seps. and the Br deriv. remains in soln. give exclusively a di-Br compd. C5H8Br2.  If, however, equimol. amts. of Me2C:CHMe and (a) are brought together in cold Et2O they combine and sep. practically quant. as an oil which, when the Et2O is poured off, undergoes an energetic reaction just like when Me2C:CHMe and (a) are brought together without a diluent.  It is, therefore, not the addition product stable at low temps. which dets. the course of the substitution reaction but some part of it (which could not be isolated) in the mixt. formed when the temp. is raised.  In the substitution reaction it is one of the primary H atoms, not the tertiary atom, which is replaced.  The primary addition is, therefore, detd. by the co´operation of the Br-N secondary valences and the C double bond, and the further course of the reaction by the mobility of the H atoms; according to the well-known rule, the double bond loosens the H on the adjacent C atom.  In harmony with these views it was found that (a) does not attack compds. satd. in the usual sense (except Me3CBr) and a series of compds. unsatd. in the ordinary sense but lacking the conditions of easy addition or of mobile H atoms (EtBr, iso-PrBr, (CH2Br)2, PhCH2Br and CH2(CO2Et)2 in the first group and C2H4, C2H2, maleic and fumaric acids, PhCH:CHCO2H, PhCH:CHCO2Et and PhCH:CHCHO in the second group).  Malonic ester, in spite of the mobile H atoms, lacks a grouping appropriate for the primary addition; this, however, is present in the deriv.  EtO2CCH2CONH2 which in Me3CO smoothly forms the compd. EtO2CCHBrCONH2, the transient yellow color appearing during the course of its prepn. indicating the formation of a Br-N compd. with pentavalent N in which the migration of the Br from N to C occurs by intramol. substitution.  The indifference of the other compds. of the second group is easily explained by the absence of a reactively influenced H atom.  On the other hand, AcCH2CO2Et, PhOH and, to a less marked degree, PhOMe react with (a) just like Me2C:CMe2 and Me2C:CHMe.  The same is true of Me3CBr, PhCH:CH2, MeCH:CHCO2H, NCCH2CO2Et, AcH, HCO2H and HCO2Et.  The (a) used was recrystd. from C6H6, m. 108° and was colorless; as diluents were used Et2O (in which it is not sol. but dissolves as the reaction proceeds and AcNH2 seps.) or Me2CO which dissolves (a) readily without being itself markedly brominated in the cold.  In general, as soon as the starch-iodide reaction was no longer given, the AcNH2, was removed, after addition of Et2O, by shaking with Na2CO3 and washing with H2O and the H2O-insol. layer was dried with Na2SO4 and fractionated in vacuo.  Without a diluent (a) acts on easily brominated compds. with much evolution of heat, darkening and violent decompn., the unattacked (a) itself being thereby decompd. with liberation of Br.  From 10 g. cold Me2C:CHMe treated with four 10-g. portions of (a) in 60 cc. Me2CO was obtained 9 g. of a compound, C5H8Br2 (b) (found 69.74% Br; calcd., 70.14), b12 54-5°, decolorizes KMnO4 and Br-H2O in alc.; no mono-Br deriv. is formed, even when a large excess of Me2C:CHMe is used (20 g. to 20 of Br). Me2C:CBrMe, prepd. by Bauer's method (Bull. soc. chim. 2, 149(1860)) but from pure Me2C:CHMe instead of amylene, b766 119-20°; it reacts much more slowly than Me2C:CHMe with (a); 14.9 g. added at room temp. to 13.8 g. (a) in 60 cc. Me2CO and allowed to stand 24 hrs. without cooling, gave, besides unchanged Me2C:CBrMe, a fraction b25 96-8° with 69.43% Br.  This dibromotrimethylethylene partly polymerizes on cooling and unlike (b) has an intense odor and attacks the eyes.  From 10 g. Me2C:CMe2 in 36 cc. cold Et2O and 16 g. (a) is obtained about 3 g. of not quite pure bromotetramethylethylene (found 46.3% Br; calcd. 49.0%), b15, 60-90°, decolorizes KMnO4, easily decomps. and polymerizes.  Me3CBr (37 g.) in 10 cc. cold Et2O slowly treated with 37 g. (a) yields 7 g. Me2C(CH2Br)Br, b36 60-1°, b. 149°.  From 44.3 g. PhOH in 145 cc. cold Et2O treated at 12 hr. intervals With, 20, 20 and 25 g. (a) is obtained p-BrC6H4OH, m. 64°, b21 1.39°, b, 236°.  PhOMe (10.8 g.) and 13.8 g. (a) in 65 cc. Me2CO after 24 hrs. at room temp. gave 17 g. p-BrC6H4OMe, m. 11-1.5°, b. 215°.  AcCH2CO2Et (21.7 g.) in 100 cc. cold Et2O treated in the course of 1 day with 8 + 8 + 7 g. (a) yields 15 g. AcCHBrCO2Et, b18 106-8°.  From 2 g. EtO2CCH2CONH2 (prepd. by heating EtO2CCH2C(OEt):NH.HCl at 125-30°) in 5 cc. cold Me2CO, slowly treated with 2 g. (a) in 5 cc. Me2CO and allowed to stand 24 hrs. to disappearance of the yellow color and the starch-iodide reaction, is obtained a mixt. of AcNH2 and EtO2CCHBrCONH2</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprQjLugWJXH7Vg90H21EOLACvtfcHk0lj1cfU6kD_rig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaC1MXot1ek&md5=d796a70a33b020369681c460b7d278f0</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1002%2Fcber.19190520109&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcber.19190520109%26sid%3Dliteratum%253Aachs%26aulast%3DWohl%26aufirst%3DA.%26atitle%3DBromierung%2520unges%25C3%25A4ttigter%2520Verbindungen%2520mit%2520N-Brom-acetamid%252C%2520ein%2520Beitrag%2520zur%2520Lehre%2520vom%2520Verlauf%2520chemischer%2520Vorg%25C3%25A4nge%26jtitle%3DBer.%2520Dtsch.%2520Chem.%2520Ges.%26date%3D1919%26volume%3D52%26spage%3D51%26epage%3D63%26doi%3D10.1002%2Fcber.19190520109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ziegler, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schenck, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krockow, E. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siebert, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wenz, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weber, H.</span></span> <span> </span><span class="NLM_article-title">Die Synthese des Cantharidins</span>. <i>Justus Liebigs Ann. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1942</span>,  <span class="NLM_volume"><i>551</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">79</span>, <span class="refDoi"> DOI: 10.1002/jlac.19425510102</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=10.1002%2Fjlac.19425510102" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=1%3ACAS%3A528%3ADyaH3sXjtlKisQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=551&publication_year=1942&pages=1-79&author=K.+Zieglerauthor=G.+Schenckauthor=E.+W.+Krockowauthor=A.+Siebertauthor=A.+Wenzauthor=H.+Weber&title=Die+Synthese+des+Cantharidins&doi=10.1002%2Fjlac.19425510102"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of cantharidin</span></div><div class="casAuthors">Ziegler, K.; Schenck, G.; Krockow, E. W.; Siebert, A.; Wenz, A.; Weber, H.</div><div class="citationInfo"><span class="NLM_cas:title">Justus Liebigs Annalen der Chemie</span>
        (<span class="NLM_cas:date">1942</span>),
    <span class="NLM_cas:volume">551</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1-79</span>CODEN:
                <span class="NLM_cas:coden">JLACBF</span>;
        ISSN:<span class="NLM_cas:issn">0075-4617</span>.
    </div><div class="casAbstract">Di-Me 3,6-endomethylenehexahydrophthalate (21.2 g.), shaken 24 h. at room temp. with 800 cc. 0.3 N Ph3CNa in ether, the soln. cooled in ice-salt, treated with 45 g. MeI (better with 28 cc. Me2SO4), shaken 12 h. at room temp., the residue hydrolyzed by refluxing with 50 g. KOH in 250 cc. MeOH for 72 h. and fractionated with Na2CO3 or better by boiling with 1 l. and then with 0.5 l. petr. ether (60-80°), gives as the sol. portion 62% of cis-1,2-dimethyl-3,6-endomethylenehexahydrophthalic anhydride (methylenecantharidin), m. 206° (Me ester of the acid, m. 57°), and 1.5 g. of the trans-acid (trans-methylenecantharidic acid), m. 320-3° (Me ester, m. 44°); the anhydride does not appear to be formed.  Various attempts to methylate di-Me norcantharidate were not successful.  Fumaronitrile (I) results in 68% yield from 50 g. of the diamide, 250 g. p-MeC6H4-SO2Cl and 600 cc. dry C5H5N on boiling exactly 20 min., distn. of 350 cc. C5H5N, addn. of 50 cc. H2O, extn. with ether, removal of the ether and crystn. of the I.  (CH2:CH)2 (0.3 mol) and 0.2 mol I in 50 cc. PhMe, heated 24 h. at 100°, give 25% of trans-4,5-dicyanocyclohexene (II), b15 166-70°, m. 125°; considerable rubberlike polymer is formed; the use of 20 g. (CH2:CH)2 and 1.9 g.  I in 30 cc. PhMe gives 70% of II but it is difficult to purify.  The passage of (CH2:CH)2 into 33 g. I in 25 cc. PhMe at 131° (bath temp. 170-80°) during 76 h. gives 34% absorption; repetition 3 times (73 h., 118 h. and 165 h.) gives 76% pure II.  This is not methylated smoothly.  1,2-Dimethyl-1,2,3,6-tetrahydrophthalic anhydride (III), m. 101°, results in 50% yield by passage of (CH2:CH)2 into a boiling soln. of 50 g. dimethylmaleic anhydride (IV) and 25 cc. decalin for 720 h. (8 passages) or in 60% yield by carrying out the reaction in a 3-1. Cu autoclave with 185 g. IV and 80 g. (CH2:CH)2 at 160° for 26 h. (the flask is of sufficient size so that most of the (CH2:CH)2 remains in the gaseous phase).  The crude III (202 g.) is purified by heating with 160 g. KOH in 2 l. H2O in a current of steam, clarifying with charcoal, pptg. with concd. HCl and extg. with C6H6 for 24 h.; this gives 50-60 g. of IV and 80-5 g. of the acid corresponding to III, distg. at 265-9°; a better purifn. is effected by soln. in AcOH and adding dropwise and with cooling 115 g. Br, giving 183 g. of the dibromide (V), m. 181°; boiling 210 g. with 90 g. Zn in 900 cc. MeOH for 2 h. gives 90% of III.  III. is stable at 400°; it is hydrolyzed by alkali to the acid, m. 200° (formation of III); III also results slowly on heating the acid with H2O.  Catalytic redn. of III gives desoxycantharidin (VA) (Gadamer, C. A. 9, 2084), m. 129°; the acid m. 180°; characteristic is the rapid formation of the anhydride on boiling with H2O.  The characteristic instability of cantharidindicarboxylic acids is the result of the presence of the bridge.  V (17 g.), added in small portions to 15 g. NaOH in 50 cc. boiling H2O, gives a mixt., sepd. by extn. with petr. ether into an ethylene oxide (VI) or keto anhydride (VII), m. 182°, and the corresponding acid, m. 178°.  V (20 g.) and 50 g. Me3N, heated 20 h. at 100°, give large amts. of non-volatile products and about 10% of 1,2-dimethyl-1,2-dihydrophthalic anhydride (VIII), b2 112°, m. 70°.  The corresponding acid m. 158° (formation of VIII).  Catalytic redn. of VIII gives VA.  VIII yields 30% of a dibromide, m. 126°, and a more-sol. product (m. p. not given); this loses only 1 Br with AgNO3 in EtOH or with aq. Me2CO.  VIII and NH3 at 250° give dehydrocantharidinimide, m. 136°.  III (18 g.) and 18 g. powd. (CH2CO)2NBr in 80 cc. CCl4, heated 5 h., give 24-5 g. of a mixt. of 6-bromo-1,2-dimethyl-1,2,3,6-tetrahydrophthalic anhydride (IX), sepd. into a small amt. of an isomer, m. 106°, and a larger amt. of an isomer, m. 72°; the latter spontaneously loses HBr.  On heating at 150° and then at 180° IX gives VIII, the yield depending on the exptl. conditions.  IX (51 g.) and 170 cc. 20% NaOH, boiled 20 min. and repeatedly crystd. from H2O, give isocantharic acid Nr.  2 (X), m. 204-6°; this liberates CO2 from Na2CO2 and is unsatd. toward KMnO4; Me ester, m. 72°; if the crude product is boiled with AcCl for 5 h., there results 1,2-dimethyl-6-acetoxy-1, ,2,3,6-tetrahydrophthalic anhydride, b. 310°, m. 101.5-2°; this also results on warming 15 g. III, 22 g. SeO2 and 37 cc. Ac2O for 48 h. at 60°.  Catalytic redn. of X gives dihydrocantharic acid, m. 263° (di-Me ester (XI), m. 58-60°).  The Me ester of X and (CH2CO)2NBr give a Br deriv., m. 166°; catalytic redn. gives XI, m. 65°.  The nonvolatile fraction from the prepn. of VIII (100 g.) in 200 cc. H2O, dropped into a boiling soln. of 40 g. NaOH in 200 cc. H2O, the soln. acidified and extd. with ether, gives pseudocantharic acid (XII), m. 187°; Me ester, m. 100°; catalytic redn. gives the dihydro deriv., m. 270-3°.  IV (100 g.) and 127 g. cyclohexadiene (best result if dissolved in an equal vol. of C6H6), heated 3 days at 170-80°, the cryst. reaction product distd. with steam and crystd. from AcOH or decalin, or soln. in warm alkali, pptn. with acid and crystn. from AcOH, give 87.5% of 1,2-dimethyl-3,6-endovinylenehexahydrophthalic anhydride (XIII), m. 263.5°.  Mixing a soln. of 10 g. XII in 70 cc. 4 N NaOH and 150 cc. H2O at 0° and a NaOBr soln. prepd. from 30 cc. 4 N NaOH and 30 g. ice with 2.6 cc. Br at -3 to -5° with cooling gives, after 5 min., 10-11 g. of a Na salt; acidification with H2SO4 and crystn. from EtOH give the bromolactonic acid (XIV), C12H15O4Br, m. 231-2° (decompn.); Me ester, m. 164-5°.  The Na salt boiled with H2O, EtOH or Me2CO gives the dilactone, C12H14O4, m. about 375°; it is stable to KMnO4 and insol. in Na2CO3; boiling with 10 parts of 2 N NaOH gives the hydroxylactonic acid (XV), whose Me ester m. 177-8°; heating the acid above 260° gives the dilactone; XV results on boiling XIV with 2 N KMnO4.  Oxidn. of XIII in 4 mols. of 2 N NaOH with KMnO4 gives 1,2-dimethyl-3,6-endo(dihydroxyethylene)hexahydrophthalic anhydride [3,6-endo(dihydroxyethylene)desoxycantharidin] (XVI), m. 303°; Me2CO contg. concd. H2SO4 gives the dimethylmethylene ether, C15H20O5, m. 214-15°.  HNO3 (d. 1.5) converts XIII into a dinitrate, m. 157-8°; 20 g. XIII, heated with 40 cc. HNO3 (d. 1.4) and 40 cc. H2O for 15 min. at 100°, gives 3,6-endo.ovrddot.oxalyldesoxycantharidic acid (4,5-diketo-3,6-endoethylene-1,2-dimethylhexahydrophthalic acid) C12H14O6; from H2O it seps. in a colorless form (XVII), turns yellow at 260°, m. 315-20° (slow heating), 338-40° (decompn.) in a bath heated to 330°; yellow di-Me ester, m. 173-4°; Ac2O gives the yellow anhydride, with the same m. p. as the acids; on standing in air it spontaneously absorbs H2O and forms XVII.  The crude oxidn. product of XIII with dil. HNO3, evapd. with HNO3 (d. 1.5), gives 1,2-dimethylcyclohexane-cis-1,2,3,6-tetracarboxylic dianhydride (XVIII), m. 245-6°; boiling H2O slowly dissolves XVIII and careful evapn. gives the acid.  XVIII and CH2N2 in ether contg. some H2O, on standing 2-3 days, give the cis-tetra-Me ester, m. 108-9°; in Me2CO contg. H2O, CH2N2, acting 3 days, gives the di-Me ester, m. 156°, which with CH2N2 in ether gives the tetra-Me ester.  Neutralization of XVIII with 2 N MeONa (to phenolphthalein), addn. of HCl to Congo-red reaction and reaction with CH2N2 gives the tetra-Me ester, whereas evapn. of the soln. to dryness and treatment of the residue with Me2SO4-NaOH under strictly defined conditions gives tetra-Me 1,2-dimethylcyclohexane-1,2-cis-3,6-trans-tetracarboxylate (XIX), m. 111-12°.  XIX boiled with 5-6 parts of 2.6 N MeOH-KOH for 20-5 min. gives the trans-1,2-di-Me ester (XX), with 1 mol. H2O (lost at 120°), m. 208°; this also results by the acid hydrolysis (20.2% HCl) of XIX or of the cis-tetra-Me ester.  The Ag salt of XX and Br in CCl4 give acidic products (XXI) (extd. from ether by Na2CO3) and Me epihydrobromocantharate, m. 115-16°; boiling with 6-7 parts of 48% HBr for 1.5 h. gives the acid (XXII), with 1 mol. H2O, m. 185-6°; heating the acid over a free flame gives HBr, cantharic acid and cantharidin.  XXI contains 4-bromo-2,3-carbomethoxy-2,3-dimethylcyclohexane-1-carboxylic acid, m. 119°, and the ester lactone C11H13O5(OMe), m. 184-5°; hydrolysis of the lactone with 48% HBr gives the lactonedicarboxylic acid (XXIII), m. 296-7°, with a noticeable change in structure at 205-20°; Ac2O gives the anhydride (XXIV), m. 296-7°.  The configuration of cantharidin is discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpy7hYVkjr6wLVg90H21EOLACvtfcHk0lg9tawLr9irsw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaH3sXjtlKisQ%253D%253D&md5=e48588ac81b8488c9bbe36e21f223322</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1002%2Fjlac.19425510102&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjlac.19425510102%26sid%3Dliteratum%253Aachs%26aulast%3DZiegler%26aufirst%3DK.%26aulast%3DSchenck%26aufirst%3DG.%26aulast%3DKrockow%26aufirst%3DE.%2BW.%26aulast%3DSiebert%26aufirst%3DA.%26aulast%3DWenz%26aufirst%3DA.%26aulast%3DWeber%26aufirst%3DH.%26atitle%3DDie%2520Synthese%2520des%2520Cantharidins%26jtitle%3DJustus%2520Liebigs%2520Ann.%2520Chem.%26date%3D1942%26volume%3D551%26spage%3D1%26epage%3D79%26doi%3D10.1002%2Fjlac.19425510102" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cai, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robinson, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ke, H.</span></span> <span> </span><span class="NLM_article-title">Kinetic and Structural Studies of Phosphodiesterase-8A and Implication on the Inhibitor Selectivity</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>47</i></span>,  <span class="NLM_fpage">12760</span>– <span class="NLM_lpage">12768</span>, <span class="refDoi"> DOI: 10.1021/bi801487x</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi801487x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtlaktb3P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2008&pages=12760-12768&author=H.+Wangauthor=Z.+Yanauthor=S.+Yangauthor=J.+Caiauthor=H.+Robinsonauthor=H.+Ke&title=Kinetic+and+Structural+Studies+of+Phosphodiesterase-8A+and+Implication+on+the+Inhibitor+Selectivity&doi=10.1021%2Fbi801487x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Kinetic and Structural Studies of Phosphodiesterase-8A and Implication on the Inhibitor Selectivity</span></div><div class="casAuthors">Wang, Huanchen; Yan, Zier; Yang, Serena; Cai, Jiwen; Robinson, Howard; Ke, Hengming</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">48</span>),
    <span class="NLM_cas:pages">12760-12768</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Cyclic nucleotide phosphodiesterase-8 (PDE8) is a family of cAMP-specific enzymes and plays important roles in many biol. processes, including T-cell activation, testosterone prodn., adrenocortical hyperplasia, and thyroid function.  However, no PDE8 selective inhibitors are available for trial treatment of human diseases.  Here we report kinetic properties of the highly active PDE8A1 catalytic domain prepd. from refolding and its crystal structures in the unliganded and 3-isobutyl-1-methylxanthine (IBMX) bound forms at 1.9 and 2.1 Å resolns., resp.  The PDE8A1 catalytic domain has a Km of 1.8 μM, Vmax of 6.1 μmol/min/mg, a kcat of 4.0 s-1 for cAMP, and a Km of 1.6 mM, Vmax of 2.5 μmol/min/mg, a kcat of 1.6 s-1 for cGMP, thus indicating that the substrate specificity of PDE8 is dominated by Km.  The structure of the PDE8A1 catalytic domain has similar topol. as those of other PDE families but contains two extra helixes around Asn685-Thr710.  Since this fragment is distant from the active site of the enzyme, its impact on the catalysis is unclear.  The PDE8A1 catalytic domain is insensitive to the IBMX inhibition (IC50 = 700 μM).  The unfavorable interaction of IBMX in the PDE8A1-IBMX structure suggests an important role of Tyr748 in the inhibitor binding.  Indeed, the mutation of Tyr748 to phenylalanine increases the PDE8A1 sensitivity to several nonselective or family selective PDE inhibitors.  Thus, the structural and mutagenesis studies provide not only insight into the enzymic properties but also guidelines for design of PDE8 selective inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpqkXukMGQCC7Vg90H21EOLACvtfcHk0lg9tawLr9irsw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtlaktb3P&md5=6cb6b603ec147d1bd4ec7a7f7c493d59</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1021%2Fbi801487x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi801487x%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DH.%26aulast%3DYan%26aufirst%3DZ.%26aulast%3DYang%26aufirst%3DS.%26aulast%3DCai%26aufirst%3DJ.%26aulast%3DRobinson%26aufirst%3DH.%26aulast%3DKe%26aufirst%3DH.%26atitle%3DKinetic%2520and%2520Structural%2520Studies%2520of%2520Phosphodiesterase-8A%2520and%2520Implication%2520on%2520the%2520Inhibitor%2520Selectivity%26jtitle%3DBiochemistry%26date%3D2008%26volume%3D47%26spage%3D12760%26epage%3D12768%26doi%3D10.1021%2Fbi801487x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Di, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kerns, E. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McConnell, O. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carter, G. T.</span></span> <span> </span><span class="NLM_article-title">High Throughput Artificial Membrane Permeability Assay for Blood-Brain Barrier</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">223</span>– <span class="NLM_lpage">232</span>, <span class="refDoi"> DOI: 10.1016/s0223-5234(03)00012-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=10.1016%2FS0223-5234%2803%2900012-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=12667689" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=1%3ACAS%3A528%3ADC%252BD3sXitlKju7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2003&pages=223-232&author=L.+Diauthor=E.+H.+Kernsauthor=K.+Fanauthor=O.+J.+McConnellauthor=G.+T.+Carter&title=High+Throughput+Artificial+Membrane+Permeability+Assay+for+Blood-Brain+Barrier&doi=10.1016%2Fs0223-5234%2803%2900012-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">High throughput artificial membrane permeability assay for blood-brain barrier</span></div><div class="casAuthors">Di, Li; Kerns, Edward H.; Fan, Kristi; McConnell, Oliver J.; Carter, Guy T.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">223-232</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Editions Scientifiques et Medicales Elsevier</span>)
        </div><div class="casAbstract">The recent advances in high throughput screening for biol. activities and combinatorial chem. have greatly expanded the no. of drug candidates.  Rapid screening for BBB penetration potential early in drug discovery programs provides important information for compd. selection and guidance of synthesis for desirable CNS properties.  In this paper, we discuss a modification of the parallel artificial membrane permeation assay (PAMPA) for the prediction of blood-brain barrier penetration (PAMPA-BBB).  The assay was developed with 30 structurally diverse com. drugs and validated with 14 Wyeth Research compds.  The PAMPA-BBB assay has the advantages of: predicting passive blood-brain barrier penetration with high success, high throughput, low cost, and reproducibility.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZCg9Ka4mziLVg90H21EOLACvtfcHk0lg9tawLr9irsw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXitlKju7c%253D&md5=d228d5808ba8df23deed92c5e2bf3863</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1016%2FS0223-5234%2803%2900012-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0223-5234%252803%252900012-6%26sid%3Dliteratum%253Aachs%26aulast%3DDi%26aufirst%3DL.%26aulast%3DKerns%26aufirst%3DE.%2BH.%26aulast%3DFan%26aufirst%3DK.%26aulast%3DMcConnell%26aufirst%3DO.%2BJ.%26aulast%3DCarter%26aufirst%3DG.%2BT.%26atitle%3DHigh%2520Throughput%2520Artificial%2520Membrane%2520Permeability%2520Assay%2520for%2520Blood-Brain%2520Barrier%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2003%26volume%3D38%26spage%3D223%26epage%3D232%26doi%3D10.1016%2Fs0223-5234%2803%2900012-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Farooq, M. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Min, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goshgarian, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gorelick, P. B.</span></span> <span> </span><span class="NLM_article-title">Pharmacotherapy for Vascular Cognitive Impairment</span>. <i>CNS Drugs</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>31</i></span>,  <span class="NLM_fpage">759</span>– <span class="NLM_lpage">776</span>, <span class="refDoi"> DOI: 10.1007/s40263-017-0459-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=10.1007%2Fs40263-017-0459-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=28786085" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtlaku7vM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2017&pages=759-776&author=M.+U.+Farooqauthor=J.+Minauthor=C.+Goshgarianauthor=P.+B.+Gorelick&title=Pharmacotherapy+for+Vascular+Cognitive+Impairment&doi=10.1007%2Fs40263-017-0459-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacotherapy for Vascular Cognitive Impairment</span></div><div class="casAuthors">Farooq, Muhammad U.; Min, Jiangyong; Goshgarian, Christopher; Gorelick, Philip B.</div><div class="citationInfo"><span class="NLM_cas:title">CNS Drugs</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">759-776</span>CODEN:
                <span class="NLM_cas:coden">CNDREF</span>;
        ISSN:<span class="NLM_cas:issn">1172-7047</span>.
    
            (<span class="NLM_cas:orgname">Springer International Publishing AG</span>)
        </div><div class="casAbstract">A review.  Vascular cognitive impairment (VCI) is the second most common type of dementia after Alzheimer's disease (AD).  Stroke and cardiovascular risk factors have been linked to both AD and VCI and potentially can affect cognitive function in mid and later life.  Various pharmacol. agents, including donepezil, galantamine, and memantine, approved for the treatment of AD have shown modest cognitive benefits in patients with vascular dementia (VaD).  However, their functional and global benefits have been inconsistent.  Donepezil has shown some cognitive benefit in patients with VaD only, and galantamine has shown some benefit in mixed dementia (AD/VaD).  The benefits of other drugs such as rivastigmine, memantine, nimodipine, and piracetam are not clear.  Some other supplements and herbal therapies, such as citicoline, actovegin, huperzine A, and vinpocetine, have also been studied in patients with VaD, but their beneficial effects are not well established.  Non-drug therapies and lifestyle modifications such as diet, exercise, and vascular risk factor control are important in the management of VCI and should not be ignored.  However, there is a need for more robust clin. trials focusing on executive function and other cognitive measures and incorporation of newer imaging modalities to provide addnl. evidence about the utility of these strategies in patients with VCI.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoOL6PkMSfYd7Vg90H21EOLACvtfcHk0ljk-IydZPo2Tw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtlaku7vM&md5=50bb4f3b295af1b7a0d16d81b8c0f5e4</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1007%2Fs40263-017-0459-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs40263-017-0459-3%26sid%3Dliteratum%253Aachs%26aulast%3DFarooq%26aufirst%3DM.%2BU.%26aulast%3DMin%26aufirst%3DJ.%26aulast%3DGoshgarian%26aufirst%3DC.%26aulast%3DGorelick%26aufirst%3DP.%2BB.%26atitle%3DPharmacotherapy%2520for%2520Vascular%2520Cognitive%2520Impairment%26jtitle%3DCNS%2520Drugs%26date%3D2017%26volume%3D31%26spage%3D759%26epage%3D776%26doi%3D10.1007%2Fs40263-017-0459-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bhatia, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, N.</span></span> <span> </span><span class="NLM_article-title">Tadalafil Ameliorates Memory Deficits, Oxidative Stress, Endothelial Dysfunction and Neuropathological Changes in Rat Model of Hyperhomocysteinemia Induced Vascular Dementia</span>. <i>Int. J. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">13</span>, <span class="refDoi"> DOI: 10.1080/00207454.2020.1817009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=10.1080%2F00207454.2020.1817009" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2020&pages=1-13&author=P.+Bhatiaauthor=N.+Singh&title=Tadalafil+Ameliorates+Memory+Deficits%2C+Oxidative+Stress%2C+Endothelial+Dysfunction+and+Neuropathological+Changes+in+Rat+Model+of+Hyperhomocysteinemia+Induced+Vascular+Dementia&doi=10.1080%2F00207454.2020.1817009"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1080%2F00207454.2020.1817009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F00207454.2020.1817009%26sid%3Dliteratum%253Aachs%26aulast%3DBhatia%26aufirst%3DP.%26aulast%3DSingh%26aufirst%3DN.%26atitle%3DTadalafil%2520Ameliorates%2520Memory%2520Deficits%252C%2520Oxidative%2520Stress%252C%2520Endothelial%2520Dysfunction%2520and%2520Neuropathological%2520Changes%2520in%2520Rat%2520Model%2520of%2520Hyperhomocysteinemia%2520Induced%2520Vascular%2520Dementia%26jtitle%3DInt.%2520J.%2520Neurosci.%26date%3D2020%26spage%3D1%26epage%3D13%26doi%3D10.1080%2F00207454.2020.1817009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jian, W.-X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhan, J.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chu, S.-F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, N.-H.</span></span> <span> </span><span class="NLM_article-title">Donepezil Attenuates Vascular Dementia in Rats through Increasing BDNF Induced by Reducing HDAC6 Nuclear Translocation</span>. <i>Acta Pharmacol. Sin.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>41</i></span>,  <span class="NLM_fpage">588</span>– <span class="NLM_lpage">598</span>, <span class="refDoi"> DOI: 10.1038/s41401-019-0334-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=10.1038%2Fs41401-019-0334-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=31913348" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=1%3ACAS%3A528%3ADC%252BB3cXlslejtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2020&pages=588-598&author=W.-X.+Jianauthor=Z.+Zhangauthor=J.-H.+Zhanauthor=S.-F.+Chuauthor=Y.+Pengauthor=M.+Zhaoauthor=Q.+Wangauthor=N.-H.+Chen&title=Donepezil+Attenuates+Vascular+Dementia+in+Rats+through+Increasing+BDNF+Induced+by+Reducing+HDAC6+Nuclear+Translocation&doi=10.1038%2Fs41401-019-0334-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Donepezil attenuates vascular dementia in rats through increasing BDNF induced by reducing HDAC6 nuclear translocation</span></div><div class="casAuthors">Jian, Wen-xuan; Zhang, Zhao; Zhan, Jia-hong; Chu, Shi-feng; Peng, Ye; Zhao, Ming; Wang, Qi; Chen, Nai-hong</div><div class="citationInfo"><span class="NLM_cas:title">Acta Pharmacologica Sinica</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">588-598</span>CODEN:
                <span class="NLM_cas:coden">APSCG5</span>;
        ISSN:<span class="NLM_cas:issn">1671-4083</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Vascular dementia (VD) is the second most common dementia disease after Alzheimer's diseases (AD) in the world.  Donepezil is used to treat mild to moderate AD, and it has been shown to treat cognitive impairment and memory deficits caused by VD.  However, the action mechanism of donepezil against VD has not been clarified.  In this study, a bilateral common carotid artery occlusion (BCCAO) model was established in rats to simulate the pathol. of VD.  Two weeks after the surgery, the rats were administered donepezil (10 mg.kg-1.d-1, ig) for 3 wk, and then subjected to behavioral tests.  We showed that donepezil treatment significantly improved the performance of BCCAO rats in Morris Water Mazes test and Step-down test.  Furthermore, we showed that donepezil treatment significantly attenuated neurodegeneration and restored the synapse dendritic spines d. in cortex and hippocampus.  We revealed that donepezil treatment significantly increased BDNF expression in cortex and hippocampus.  Interestingly, donepezil treatment significantly decreased nuclear translocation of HDAC6 and the binding between HDAC6 and BDNF promoter IV in cortex, but not in the hippocampus.  The attenuated neurodegeneration by donepezil in cortex and hippocampus might due to the reduced ROS levels and increased phosphorylation of AMPK, whereas increased phosphorylation of AKT was only detected in cortex.  In conclusion, our results demonstrate that donepezil attenuates neurodegeneration in cortex and hippocampus via increasing BDNF expression; the regulation of donepezil on HDAC6 occurred in cortex, but not in the hippocampus.  This study further clarifies the pharmacol. mechanism of donepezil, while also emphasizes the promising epigenetic regulation of HDAC6.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrTRc2zIX7VObVg90H21EOLACvtfcHk0ljk-IydZPo2Tw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXlslejtw%253D%253D&md5=c7a27dad86c11efa1f1866770c4c03a3</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1038%2Fs41401-019-0334-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41401-019-0334-5%26sid%3Dliteratum%253Aachs%26aulast%3DJian%26aufirst%3DW.-X.%26aulast%3DZhang%26aufirst%3DZ.%26aulast%3DZhan%26aufirst%3DJ.-H.%26aulast%3DChu%26aufirst%3DS.-F.%26aulast%3DPeng%26aufirst%3DY.%26aulast%3DZhao%26aufirst%3DM.%26aulast%3DWang%26aufirst%3DQ.%26aulast%3DChen%26aufirst%3DN.-H.%26atitle%3DDonepezil%2520Attenuates%2520Vascular%2520Dementia%2520in%2520Rats%2520through%2520Increasing%2520BDNF%2520Induced%2520by%2520Reducing%2520HDAC6%2520Nuclear%2520Translocation%26jtitle%3DActa%2520Pharmacol.%2520Sin.%26date%3D2020%26volume%3D41%26spage%3D588%26epage%3D598%26doi%3D10.1038%2Fs41401-019-0334-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sun, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ge, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qin, Y.</span></span> <span> </span><span class="NLM_article-title"><span class="smallcaps smallerCapital">dl</span>-3-<i>n</i>-Butylphthalide Regulates Cholinergic Dysfunction in Chronic Cerebral Hypoperfusion Rats</span>. <i>J. Int. Med. Res.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>48</i></span>,  <span class="NLM_fpage">0300060520936177</span>, <span class="refDoi"> DOI: 10.1177/0300060520936177</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=10.1177%2F0300060520936177" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=32644834" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2020&pages=0300060520936177&author=Y.+Sunauthor=Z.+Zhaoauthor=Q.+Liauthor=C.+Wangauthor=X.+Geauthor=X.+Wangauthor=G.+Wangauthor=Y.+Qin&title=dl-3-n-Butylphthalide+Regulates+Cholinergic+Dysfunction+in+Chronic+Cerebral+Hypoperfusion+Rats&doi=10.1177%2F0300060520936177"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1177%2F0300060520936177&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F0300060520936177%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DY.%26aulast%3DZhao%26aufirst%3DZ.%26aulast%3DLi%26aufirst%3DQ.%26aulast%3DWang%26aufirst%3DC.%26aulast%3DGe%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DG.%26aulast%3DQin%26aufirst%3DY.%26atitle%3Ddl-3-n-Butylphthalide%2520Regulates%2520Cholinergic%2520Dysfunction%2520in%2520Chronic%2520Cerebral%2520Hypoperfusion%2520Rats%26jtitle%3DJ.%2520Int.%2520Med.%2520Res.%26date%3D2020%26volume%3D48%26spage%3D0300060520936177%26doi%3D10.1177%2F0300060520936177" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jain, A. N.</span></span> <span> </span><span class="NLM_article-title">Surflex: Fully Automatic Flexible Molecular Docking Using a Molecular Similarity-Based Search Engine</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">499</span>– <span class="NLM_lpage">511</span>, <span class="refDoi"> DOI: 10.1021/jm020406h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm020406h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=1%3ACAS%3A528%3ADC%252BD3sXkvFKjsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=499-511&author=A.+N.+Jain&title=Surflex%3A+Fully+Automatic+Flexible+Molecular+Docking+Using+a+Molecular+Similarity-Based+Search+Engine&doi=10.1021%2Fjm020406h"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Surflex: fully automatic flexible molecular docking using a molecular similarity-based search engine</span></div><div class="casAuthors">Jain, Ajay N.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">499-511</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Surflex is a fully automatic flexible mol. docking algorithm that combines the scoring function from the Hammerhead docking system with a search engine that relies on a surface-based mol. similarity method as a means to rapidly generate suitable putative poses for mol. fragments.  Results are presented evaluating reliability and accuracy of dockings compared with crystallog. exptl. results on 81 protein/ligand pairs of substantial structural diversity.  In over 80% of the complexes, Surflex's highest scoring docked pose was within 2.5 Å root-mean-square deviation (rmsd), with over 90% of the complexes having one of the top ranked poses within 2.5 Å rmsd.  Results are also presented assessing Surflex's utility as a screening tool on two protein targets (thymidine kinase and estrogen receptor) using data sets on which competing methods were run.  Performance of Surflex was significantly better, with true pos. rates of greater than 80% at false pos. rates of less than 1%.  Docking time was roughly linear in no. of rotatable bonds, beginning with a few seconds for rigid mols. and adding approx. 10 s per rotatable bond.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrawn5WHbx5p7Vg90H21EOLACvtfcHk0lhbHNe83fc2vw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXkvFKjsA%253D%253D&md5=67a08aafeadf69101d56b2f60a922359</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1021%2Fjm020406h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm020406h%26sid%3Dliteratum%253Aachs%26aulast%3DJain%26aufirst%3DA.%2BN.%26atitle%3DSurflex%253A%2520Fully%2520Automatic%2520Flexible%2520Molecular%2520Docking%2520Using%2520a%2520Molecular%2520Similarity-Based%2520Search%2520Engine%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26spage%3D499%26epage%3D511%26doi%3D10.1021%2Fjm020406h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yan, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cai, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ke, H.</span></span> <span> </span><span class="NLM_article-title">Refolding and Kinetic Characterization of the Phosphodiesterase-8A Catalytic Domain</span>. <i>Protein Expression Purif.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>64</i></span>,  <span class="NLM_fpage">82</span>– <span class="NLM_lpage">88</span>, <span class="refDoi"> DOI: 10.1016/j.pep.2008.10.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=10.1016%2Fj.pep.2008.10.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=18984055" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsFansrvN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2009&pages=82-88&author=Z.+Yanauthor=H.+Wangauthor=J.+Caiauthor=H.+Ke&title=Refolding+and+Kinetic+Characterization+of+the+Phosphodiesterase-8A+Catalytic+Domain&doi=10.1016%2Fj.pep.2008.10.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Refolding and kinetic characterization of the phosphodiesterase-8A catalytic domain</span></div><div class="casAuthors">Yan, Zier; Wang, Huanchen; Cai, Jiwen; Ke, Hengming</div><div class="citationInfo"><span class="NLM_cas:title">Protein Expression & Purification</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">64</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">82-88</span>CODEN:
                <span class="NLM_cas:coden">PEXPEJ</span>;
        ISSN:<span class="NLM_cas:issn">1046-5928</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Cyclic nucleotide phosphodiesterase-8 (PDE8) hydrolyzes the second messenger cAMP and is involved in many biol. processes such as testosterone prodn.  Although the bacterial and mammalian expression systems have been extensively tried, prodn. of large quantity of sol. and active PDE8 remains to be a major hurdle for pharmacol. and structural studies.  Reported here is a detailed protocol of refolding and purifn. of large quantity of the PDE8A1 catalytic domain (residues 480-820) and kinetic characterization of the refolded protein.  This protocol yielded about 8 mg of the PDE8A catalytic domain from 2 l Escherichia coli culture, which has at least 40-fold higher activity than those reported in literature.  The PDE8A1 catalytic domain has kcat of 4.0 s-1 for Mn2+ and 2.9 s-1 for Mg2+, and the Km values of 1-1.8 μM.  In addn., the PDE8A1 (205-820) fragment that contains both PAS and catalytic domains was expressed in E. coli and refolded.  This PDE8A1 (205-820) fragment has kcat of 1.1 s-1 and Km of 0.28 μM, but aggregated at high concn.  The Km of PDE8A1 (205-820) is 2- to 7-fold higher than the Km values of 40-150 nM for the full-length PDE8s in literature, but about 6-fold lower than that of the catalytic domain.  Thus, the Km difference likely implies an allosteric regulation of the PDE8A activity by its PAS domain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpptbTvyV50hrVg90H21EOLACvtfcHk0lhbHNe83fc2vw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsFansrvN&md5=0e059481f27093b8393de0fe4378cc85</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1016%2Fj.pep.2008.10.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pep.2008.10.005%26sid%3Dliteratum%253Aachs%26aulast%3DYan%26aufirst%3DZ.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DCai%26aufirst%3DJ.%26aulast%3DKe%26aufirst%3DH.%26atitle%3DRefolding%2520and%2520Kinetic%2520Characterization%2520of%2520the%2520Phosphodiesterase-8A%2520Catalytic%2520Domain%26jtitle%3DProtein%2520Expression%2520Purif.%26date%3D2009%26volume%3D64%26spage%3D82%26epage%3D88%26doi%3D10.1016%2Fj.pep.2008.10.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cai, Y.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, Y.-K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shao, Y.-X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, H.-B.</span></span> <span> </span><span class="NLM_article-title">Identification of Novel Phosphodiesterase-4D Inhibitors Prescreened by Molecular Dynamics-Augmented Modeling and Validated by Bioassay</span>. <i>J. Chem. Inf. Model.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">972</span>– <span class="NLM_lpage">981</span>, <span class="refDoi"> DOI: 10.1021/ci400063s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ci400063s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=1%3ACAS%3A528%3ADC%252BC3sXktlersrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2013&pages=972-981&author=Z.+Liauthor=Y.-H.+Caiauthor=Y.-K.+Chengauthor=X.+Luauthor=Y.-X.+Shaoauthor=X.+Liauthor=M.+Liuauthor=P.+Liuauthor=H.-B.+Luo&title=Identification+of+Novel+Phosphodiesterase-4D+Inhibitors+Prescreened+by+Molecular+Dynamics-Augmented+Modeling+and+Validated+by+Bioassay&doi=10.1021%2Fci400063s"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of Novel Phosphodiesterase-4D Inhibitors Prescreened by Molecular Dynamics-Augmented Modeling and Validated by Bioassay</span></div><div class="casAuthors">Li, Zhe; Cai, Ying-Hong; Cheng, Yuen-Kit; Lu, Xiao; Shao, Yong-Xian; Li, Xingshu; Liu, Ming; Liu, Peiqing; Luo, Hai-Bin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">972-981</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Phosphodiesterase-4D (PDE4D) has been proved to be a potential therapeutic target against strokes.  In the present study, a procedure of integrating pharmacophore, mol. docking, mol. dynamics (MD) simulations, binding free energy calcns., and finally validation with bioassay was developed and described to search for novel PDE4D inhibitors from the SPECS database.  Among the 29 compds. selected by our MD-augmented strategy, 15 hits were found with IC50 between 1.9 and 50 μM (a hit rate of 52%) and 6 potent hits showed IC50 less than 10 μM, which suggested that MD simulations can explore the intermol. interactions of PDE4D-inhibitor complexes more precisely and thus significantly enhanced the hit rate of this screening.  The effective and efficient integrated procedures described in this study could be readily applied to screening studies toward other drug targets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoV8kRufl7wP7Vg90H21EOLACvtfcHk0lhbHNe83fc2vw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXktlersrs%253D&md5=f35d422becdcfaafa25eb5fbd9631f72</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1021%2Fci400063s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci400063s%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DCai%26aufirst%3DY.-H.%26aulast%3DCheng%26aufirst%3DY.-K.%26aulast%3DLu%26aufirst%3DX.%26aulast%3DShao%26aufirst%3DY.-X.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DLiu%26aufirst%3DM.%26aulast%3DLiu%26aufirst%3DP.%26aulast%3DLuo%26aufirst%3DH.-B.%26atitle%3DIdentification%2520of%2520Novel%2520Phosphodiesterase-4D%2520Inhibitors%2520Prescreened%2520by%2520Molecular%2520Dynamics-Augmented%2520Modeling%2520and%2520Validated%2520by%2520Bioassay%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2013%26volume%3D53%26spage%3D972%26epage%3D981%26doi%3D10.1021%2Fci400063s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Y.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geng, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, H.-B.</span></span> <span> </span><span class="NLM_article-title">Optimization of Chromeno[2,3-c]pyrrol-9(2<i>H</i>)-ones as Highly Potent, Selective, and Orally Bioavailable PDE5 Inhibitors: Structure–Activity Relationship, X-ray Crystal Structure, and Pharmacodynamic Effect on Pulmonary Arterial Hypertension</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">8468</span>– <span class="NLM_lpage">8473</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b01209</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b01209" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhsFyqtLfO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=8468-8473&author=D.+Wuauthor=Y.+Huangauthor=Y.+Chenauthor=Y.-Y.+Huangauthor=H.+Gengauthor=T.+Zhangauthor=C.+Zhangauthor=Z.+Liauthor=L.+Guoauthor=J.+Chenauthor=H.-B.+Luo&title=Optimization+of+Chromeno%5B2%2C3-c%5Dpyrrol-9%282H%29-ones+as+Highly+Potent%2C+Selective%2C+and+Orally+Bioavailable+PDE5+Inhibitors%3A+Structure%E2%80%93Activity+Relationship%2C+X-ray+Crystal+Structure%2C+and+Pharmacodynamic+Effect+on+Pulmonary+Arterial+Hypertension&doi=10.1021%2Facs.jmedchem.8b01209"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Optimization of Chromeno[2,3-c]pyrrol-9(2H)-ones as Highly Potent, Selective, and Orally Bioavailable PDE5 Inhibitors: Structure-Activity Relationship, X-ray Crystal Structure, and Pharmacodynamic Effect on Pulmonary Arterial Hypertension</span></div><div class="casAuthors">Wu, Deyan; Huang, Yadan; Chen, Yiping; Huang, Yi-You; Geng, Haiju; Zhang, Tianhua; Zhang, Chen; Li, Zhe; Guo, Lei; Chen, Jianwen; Luo, Hai-Bin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">8468-8473</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">To further explore the structure-activity relationship around the chromeno[2,3-c]pyrrol-9(2H)-one scaffold, 19 derivs. as inhibitors against PDE5 were discovered.  The most potent inhibitor 3 has an IC50 of 0.32 nM with remarkable selectivity and druglike profile.  Oral administration of 3 (1.25 mg/kg) caused comparable therapeutic effects to sildenafil (10.0 mg/kg) against pulmonary arterial hypertension.  Further, different binding patterns from sildenafil were revealed in cocrystal structures, which provide structural templates for discovery of highly potent PDE5 inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrpoBU299FP4bVg90H21EOLACvtfcHk0liy1baO3lk5GQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhsFyqtLfO&md5=68091f0dd4d25dc79ac8ffb2f02832d9</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b01209&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b01209%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DD.%26aulast%3DHuang%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DHuang%26aufirst%3DY.-Y.%26aulast%3DGeng%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DT.%26aulast%3DZhang%26aufirst%3DC.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DGuo%26aufirst%3DL.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DLuo%26aufirst%3DH.-B.%26atitle%3DOptimization%2520of%2520Chromeno%255B2%252C3-c%255Dpyrrol-9%25282H%2529-ones%2520as%2520Highly%2520Potent%252C%2520Selective%252C%2520and%2520Orally%2520Bioavailable%2520PDE5%2520Inhibitors%253A%2520Structure%25E2%2580%2593Activity%2520Relationship%252C%2520X-ray%2520Crystal%2520Structure%252C%2520and%2520Pharmacodynamic%2520Effect%2520on%2520Pulmonary%2520Arterial%2520Hypertension%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D8468%26epage%3D8473%26doi%3D10.1021%2Facs.jmedchem.8b01209" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robinson, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ke, H.</span></span> <span> </span><span class="NLM_article-title">Multiple Elements Jointly Determine Inhibitor Selectivity of Cyclic Nucleotide Phosphodiesterases 4 and 7</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>280</i></span>,  <span class="NLM_fpage">30949</span>– <span class="NLM_lpage">30955</span>, <span class="refDoi"> DOI: 10.1074/jbc.m504398200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=10.1074%2Fjbc.M504398200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=15994308" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=1%3ACAS%3A528%3ADC%252BD2MXpsVCmt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=280&publication_year=2005&pages=30949-30955&author=H.+Wangauthor=Y.+Liuauthor=Y.+Chenauthor=H.+Robinsonauthor=H.+Ke&title=Multiple+Elements+Jointly+Determine+Inhibitor+Selectivity+of+Cyclic+Nucleotide+Phosphodiesterases+4+and+7&doi=10.1074%2Fjbc.m504398200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Multiple Elements Jointly Determine Inhibitor Selectivity of Cyclic Nucleotide Phosphodiesterases 4 and 7</span></div><div class="casAuthors">Wang, Huanchen; Liu, Yudong; Chen, Yuxiang; Robinson, Howard; Ke, Hengming</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">280</span>
        (<span class="NLM_cas:issue">35</span>),
    <span class="NLM_cas:pages">30949-30955</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Phosphodiesterase (PDE) inhibitors have been widely studied as therapeutics for treatment of human diseases.  However, the mechanism by which each PDE family recognizes selectively a category of inhibitors remains a puzzle.  Here we report the crystal structure of PDE7A1 catalytic domain in complex with non-selective inhibitor 3-isobutyl-1-methylxanthine and kinetic anal. on the mutants of PDE7A1 and PDE4D2.  Our studies suggest at least three elements play crit. roles in inhibitor selectivity: 1) the conformation and position of an invariant glutamine, 2) the natures of scaffolding residues, and 3) residues that alter shape and size of the binding pocket.  Kinetic anal. shows that single PDE7 to PDE4 mutations increase the sensitivity of PDE7 to PDE4 inhibitors but are not sufficient to render the engineered enzymes comparable with the wild types.  The triple S373Y/S377T/I412S mutation of PDE7A1 produces a PDE4-like enzyme, implying that multiple elements must work together to det. inhibitor selectivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp3hRnOJlxTlrVg90H21EOLACvtfcHk0liy1baO3lk5GQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXpsVCmt7k%253D&md5=306c19c96f9841d1f5b55d63729b9870</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M504398200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M504398200%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DH.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DRobinson%26aufirst%3DH.%26aulast%3DKe%26aufirst%3DH.%26atitle%3DMultiple%2520Elements%2520Jointly%2520Determine%2520Inhibitor%2520Selectivity%2520of%2520Cyclic%2520Nucleotide%2520Phosphodiesterases%25204%2520and%25207%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2005%26volume%3D280%26spage%3D30949%26epage%3D30955%26doi%3D10.1074%2Fjbc.m504398200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Park, S.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahmad, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Philp, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baar, K.</span></span> <span> </span><span class="NLM_article-title">Resveratrol Ameliorates Aging-Related Metabolic Phenotypes by Inhibiting cAMP Phosphodiesterases</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>148</i></span>,  <span class="NLM_fpage">421</span>– <span class="NLM_lpage">433</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2012.01.017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=10.1016%2Fj.cell.2012.01.017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=22304913" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvFakurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=148&publication_year=2012&pages=421-433&author=S.-J.+Parkauthor=F.+Ahmadauthor=A.+Philpauthor=K.+Baar&title=Resveratrol+Ameliorates+Aging-Related+Metabolic+Phenotypes+by+Inhibiting+cAMP+Phosphodiesterases&doi=10.1016%2Fj.cell.2012.01.017"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Resveratrol Ameliorates Aging-Related Metabolic Phenotypes by Inhibiting cAMP Phosphodiesterases</span></div><div class="casAuthors">Park, Sung-Jun; Ahmad, Faiyaz; Philp, Andrew; Baar, Keith; Williams, Tishan; Luo, Haibin; Ke, Hengming; Rehmann, Holger; Taussig, Ronald; Brown, Alexandra L.; Kim, Myung K.; Beaven, Michael A.; Burgin, Alex B.; Manganiello, Vincent; Chung, Jay H.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">148</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">421-433</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Resveratrol, a polyphenol in red wine, has been reported as a calorie restriction mimetic with potential antiaging and antidiabetogenic properties.  It is widely consumed as a nutritional supplement, but its mechanism of action remains a mystery.  Here, we report that the metabolic effects of resveratrol result from competitive inhibition of cAMP-degrading phosphodiesterases, leading to elevated cAMP levels.  The resulting activation of Epac1, a cAMP effector protein, increases intracellular Ca2+ levels and activates the CamKKβ-AMPK pathway via phospholipase C and the ryanodine receptor Ca2+-release channel.  As a consequence, resveratrol increases NAD+ and the activity of Sirt1.  Inhibiting PDE4 with rolipram reproduces all of the metabolic benefits of resveratrol, including prevention of diet-induced obesity and an increase in mitochondrial function, phys. stamina, and glucose tolerance in mice.  Therefore, administration of PDE4 inhibitors may also protect against and ameliorate the symptoms of metabolic diseases assocd. with aging.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo8zHottwfaS7Vg90H21EOLACvtfcHk0liy1baO3lk5GQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvFakurc%253D&md5=6e8e92e1140c0c63c0fc92314e0f0c5c</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2012.01.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2012.01.017%26sid%3Dliteratum%253Aachs%26aulast%3DPark%26aufirst%3DS.-J.%26aulast%3DAhmad%26aufirst%3DF.%26aulast%3DPhilp%26aufirst%3DA.%26aulast%3DBaar%26aufirst%3DK.%26atitle%3DResveratrol%2520Ameliorates%2520Aging-Related%2520Metabolic%2520Phenotypes%2520by%2520Inhibiting%2520cAMP%2520Phosphodiesterases%26jtitle%3DCell%26date%3D2012%26volume%3D148%26spage%3D421%26epage%3D433%26doi%3D10.1016%2Fj.cell.2012.01.017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geng, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lai, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, H.-B.</span></span> <span> </span><span class="NLM_article-title">Discovery and Optimization of Chromeno[2,3-c]pyrrol-9(2H)-ones as Novel Selective and Orally Bioavailable Phosphodiesterase 5 Inhibitors for the Treatment of Pulmonary Arterial Hypertension</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">6622</span>– <span class="NLM_lpage">6637</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00523</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00523" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtFCju7bL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=6622-6637&author=D.+Wuauthor=T.+Zhangauthor=Y.+Chenauthor=Y.+Huangauthor=H.+Gengauthor=Y.+Yuauthor=C.+Zhangauthor=Z.+Laiauthor=Y.+Wuauthor=X.+Guoauthor=J.+Chenauthor=H.-B.+Luo&title=Discovery+and+Optimization+of+Chromeno%5B2%2C3-c%5Dpyrrol-9%282H%29-ones+as+Novel+Selective+and+Orally+Bioavailable+Phosphodiesterase+5+Inhibitors+for+the+Treatment+of+Pulmonary+Arterial+Hypertension&doi=10.1021%2Facs.jmedchem.7b00523"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and Optimization of Chromeno[2,3-c]pyrrol-9(2H)-ones as Novel Selective and Orally Bioavailable Phosphodiesterase 5 Inhibitors for the Treatment of Pulmonary Arterial Hypertension</span></div><div class="casAuthors">Wu, Deyan; Zhang, Tianhua; Chen, Yiping; Huang, Yadan; Geng, Haiju; Yu, Yanfa; Zhang, Chen; Lai, Zengwei; Wu, Yinuo; Guo, Xiaolei; Chen, Jianwen; Luo, Hai-Bin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">6622-6637</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Phosphodiesterase 5 (PDE5) inhibitors have been used as clin. agents to treat erectile dysfunction and pulmonary arterial hypertension (PAH).  Herein, the authors detail the discovery of a novel series of chromeno[2,3-c]pyrrol-9(2H)-one derivs. as selective and orally bioavailable inhibitors against phosphodiesterase 5.  Medicinal chem. optimization resulted in compd. 2 (3-(benzo[d][1,3]dioxol-5-ylmethyl)-1-(thiazol-2-yl)chromeno[2,3-c]pyrrol-9(2H)-one), which exhibits a desirable inhibitory potency of 5.6 nM with remarkable selectivity as well as excellent pharmacokinetic properties and an oral bioavailability of 63.4%.  In addn., oral administration of 2 at a dose of 5.0 mg/kg caused better pharmacodynamics effects on both mPAP (mean pulmonary artery pressure) and RVHI (index of right ventricle hypertrophy) than sildenafil citrate at a dose of 10.0 mg/kg.  These activities along with its reasonable druglike properties, such as human liver microsomal stability, cytochrome inhibition, hERG inhibition, and pharmacol. safety, indicate that 2 is a potential candidate for the treatment of PAH.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrWWPn7AuEJbbVg90H21EOLACvtfcHk0lgZeMg85e2R8w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtFCju7bL&md5=b12716eb2b3e9ee0616300e4a788acfd</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00523&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00523%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DD.%26aulast%3DZhang%26aufirst%3DT.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DHuang%26aufirst%3DY.%26aulast%3DGeng%26aufirst%3DH.%26aulast%3DYu%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DC.%26aulast%3DLai%26aufirst%3DZ.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DGuo%26aufirst%3DX.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DLuo%26aufirst%3DH.-B.%26atitle%3DDiscovery%2520and%2520Optimization%2520of%2520Chromeno%255B2%252C3-c%255Dpyrrol-9%25282H%2529-ones%2520as%2520Novel%2520Selective%2520and%2520Orally%2520Bioavailable%2520Phosphodiesterase%25205%2520Inhibitors%2520for%2520the%2520Treatment%2520of%2520Pulmonary%2520Arterial%2520Hypertension%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D6622%26epage%3D6637%26doi%3D10.1021%2Facs.jmedchem.7b00523" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Y.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, Y.-F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, H.-B.</span></span> <span> </span><span class="NLM_article-title">Validation of Phosphodiesterase-10 as a Novel Target for Pulmonary Arterial Hypertension via Highly Selective and Subnanomolar Inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">3707</span>– <span class="NLM_lpage">3721</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.9b00224</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.9b00224" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=1%3ACAS%3A528%3ADC%252BC1MXlt1yks7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2019&pages=3707-3721&author=Y.-Y.+Huangauthor=Y.-F.+Yuauthor=C.+Zhangauthor=Y.+Chenauthor=Q.+Zhouauthor=Z.+Liauthor=S.+Zhouauthor=Z.+Liauthor=L.+Guoauthor=D.+Wuauthor=Y.+Wuauthor=H.-B.+Luo&title=Validation+of+Phosphodiesterase-10+as+a+Novel+Target+for+Pulmonary+Arterial+Hypertension+via+Highly+Selective+and+Subnanomolar+Inhibitors&doi=10.1021%2Facs.jmedchem.9b00224"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Validation of Phosphodiesterase-10 as a Novel Target for Pulmonary Arterial Hypertension via Highly Selective and Subnanomolar Inhibitors</span></div><div class="casAuthors">Huang, Yi-You; Yu, Yan-Fa; Zhang, Chen; Chen, Yiping; Zhou, Qian; Li, Zhuoming; Zhou, Sihang; Li, Zhe; Guo, Lei; Wu, Deyan; Wu, Yinuo; Luo, Hai-Bin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">3707-3721</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Pulmonary arterial hypertension (PAH) causes pathol. increase in pulmonary vascular resistance, leading to right-heart failure and eventual death.  Previously, phosphodiesterase-10 (PDE10) was reported to be a promising target for PAH based on the studies with a nonselective PDE inhibitor papaverine, but little progress has been made to confirm the practical application of PDE10 inhibitors.  To validate whether PAH is ameliorated by PDE10 inhibition rather than other PDE isoforms, here we report an integrated strategy to discover highly selective PDE10 inhibitors as chem. probes.  Structural optimization resulted in a PDE10 inhibitor 2b with subnanomolar affinity and good selectivity of >45 000-fold against other PDEs.  The cocrystal structure of the PDE10-2b complex revealed an important H-bond interaction between 2b and Tyr693.  Finally, compd. 2b significantly decreased the arterial pressure in PAH rats and thus validated the potential of PDE10 as a novel anti-PAH target.  These findings suggest that PDE10 inhibition may be a viable treatment option for PAH.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqBy0isM1x_z7Vg90H21EOLACvtfcHk0lgZeMg85e2R8w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXlt1yks7Y%253D&md5=eb543109abd51256d9216dc4ad3ed6fa</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.9b00224&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.9b00224%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DY.-Y.%26aulast%3DYu%26aufirst%3DY.-F.%26aulast%3DZhang%26aufirst%3DC.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DZhou%26aufirst%3DQ.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DZhou%26aufirst%3DS.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DGuo%26aufirst%3DL.%26aulast%3DWu%26aufirst%3DD.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DLuo%26aufirst%3DH.-B.%26atitle%3DValidation%2520of%2520Phosphodiesterase-10%2520as%2520a%2520Novel%2520Target%2520for%2520Pulmonary%2520Arterial%2520Hypertension%2520via%2520Highly%2520Selective%2520and%2520Subnanomolar%2520Inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2019%26volume%3D62%26spage%3D3707%26epage%3D3721%26doi%3D10.1021%2Facs.jmedchem.9b00224" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Y.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, H.-B.</span></span> <span> </span><span class="NLM_article-title">Discovery of Highly Selective and Orally Available Benzimidazole-Based Phosphodiesterase 10 Inhibitors with Improved Solubility and Pharmacokinetic Properties for Treatment of Pulmonary Arterial Hypertension</span>. <i>Acta Pharm. Sin. B</i> <span class="NLM_year" style="font-weight: bold;">2020</span>, <span class="refDoi"> DOI: 10.1016/j.apsb.2020.04.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=10.1016%2Fj.apsb.2020.04.003" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2020&author=Y.+Yangauthor=S.+Zhangauthor=Q.+Zhouauthor=C.+Zhangauthor=Y.+Gaoauthor=H.+Wangauthor=Z.+Liauthor=D.+Wuauthor=Y.+Wuauthor=Y.-Y.+Huangauthor=L.+Guoauthor=H.-B.+Luo&title=Discovery+of+Highly+Selective+and+Orally+Available+Benzimidazole-Based+Phosphodiesterase+10+Inhibitors+with+Improved+Solubility+and+Pharmacokinetic+Properties+for+Treatment+of+Pulmonary+Arterial+Hypertension&doi=10.1016%2Fj.apsb.2020.04.003"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1016%2Fj.apsb.2020.04.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.apsb.2020.04.003%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DS.%26aulast%3DZhou%26aufirst%3DQ.%26aulast%3DZhang%26aufirst%3DC.%26aulast%3DGao%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DWu%26aufirst%3DD.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DHuang%26aufirst%3DY.-Y.%26aulast%3DGuo%26aufirst%3DL.%26aulast%3DLuo%26aufirst%3DH.-B.%26atitle%3DDiscovery%2520of%2520Highly%2520Selective%2520and%2520Orally%2520Available%2520Benzimidazole-Based%2520Phosphodiesterase%252010%2520Inhibitors%2520with%2520Improved%2520Solubility%2520and%2520Pharmacokinetic%2520Properties%2520for%2520Treatment%2520of%2520Pulmonary%2520Arterial%2520Hypertension%26jtitle%3DActa%2520Pharm.%2520Sin.%2520B%26date%3D2020%26doi%3D10.1016%2Fj.apsb.2020.04.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, Y.-F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geng, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tian, Y.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J.-W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, H.-B.</span></span> <span> </span><span class="NLM_article-title">Discovery of Potent, Selective, and Orally Bioavailable Inhibitors against Phosphodiesterase-9, a Novel Target for the Treatment of Vascular Dementia</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">4218</span>– <span class="NLM_lpage">4224</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b01041</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b01041" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=1%3ACAS%3A528%3ADC%252BC1MXmtVCjtr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2019&pages=4218-4224&author=Y.+Wuauthor=Q.+Zhouauthor=T.+Zhangauthor=Z.+Liauthor=Y.-P.+Chenauthor=P.+Zhangauthor=Y.-F.+Yuauthor=H.+Gengauthor=Y.-J.+Tianauthor=C.+Zhangauthor=Y.+Wangauthor=J.-W.+Chenauthor=Y.+Chenauthor=H.-B.+Luo&title=Discovery+of+Potent%2C+Selective%2C+and+Orally+Bioavailable+Inhibitors+against+Phosphodiesterase-9%2C+a+Novel+Target+for+the+Treatment+of+Vascular+Dementia&doi=10.1021%2Facs.jmedchem.8b01041"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Potent, Selective, and Orally Bioavailable Inhibitors against Phosphodiesterase-9, a Novel Target for the Treatment of Vascular Dementia</span></div><div class="casAuthors">Wu, Yinuo; Zhou, Qian; Zhang, Tianhua; Li, Zhe; Chen, Yi-Ping; Zhang, Pei; Yu, Yan-Fa; Geng, Haiju; Tian, Yi-Jing; Zhang, Chen; Wang, Yu; Chen, Jian-Wen; Chen, Yan; Luo, Hai-Bin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">4218-4224</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">To identify phosphodiesterase-9 (PDE9) as a novel target for the treatment of vascular dementia (VaD), a series of pyrazolopyrimidinone analogs were discovered based on a hit 1.  Hit-to-lead optimization resulted in a potent inhibitor 2 with excellent selectivity and physicochem. properties to enable in vivo studies.  Oral administration of 2 (5.0 mg/kg) caused notable therapeutic effects in the VaD mouse model, providing a promising lead or chem. probe for investigating the biol. functions of PDE9 inhibition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrh0_gKOVCmpLVg90H21EOLACvtfcHk0lgZeMg85e2R8w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXmtVCjtr0%253D&md5=383a19c865240aa6b6e2ec97308da917</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b01041&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b01041%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DY.%26aulast%3DZhou%26aufirst%3DQ.%26aulast%3DZhang%26aufirst%3DT.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DChen%26aufirst%3DY.-P.%26aulast%3DZhang%26aufirst%3DP.%26aulast%3DYu%26aufirst%3DY.-F.%26aulast%3DGeng%26aufirst%3DH.%26aulast%3DTian%26aufirst%3DY.-J.%26aulast%3DZhang%26aufirst%3DC.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DJ.-W.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DLuo%26aufirst%3DH.-B.%26atitle%3DDiscovery%2520of%2520Potent%252C%2520Selective%252C%2520and%2520Orally%2520Bioavailable%2520Inhibitors%2520against%2520Phosphodiesterase-9%252C%2520a%2520Novel%2520Target%2520for%2520the%2520Treatment%2520of%2520Vascular%2520Dementia%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2019%26volume%3D62%26spage%3D4218%26epage%3D4224%26doi%3D10.1021%2Facs.jmedchem.8b01041" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, H.-B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span> <span> </span><span class="NLM_article-title">Design, Synthesis, and Evaluation of Multitarget-Directed Resveratrol Derivatives for the Treatment of Alzheimer’s Disease</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">5843</span>– <span class="NLM_lpage">5859</span>, <span class="refDoi"> DOI: 10.1021/jm400567s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm400567s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtVWhtrrK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=5843-5859&author=C.+Luauthor=Y.+Guoauthor=J.+Yanauthor=Z.+Luoauthor=H.-B.+Luoauthor=M.+Yanauthor=L.+Huangauthor=X.+Li&title=Design%2C+Synthesis%2C+and+Evaluation+of+Multitarget-Directed+Resveratrol+Derivatives+for+the+Treatment+of+Alzheimer%E2%80%99s+Disease&doi=10.1021%2Fjm400567s"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Design, Synthesis, and Evaluation of Multitarget-Directed Resveratrol Derivatives for the Treatment of Alzheimer's Disease</span></div><div class="casAuthors">Lu, Chuanjun; Guo, Yueyan; Yan, Jun; Luo, Zonghua; Luo, Hai-Bin; Yan, Ming; Huang, Ling; Li, Xingshu</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">5843-5859</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A series of multitarget-directed resveratrol derivs. was designed and synthesized for the treatment of Alzheimer's disease (AD).  In vitro studies indicated that most of the target compds. exhibit significant inhibition of self-induced β-amyloid (Aβ) aggregation and Cu(II)-induced Aβ1-42 aggregation and acted as potential antioxidants and biometal chelators.  In particular, compds. I (R = Me) (II) and I (R = H) (III) are potential lead compds. for AD therapy (II, IC50 = 7.56 μM and III, IC50 = 6.51 μM for self-induced Aβ aggregation; the oxygen radical absorbance capacity assay using fluorescein (ORAC-FL) values are 4.72 and 4.70, resp.).  Moreover, these compds. are capable of disassembling the highly structured Aβ fibrils generated by self- and Cu(II)-induced Aβ aggregation.  Furthermore, II crossed the blood-brain barrier (BBB) in vitro and did not exhibit any acute toxicity in mice at doses of up to 2000 mg/kg.  Taken together, the data indicate that II is a very promising lead compd. for AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpxibZnQJ-ZTLVg90H21EOLACvtfcHk0lhvKjD3dn5mFg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtVWhtrrK&md5=58824e2df9bdc9fc4216ac9cbeafc87c</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1021%2Fjm400567s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400567s%26sid%3Dliteratum%253Aachs%26aulast%3DLu%26aufirst%3DC.%26aulast%3DGuo%26aufirst%3DY.%26aulast%3DYan%26aufirst%3DJ.%26aulast%3DLuo%26aufirst%3DZ.%26aulast%3DLuo%26aufirst%3DH.-B.%26aulast%3DYan%26aufirst%3DM.%26aulast%3DHuang%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DX.%26atitle%3DDesign%252C%2520Synthesis%252C%2520and%2520Evaluation%2520of%2520Multitarget-Directed%2520Resveratrol%2520Derivatives%2520for%2520the%2520Treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520Disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D5843%26epage%3D5859%26doi%3D10.1021%2Fjm400567s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=7CWA" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=7CWA','PDB','7CWA'); return false;">PDB: 7CWA</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=7CWF" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=7CWF','PDB','7CWF'); return false;">PDB: 7CWF</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=7CWG" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=7CWG','PDB','7CWG'); return false;">PDB: 7CWG</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3ECN" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3ECN','PDB','3ECN'); return false;">PDB: 3ECN</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i71"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c01573">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_11807"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.jmedchem.0c01573?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c01573</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Molecular formula strings and some data (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c01573/suppl_file/jm0c01573_si_001.csv">CSV</a>)</p></li><li><p class="inline">In vivo pharmacokinetics analysis; druglike profile of compound <b>3a</b>; PAMPA–BBB procedures; general procedures for crystallization trials; <sup>1</sup>H NMR, <sup>13</sup>C NMR, and high-resolution mass spectra data for targeted compounds; and purity of the tested compounds (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c01573/suppl_file/jm0c01573_si_002.pdf">PDF</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c01573/suppl_file/jm0c01573_si_001.csv">jm0c01573_si_001.csv (1.31 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c01573/suppl_file/jm0c01573_si_002.pdf">jm0c01573_si_002.pdf (3.33 MB)</a></li></ul></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">The atomic coordinates and structure factors have been deposited into the RCSB Protein Data Bank with accession numbers <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=7CWA">7CWA</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=7CWF">7CWF</a>, and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=7CWG">7CWG</a>. Authors will release the atomic coordinates and experimental data upon article publication.</p><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.0c01573&amp;pbContext=%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2020.63.issue-24%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.0c01573%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.0c01573" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                6MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"6799fd9dac4b3d60","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
